,email,name,typeEntity,orcidid,typeRole,note,url,gridid,rorid,biotoolsID,accessibility,owner,publication
0,janice.reichert@antibodysociety.org,Janice M Reichert,Person,,,,,,,covid-19-antibody-therapeutics-tracker,,Kigaard,"[{'doi': '10.1093/ABT/TBAA020', 'metadata': {'abstract': '© 2020 Oxford University Press. All rights reserved.Facing the COVID-19 global healthcare crisis, scientists worldwide are collaborating to develop prophylactic and therapeutic interventions against the disease. Antibody therapeutics hold enormous promise for the treatment of COVID-19. In March 2020, the Chinese Antibody Society, in collaboration with The Antibody Society, initiated the “COVID-19 Antibody Therapeutics Tracker” (“Tracker”) (https://chineseantibody.org/covid-19-track/) program to track the antibody-based COVID-19 interventions in preclinical and clinical development globally. The data are collected from the public domain and verified by volunteers on an ongoing basis. Here, we present exploratory data analyses and visualization to demonstrate the latest trends of COVID-19 antibody development, based on data for over 150 research and development programs and molecules included in the “Tracker” as of 8 August 2020. We categorized the data mainly by their targets, formats, development status, developers and country of origin. Although details are limited in some cases, all of the anti-SARS-CoV-2 antibody candidates appear to target the viral spike protein (S protein), and most are full-length monoclonal antibodies. Most of the current COVID-19 antibody therapeutic candidates in clinical trials are repurposed drugs aimed at targets other than virus-specific proteins, while most of these virus-specific therapeutic antibodies are in discovery or preclinical studies. As of 8 August 2020, eight antibody candidates targeting the SARS-CoV-2 S protein have entered clinical studies, including LY-CoV555, REGN-COV2, JS016, TY027, CT-P59, BRII-196, BRII-198 and SCTA01. Ongoing clinical trials of SARS-CoV-2 neutralizing antibodies will help define the utility of these antibodies as a new class of therapeutics for treating COVID-19 and future coronavirus infections.', 'authors': [{'name': 'Yang L.'}, {'name': 'Liu W.'}, {'name': 'Yu X.'}, {'name': 'Wu M.'}, {'name': 'Reichert J.M.'}, {'name': 'Ho M.'}], 'citationCount': 31, 'date': '2020-01-01T00:00:00Z', 'journal': 'Antibody Therapeutics', 'title': 'COVID-19 antibody therapeutics tracker: A global online database of antibody therapeutics for the prevention and treatment of COVID-19'}, 'pmcid': 'PMC7454247'}]"
1,homi@mail.nih.gov,Mitchell Ho,Person,https://orcid.org/0000-0002-9152-5405,,,,,,covid-19-antibody-therapeutics-tracker,,Kigaard,"[{'doi': '10.1093/ABT/TBAA020', 'metadata': {'abstract': '© 2020 Oxford University Press. All rights reserved.Facing the COVID-19 global healthcare crisis, scientists worldwide are collaborating to develop prophylactic and therapeutic interventions against the disease. Antibody therapeutics hold enormous promise for the treatment of COVID-19. In March 2020, the Chinese Antibody Society, in collaboration with The Antibody Society, initiated the “COVID-19 Antibody Therapeutics Tracker” (“Tracker”) (https://chineseantibody.org/covid-19-track/) program to track the antibody-based COVID-19 interventions in preclinical and clinical development globally. The data are collected from the public domain and verified by volunteers on an ongoing basis. Here, we present exploratory data analyses and visualization to demonstrate the latest trends of COVID-19 antibody development, based on data for over 150 research and development programs and molecules included in the “Tracker” as of 8 August 2020. We categorized the data mainly by their targets, formats, development status, developers and country of origin. Although details are limited in some cases, all of the anti-SARS-CoV-2 antibody candidates appear to target the viral spike protein (S protein), and most are full-length monoclonal antibodies. Most of the current COVID-19 antibody therapeutic candidates in clinical trials are repurposed drugs aimed at targets other than virus-specific proteins, while most of these virus-specific therapeutic antibodies are in discovery or preclinical studies. As of 8 August 2020, eight antibody candidates targeting the SARS-CoV-2 S protein have entered clinical studies, including LY-CoV555, REGN-COV2, JS016, TY027, CT-P59, BRII-196, BRII-198 and SCTA01. Ongoing clinical trials of SARS-CoV-2 neutralizing antibodies will help define the utility of these antibodies as a new class of therapeutics for treating COVID-19 and future coronavirus infections.', 'authors': [{'name': 'Yang L.'}, {'name': 'Liu W.'}, {'name': 'Yu X.'}, {'name': 'Wu M.'}, {'name': 'Reichert J.M.'}, {'name': 'Ho M.'}], 'citationCount': 31, 'date': '2020-01-01T00:00:00Z', 'journal': 'Antibody Therapeutics', 'title': 'COVID-19 antibody therapeutics tracker: A global online database of antibody therapeutics for the prevention and treatment of COVID-19'}, 'pmcid': 'PMC7454247'}]"
2,alpha.tom.kodamullil@scai.fraunhofer.de,Alpha Tom Kodamullil,Person,https://orcid.org/0000-0001-9896-3531,,,,,,covid-19-knowledge-graph,,Kigaard,"[{'doi': '10.1101/2020.04.14.040667'}, {'doi': '10.1093/bioinformatics/btaa834', 'metadata': {'abstract': '© 2020 The Author(s) 2020. Published by Oxford University Press.The COVID-19 crisis has elicited a global response by the scientific community that has led to a burst of publications on the pathophysiology of the virus. However, without coordinated efforts to organize this knowledge, it can remain hidden away from individual research groups. By extracting and formalizing this knowledge in a structured and computable form, as in the form of a knowledge graph, researchers can readily reason and analyze this information on a much larger scale. Here, we present the COVID-19 Knowledge Graph, an expansive cause-and-effect network constructed from scientific literature on the new coronavirus that aims to provide a comprehensive view of its pathophysiology. To make this resource available to the research community and facilitate its exploration and analysis, we also implemented a web application and released the KG in multiple standard formats.', 'authors': [{'name': 'Domingo-Fernandez D.'}, {'name': 'Baksi S.'}, {'name': 'Schultz B.'}, {'name': 'Gadiya Y.'}, {'name': 'Karki R.'}, {'name': 'Raschka T.'}, {'name': 'Ebeling C.'}, {'name': 'Hofmann-Apitius M.'}, {'name': 'Kodamullil A.T.'}], 'citationCount': 7, 'date': '2021-05-01T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'COVID-19 Knowledge Graph: A computable, multi-modal, cause-and-effect knowledge model of COVID-19 pathophysiology'}, 'type': ['Primary']}]"
3,zhiyong.lu@nih.gov,Zhiyong Lu,Person,,['Primary contact'],,,,,covid-19-ct-cxr,Open access,Kigaard,"[{'doi': '10.1109/TBDATA.2020.3035935', 'metadata': {'abstract': '© 2015 IEEE.The latest threat to global health is the COVID-19 outbreak. Although there exist large datasets of chest X-rays (CXR) and computed tomography (CT) scans, few COVID-19 image collections are currently available due to patient privacy. At the same time, there is a rapid growth of COVID-19-relevant articles in the biomedical literature, including those that report findings on radiographs. Here, we present COVID-19-CT-CXR, a public database of COVID-19 CXR and CT images, which are automatically extracted from COVID-19-relevant articles from the PubMed Central Open Access (PMC-OA) Subset. We extracted figures, associated captions, and relevant figure descriptions in the article and separated compound figures into subfigures. Because a large portion of figures in COVID-19 articles are not CXR or CT, we designed a deep-learning model to distinguish them from other figure types and to classify them accordingly. The final database includes 1,327 CT and 263 CXR images (as of May 9, 2020) with their relevant text. To demonstrate the utility of COVID-19-CT-CXR, we conducted four case studies. (1) We show that COVID-19-CT-CXR, when used as additional training data, is able to contribute to improved deep-learning (DL) performance for the classification of COVID-19 and non-COVID-19 CT. (2) We collected CT images of influenza, another common infectious respiratory illness that may present similarly to COVID-19, and fine-tuned a baseline deep neural network to distinguish a diagnosis of COVID-19, influenza, or normal or other types of diseases on CT. (3) We fine-tuned an unsupervised one-class classifier from non-COVID-19 CXR and performed anomaly detection to detect COVID-19 CXR. (4) From text-mined captions and figure descriptions, we compared 15 clinical symptoms and 20 clinical findings of COVID-19 versus those of influenza to demonstrate the disease differences in the scientific publications. Our database is unique, as the figures are retrieved along with relevant text with fine-grained descriptions, and it can be extended easily in the future. We believe that our work is complementary to existing resources and hope that it will contribute to medical image analysis of the COVID-19 pandemic. The dataset, code, and DL models are publicly available at https://github.com/ncbi-nlp/COVID-19-CT-CXR.', 'authors': [{'name': 'Peng Y.'}, {'name': 'Tang Y.'}, {'name': 'Lee S.'}, {'name': 'Zhu Y.'}, {'name': 'Summers R.M.'}, {'name': 'Lu Z.'}], 'citationCount': 1, 'date': '2021-03-01T00:00:00Z', 'journal': 'IEEE Transactions on Big Data', 'title': 'COVID-19-CT-CXR: A freely accessible and weakly labeled chest X-Ray and CT image collection on COVID-19 from biomedical literature'}, 'pmcid': 'PMC8117951', 'pmid': '33997112', 'type': ['Primary']}]"
4,rls@ebi.ac.uk,Rodrigo Lopez,Person,https://orcid.org/0000-0003-1256-7306,['Primary contact'],,,,,covid-19-data-portal,,Kigaard,"[{'doi': '10.1093/NAR/GKAB417', 'metadata': {'abstract': '© 2021 The Author(s). Published by Oxford University Press on behalf of Nucleic Acids Research.The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic will be remembered as one of the defining events of the 21st century. The rapid global outbreak has had significant impacts on human society and is already responsible for millions of deaths. Understanding and tackling the impact of the virus has required a worldwide mobilisation and coordination of scientific research. The COVID-19 Data Portal (https://www.covid19dataportal.org/) was first released as part of the European COVID-19 Data Platform, on April 20th 2020 to facilitate rapid and open data sharing and analysis, to accelerate global SARS-CoV-2 and COVID-19 research. The COVID-19 Data Portal has fortnightly feature releases to continue to add new data types, search options, visualisations and improvements based on user feedback and research. The open datasets and intuitive suite of search, identification and download services, represent a truly FAIR (Findable, Accessible, Interoperable and Reusable) resource that enables researchers to easily identify and quickly obtain the key datasets needed for their COVID-19 research.', 'authors': [{'name': 'Harrison P.W.'}, {'name': 'Lopez R.'}, {'name': 'Rahman N.'}, {'name': 'Allen S.G.'}, {'name': 'Aslam R.'}, {'name': 'Buso N.'}, {'name': 'Cummins C.'}, {'name': 'Fathy Y.'}, {'name': 'Felix E.'}, {'name': 'Glont M.'}, {'name': 'Jayathilaka S.'}, {'name': 'Kadam S.'}, {'name': 'Kumar M.'}, {'name': 'Lauer K.B.'}, {'name': 'Malhotra G.'}, {'name': 'Mosaku A.'}, {'name': 'Edbali O.'}, {'name': 'Park Y.M.'}, {'name': 'Parton A.'}, {'name': 'Pearce M.'}, {'name': 'Estrada Pena J.F.'}, {'name': 'Rossetto J.'}, {'name': 'Russell C.'}, {'name': 'Selvakumar S.'}, {'name': 'Sitja X.P.'}, {'name': 'Sokolov A.'}, {'name': 'Thorne R.'}, {'name': 'Ventouratou M.'}, {'name': 'Walter P.'}, {'name': 'Yordanova G.'}, {'name': 'Zadissa A.'}, {'name': 'Cochrane G.'}, {'name': 'Blomberg N.'}, {'name': 'Apweiler R.'}], 'citationCount': 1, 'date': '2021-07-02T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'The COVID-19 Data Portal: Accelerating SARS-CoV-2 and COVID-19 research through rapid open access data sharing'}, 'pmid': '34048576'}]"
5,cochrane@ebi.ac.uk,Guy Cochrane,Person,https://orcid.org/0000-0001-7954-7057,['Primary contact'],,,,,covid-19-data-portal,,Kigaard,"[{'doi': '10.1093/NAR/GKAB417', 'metadata': {'abstract': '© 2021 The Author(s). Published by Oxford University Press on behalf of Nucleic Acids Research.The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic will be remembered as one of the defining events of the 21st century. The rapid global outbreak has had significant impacts on human society and is already responsible for millions of deaths. Understanding and tackling the impact of the virus has required a worldwide mobilisation and coordination of scientific research. The COVID-19 Data Portal (https://www.covid19dataportal.org/) was first released as part of the European COVID-19 Data Platform, on April 20th 2020 to facilitate rapid and open data sharing and analysis, to accelerate global SARS-CoV-2 and COVID-19 research. The COVID-19 Data Portal has fortnightly feature releases to continue to add new data types, search options, visualisations and improvements based on user feedback and research. The open datasets and intuitive suite of search, identification and download services, represent a truly FAIR (Findable, Accessible, Interoperable and Reusable) resource that enables researchers to easily identify and quickly obtain the key datasets needed for their COVID-19 research.', 'authors': [{'name': 'Harrison P.W.'}, {'name': 'Lopez R.'}, {'name': 'Rahman N.'}, {'name': 'Allen S.G.'}, {'name': 'Aslam R.'}, {'name': 'Buso N.'}, {'name': 'Cummins C.'}, {'name': 'Fathy Y.'}, {'name': 'Felix E.'}, {'name': 'Glont M.'}, {'name': 'Jayathilaka S.'}, {'name': 'Kadam S.'}, {'name': 'Kumar M.'}, {'name': 'Lauer K.B.'}, {'name': 'Malhotra G.'}, {'name': 'Mosaku A.'}, {'name': 'Edbali O.'}, {'name': 'Park Y.M.'}, {'name': 'Parton A.'}, {'name': 'Pearce M.'}, {'name': 'Estrada Pena J.F.'}, {'name': 'Rossetto J.'}, {'name': 'Russell C.'}, {'name': 'Selvakumar S.'}, {'name': 'Sitja X.P.'}, {'name': 'Sokolov A.'}, {'name': 'Thorne R.'}, {'name': 'Ventouratou M.'}, {'name': 'Walter P.'}, {'name': 'Yordanova G.'}, {'name': 'Zadissa A.'}, {'name': 'Cochrane G.'}, {'name': 'Blomberg N.'}, {'name': 'Apweiler R.'}], 'citationCount': 1, 'date': '2021-07-02T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'The COVID-19 Data Portal: Accelerating SARS-CoV-2 and COVID-19 research through rapid open access data sharing'}, 'pmid': '34048576'}]"
6,hua.xu@uth.tmc.edu,Hua Xu,Person,https://orcid.org/0000-0002-5274-4672,,,,,,covid-19-testnorm,,Kigaard,"[{'doi': '10.1093/JAMIA/OCAA145', 'metadata': {'abstract': '© The Author(s) 2020.Large observational data networks that leverage routine clinical practice data in electronic health records (EHRs) are critical resources for research on coronavirus disease 2019 (COVID-19). Data normalization is a key challenge for the secondary use of EHRs for COVID-19 research across institutions. In this study, we addressed the challenge of automating the normalization of COVID-19 diagnostic tests, which are critical data elements, but for which controlled terminology terms were published after clinical implementation. We developed a simple but effective rule-based tool called COVID-19 TestNorm to automatically normalize local COVID-19 testing names to standard LOINC (Logical Observation Identifiers Names and Codes) codes. COVID-19 TestNorm was developed and evaluated using 568 test names collected from 8 healthcare systems. Our results show that it could achieve an accuracy of 97.4% on an independent test set. COVID-19 TestNorm is available as an open-source package for developers and as an online Web application for end users (https://clamp.uth.edu/covid/loinc.php). We believe that it will be a useful tool to support secondary use of EHRs for research on COVID-19.', 'authors': [{'name': 'Dong X.'}, {'name': 'Li J.'}, {'name': 'Soysal E.'}, {'name': 'Bian J.'}, {'name': 'DuVall S.L.'}, {'name': 'Hanchrow E.'}, {'name': 'Liu H.'}, {'name': 'Lynch K.E.'}, {'name': 'Matheny M.'}, {'name': 'Natarajan K.'}, {'name': 'Ohno-Machado L.'}, {'name': 'Pakhomov S.'}, {'name': 'Reeves R.M.'}, {'name': 'Sitapati A.M.'}, {'name': 'Abhyankar S.'}, {'name': 'Cullen T.'}, {'name': 'Deckard J.'}, {'name': 'Jiang X.'}, {'name': 'Murphy R.'}, {'name': 'Xu H.'}], 'citationCount': 5, 'date': '2020-09-01T00:00:00Z', 'journal': 'Journal of the American Medical Informatics Association', 'title': 'COVID-19 testnorm: A tool to normalize COVID-19 testing names to LOINC codes'}, 'pmcid': 'PMC7337837', 'pmid': '32569358'}]"
7,,Masoud Rouhizadeh,Person,,['Primary contact'],,,,,covid-19-signsym,,Kigaard,"[{'doi': '10.1093/JAMIA/OCAB015', 'metadata': {'abstract': '© 2021 The Author(s). Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved.The COVID-19 pandemic swept across the world rapidly, infecting millions of people. An efficient tool that can accurately recognize important clinical concepts of COVID-19 from free text in electronic health records (EHRs) will be valuable to accelerate COVID-19 clinical research. To this end, this study aims at adapting the existing CLAMP natural language processing tool to quickly build COVID-19 SignSym, which can extract COVID-19 signs/symptoms and their 8 attributes (body location, severity, temporal expression, subject, condition, uncertainty, negation, and course) from clinical text. The extracted information is also mapped to standard concepts in the Observational Medical Outcomes Partnership common data model. A hybrid approach of combining deep learning-based models, curated lexicons, and pattern-based rules was applied to quickly build the COVID-19 SignSym from CLAMP, with optimized performance. Our extensive evaluation using 3 external sites with clinical notes of COVID-19 patients, as well as the online medical dialogues of COVID-19, shows COVID-19 SignSym can achieve high performance across data sources. The workflow used for this study can be generalized to other use cases, where existing clinical natural language processing tools need to be customized for specific information needs within a short time. COVID-19 SignSym is freely accessible to the research community as a downloadable package (https://clamp.uth.edu/covid/nlp.php) and has been used by 16 healthcare organizations to support clinical research of COVID-19.', 'authors': [{'name': 'Wang J.'}, {'name': 'Abu-El-Rub N.'}, {'name': 'Gray J.'}, {'name': 'Pham H.A.'}, {'name': 'Zhou Y.'}, {'name': 'Manion F.J.'}, {'name': 'Liu M.'}, {'name': 'Song X.'}, {'name': 'Xu H.'}, {'name': 'Rouhizadeh M.'}, {'name': 'Zhang Y.'}], 'citationCount': 1, 'date': '2021-06-01T00:00:00Z', 'journal': 'Journal of the American Medical Informatics Association', 'title': 'COVID-19 SignSym: A fast adaptation of a general clinical NLP tool to identify and normalize COVID-19 signs and symptoms to OMOP common data model'}, 'pmcid': 'PMC7989301', 'pmid': '33674830', 'type': ['Primary']}]"
8,,Yaoyun Zhang,Person,https://orcid.org/0000-0001-9220-3101,['Primary contact'],,,,,covid-19-signsym,,Kigaard,"[{'doi': '10.1093/JAMIA/OCAB015', 'metadata': {'abstract': '© 2021 The Author(s). Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved.The COVID-19 pandemic swept across the world rapidly, infecting millions of people. An efficient tool that can accurately recognize important clinical concepts of COVID-19 from free text in electronic health records (EHRs) will be valuable to accelerate COVID-19 clinical research. To this end, this study aims at adapting the existing CLAMP natural language processing tool to quickly build COVID-19 SignSym, which can extract COVID-19 signs/symptoms and their 8 attributes (body location, severity, temporal expression, subject, condition, uncertainty, negation, and course) from clinical text. The extracted information is also mapped to standard concepts in the Observational Medical Outcomes Partnership common data model. A hybrid approach of combining deep learning-based models, curated lexicons, and pattern-based rules was applied to quickly build the COVID-19 SignSym from CLAMP, with optimized performance. Our extensive evaluation using 3 external sites with clinical notes of COVID-19 patients, as well as the online medical dialogues of COVID-19, shows COVID-19 SignSym can achieve high performance across data sources. The workflow used for this study can be generalized to other use cases, where existing clinical natural language processing tools need to be customized for specific information needs within a short time. COVID-19 SignSym is freely accessible to the research community as a downloadable package (https://clamp.uth.edu/covid/nlp.php) and has been used by 16 healthcare organizations to support clinical research of COVID-19.', 'authors': [{'name': 'Wang J.'}, {'name': 'Abu-El-Rub N.'}, {'name': 'Gray J.'}, {'name': 'Pham H.A.'}, {'name': 'Zhou Y.'}, {'name': 'Manion F.J.'}, {'name': 'Liu M.'}, {'name': 'Song X.'}, {'name': 'Xu H.'}, {'name': 'Rouhizadeh M.'}, {'name': 'Zhang Y.'}], 'citationCount': 1, 'date': '2021-06-01T00:00:00Z', 'journal': 'Journal of the American Medical Informatics Association', 'title': 'COVID-19 SignSym: A fast adaptation of a general clinical NLP tool to identify and normalize COVID-19 signs and symptoms to OMOP common data model'}, 'pmcid': 'PMC7989301', 'pmid': '33674830', 'type': ['Primary']}]"
9,,Christoph Schönenberger,Person,,"['Primary contact', 'Developer', 'Maintainer', 'Support']",,,,,covid-19_dashboard,Open access,hans,
10,alpha.tom.kodamullil@scai.fraunhofer.de,Martin Hofmann-Apitius,Person,,,,,,,covid-19-ontology,,Kigaard,"[{'doi': '10.1093/BIOINFORMATICS/BTAA1057', 'metadata': {'abstract': '© The Author(s) 2020. Published by Oxford University Press.Motivation: The COVID-19 pandemic has prompted an impressive, worldwide response by the academic community. In order to support text mining approaches as well as data description, linking and harmonization in the context of COVID-19, we have developed an ontology representing major novel coronavirus (SARS-CoV-2) entities. The ontology has a strong scope on chemical entities suited for drug repurposing, as this is a major target of ongoing COVID-19 therapeutic development. Results: The ontology comprises 2270 classes of concepts and 38 987 axioms (2622 logical axioms and 2434 declaration axioms). It depicts the roles of molecular and cellular entities in virus-host interactions and in the virus life cycle, as well as a wide spectrum of medical and epidemiological concepts linked to COVID-19. The performance of the ontology has been tested on Medline and the COVID-19 corpus provided by the Allen Institute. Availabilityand implementation: COVID-19 Ontology is released under a Creative Commons 4.0 License and shared via https://github.com/covid-19-ontology/covid-19. The ontology is also deposited in BioPortal at https://bioportal.bioontology.org/ontologies/COVID-19.', 'authors': [{'name': 'Sargsyan A.'}, {'name': 'Kodamullil A.T.'}, {'name': 'Baksi S.'}, {'name': 'Darms J.'}, {'name': 'Madan S.'}, {'name': 'Gebel S.'}, {'name': 'Keminer O.'}, {'name': 'Jose G.M.'}, {'name': 'Balabin H.'}, {'name': 'DeLong L.N.'}, {'name': 'Kohler M.'}, {'name': 'Jacobs M.'}, {'name': 'Hofmann-Apitius M.'}], 'date': '2020-12-15T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'The COVID-19 ontology'}, 'pmid': '33346828'}]"
11,mazumder@gwu.edu,R Mazumder,Person,,,,,,,covid-19-biomarkers-oncomx,,Kigaard,[{'doi': '10.1101/2020.09.09.196220'}]
12,bdeverma@broadinstitute.org,Shing Hei Zhan,Person,,,,,,,covid-19-cg,,Kigaard,[{'doi': '10.1101/2020.09.23.310565'}]
13,alinac@broadinstitute.org,Yujia Alina Chan,Person,,,,,,,covid-19-cg,,Kigaard,[{'doi': '10.1101/2020.09.23.310565'}]
14,zhan@zoology.ubc.ca,Benjamin E. Deverman,Person,,,,,,,covid-19-cg,,Kigaard,[{'doi': '10.1101/2020.09.23.310565'}]
15,richard.neher@unibas.ch,,Person,,,,,,,covid-19-scenarios,,Kigaard,[{'doi': '10.1101/2020.05.05.20091363'}]
16,joseph.hearnshaw@rothamsted.ac.uk,Joseph Hearnshaw,Person,https://orcid.org/0000-0002-0438-9266,['Primary contact'],Bioinformatics Software Engineer,,,,covid-19_knetminer,Open access,josephhearnshaw,
17,ajit.singh@rothamsted.ac.uk,Ajit Singh,Person,http://orcid.org/0000-0001-6239-9967,,Senior Bioinformatics Software Engineer,,,,covid-19_knetminer,Open access,josephhearnshaw,
18,marco.brandizi@rothamsted.ac.uk,Marco Brandizi,Person,https://orcid.org/0000-0002-5427-2496,,Senior Software Engineer and bioinformatics specialist,,,,covid-19_knetminer,Open access,josephhearnshaw,
19,keywan.hassani-pak@rothamsted.ac.uk,Keywan Hassani-Pak,Person,http://orcid.org/0000-0001-9625-0511,['Contributor'],Head of Bioinformatics at Rothamsted Research,,,,covid-19_knetminer,Open access,josephhearnshaw,
20,erik.cuevas@cucei.udg.mx,Erik Cuevas,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/2841735-erik,,,covid19-transmission-model,Open access (with restrictions),Kigaard,"[{'doi': '10.1016/j.compbiomed.2020.103827', 'metadata': {'abstract': '© 2020 Elsevier LtdThe rapid spread of the coronavirus disease (COVID-19) has become a global threat affecting almost all countries in the world. As countries reach the infection peak, it is planned to return a new normal under different coexistence conditions in order to reduce the economic effects produced by the total or partial closure of companies, universities, shops, etc. Under such circumstances, the use of mathematical models to evaluate the transmission risk of COVID-19 in various facilities represents an important tool in assisting authorities to make informed decisions. On the other hand, agent-based modeling is a relatively new approach to model complex systems composed of agents whose behavior is described using simple rules. Different from classical mathematical models (which consider a homogenous population), agent-based approaches model individuals with distinct characteristics and provide more realistic results. In this paper, an agent-based model to evaluate the COVID-19 transmission risks in facilities is presented. The proposed scheme has been designed to simulate the spatiotemporal transmission process. In the model, simulated agents make decisions depending on the programmed rules. Such rules correspond to spatial patterns and infection conditions under which agents interact to characterize the transmission process. The model also includes an individual profile for each agent, which defines its main social characteristics and health conditions used during its interactions. In general, this profile partially determines the behavior of the agent during its interactions with other individuals. Several hypothetical scenarios have been considered to show the performance of the proposed model. Experimental results have demonstrated that the simulations provide useful information to produce strategies for reducing the transmission risks of COVID-19 within the facilities.', 'authors': [{'name': 'Cuevas E.'}], 'citationCount': 31, 'date': '2020-06-01T00:00:00Z', 'journal': 'Computers in Biology and Medicine', 'title': 'An agent-based model to evaluate the COVID-19 transmission risks in facilities'}, 'type': ['Primary']}]"
21,,Emmanuel Olivar,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/9879987-emmanuel-olivar,,,covid19-infections-eu,Open access (with restrictions),Kigaard,
22,,Deepesh B,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/2396029-deepesh-b,,,covid19spread-model,Open access (with restrictions),zsmag19,
23,,Sohini Sarkar,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/15498921-sohini-sarkar,,,covid19-textanalytics,Open access (with restrictions),Kigaard,
24,,ThomasV,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/6011706-thomasv,,,covid19-infections,Open access (with restrictions),Kigaard,
25,,Pavel Roslovets,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/7326344-pavel-roslovets,,,covid19-propagation-simulator-simulink,Open access (with restrictions),Kigaard,
26,,Akhilesh  Kumar,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/8396591-akhilesh-kumar,,,covid19-forecasting-ml,Open access (with restrictions),Kigaard,
27,,JM2,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/10845200-jm2,,,covid19-world-spread-animation,Open access (with restrictions),Kigaard,
28,justaddcoffee@gmail.com,Justin Reese,Person,,,,,,,kg-covid-19,,Niclaskn,[{'doi': '10.1101/2020.08.17.254839'}]
29,tianxia@hust.edu.cn,,Person,,,,,,,ai-ct-covid-19,,Kigaard,[{'doi': '10.1101/2020.05.10.20096073'}]
30,xbai@hust.edu.cn,,Person,,,,,,,ai-ct-covid-19,,Kigaard,[{'doi': '10.1101/2020.05.10.20096073'}]
31,zhenli@hust.edu.cn,,Person,,,,,,,ai-ct-covid-19,,Kigaard,[{'doi': '10.1101/2020.05.10.20096073'}]
32,hqzcsx@sina.com,,Person,,,,,,,ai-ct-covid-19,,Kigaard,[{'doi': '10.1101/2020.05.10.20096073'}]
33,,Diego Caccavo,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/11327905-diego-caccavo,,,sird-model-covid19,Open access (with restrictions),Kigaard,"[{'doi': '10.1101/2020.03.19.20039388', 'type': ['Other']}]"
34,,Fulden Buyukozturk,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/4222845-fulden-buyukozturk,,,simbiology-covid-19-seir-model,Open access (with restrictions),Kigaard,
35,,Akhilesh  Kumar,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/8396591-akhilesh-kumar,,,analysis-forecast-covid19-patients-worldwide,Open access (with restrictions),Kigaard,
36,,Axel Ahrens,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/5998459-axel-ahrens,,,john-hopkins-covid19-cases-loader,Open access (with restrictions),Kigaard,
37,,MH,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/8663306-mh,,,ecdc-covid19-tracking,Open access (with restrictions),Kigaard,
38,,Lajos Varga,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/3967755-lajos-varga,,,reading-visualizing-covid19-data,Open access (with restrictions),Kigaard,
39,,steed huang,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/6205312-steed-huang,,,round-variance-sars-cov-2-gene-sequence-covid19,Open access (with restrictions),Kigaard,
40,,Akhilesh  Kumar,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/8396591-akhilesh-kumar,,,india-covid19-patients-forecastive-model-standalone-app,Open access (with restrictions),Kigaard,
41,,Ben T.  Nohara,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/14029343-ben-t-nohara,,,future-trends-covid19-infections-ny-city-tokyo,Open access (with restrictions),Kigaard,
42,irfanzafar892@gmail.com,Muhammad Irfan,Person,,['Primary contact'],,,,,who-covid-19-dashboard,,Kigaard,"[{'doi': '10.21203/RS.3.RS-394938/V1', 'type': ['Primary']}]"
43,ayates@ebi.ac.uk,Andrew D. Yates,Person,,,,,,,ensembl-covid19,,zsmag19,[{'doi': '10.1101/2020.12.18.422865'}]
44,felix.schuermann@epfl.ch,Felix Schürmann,Person,,,,,,,arc-covid19,Open access (with restrictions),Kigaard,"[{'doi': '10.3389/FPUBH.2021.607677', 'metadata': {'abstract': '© Copyright © 2021 Courcol, Invernizzi, Landry, Minisini, Baumgartner, Bonhoeffer, Chabriw, Clerc, Daniels, Getta, Girod, Kazala, Markram, Pasqualini, Martínez-Pérez, Peaudecerf, Peaudecerf, Pfreundt, Roller, Słomka, Vasse, Wheeler, Metzger, Stocker and Schürmann.In 2020 the world was hit by the COVID-19 pandemic putting entire governments and civil societies in crisis mode. Around the globe unprecedented shortages of equipment and qualified personnel were reported in hospitals and diagnostic laboratories. When a crisis is global, supply chains are strained worldwide and external help may not be readily available. In Switzerland, as part of the efforts of the Swiss National COVID-19 Science Task Force, we developed a tailor-made web-based tool where needs and offers for critical laboratory equipment and expertise can be brought together, coordinated, prioritized, and validated. This Academic Resources for COVID-19 (ARC) Platform presents the specialized needs of diagnostic laboratories to academic research groups at universities, allowing the sourcing of said needs from unconventional supply channels, while keeping the entities tasked with coordination of the crisis response in control of each part of the process. An instance of the ARC Platform is operated in Switzerland (arc.epfl.ch) catering to the diagnostic efforts in Switzerland and sourcing from the Swiss academic sector. The underlying technology has been released as open source so that others can adopt the customizable web-platform for need/supply match-making in their own relief efforts, during the COVID-19 pandemic or any future disaster.', 'authors': [{'name': 'Courcol J.-D.'}, {'name': 'Invernizzi C.F.'}, {'name': 'Landry Z.C.'}, {'name': 'Minisini M.'}, {'name': 'Baumgartner D.A.'}, {'name': 'Bonhoeffer S.'}, {'name': 'Chabriw B.'}, {'name': 'Clerc E.E.'}, {'name': 'Daniels M.'}, {'name': 'Getta P.'}, {'name': 'Girod M.'}, {'name': 'Kazala K.'}, {'name': 'Markram H.'}, {'name': 'Pasqualini A.'}, {'name': 'Martinez-Perez C.'}, {'name': 'Peaudecerf F.J.'}, {'name': 'Peaudecerf M.S.'}, {'name': 'Pfreundt U.'}, {'name': 'Roller B.R.K.'}, {'name': 'Slomka J.'}, {'name': 'Vasse M.'}, {'name': 'Wheeler J.D.'}, {'name': 'Metzger C.M.J.A.'}, {'name': 'Stocker R.'}, {'name': 'Schurmann F.'}], 'date': '2021-02-16T00:00:00Z', 'journal': 'Frontiers in Public Health', 'title': 'ARC: An Open Web-Platform for Request/Supply Matching for a Prioritized and Controlled COVID-19 Response'}, 'pmcid': 'PMC7921781', 'pmid': '33665184', 'type': ['Primary']}]"
45,techsupport_arc@epfl.ch,Academic Resources Platform for COVID-19,Project,,['Support'],,,,,arc-covid19,Open access (with restrictions),Kigaard,"[{'doi': '10.3389/FPUBH.2021.607677', 'metadata': {'abstract': '© Copyright © 2021 Courcol, Invernizzi, Landry, Minisini, Baumgartner, Bonhoeffer, Chabriw, Clerc, Daniels, Getta, Girod, Kazala, Markram, Pasqualini, Martínez-Pérez, Peaudecerf, Peaudecerf, Pfreundt, Roller, Słomka, Vasse, Wheeler, Metzger, Stocker and Schürmann.In 2020 the world was hit by the COVID-19 pandemic putting entire governments and civil societies in crisis mode. Around the globe unprecedented shortages of equipment and qualified personnel were reported in hospitals and diagnostic laboratories. When a crisis is global, supply chains are strained worldwide and external help may not be readily available. In Switzerland, as part of the efforts of the Swiss National COVID-19 Science Task Force, we developed a tailor-made web-based tool where needs and offers for critical laboratory equipment and expertise can be brought together, coordinated, prioritized, and validated. This Academic Resources for COVID-19 (ARC) Platform presents the specialized needs of diagnostic laboratories to academic research groups at universities, allowing the sourcing of said needs from unconventional supply channels, while keeping the entities tasked with coordination of the crisis response in control of each part of the process. An instance of the ARC Platform is operated in Switzerland (arc.epfl.ch) catering to the diagnostic efforts in Switzerland and sourcing from the Swiss academic sector. The underlying technology has been released as open source so that others can adopt the customizable web-platform for need/supply match-making in their own relief efforts, during the COVID-19 pandemic or any future disaster.', 'authors': [{'name': 'Courcol J.-D.'}, {'name': 'Invernizzi C.F.'}, {'name': 'Landry Z.C.'}, {'name': 'Minisini M.'}, {'name': 'Baumgartner D.A.'}, {'name': 'Bonhoeffer S.'}, {'name': 'Chabriw B.'}, {'name': 'Clerc E.E.'}, {'name': 'Daniels M.'}, {'name': 'Getta P.'}, {'name': 'Girod M.'}, {'name': 'Kazala K.'}, {'name': 'Markram H.'}, {'name': 'Pasqualini A.'}, {'name': 'Martinez-Perez C.'}, {'name': 'Peaudecerf F.J.'}, {'name': 'Peaudecerf M.S.'}, {'name': 'Pfreundt U.'}, {'name': 'Roller B.R.K.'}, {'name': 'Slomka J.'}, {'name': 'Vasse M.'}, {'name': 'Wheeler J.D.'}, {'name': 'Metzger C.M.J.A.'}, {'name': 'Stocker R.'}, {'name': 'Schurmann F.'}], 'date': '2021-02-16T00:00:00Z', 'journal': 'Frontiers in Public Health', 'title': 'ARC: An Open Web-Platform for Request/Supply Matching for a Prioritized and Controlled COVID-19 Response'}, 'pmcid': 'PMC7921781', 'pmid': '33665184', 'type': ['Primary']}]"
46,,Kevin Chng,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/12813571-kevin-chng,,,track-global-spread-covid19,Open access (with restrictions),Kigaard,
47,,Andrea Augello,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/13386448-andrea-augello,,,covid-19-data-analysis,Open access (with restrictions),Kigaard,
48,wellington.santos@ufpe.br,,Person,,,,,,,covid-sgis,,Kigaard,[{'doi': '10.1101/2020.05.30.20117945'}]
49,robert.hinch@gmail.com,,Person,,,,,,,openabm-covid19,,Niclaskn,[{'doi': '10.1101/2020.09.16.20195925'}]
50,william.probert@bdi.ox.ac.uk,,Person,,,,,,,openabm-covid19,,Niclaskn,[{'doi': '10.1101/2020.09.16.20195925'}]
51,christophe.fraser@bdi.ox.ac.uk,,Person,,,,,,,openabm-covid19,,Niclaskn,[{'doi': '10.1101/2020.09.16.20195925'}]
52,chu@mathematica-mpr.com,Cindy Hu,Person,https://orcid.org/0000-0002-4299-3931,['Primary contact'],,,,,19andme,,Kigaard,"[{'doi': '10.21203/RS.3.RS-456971/V1', 'type': ['Primary']}]"
53,communications@mathematica-mpr.com,Mathematica,Institute,,['Support'],,https://github.com/mathematica-mpr,,,19andme,,Kigaard,"[{'doi': '10.21203/RS.3.RS-456971/V1', 'type': ['Primary']}]"
54,alex.ter-sarkisov@city.ac.uk,,Person,,,,,,,covid-ct-mask-net,,Kigaard,"[{'doi': '10.1101/2020.10.11.20211052'}, {'doi': '10.1101/2020.10.23.20218461'}, {'doi': '10.31763/sitech.v1i2.202', 'type': ['Primary']}]"
55,arnab.pain@kaust.edu.sa,Arnab Pain,Person,https://orcid.org/0000-0002-1755-2819,['Primary contact'],,,,,assaym,,Kigaard,[{'doi': '10.1101/2020.12.18.423467'}]
56,,Raeece Naeem,Person,https://orcid.org/0000-0003-1734-1007,,,,,,assaym,,Kigaard,[{'doi': '10.1101/2020.12.18.423467'}]
57,amritamicrobio@gmail.com,Amrita Nandan,Person,,['Primary contact'],,,,,covam,,Kigaard,"[{'doi': '10.21203/RS.3.RS-522417/V1', 'type': ['Primary']}]"
58,vishmicro@gmail.com,Vishwas Sharma,Person,,['Primary contact'],,,,,covam,,Kigaard,"[{'doi': '10.21203/RS.3.RS-522417/V1', 'type': ['Primary']}]"
59,d.vanklaveren@erasmusmc.nl,David van Klaveren,Person,,['Primary contact'],,,,,cope,,Kigaard,[{'doi': '10.1101/2020.12.30.20249023'}]
60,sminaee@snap.com,Shervin Minaee,Person,,,,,,,deep-covid,,Kigaard,"[{'doi': '10.1016/J.MEDIA.2020.101794', 'metadata': {'abstract': '© 2020The COVID-19 pandemic is causing a major outbreak in more than 150 countries around the world, having a severe impact on the health and life of many people globally. One of the crucial step in fighting COVID-19 is the ability to detect the infected patients early enough, and put them under special care. Detecting this disease from radiography and radiology images is perhaps one of the fastest ways to diagnose the patients. Some of the early studies showed specific abnormalities in the chest radiograms of patients infected with COVID-19. Inspired by earlier works, we study the application of deep learning models to detect COVID-19 patients from their chest radiography images. We first prepare a dataset of 5000 Chest X-rays from the publicly available datasets. Images exhibiting COVID-19 disease presence were identified by board-certified radiologist. Transfer learning on a subset of 2000 radiograms was used to train four popular convolutional neural networks, including ResNet18, ResNet50, SqueezeNet, and DenseNet-121, to identify COVID-19 disease in the analyzed chest X-ray images. We evaluated these models on the remaining 3000 images, and most of these networks achieved a sensitivity rate of 98% ( ± 3%), while having a specificity rate of around 90%. Besides sensitivity and specificity rates, we also present the receiver operating characteristic (ROC) curve, precision-recall curve, average prediction, and confusion matrix of each model. We also used a technique to generate heatmaps of lung regions potentially infected by COVID-19 and show that the generated heatmaps contain most of the infected areas annotated by our board certified radiologist. While the achieved performance is very encouraging, further analysis is required on a larger set of COVID-19 images, to have a more reliable estimation of accuracy rates. The dataset, model implementations (in PyTorch), and evaluations, are all made publicly available for research community at https://github.com/shervinmin/DeepCovid.git', 'authors': [{'name': 'Minaee S.'}, {'name': 'Kafieh R.'}, {'name': 'Sonka M.'}, {'name': 'Yazdani S.'}, {'name': 'Jamalipour Soufi G.'}], 'citationCount': 86, 'date': '2020-10-01T00:00:00Z', 'journal': 'Medical Image Analysis', 'title': 'Deep-COVID: Predicting COVID-19 from chest X-ray images using deep transfer learning'}, 'pmcid': 'PMC7372265', 'pmid': '32781377'}]"
61,rkafieh@amt.mui.ac.ir,Rahele Kafieh,Person,,,,,,,deep-covid,,Kigaard,"[{'doi': '10.1016/J.MEDIA.2020.101794', 'metadata': {'abstract': '© 2020The COVID-19 pandemic is causing a major outbreak in more than 150 countries around the world, having a severe impact on the health and life of many people globally. One of the crucial step in fighting COVID-19 is the ability to detect the infected patients early enough, and put them under special care. Detecting this disease from radiography and radiology images is perhaps one of the fastest ways to diagnose the patients. Some of the early studies showed specific abnormalities in the chest radiograms of patients infected with COVID-19. Inspired by earlier works, we study the application of deep learning models to detect COVID-19 patients from their chest radiography images. We first prepare a dataset of 5000 Chest X-rays from the publicly available datasets. Images exhibiting COVID-19 disease presence were identified by board-certified radiologist. Transfer learning on a subset of 2000 radiograms was used to train four popular convolutional neural networks, including ResNet18, ResNet50, SqueezeNet, and DenseNet-121, to identify COVID-19 disease in the analyzed chest X-ray images. We evaluated these models on the remaining 3000 images, and most of these networks achieved a sensitivity rate of 98% ( ± 3%), while having a specificity rate of around 90%. Besides sensitivity and specificity rates, we also present the receiver operating characteristic (ROC) curve, precision-recall curve, average prediction, and confusion matrix of each model. We also used a technique to generate heatmaps of lung regions potentially infected by COVID-19 and show that the generated heatmaps contain most of the infected areas annotated by our board certified radiologist. While the achieved performance is very encouraging, further analysis is required on a larger set of COVID-19 images, to have a more reliable estimation of accuracy rates. The dataset, model implementations (in PyTorch), and evaluations, are all made publicly available for research community at https://github.com/shervinmin/DeepCovid.git', 'authors': [{'name': 'Minaee S.'}, {'name': 'Kafieh R.'}, {'name': 'Sonka M.'}, {'name': 'Yazdani S.'}, {'name': 'Jamalipour Soufi G.'}], 'citationCount': 86, 'date': '2020-10-01T00:00:00Z', 'journal': 'Medical Image Analysis', 'title': 'Deep-COVID: Predicting COVID-19 from chest X-ray images using deep transfer learning'}, 'pmcid': 'PMC7372265', 'pmid': '32781377'}]"
62,support@intermine.org,,Person,,['Support'],,,,,covidmine,,InterMine,"[{'doi': '10.1093/bioinformatics/bts577', 'metadata': {'abstract': ""InterMine is an open-source data warehouse system that facilitates the building of databases with complex data integration requirements and a need for a fast customizable query facility. Using InterMine, large biological databases can be created from a range of heterogeneous data sources, and the extensible data model allows for easy integration of new data types. The analysis tools include a flexible query builder, genomic region search and a library of 'widgets' performing various statistical analyses. The results can be exported in many commonly used formats. InterMine is a fully extensible framework where developers can add new tools and functionality. Additionally, there is a comprehensive set of web services, for which client libraries are provided in five commonly used programming languages. © The Author 2012. Published by Oxford University Press. All rights reserved."", 'authors': [{'name': 'Smith R.N.'}, {'name': 'Aleksic J.'}, {'name': 'Butano D.'}, {'name': 'Carr A.'}, {'name': 'Contrino S.'}, {'name': 'Hu F.'}, {'name': 'Lyne M.'}, {'name': 'Lyne R.'}, {'name': 'Kalderimis A.'}, {'name': 'Rutherford K.'}, {'name': 'Stepan R.'}, {'name': 'Sullivan J.'}, {'name': 'Wakeling M.'}, {'name': 'Watkins X.'}, {'name': 'Micklem G.'}], 'citationCount': 158, 'date': '2012-12-01T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'InterMine: A flexible data warehouse system for the integration and analysis of heterogeneous biological data'}}]"
63,olivier.gascuel@pasteur.fr,,Person,,,,,,,covid-align,,Kigaard,[{'doi': '10.1101/2020.05.25.114884'}]
64,tavpriteshsethi@iiitd.ac.in,,Person,,,,,,,covidnlp,Open access,Kigaard,[{'doi': '10.1101/2020.04.25.20079129'}]
65,c.chelala@qmul.ac.uk,Claude Chelala,Person,,,,,,,snpnexus-covid,,zsmag19,[{'doi': '10.1101/2020.12.18.423439'}]
66,philippe.lambin@maastrichtuniversity.nl,Philippe Lambin,Person,,,,,,,covid19riskai,,Kigaard,[{'doi': '10.1101/2021.01.05.425384'}]
67,wajidarshad@ajku.edu.pk,Wajid Arshad Abbasi,Person,https://orcid.org/0000-0001-7691-5715,['Primary contact'],,,,,covidc,,Kigaard,"[{'doi': '10.1016/J.IMU.2021.100540', 'metadata': {'abstract': '© 2021 The Author(s)Early diagnosis of Coronavirus disease 2019 (COVID-19) is significantly important, especially in the absence or inadequate provision of a specific vaccine, to stop the surge of this lethal infection by advising quarantine. This diagnosis is challenging as most of the patients having COVID-19 infection stay asymptomatic while others showing symptoms are hard to distinguish from patients having different respiratory infections such as severe flu and Pneumonia. Due to cost and time-consuming wet-lab diagnostic tests for COVID-19, there is an utmost requirement for some alternate, non-invasive, rapid, and discounted automatic screening system. A chest CT scan can effectively be used as an alternative modality to detect and diagnose the COVID-19 infection. In this study, we present an automatic COVID-19 diagnostic and severity prediction system called COVIDC (COVID-19 detection using CT scans) that uses deep feature maps from the chest CT scans for this purpose. Our newly proposed system not only detects COVID-19 but also predicts its severity by using a two-phase classification approach (COVID vs non-COVID, and COVID-19 severity) with deep feature maps and different shallow supervised classification algorithms such as SVMs and random forest to handle data scarcity. We performed a stringent COVIDC performance evaluation not only through 10-fold cross-validation and an external validation dataset but also in a real setting under the supervision of an experienced radiologist. In all the evaluation settings, COVIDC outperformed all the existing state-of-the-art methods designed to detect COVID-19 with an F1 score of 0.94 on the validation dataset and justified its use to diagnose COVID-19 effectively in the real setting by classifying correctly 9 out of 10 COVID-19 CT scans. We made COVIDC openly accessible through a cloud-based webserver and python code available at https://sites.google.com/view/wajidarshad/software and https://github.com/wajidarshad/covidc.', 'authors': [{'name': 'Abbasi W.A.'}, {'name': 'Abbas S.A.'}, {'name': 'Andleeb S.'}, {'name': 'ul Islam G.'}, {'name': 'Ajaz S.A.'}, {'name': 'Arshad K.'}, {'name': 'Khalil S.'}, {'name': 'Anjam A.'}, {'name': 'Ilyas K.'}, {'name': 'Saleem M.'}, {'name': 'Chughtai J.'}, {'name': 'Abbas A.'}], 'citationCount': 1, 'date': '2021-01-01T00:00:00Z', 'journal': 'Informatics in Medicine Unlocked', 'title': 'COVIDC: An expert system to diagnose COVID-19 and predict its severity using chest CT scans: Application in radiology'}, 'pmcid': 'PMC7901302', 'pmid': '33644298'}]"
68,maurizio.recanatini@unibo.it,Maurizio Recanatini,Person,,,,,,,covidrugnet,,Kigaard,"[{'doi': '10.1101/2021.03.05.433897', 'type': ['Primary']}]"
69,toprea@salud.unm.edu,Gergely Zahoránszky-Kőhalmi,Person,,,,,,,neo4covid19,,Niclaskn,[{'doi': '10.1101/2020.11.04.369041'}]
70,gzahoranszky@gmail.com,Tudor I. Oprea,Person,,,,,,,neo4covid19,,Niclaskn,[{'doi': '10.1101/2020.11.04.369041'}]
71,rezar@bu.edu,Reza Rawassizadeh,Person,https://orcid.org/0000-0002-2607-1777,,,,,,covidctnet,,Kigaard,"[{'doi': '10.1038/S41746-021-00399-3', 'metadata': {'abstract': '© 2021, The Author(s).Coronavirus disease 2019 (Covid-19) is highly contagious with limited treatment options. Early and accurate diagnosis of Covid-19 is crucial in reducing the spread of the disease and its accompanied mortality. Currently, detection by reverse transcriptase-polymerase chain reaction (RT-PCR) is the gold standard of outpatient and inpatient detection of Covid-19. RT-PCR is a rapid method; however, its accuracy in detection is only ~70–75%. Another approved strategy is computed tomography (CT) imaging. CT imaging has a much higher sensitivity of ~80–98%, but similar accuracy of 70%. To enhance the accuracy of CT imaging detection, we developed an open-source framework, CovidCTNet, composed of a set of deep learning algorithms that accurately differentiates Covid-19 from community-acquired pneumonia (CAP) and other lung diseases. CovidCTNet increases the accuracy of CT imaging detection to 95% compared to radiologists (70%). CovidCTNet is designed to work with heterogeneous and small sample sizes independent of the CT imaging hardware. To facilitate the detection of Covid-19 globally and assist radiologists and physicians in the screening process, we are releasing all algorithms and model parameter details as open-source. Open-source sharing of CovidCTNet enables developers to rapidly improve and optimize services while preserving user privacy and data ownership.', 'authors': [{'name': 'Javaheri T.'}, {'name': 'Homayounfar M.'}, {'name': 'Amoozgar Z.'}, {'name': 'Reiazi R.'}, {'name': 'Homayounieh F.'}, {'name': 'Abbas E.'}, {'name': 'Laali A.'}, {'name': 'Radmard A.R.'}, {'name': 'Gharib M.H.'}, {'name': 'Mousavi S.A.J.'}, {'name': 'Ghaemi O.'}, {'name': 'Babaei R.'}, {'name': 'Mobin H.K.'}, {'name': 'Hosseinzadeh M.'}, {'name': 'Jahanban-Esfahlan R.'}, {'name': 'Seidi K.'}, {'name': 'Kalra M.K.'}, {'name': 'Zhang G.'}, {'name': 'Chitkushev L.T.'}, {'name': 'Haibe-Kains B.'}, {'name': 'Malekzadeh R.'}, {'name': 'Rawassizadeh R.'}], 'date': '2021-12-01T00:00:00Z', 'journal': 'npj Digital Medicine', 'title': 'CovidCTNet: an open-source deep learning approach to diagnose covid-19 using small cohort of CT images'}, 'pmcid': 'PMC7893172', 'pmid': '33603193'}]"
72,khoo@liverpool.ac.uk,Saye Khoo,Person,,,,,,,covid19-drug-interactions,Open access,Kigaard,"[{'doi': '10.1093/JAC/DKAA340', 'metadata': {'abstract': ""© The Author(s) 2020.As global health services respond to the coronavirus pandemic, many prescribers are turning to experimental drugs. This review aims to assess the risk of drug-drug interactions in the severely ill COVID-19 patient. Experimental therapies were identified by searching ClinicalTrials.gov for 'COVID-19', '2019-nCoV', '2019 novel coronavirus' and 'SARS-CoV-2'. The last search was performed on 30 June 2020. Herbal medicines, blood-derived products and in vitro studies were excluded. We identified comorbidities by searching PubMed for the MeSH terms 'COVID-19', 'Comorbidity' and 'Epidemiological Factors'. Potential drug-drug interactions were evaluated according to known pharmacokinetics, overlapping toxicities and QT risk. Drug-drug interactions were graded GREEN and YELLOW: no clinically significant interaction; AMBER: Caution; RED: Serious risk. A total of 2378 records were retrieved from ClinicalTrials.gov, which yielded 249 drugs that met inclusion criteria. Thirteen primary compounds were screened against 512 comedications. A full database of these interactions is available at www.covid19-druginteractions.org. Experimental therapies for COVID-19 present a risk of drug-drug interactions, with lopinavir/ritonavir (10% RED, 41% AMBER; mainly a perpetrator of pharmacokinetic interactions but also risk of QT prolongation particularly when given with concomitant drugs that can prolong QT), chloroquine and hydroxychloroquine (both 7% RED and 27% AMBER, victims of some interactions due to metabolic profile but also perpetrators of QT prolongation) posing the greatest risk. With management, these risks can be mitigated. We have published a drug-drug interaction resource to facilitate medication review for the critically ill patient."", 'authors': [{'name': 'Hodge C.'}, {'name': 'Marra F.'}, {'name': 'Marzolini C.'}, {'name': 'Boyle A.'}, {'name': 'Gibbons S.'}, {'name': 'Siccardi M.'}, {'name': 'Burger D.'}, {'name': 'Back D.'}, {'name': 'Khoo S.'}], 'citationCount': 12, 'date': '2020-12-01T00:00:00Z', 'journal': 'Journal of Antimicrobial Chemotherapy', 'title': 'Drug interactions: A review of the unseen danger of experimental COVID-19 therapies'}, 'pmcid': 'PMC7454591', 'pmid': '32750131'}]"
73,mmon4544@uni.sydney.edu.au,Maram Mahmoud A. Monshi,Person,https://orcid.org/0000-0001-5622-1601,['Primary contact'],,,,,covidxraynet,,Kigaard,"[{'doi': '10.1016/J.COMPBIOMED.2021.104375', 'metadata': {'abstract': '© 2021 Elsevier LtdTo mitigate the spread of the current coronavirus disease 2019 (COVID-19) pandemic, it is crucial to have an effective screening of infected patients to be isolated and treated. Chest X-Ray (CXR) radiological imaging coupled with Artificial Intelligence (AI) applications, in particular Convolutional Neural Network (CNN), can speed the COVID-19 diagnostic process. In this paper, we optimize the data augmentation and the CNN hyperparameters for detecting COVID-19 from CXRs in terms of validation accuracy. This optimization increases the accuracy of the popular CNN architectures such as the Visual Geometry Group network (VGG-19) and the Residual Neural Network (ResNet-50), by 11.93% and 4.97%, respectively. We then proposed CovidXrayNet model that is based on EfficientNet-B0 and our optimization results. We evaluated CovidXrayNet on two datasets, including our generated balanced COVIDcxr dataset (960 CXRs) and the benchmark COVIDx dataset (15,496 CXRs). With only 30 epochs of training, CovidXrayNet achieves state-of-the-art accuracy of 95.82% on the COVIDx dataset in the three-class classification task (COVID-19, normal or pneumonia). The CovidXRayNet model, the COVIDcxr dataset, and several optimization experiments are publicly available at https://github.com/MaramMonshi/CovidXrayNet.', 'authors': [{'name': 'Monshi M.M.A.'}, {'name': 'Poon J.'}, {'name': 'Chung V.'}, {'name': 'Monshi F.M.'}], 'citationCount': 3, 'date': '2021-06-01T00:00:00Z', 'journal': 'Computers in Biology and Medicine', 'title': 'CovidXrayNet: Optimizing data augmentation and CNN hyperparameters for improved COVID-19 detection from CXR'}, 'pmcid': 'PMC8048393', 'pmid': '33866253', 'type': ['Primary']}]"
74,adas8@worldbank.org,,Person,,,,,,,cocomorp,,Kigaard,[{'doi': '10.1101/2020.04.27.20081794'}]
75,ahmadian.hosseini@gmail.com,Ali Ahmadian,Person,https://orcid.org/0000-0002-0106-7050,['Primary contact'],,,,,graphcovidnet,,Kigaard,"[{'doi': '10.1038/S41598-021-87523-1', 'pmcid': 'PMC8050058', 'pmid': '33859222', 'type': ['Primary']}]"
76,xlin@hsph.harvard.edu,Xihong Lin,Person,,['Primary contact'],,,,,hyper-testing,,Kigaard,"[{'doi': '10.1101/2021.02.24.21252394', 'type': ['Primary']}]"
77,bcleary@broadinstitute.org,Brian Cleary,Person,,['Primary contact'],,,,,hyper-testing,,Kigaard,"[{'doi': '10.1101/2021.02.24.21252394', 'type': ['Primary']}]"
78,dobriban@wharton.upenn.edu,Edgar Dobriban,Person,,['Primary contact'],,,,,hyper-testing,,Kigaard,"[{'doi': '10.1101/2021.02.24.21252394', 'type': ['Primary']}]"
79,fattah@eee.buet.ac.bd,Shaikh Anowarul Fattah,Person,,,,,,,covxnet,,Kigaard,"[{'doi': '10.1016/J.COMPBIOMED.2020.103869', 'metadata': {'abstract': '© 2020 Elsevier LtdWith the recent outbreak of COVID-19, fast diagnostic testing has become one of the major challenges due to the critical shortage of test kit. Pneumonia, a major effect of COVID-19, needs to be urgently diagnosed along with its underlying reasons. In this paper, deep learning aided automated COVID-19 and other pneumonia detection schemes are proposed utilizing a small amount of COVID-19 chest X-rays. A deep convolutional neural network (CNN) based architecture, named as CovXNet, is proposed that utilizes depthwise convolution with varying dilation rates for efficiently extracting diversified features from chest X-rays. Since the chest X-ray images corresponding to COVID-19 caused pneumonia and other traditional pneumonias have significant similarities, at first, a large number of chest X-rays corresponding to normal and (viral/bacterial) pneumonia patients are used to train the proposed CovXNet. Learning of this initial training phase is transferred with some additional fine-tuning layers that are further trained with a smaller number of chest X-rays corresponding to COVID-19 and other pneumonia patients. In the proposed method, different forms of CovXNets are designed and trained with X-ray images of various resolutions and for further optimization of their predictions, a stacking algorithm is employed. Finally, a gradient-based discriminative localization is integrated to distinguish the abnormal regions of X-ray images referring to different types of pneumonia. Extensive experimentations using two different datasets provide very satisfactory detection performance with accuracy of 97.4% for COVID/Normal, 96.9% for COVID/Viral pneumonia, 94.7% for COVID/Bacterial pneumonia, and 90.2% for multiclass COVID/normal/Viral/Bacterial pneumonias. Hence, the proposed schemes can serve as an efficient tool in the current state of COVID-19 pandemic. All the architectures are made publicly available at: https://github.com/Perceptron21/CovXNet.', 'authors': [{'name': 'Mahmud T.'}, {'name': 'Rahman M.A.'}, {'name': 'Fattah S.A.'}], 'citationCount': 80, 'date': '2020-07-01T00:00:00Z', 'journal': 'Computers in Biology and Medicine', 'title': 'CovXNet: A multi-dilation convolutional neural network for automatic COVID-19 and other pneumonia detection from chest X-ray images with transferable multi-receptive feature optimization'}, 'pmcid': 'PMC7305745', 'pmid': '32658740'}]"
80,,Asif Iqbal Khan,Person,,,,,,,coronet,,Kigaard,"[{'doi': '10.1016/J.CMPB.2020.105581', 'metadata': {'abstract': '© 2020Background and Objective: The novel Coronavirus also called COVID-19 originated in Wuhan, China in December 2019 and has now spread across the world. It has so far infected around 1.8 million people and claimed approximately 114,698 lives overall. As the number of cases are rapidly increasing, most of the countries are facing shortage of testing kits and resources. The limited quantity of testing kits and increasing number of daily cases encouraged us to come up with a Deep Learning model that can aid radiologists and clinicians in detecting COVID-19 cases using chest X-rays. Methods: In this study, we propose CoroNet, a Deep Convolutional Neural Network model to automatically detect COVID-19 infection from chest X-ray images. The proposed model is based on Xception architecture pre-trained on ImageNet dataset and trained end-to-end on a dataset prepared by collecting COVID-19 and other chest pneumonia X-ray images from two different publically available databases. Results: CoroNet has been trained and tested on the prepared dataset and the experimental results show that our proposed model achieved an overall accuracy of 89.6%, and more importantly the precision and recall rate for COVID-19 cases are 93% and 98.2% for 4-class cases (COVID vs Pneumonia bacterial vs pneumonia viral vs normal). For 3-class classification (COVID vs Pneumonia vs normal), the proposed model produced a classification accuracy of 95%. The preliminary results of this study look promising which can be further improved as more training data becomes available. Conclusion: CoroNet achieved promising results on a small prepared dataset which indicates that given more data, the proposed model can achieve better results with minimum pre-processing of data. Overall, the proposed model substantially advances the current radiology based methodology and during COVID-19 pandemic, it can be very helpful tool for clinical practitioners and radiologists to aid them in diagnosis, quantification and follow-up of COVID-19 cases.', 'authors': [{'name': 'Khan A.I.'}, {'name': 'Shah J.L.'}, {'name': 'Bhat M.M.'}], 'citationCount': 182, 'date': '2020-11-01T00:00:00Z', 'journal': 'Computer Methods and Programs in Biomedicine', 'title': 'CoroNet: A deep neural network for detection and diagnosis of COVID-19 from chest x-ray images'}, 'pmcid': 'PMC7274128', 'pmid': '32534344'}]"
81,renato.polimanti@yale.edu,,Person,,,,,,,ace2-netlas,,Kigaard,[{'doi': '10.1101/2020.10.27.20220665'}]
82,markus.schwehm@explosys.de,Markus Schwehm,Person,,,,,,,covidsim,,Kigaard,[{'doi': '10.1101/2020.03.20.20039776'}]
83,nick.wilson@otago.ac.nz,Nick Wilson,Person,,['Primary contact'],,,,,covidsim,,Kigaard,[{'doi': '10.1101/2020.03.20.20039776'}]
84,,Johns Hopkins University Center for Systems Science and Engineering,Institute,,,,https://systems.jhu.edu,,,johns_hopkins_coronavirus,Open access,hans,"[{'doi': '10.1016/S1473-3099(20)30120-1', 'metadata': {'authors': [{'name': 'Dong E.'}, {'name': 'Du H.'}, {'name': 'Gardner L.'}], 'citationCount': 2723, 'date': '2020-05-01T00:00:00Z', 'journal': 'The Lancet Infectious Diseases', 'title': 'An interactive web-based dashboard to track COVID-19 in real time'}, 'pmid': '32087114', 'type': ['Primary']}]"
85,,ESRI Living Atlas Team,Institute,,,,https://livingatlas.arcgis.com,,,johns_hopkins_coronavirus,Open access,hans,"[{'doi': '10.1016/S1473-3099(20)30120-1', 'metadata': {'authors': [{'name': 'Dong E.'}, {'name': 'Du H.'}, {'name': 'Gardner L.'}], 'citationCount': 2723, 'date': '2020-05-01T00:00:00Z', 'journal': 'The Lancet Infectious Diseases', 'title': 'An interactive web-based dashboard to track COVID-19 in real time'}, 'pmid': '32087114', 'type': ['Primary']}]"
86,,Johns Hopkins University Applied Physics Lab,Institute,,,,https://www.jhuapl.edu,,,johns_hopkins_coronavirus,Open access,hans,"[{'doi': '10.1016/S1473-3099(20)30120-1', 'metadata': {'authors': [{'name': 'Dong E.'}, {'name': 'Du H.'}, {'name': 'Gardner L.'}], 'citationCount': 2723, 'date': '2020-05-01T00:00:00Z', 'journal': 'The Lancet Infectious Diseases', 'title': 'An interactive web-based dashboard to track COVID-19 in real time'}, 'pmid': '32087114', 'type': ['Primary']}]"
87,jhusystems@gmail.com,,,,['Support'],,,,,johns_hopkins_coronavirus,Open access,hans,"[{'doi': '10.1016/S1473-3099(20)30120-1', 'metadata': {'authors': [{'name': 'Dong E.'}, {'name': 'Du H.'}, {'name': 'Gardner L.'}], 'citationCount': 2723, 'date': '2020-05-01T00:00:00Z', 'journal': 'The Lancet Infectious Diseases', 'title': 'An interactive web-based dashboard to track COVID-19 in real time'}, 'pmid': '32087114', 'type': ['Primary']}]"
88,zjxu@simm.ac.cn,Zhijian Xu,Person,,,,,,,d3targets-2019-ncov,,Kigaard,"[{'doi': '10.1016/J.APSB.2020.04.006', 'metadata': {'abstract': '© 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical SciencesA highly effective medicine is urgently required to cure coronavirus disease 2019 (COVID-19). For the purpose, we developed a molecular docking based webserver, namely D3Targets-2019-nCoV, with two functions, one is for predicting drug targets for drugs or active compounds observed from clinic or in vitro/in vivo studies, the other is for identifying lead compounds against potential drug targets via docking. This server has its unique features, (1) the potential target proteins and their different conformations involving in the whole process from virus infection to replication and release were included as many as possible; (2) all the potential ligand-binding sites with volume larger than 200 Å3 on a protein structure were identified for docking; (3) correlation information among some conformations or binding sites was annotated; (4) it is easy to be updated, and is accessible freely to public (https://www.d3pharma.com/D3Targets-2019-nCoV/index.php). Currently, the webserver contains 42 proteins [20 severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) encoded proteins and 22 human proteins involved in virus infection, replication and release] with 69 different conformations/structures and 557 potential ligand-binding pockets in total. With 6 examples, we demonstrated that the webserver should be useful to medicinal chemists, pharmacologists and clinicians for efficiently discovering or developing effective drugs against the SARS-CoV-2 to cure COVID-19.', 'authors': [{'name': 'Shi Y.'}, {'name': 'Zhang X.'}, {'name': 'Mu K.'}, {'name': 'Peng C.'}, {'name': 'Zhu Z.'}, {'name': 'Wang X.'}, {'name': 'Yang Y.'}, {'name': 'Xu Z.'}, {'name': 'Zhu W.'}], 'citationCount': 26, 'date': '2020-07-01T00:00:00Z', 'journal': 'Acta Pharmaceutica Sinica B', 'title': 'D3Targets-2019-nCoV: a webserver for predicting drug targets and for multi-target and multi-site based virtual screening against COVID-19'}, 'pmcid': 'PMC7169934', 'pmid': '32318328'}]"
89,wlzhu@simm.ac.cn,Weiliang Zhu,Person,,,,,,,d3targets-2019-ncov,,Kigaard,"[{'doi': '10.1016/J.APSB.2020.04.006', 'metadata': {'abstract': '© 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical SciencesA highly effective medicine is urgently required to cure coronavirus disease 2019 (COVID-19). For the purpose, we developed a molecular docking based webserver, namely D3Targets-2019-nCoV, with two functions, one is for predicting drug targets for drugs or active compounds observed from clinic or in vitro/in vivo studies, the other is for identifying lead compounds against potential drug targets via docking. This server has its unique features, (1) the potential target proteins and their different conformations involving in the whole process from virus infection to replication and release were included as many as possible; (2) all the potential ligand-binding sites with volume larger than 200 Å3 on a protein structure were identified for docking; (3) correlation information among some conformations or binding sites was annotated; (4) it is easy to be updated, and is accessible freely to public (https://www.d3pharma.com/D3Targets-2019-nCoV/index.php). Currently, the webserver contains 42 proteins [20 severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) encoded proteins and 22 human proteins involved in virus infection, replication and release] with 69 different conformations/structures and 557 potential ligand-binding pockets in total. With 6 examples, we demonstrated that the webserver should be useful to medicinal chemists, pharmacologists and clinicians for efficiently discovering or developing effective drugs against the SARS-CoV-2 to cure COVID-19.', 'authors': [{'name': 'Shi Y.'}, {'name': 'Zhang X.'}, {'name': 'Mu K.'}, {'name': 'Peng C.'}, {'name': 'Zhu Z.'}, {'name': 'Wang X.'}, {'name': 'Yang Y.'}, {'name': 'Xu Z.'}, {'name': 'Zhu W.'}], 'citationCount': 26, 'date': '2020-07-01T00:00:00Z', 'journal': 'Acta Pharmaceutica Sinica B', 'title': 'D3Targets-2019-nCoV: a webserver for predicting drug targets and for multi-target and multi-site based virtual screening against COVID-19'}, 'pmcid': 'PMC7169934', 'pmid': '32318328'}]"
90,,Petrônio C.L. Silva,Person,,,,,,,covid-abs,,Kigaard,"[{'doi': '10.1016/J.CHAOS.2020.110088', 'metadata': {'abstract': '© 2020The COVID-19 pandemic due to the SARS-CoV-2 coronavirus has directly impacted the public health and economy worldwide. To overcome this problem, countries have adopted different policies and non-pharmaceutical interventions for controlling the spread of the virus. This paper proposes the COVID-ABS, a new SEIR (Susceptible-Exposed-Infected-Recovered) agent-based model that aims to simulate the pandemic dynamics using a society of agents emulating people, business and government. Seven different scenarios of social distancing interventions were analyzed, with varying epidemiological and economic effects: (1) do nothing, (2) lockdown, (3) conditional lockdown, (4) vertical isolation, (5) partial isolation, (6) use of face masks, and (7) use of face masks together with 50% of adhesion to social isolation. In the impossibility of implementing scenarios with lockdown, which present the lowest number of deaths and highest impact on the economy, scenarios combining the use of face masks and partial isolation can be the more realistic for implementation in terms of social cooperation. The COVID-ABS model was implemented in Python programming language, with source code publicly available. The model can be easily extended to other societies by changing the input parameters, as well as allowing the creation of a multitude of other scenarios. Therefore, it is a useful tool to assist politicians and health authorities to plan their actions against the COVID-19 epidemic.', 'authors': [{'name': 'Silva P.C.L.'}, {'name': 'Batista P.V.C.'}, {'name': 'Lima H.S.'}, {'name': 'Alves M.A.'}, {'name': 'Guimaraes F.G.'}, {'name': 'Silva R.C.P.'}], 'citationCount': 64, 'date': '2020-10-01T00:00:00Z', 'journal': 'Chaos, Solitons and Fractals', 'title': 'COVID-ABS: An agent-based model of COVID-19 epidemic to simulate health and economic effects of social distancing interventions'}, 'pmcid': 'PMC7340090', 'pmid': '32834624'}]"
91,dhiraj.murthy@austin.utexas.edu,Dhiraj Murthy,Person,,['Primary contact'],,,,,coverifi,,Kigaard,"[{'doi': '10.1016/J.OSNEM.2021.100123', 'metadata': {'abstract': '© 2021 Elsevier B.V.There is an abundance of misinformation, disinformation, and “fake news” related to COVID-19, leading the director-general of the World Health Organization to term this an ‘infodemic’. Given the high volume of COVID-19 content on the Internet, many find it difficult to evaluate veracity. Vulnerable and marginalized groups are being misinformed and subject to high levels of stress. Riots and panic buying have also taken place due to “fake news”. However, individual research-led websites can make a major difference in terms of providing accurate information. For example, the Johns Hopkins Coronavirus Resource Center website has over 81 million entries linked to it on Google. With the outbreak of COVID-19 and the knowledge that deceptive news has the potential to measurably affect the beliefs of the public, new strategies are needed to prevent the spread of misinformation. This study seeks to make a timely intervention to the information landscape through a COVID-19 “fake news”, misinformation, and disinformation website. In this article, we introduce CoVerifi, a web application which combines both the power of machine learning and the power of human feedback to assess the credibility of news. By allowing users the ability to “vote” on news content, the CoVerifi platform will allow us to release labelled data as open source, which will enable further research on preventing the spread of COVID-19-related misinformation. We discuss the development of CoVerifi and the potential utility of deploying the system at scale for combating the COVID-19 “infodemic”.', 'authors': [{'name': 'Kolluri N.L.'}, {'name': 'Murthy D.'}], 'date': '2021-03-01T00:00:00Z', 'journal': 'Online Social Networks and Media', 'title': 'CoVerifi: A COVID-19 news verification system'}, 'pmcid': 'PMC7825993', 'pmid': '33521412'}]"
92,alex@lji.org,Alessandro Sette,Person,,,,,,,ncov,,Niclaskn,[{'doi': '10.1101/2020.02.12.946087'}]
93,shamshirbands@yuntech.edu.tw,Shahab S. Band,Person,,['Primary contact'],,,,,covidmulti-net,,Kigaard,"[{'doi': '10.1101/2021.05.19.21257430', 'type': ['Primary']}]"
94,h.alinejad@unsw.edu.au,Hamid Alinejad-Rokny,Person,,['Primary contact'],,,,,covidmulti-net,,Kigaard,"[{'doi': '10.1101/2021.05.19.21257430', 'type': ['Primary']}]"
95,hello@coronavirus.app,,,,['Support'],,,,,the_coronavirus_app,Restricted access,hans,
96,,Coronavirus App Credits and Sources,,,,,https://www.notion.so/coronavirus/What-are-your-sources-4f3f962953f1418da96eae1b5fe06039,,,the_coronavirus_app,Restricted access,hans,
97,thibautjombart@gmail.com,,Person,,,,,,,trendbreaker,,Kigaard,[{'doi': '10.1101/2020.09.02.20186502'}]
98,stephane.ghozzi@mailbox.org,,Person,,,,,,,trendbreaker,,Kigaard,[{'doi': '10.1101/2020.09.02.20186502'}]
99,mail@dirk-schumacher.net,,Person,,,,,,,trendbreaker,,Kigaard,[{'doi': '10.1101/2020.09.02.20186502'}]
100,quentin.leclerc@lshtm.ac.uk,,Person,,,,,,,trendbreaker,,Kigaard,[{'doi': '10.1101/2020.09.02.20186502'}]
101,mark.jit@lshtm.ac.uk,,Person,,,,,,,trendbreaker,,Kigaard,[{'doi': '10.1101/2020.09.02.20186502'}]
102,stefan.flasche@lshtm.ac.uk,,Person,,,,,,,trendbreaker,,Kigaard,[{'doi': '10.1101/2020.09.02.20186502'}]
103,felix.greaves@phe.gov.uk,,Person,,,,,,,trendbreaker,,Kigaard,[{'doi': '10.1101/2020.09.02.20186502'}]
104,tom.ward@cabinetoffice.gov.uk,,Person,,,,,,,trendbreaker,,Kigaard,[{'doi': '10.1101/2020.09.02.20186502'}]
105,r.eggo@lshtm.ac.uk,,Person,,,,,,,trendbreaker,,Kigaard,[{'doi': '10.1101/2020.09.02.20186502'}]
106,emily.nightingale@lshtm.ac.uk,,Person,,,,,,,trendbreaker,,Kigaard,[{'doi': '10.1101/2020.09.02.20186502'}]
107,sophie.meakin@lshtm.ac.uk,,Person,,,,,,,trendbreaker,,Kigaard,[{'doi': '10.1101/2020.09.02.20186502'}]
108,oliver.brady@lshtm.ac.uk,,Person,,,,,,,trendbreaker,,Kigaard,[{'doi': '10.1101/2020.09.02.20186502'}]
109,graham.medley@lshtm.ac.uk,,Person,,,,,,,trendbreaker,,Kigaard,[{'doi': '10.1101/2020.09.02.20186502'}]
110,hoehle@math.su.se,,Person,,,,,,,trendbreaker,,Kigaard,[{'doi': '10.1101/2020.09.02.20186502'}]
111,john.edmunds@lshtm.ac.uk,,Person,,,,,,,trendbreaker,,Kigaard,[{'doi': '10.1101/2020.09.02.20186502'}]
112,mealser@gmail.com,Mohammed Alser,Person,https://orcid.org/0000-0002-6117-3701,['Primary contact'],,,,,covidhunter,,Kigaard,[{'doi': '10.1101/2021.02.06.21251265'}]
113,jollier.liu@gmail.com,Boxiang Liu,Person,,,,,,,cov-seq,,Kigaard,"[{'doi': '10.1101/2020.05.01.071050'}, {'doi': '10.2196/22299', 'metadata': {'abstract': '© Boxiang Liu, Kaibo Liu, He Zhang, Liang Zhang, Yuchen Bian, Liang Huang. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 02.10.2020. This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/)Background: COVID-19 became a global pandemic not long after its identification in late 2019. The genomes of SARS-CoV-2 are being rapidly sequenced and shared on public repositories. To keep up with these updates, scientists need to frequently refresh and reclean data sets, which is an ad hoc and labor-intensive process. Further, scientists with limited bioinformatics or programming knowledge may find it difficult to analyze SARS-CoV-2 genomes. Objective: To address these challenges, we developed CoV-Seq, an integrated web server that enables simple and rapid analysis of SARS-CoV-2 genomes. Methods: CoV-Seq is implemented in Python and JavaScript. The web server and source code URLs are provided in this article. Results: Given a new sequence, CoV-Seq automatically predicts gene boundaries and identifies genetic variants, which are displayed in an interactive genome visualizer and are downloadable for further analysis. A command-line interface is available for high-throughput processing. In addition, we aggregated all publicly available SARS-CoV-2 sequences from the Global Initiative on Sharing Avian Influenza Data (GISAID), National Center for Biotechnology Information (NCBI), European Nucleotide Archive (ENA), and China National GeneBank (CNGB), and extracted genetic variants from these sequences for download and downstream analysis. The CoV-Seq database is updated weekly. Conclusions: We have developed CoV-Seq, an integrated web service for fast and easy analysis of custom SARS-CoV-2 sequences. The web server provides an interactive module for the analysis of custom sequences and a weekly updated database of genetic variants of all publicly accessible SARS-CoV-2 sequences. We believe CoV-Seq will help improve our understanding of the genetic underpinnings of COVID-19.', 'authors': [{'name': 'Liu B.'}, {'name': 'Liu K.'}, {'name': 'Zhang H.'}, {'name': 'Zhang L.'}, {'name': 'Bian Y.'}, {'name': 'Huang L.'}], 'citationCount': 3, 'date': '2020-10-02T00:00:00Z', 'journal': 'Journal of Medical Internet Research', 'title': 'CoV-Seq, a new tool for SARS-CoV-2 genome analysis and visualization: Development and usability study'}, 'type': ['Primary']}]"
114,zhf11@pitt.edu,Zhiwei Feng,Person,https://orcid.org/0000-0001-6533-8932,,,,,,virus-ckb,,zsmag19,"[{'doi': '10.1093/BIB/BBAA155', 'metadata': {'abstract': '© 2020 The Author(s) 2020. Published by Oxford University Press. All rights reserved.Given the scale and rapid spread of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is an urgent need for medicines that can help before vaccines are available. In this study, we present a viral-associated disease-specific chemogenomics knowledgebase (Virus-CKB) and apply our computational systems pharmacology-target mapping to rapidly predict the FDA-approved drugs which can quickly progress into clinical trials to meet the urgent demand of the COVID-19 outbreak. Virus-CKB reuses the underlying platform of our DAKB-GPCRs but adds new features like multiple-compound support, multi-cavity protein support and customizable symbol display. Our one-stop computing platform describes the chemical molecules, genes and proteins involved in viral-associated diseases regulation. To date, Virus-CKB archived 65 antiviral drugs in the market, 107 viral-related targets with 189 available 3D crystal or cryo-EM structures and 2698 chemical agents reported for these target proteins. Moreover, Virus-CKB is implemented with web applications for the prediction of the relevant protein targets and analysis and visualization of the outputs, including HTDocking, TargetHunter, BBB predictor, NGL Viewer, Spider Plot, etc. The Virus-CKB server is accessible at https://www.cbligand.org/g/virus-ckb.', 'authors': [{'name': 'Feng Z.'}, {'name': 'Chen M.'}, {'name': 'Liang T.'}, {'name': 'Shen M.'}, {'name': 'Chen H.'}, {'name': 'Xie X.-Q.'}], 'citationCount': 5, 'date': '2021-03-01T00:00:00Z', 'journal': 'Briefings in Bioinformatics', 'title': 'Virus-CKB: An integrated bioinformatics platform and analysis resource for COVID-19 research'}, 'pmcid': 'PMC7454273', 'pmid': '32715315'}]"
115,xix15@pitt.edu,Xiang-Qun Xie,Person,,,,,,,virus-ckb,,zsmag19,"[{'doi': '10.1093/BIB/BBAA155', 'metadata': {'abstract': '© 2020 The Author(s) 2020. Published by Oxford University Press. All rights reserved.Given the scale and rapid spread of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is an urgent need for medicines that can help before vaccines are available. In this study, we present a viral-associated disease-specific chemogenomics knowledgebase (Virus-CKB) and apply our computational systems pharmacology-target mapping to rapidly predict the FDA-approved drugs which can quickly progress into clinical trials to meet the urgent demand of the COVID-19 outbreak. Virus-CKB reuses the underlying platform of our DAKB-GPCRs but adds new features like multiple-compound support, multi-cavity protein support and customizable symbol display. Our one-stop computing platform describes the chemical molecules, genes and proteins involved in viral-associated diseases regulation. To date, Virus-CKB archived 65 antiviral drugs in the market, 107 viral-related targets with 189 available 3D crystal or cryo-EM structures and 2698 chemical agents reported for these target proteins. Moreover, Virus-CKB is implemented with web applications for the prediction of the relevant protein targets and analysis and visualization of the outputs, including HTDocking, TargetHunter, BBB predictor, NGL Viewer, Spider Plot, etc. The Virus-CKB server is accessible at https://www.cbligand.org/g/virus-ckb.', 'authors': [{'name': 'Feng Z.'}, {'name': 'Chen M.'}, {'name': 'Liang T.'}, {'name': 'Shen M.'}, {'name': 'Chen H.'}, {'name': 'Xie X.-Q.'}], 'citationCount': 5, 'date': '2021-03-01T00:00:00Z', 'journal': 'Briefings in Bioinformatics', 'title': 'Virus-CKB: An integrated bioinformatics platform and analysis resource for COVID-19 research'}, 'pmcid': 'PMC7454273', 'pmid': '32715315'}]"
116,biobai@zju.edu.cn,Youhuang Bai,Person,,,,,,,overcovid,,zsmag19,"[{'doi': '10.1093/BIB/BBAA416', 'metadata': {'abstract': ""© 2021 The Author(s) 2021. Published by Oxford University Press. All rights reserved.The coronavirus disease 2019 (COVID-19) pandemic, caused by the coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has created an unprecedented threat to public health. The pandemic has been sweeping the globe, impacting more than 200 countries, with more outbreaks still lurking on the horizon. At the time of the writing, no approved drugs or vaccines are available to treat COVID-19 patients, prompting an urgent need to decipher mechanisms underlying the pathogenesis and develop curative treatments. To fight COVID-19, researchers around the world have provided specific tools and molecular information for SARS-CoV-2. These pieces of information can be integrated to aid computational investigations and facilitate clinical research. This paper reviews current knowledge, the current status of drug development and various resources for key steps toward effective treatment of COVID-19, including the phylogenetic characteristics, genomic conservation and interaction data. The final goal of this paper is to provide information that may be utilized in bioinformatics approaches and aid target prioritization and drug repurposing. Several SARS-CoV-2-related tools/databases were reviewed, and a web-portal named OverCOVID (http://bis.zju.edu.cn/overcovid/) is constructed to provide a detailed interpretation of SARS-CoV-2 basics and share a collection of resources that may contribute to therapeutic advances. These information could improve researchers' understanding of SARS-CoV-2 and help to accelerate the development of new antiviral treatments."", 'authors': [{'name': 'Ahsan A.'}, {'name': 'Liu Y.'}, {'name': 'Feng C.'}, {'name': 'Zhou Y.'}, {'name': 'Ma G.'}, {'name': 'Bai Y.'}, {'name': 'Chen M.'}], 'date': '2021-03-01T00:00:00Z', 'journal': 'Briefings in Bioinformatics', 'title': 'Bioinformatics resources facilitate understanding and harnessing clinical research of SARS-CoV-2'}, 'pmcid': 'PMC7929412', 'pmid': '33432321'}]"
117,mchen@zju.edu.cn,Ming Chen,Person,https://orcid.org/0000-0002-9677-1699,,,,,,overcovid,,zsmag19,"[{'doi': '10.1093/BIB/BBAA416', 'metadata': {'abstract': ""© 2021 The Author(s) 2021. Published by Oxford University Press. All rights reserved.The coronavirus disease 2019 (COVID-19) pandemic, caused by the coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has created an unprecedented threat to public health. The pandemic has been sweeping the globe, impacting more than 200 countries, with more outbreaks still lurking on the horizon. At the time of the writing, no approved drugs or vaccines are available to treat COVID-19 patients, prompting an urgent need to decipher mechanisms underlying the pathogenesis and develop curative treatments. To fight COVID-19, researchers around the world have provided specific tools and molecular information for SARS-CoV-2. These pieces of information can be integrated to aid computational investigations and facilitate clinical research. This paper reviews current knowledge, the current status of drug development and various resources for key steps toward effective treatment of COVID-19, including the phylogenetic characteristics, genomic conservation and interaction data. The final goal of this paper is to provide information that may be utilized in bioinformatics approaches and aid target prioritization and drug repurposing. Several SARS-CoV-2-related tools/databases were reviewed, and a web-portal named OverCOVID (http://bis.zju.edu.cn/overcovid/) is constructed to provide a detailed interpretation of SARS-CoV-2 basics and share a collection of resources that may contribute to therapeutic advances. These information could improve researchers' understanding of SARS-CoV-2 and help to accelerate the development of new antiviral treatments."", 'authors': [{'name': 'Ahsan A.'}, {'name': 'Liu Y.'}, {'name': 'Feng C.'}, {'name': 'Zhou Y.'}, {'name': 'Ma G.'}, {'name': 'Bai Y.'}, {'name': 'Chen M.'}], 'date': '2021-03-01T00:00:00Z', 'journal': 'Briefings in Bioinformatics', 'title': 'Bioinformatics resources facilitate understanding and harnessing clinical research of SARS-CoV-2'}, 'pmcid': 'PMC7929412', 'pmid': '33432321'}]"
118,lum4003@med.cornell.edu,Luigi Marchionni,Person,,['Primary contact'],,,,,covid19census,,Kigaard,"[{'doi': '10.1093/DATABASE/BAAB027', 'metadata': {'abstract': ""© 2021 The Author(s). Published by Oxford University Press.Since the beginning of the coronavirus disease-2019 (COVID-19) pandemic in 2020, there has been a tremendous accumulation of data capturing different statistics including the number of tests, confirmed cases and deaths. This data wealth offers a great opportunity for researchers to model the effect of certain variables on COVID-19 morbidity and mortality and to get a better understanding of the disease at the epidemiological level. However, in order to draw any reliable and unbiased estimate, models also need to take into account other variables and metrics available from a plurality of official and unofficial heterogenous resources. In this study, we introduce covid19census, an R package that extracts from many different repositories and combines together COVID-19 metrics and other demographic, environment- and health-related variables of the USA and Italy at the county and regional levels, respectively. The package is equipped with a number of user-friendly functions that dynamically extract the data over different timepoints and contains a detailed description of the included variables. To demonstrate the utility of this tool, we used it to extract and combine different county-level data from the USA, which we subsequently used to model the effect of diabetes on COVID-19 mortality at the county level, taking into account other variables that may influence such effects. In conclusion, it was observed that the 'covid19census' package allows to easily extract area-level data from both the USA and Italy using few functions. These comprehensive data can be used to provide reliable estimates of the effect of certain variables on COVID-19 outcomes."", 'authors': [{'name': 'Zanettini C.'}, {'name': 'Omar M.'}, {'name': 'Dinalankara W.'}, {'name': 'Imada E.L.'}, {'name': 'Colantuoni E.'}, {'name': 'Parmigiani G.'}, {'name': 'Marchionni L.'}], 'date': '2021-01-01T00:00:00Z', 'journal': 'Database', 'title': 'Covid19census: U.S. And Italy COVID-19 metrics and other epidemiological data'}, 'pmcid': 'PMC8122363', 'pmid': '33991092', 'type': ['Primary']}]"
119,soarescmsa@gmail.com,,Person,,,,,,,er-cov,,Kigaard,[{'doi': '10.1101/2020.04.10.20061036'}]
120,thams@math.ku.dk,Nikolaj Theodor Thams,Person,,"['Primary contact', 'Developer', 'Maintainer']",,,,,ucph_covid19_dashboard,Open access,Pbm,
121,m.jakobsen@math.ku.dk,Martin Emil Jakobsen,Person,,"['Primary contact', 'Developer', 'Maintainer']",,,,,ucph_covid19_dashboard,Open access,Pbm,
122,pbm@math.ku.dk,Phillip Bredahl Mogensen,Person,,"['Primary contact', 'Developer', 'Maintainer']",,,,,ucph_covid19_dashboard,Open access,Pbm,
123,,Copenhagen Causality Lab (CoCaLa),,,['Developer'],,https://www.math.ku.dk/english/research/spt/cocala/,,,ucph_covid19_dashboard,Open access,Pbm,
124,,Johns Hopkins University,Institute,,['Provider'],,https://www.jhu.edu/,,,ucph_covid19_dashboard,Open access,Pbm,
125,,Danish State Serum Institute (SSI),,,,,https://www.ssi.dk/,,,ucph_covid19_dashboard,Open access,Pbm,
126,zicheng.hu@ucsf.edu,,Person,,,,,,,geneva,,Niclaskn,[{'doi': '10.1101/2020.10.20.20216150'}]
127,ckerr@idmod.org,,Person,,,,,,,covasim,,Kigaard,[{'doi': '10.1101/2020.05.10.20097469'}]
128,weigang@genectr.hunter.cuny.edu,Weigang Qiu,Person,,,,,,,cov-genome-tracker,,Kigaard,[{'doi': '10.1101/2020.04.10.036343'}]
129,dilie66@gmail.com,Lia Di,Person,,,,,,,cov-genome-tracker,,Kigaard,[{'doi': '10.1101/2020.04.10.036343'}]
130,indrajit@nitttrkol.ac.in,Indrajit Saha,Person,,['Primary contact'],,,,,covid-deeppredictor,Open access (with restrictions),Kigaard,"[{'doi': '10.3389/FGENE.2021.569120', 'metadata': {'abstract': '© Copyright © 2021 Saha, Ghosh, Maity, Seal and Plewczynski.The COVID-19 disease for Novel coronavirus (SARS-CoV-2) has turned out to be a global pandemic. The high transmission rate of this pathogenic virus demands an early prediction and proper identification for the subsequent treatment. However, polymorphic nature of this virus allows it to adapt and sustain in different kinds of environment which makes it difficult to predict. On the other hand, there are other pathogens like SARS-CoV-1, MERS-CoV, Ebola, Dengue, and Influenza as well, so that a predictor is highly required to distinguish them with the use of their genomic information. To mitigate this problem, in this work COVID-DeepPredictor is proposed on the framework of deep learning to identify an unknown sequence of these pathogens. COVID-DeepPredictor uses Long Short Term Memory as Recurrent Neural Network for the underlying prediction with an alignment-free technique. In this regard, k-mer technique is applied to create Bag-of-Descriptors (BoDs) in order to generate Bag-of-Unique-Descriptors (BoUDs) as vocabulary and subsequently embedded representation is prepared for the given virus sequences. This predictor is not only validated for the dataset using (Formula presented.) -fold cross-validation but also for unseen test datasets of SARS-CoV-2 sequences and sequences from other viruses as well. To verify the efficacy of COVID-DeepPredictor, it has been compared with other state-of-the-art prediction techniques based on Linear Discriminant Analysis, Random Forests, and Gradient Boosting Method. COVID-DeepPredictor achieves 100% prediction accuracy on validation dataset while on test datasets, the accuracy ranges from 99.51 to 99.94%. It shows superior results over other prediction techniques as well. In addition to this, accuracy and runtime of COVID-DeepPredictor are considered simultaneously to determine the value of k in k-mer, a comparative study among k values in k-mer, Bag-of-Descriptors (BoDs), and Bag-of-Unique-Descriptors (BoUDs) and a comparison between COVID-DeepPredictor and Nucleotide BLAST have also been performed. The code, training, and test datasets used for COVID-DeepPredictor are available at http://www.nitttrkol.ac.in/indrajit/projects/COVID-DeepPredictor/.', 'authors': [{'name': 'Saha I.'}, {'name': 'Ghosh N.'}, {'name': 'Maity D.'}, {'name': 'Seal A.'}, {'name': 'Plewczynski D.'}], 'date': '2021-02-11T00:00:00Z', 'journal': 'Frontiers in Genetics', 'title': 'COVID-DeepPredictor: Recurrent Neural Network to Predict SARS-CoV-2 and Other Pathogenic Viruses'}, 'pmcid': 'PMC7906283', 'pmid': '33643375', 'type': ['Primary']}]"
131,raghava@iiitd.ac.in,Gajendra P.S. Raghava,Person,,,,,,,coronavir,,Kigaard,"[{'doi': '10.1089/MAB.2020.0035', 'metadata': {'abstract': '© 2020 Mary Ann Liebert, Inc. publishers.A web-based resource CoronaVIR (http://webs.iiitd.edu.in/raghava/coronavir/) has been developed to maintain the predicted and existing information on coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We have integrated multiple modules, including ""Genomics,""""Diagnosis,""""Immunotherapy,""and ""Drug Designing""to understand the holistic view of this pandemic medical disaster. The genomics module provides genomic information of different strains of this virus to understand genomic level alterations. The diagnosis module includes detailed information on currently-in-use diagnostics tests as well as five novel universal primer sets predicted using in silico tools. The Immunotherapy module provides information on epitope-based potential vaccine candidates (e.g., LQLPQGTTLPKGFYA, VILLNKHIDAYKTFPPTEPKKDKKKK, EITVATSRTLS, GKGQQQQGQTV, SELVIGAVILR) predicted using state-of-the-art software and resources in the field of immune informatics. These epitopes have the potential to activate both adaptive (e.g., B cell and T cell) and innate (e.g., vaccine adjuvants) immune systems as well as suitable for all strains of SARS-CoV-2. Besides, we have also predicted potential candidates for siRNA-based therapy and RNA-based vaccine adjuvants. The drug designing module maintains information about potential drug targets, tertiary structures, and potential drug molecules. These potential drug molecules were identified from FDA-approved drugs using the docking-based approach. We also compiled information from the literature and Internet on potential drugs, repurposing drugs, and monoclonal antibodies. To understand host-virus interaction, we identified cell-penetrating peptides in the virus. In this study, state-of-the-art techniques have been used for predicting the potential candidates for diagnostics and therapeutics.', 'authors': [{'name': 'Patiyal S.'}, {'name': 'Kaur D.'}, {'name': 'Kaur H.'}, {'name': 'Sharma N.'}, {'name': 'Dhall A.'}, {'name': 'Sahai S.'}, {'name': 'Agrawal P.'}, {'name': 'Maryam L.'}, {'name': 'Arora C.'}, {'name': 'Raghava G.P.S.'}], 'citationCount': 2, 'date': '2020-12-01T00:00:00Z', 'journal': 'Monoclonal Antibodies in Immunodiagnosis and Immunotherapy', 'title': 'A Web-Based Platform on Coronavirus Disease-19 to Maintain Predicted Diagnostic, Drug, and Vaccine Candidates'}, 'pmid': '33136473'}]"
132,Daniel.ward1@lshtm.ac.uk,Daniel Ward,Person,,,,,,,immuno-analytics,,Niclaskn,[{'doi': '10.1101/2020.05.11.089409'}]
133,Taane.clark@lshtm.ac.uk,Taane G Clark,Person,,,,,,,immuno-analytics,,Niclaskn,[{'doi': '10.1101/2020.05.11.089409'}]
134,dominik.heider@uni-marburg.de,Dominik Heider,Person,,,,,,,cordite,Open access,Kigaard,"[{'doi': '10.1016/J.ISCI.2020.101297', 'metadata': {'abstract': '© 2020 The AuthorsSince the outbreak in 2019, researchers are trying to find effective drugs against the SARS-CoV-2 virus based on de novo drug design and drug repurposing. The former approach is very time consuming and needs extensive testing in humans, whereas drug repurposing is more promising, as the drugs have already been tested for side effects, etc. At present, there is no treatment for COVID-19 that is clinically effective, but there is a huge amount of data from studies that analyze potential drugs. We developed CORDITE to efficiently combine state-of-the-art knowledge on potential drugs and make it accessible to scientists and clinicians. The web interface also provides access to an easy-to-use API that allows a wide use for other software and applications, e.g., for meta-analysis, design of new clinical studies, or simple literature search. CORDITE is currently empowering many scientists across all continents and accelerates research in the knowledge domains of virology and drug design. © 2020 The AuthorsMedicine; Virology; Drugs; Bioinformatics; Biological Database', 'authors': [{'name': 'Martin R.'}, {'name': 'Lochel H.F.'}, {'name': 'Welzel M.'}, {'name': 'Hattab G.'}, {'name': 'Hauschild A.-C.'}, {'name': 'Heider D.'}], 'citationCount': 7, 'date': '2020-07-24T00:00:00Z', 'journal': 'iScience', 'title': 'CORDITE: The Curated CORona Drug InTERactions Database for SARS-CoV-2'}, 'pmcid': 'PMC7305714', 'pmid': '32619700'}]"
135,,rki.de,Institute,,['Provider'],,,,,vipr,,dabrowskiw@rki.de,"[{'doi': '10.1093/nar/gkr859', 'metadata': {'abstract': ""The Virus Pathogen Database and Analysis Resource (ViPR, www.ViPRbrc.org) is an integrated repository of data and analysis tools for multiple virus families, supported by the National Institute of Allergy and Infectious Diseases (NIAID) Bioinformatics Resource Centers (BRC) program. ViPR contains information for human pathogenic viruses belonging to the Arenaviridae, Bunyaviridae, Caliciviridae, Coronaviridae, Flaviviridae, Filoviridae, Hepeviridae, Herpesviridae, Paramyxoviridae, Picornaviridae, Poxviridae, Reoviridae, Rhabdoviridae and Togaviridae families, with plans to support additional virus families in the future. ViPR captures various types of information, including sequence records, gene and protein annotations, 3D protein structures, immune epitope locations, clinical and surveillance metadata and novel data derived from comparative genomics analysis. Analytical and visualization tools for metadata-driven statistical sequence analysis, multiple sequence alignment, phylogenetic tree construction, BLAST comparison and sequence variation determination are also provided. Data filtering and analysis workflows can be combined and the results saved in personal 'Workbenches' for future use. ViPR tools and data are available without charge as a service to the virology research community to help facilitate the development of diagnostics, prophylactics and therapeutics for priority pathogens and other viruses. © The Author(s) 2011."", 'authors': [{'name': 'Pickett B.E.'}, {'name': 'Sadat E.L.'}, {'name': 'Zhang Y.'}, {'name': 'Noronha J.M.'}, {'name': 'Squires R.B.'}, {'name': 'Hunt V.'}, {'name': 'Liu M.'}, {'name': 'Kumar S.'}, {'name': 'Zaremba S.'}, {'name': 'Gu Z.'}, {'name': 'Zhou L.'}, {'name': 'Larson C.N.'}, {'name': 'Dietrich J.'}, {'name': 'Klem E.B.'}, {'name': 'Scheuermann R.H.'}], 'citationCount': 316, 'date': '2012-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'ViPR: An open bioinformatics database and analysis resource for virology research'}, 'pmcid': 'PMC3245011', 'pmid': '22006842', 'type': ['Primary']}, {'metadata': {'abstract': ""Several viruses within the Coronaviridae family have been categorized as either emerging or re-emerging human pathogens, with Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) being the most well known. The NIAID-sponsored Virus Pathogen Database and Analysis Resource (ViPR, www.viprbrc.org) supports bioinformatics workflows for a broad range of human virus pathogens and other related viruses, including the entire Coronaviridae family. ViPR provides access to sequence records, gene and protein annotations, immune epitopes, 3D structures, host factor data, and other data types through an intuitive web-based search interface. Records returned from these queries can then be subjected to web-based analyses including: multiple sequence alignment, phylogenetic inference, sequence variation determination, BLAST comparison, and metadata-driven comparative genomics statistical analysis. Additional tools exist to display multiple sequence alignments, view phylogenetic trees, visualize 3D protein structures, transfer existing reference genome annotations to new genomes, and store or share results from any search or analysis within personal private 'Workbench' spaces for future access. All of the data and integrated analysis and visualization tools in ViPR are made available without charge as a service to the Coronaviridae research community to facilitate the research and development of diagnostics, prophylactics, vaccines and therapeutics against these human pathogens. © 2012 by the authors; licensee MDPI, Basel, Switzerland."", 'authors': [{'name': 'Pickett B.E.'}, {'name': 'Greer D.S.'}, {'name': 'Zhang Y.'}, {'name': 'Stewart L.'}, {'name': 'Zhou L.'}, {'name': 'Sun G.'}, {'name': 'Gu Z.'}, {'name': 'Kumar S.'}, {'name': 'Zaremba S.'}, {'name': 'Larsen C.N.'}, {'name': 'Jen W.'}, {'name': 'Klem E.B.'}, {'name': 'Scheuermann R.H.'}], 'citationCount': 65, 'date': '2012-11-01T00:00:00Z', 'journal': 'Viruses', 'title': 'Virus pathogen Database and Analysis Resource (ViPR): A comprehensive bioinformatics Database and Analysis Resource for the Coronavirus research community'}, 'pmid': '23202522', 'type': ['Other']}]"
136,,,Person,,['Primary contact'],,http://www.viprbrc.org/brc/staticContent.spg?decorator=vipr&type=ViprInfo&subtype=Team,,,vipr,,dabrowskiw@rki.de,"[{'doi': '10.1093/nar/gkr859', 'metadata': {'abstract': ""The Virus Pathogen Database and Analysis Resource (ViPR, www.ViPRbrc.org) is an integrated repository of data and analysis tools for multiple virus families, supported by the National Institute of Allergy and Infectious Diseases (NIAID) Bioinformatics Resource Centers (BRC) program. ViPR contains information for human pathogenic viruses belonging to the Arenaviridae, Bunyaviridae, Caliciviridae, Coronaviridae, Flaviviridae, Filoviridae, Hepeviridae, Herpesviridae, Paramyxoviridae, Picornaviridae, Poxviridae, Reoviridae, Rhabdoviridae and Togaviridae families, with plans to support additional virus families in the future. ViPR captures various types of information, including sequence records, gene and protein annotations, 3D protein structures, immune epitope locations, clinical and surveillance metadata and novel data derived from comparative genomics analysis. Analytical and visualization tools for metadata-driven statistical sequence analysis, multiple sequence alignment, phylogenetic tree construction, BLAST comparison and sequence variation determination are also provided. Data filtering and analysis workflows can be combined and the results saved in personal 'Workbenches' for future use. ViPR tools and data are available without charge as a service to the virology research community to help facilitate the development of diagnostics, prophylactics and therapeutics for priority pathogens and other viruses. © The Author(s) 2011."", 'authors': [{'name': 'Pickett B.E.'}, {'name': 'Sadat E.L.'}, {'name': 'Zhang Y.'}, {'name': 'Noronha J.M.'}, {'name': 'Squires R.B.'}, {'name': 'Hunt V.'}, {'name': 'Liu M.'}, {'name': 'Kumar S.'}, {'name': 'Zaremba S.'}, {'name': 'Gu Z.'}, {'name': 'Zhou L.'}, {'name': 'Larson C.N.'}, {'name': 'Dietrich J.'}, {'name': 'Klem E.B.'}, {'name': 'Scheuermann R.H.'}], 'citationCount': 316, 'date': '2012-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'ViPR: An open bioinformatics database and analysis resource for virology research'}, 'pmcid': 'PMC3245011', 'pmid': '22006842', 'type': ['Primary']}, {'metadata': {'abstract': ""Several viruses within the Coronaviridae family have been categorized as either emerging or re-emerging human pathogens, with Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) being the most well known. The NIAID-sponsored Virus Pathogen Database and Analysis Resource (ViPR, www.viprbrc.org) supports bioinformatics workflows for a broad range of human virus pathogens and other related viruses, including the entire Coronaviridae family. ViPR provides access to sequence records, gene and protein annotations, immune epitopes, 3D structures, host factor data, and other data types through an intuitive web-based search interface. Records returned from these queries can then be subjected to web-based analyses including: multiple sequence alignment, phylogenetic inference, sequence variation determination, BLAST comparison, and metadata-driven comparative genomics statistical analysis. Additional tools exist to display multiple sequence alignments, view phylogenetic trees, visualize 3D protein structures, transfer existing reference genome annotations to new genomes, and store or share results from any search or analysis within personal private 'Workbench' spaces for future access. All of the data and integrated analysis and visualization tools in ViPR are made available without charge as a service to the Coronaviridae research community to facilitate the research and development of diagnostics, prophylactics, vaccines and therapeutics against these human pathogens. © 2012 by the authors; licensee MDPI, Basel, Switzerland."", 'authors': [{'name': 'Pickett B.E.'}, {'name': 'Greer D.S.'}, {'name': 'Zhang Y.'}, {'name': 'Stewart L.'}, {'name': 'Zhou L.'}, {'name': 'Sun G.'}, {'name': 'Gu Z.'}, {'name': 'Kumar S.'}, {'name': 'Zaremba S.'}, {'name': 'Larsen C.N.'}, {'name': 'Jen W.'}, {'name': 'Klem E.B.'}, {'name': 'Scheuermann R.H.'}], 'citationCount': 65, 'date': '2012-11-01T00:00:00Z', 'journal': 'Viruses', 'title': 'Virus pathogen Database and Analysis Resource (ViPR): A comprehensive bioinformatics Database and Analysis Resource for the Coronavirus research community'}, 'pmid': '23202522', 'type': ['Other']}]"
137,bpickett@jcvi.org,Brett Pickett,Person,http://orcid.org/0000-0001-7930-8160,['Primary contact'],,,,,vipr,,dabrowskiw@rki.de,"[{'doi': '10.1093/nar/gkr859', 'metadata': {'abstract': ""The Virus Pathogen Database and Analysis Resource (ViPR, www.ViPRbrc.org) is an integrated repository of data and analysis tools for multiple virus families, supported by the National Institute of Allergy and Infectious Diseases (NIAID) Bioinformatics Resource Centers (BRC) program. ViPR contains information for human pathogenic viruses belonging to the Arenaviridae, Bunyaviridae, Caliciviridae, Coronaviridae, Flaviviridae, Filoviridae, Hepeviridae, Herpesviridae, Paramyxoviridae, Picornaviridae, Poxviridae, Reoviridae, Rhabdoviridae and Togaviridae families, with plans to support additional virus families in the future. ViPR captures various types of information, including sequence records, gene and protein annotations, 3D protein structures, immune epitope locations, clinical and surveillance metadata and novel data derived from comparative genomics analysis. Analytical and visualization tools for metadata-driven statistical sequence analysis, multiple sequence alignment, phylogenetic tree construction, BLAST comparison and sequence variation determination are also provided. Data filtering and analysis workflows can be combined and the results saved in personal 'Workbenches' for future use. ViPR tools and data are available without charge as a service to the virology research community to help facilitate the development of diagnostics, prophylactics and therapeutics for priority pathogens and other viruses. © The Author(s) 2011."", 'authors': [{'name': 'Pickett B.E.'}, {'name': 'Sadat E.L.'}, {'name': 'Zhang Y.'}, {'name': 'Noronha J.M.'}, {'name': 'Squires R.B.'}, {'name': 'Hunt V.'}, {'name': 'Liu M.'}, {'name': 'Kumar S.'}, {'name': 'Zaremba S.'}, {'name': 'Gu Z.'}, {'name': 'Zhou L.'}, {'name': 'Larson C.N.'}, {'name': 'Dietrich J.'}, {'name': 'Klem E.B.'}, {'name': 'Scheuermann R.H.'}], 'citationCount': 316, 'date': '2012-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'ViPR: An open bioinformatics database and analysis resource for virology research'}, 'pmcid': 'PMC3245011', 'pmid': '22006842', 'type': ['Primary']}, {'metadata': {'abstract': ""Several viruses within the Coronaviridae family have been categorized as either emerging or re-emerging human pathogens, with Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) being the most well known. The NIAID-sponsored Virus Pathogen Database and Analysis Resource (ViPR, www.viprbrc.org) supports bioinformatics workflows for a broad range of human virus pathogens and other related viruses, including the entire Coronaviridae family. ViPR provides access to sequence records, gene and protein annotations, immune epitopes, 3D structures, host factor data, and other data types through an intuitive web-based search interface. Records returned from these queries can then be subjected to web-based analyses including: multiple sequence alignment, phylogenetic inference, sequence variation determination, BLAST comparison, and metadata-driven comparative genomics statistical analysis. Additional tools exist to display multiple sequence alignments, view phylogenetic trees, visualize 3D protein structures, transfer existing reference genome annotations to new genomes, and store or share results from any search or analysis within personal private 'Workbench' spaces for future access. All of the data and integrated analysis and visualization tools in ViPR are made available without charge as a service to the Coronaviridae research community to facilitate the research and development of diagnostics, prophylactics, vaccines and therapeutics against these human pathogens. © 2012 by the authors; licensee MDPI, Basel, Switzerland."", 'authors': [{'name': 'Pickett B.E.'}, {'name': 'Greer D.S.'}, {'name': 'Zhang Y.'}, {'name': 'Stewart L.'}, {'name': 'Zhou L.'}, {'name': 'Sun G.'}, {'name': 'Gu Z.'}, {'name': 'Kumar S.'}, {'name': 'Zaremba S.'}, {'name': 'Larsen C.N.'}, {'name': 'Jen W.'}, {'name': 'Klem E.B.'}, {'name': 'Scheuermann R.H.'}], 'citationCount': 65, 'date': '2012-11-01T00:00:00Z', 'journal': 'Viruses', 'title': 'Virus pathogen Database and Analysis Resource (ViPR): A comprehensive bioinformatics Database and Analysis Resource for the Coronavirus research community'}, 'pmid': '23202522', 'type': ['Other']}]"
138,,rki.de,Institute,,['Provider'],,,,,evag,,dabrowskiw@rki.de,"[{'doi': '10.1016/j.antiviral.2012.05.005', 'metadata': {'abstract': 'The European Virus Archive (EVA) was conceived as a direct response to the need for a coordinated and readily accessible collection of viruses that could be made available to academia, public health organisations and industry, initially within Europe, but ultimately throughout the world. Although scientists worldwide have accumulated virus collections since the early twentieth century, the quality of the collections and the viruses collected may vary according to the personal interests and agenda of the scientists. Moreover, when laboratories are re-organised or closed, collections are no longer maintained and gradually cease to exist. The tragedy of 9/11 and other disruptive activities have also meant that some previously available biological reagents are no longer openly exchanged between countries. In 2008, funding under the FP7-EU infrastructure programme enabled the initiation of the EVA. Within three years, it has developed from a consortium of nine European laboratories to encompass associated partners in Africa, Russia, China, Turkey, Germany and Italy. There is every reason to believe that EVA will continue to expand and ultimately exist as a globally networked, quality-controlled non-profit archive for the benefit of science. Organizations or individuals who would like to be considered as contributors are invited to contact the EVA coordinator, Jean-Louis Romette, at jean-louis.romette@univmed.fr. © 2012 Elsevier B.V..', 'authors': [{'name': 'Gould E.A.'}, {'name': 'de Lamballerie X.'}, {'name': 'Coutard B.'}, {'name': 'Fooks A.R.'}, {'name': 'Outlaw M.'}, {'name': 'Drosten C.'}, {'name': 'Guenther S.'}, {'name': 'Klempa B.'}, {'name': 'Pinschewer D.'}, {'name': 'Avsic-Zupanc T.'}, {'name': 'Sabeta C.'}, {'name': 'Lukashev A.'}, {'name': 'Eropkin M.'}, {'name': 'Koslov A.'}, {'name': 'Zverev V.'}, {'name': 'Lvov D.'}, {'name': 'Zhebrun A.'}, {'name': 'Shipulin G.'}, {'name': 'Niedrig M.'}, {'name': 'Gao Fu G.'}, {'name': 'Dong Liang G.'}, {'name': 'Ippolito G.'}, {'name': 'Koray E.'}, {'name': 'Romette J.L.'}], 'citationCount': 9, 'date': '2012-08-01T00:00:00Z', 'journal': 'Antiviral Research', 'title': 'The European Virus Archive: A new resource for virology research'}, 'pmid': '22626637', 'type': ['Primary']}]"
139,,,Person,,['Primary contact'],,http://www.european-virus-archive.com/contact-us,,,evag,,dabrowskiw@rki.de,"[{'doi': '10.1016/j.antiviral.2012.05.005', 'metadata': {'abstract': 'The European Virus Archive (EVA) was conceived as a direct response to the need for a coordinated and readily accessible collection of viruses that could be made available to academia, public health organisations and industry, initially within Europe, but ultimately throughout the world. Although scientists worldwide have accumulated virus collections since the early twentieth century, the quality of the collections and the viruses collected may vary according to the personal interests and agenda of the scientists. Moreover, when laboratories are re-organised or closed, collections are no longer maintained and gradually cease to exist. The tragedy of 9/11 and other disruptive activities have also meant that some previously available biological reagents are no longer openly exchanged between countries. In 2008, funding under the FP7-EU infrastructure programme enabled the initiation of the EVA. Within three years, it has developed from a consortium of nine European laboratories to encompass associated partners in Africa, Russia, China, Turkey, Germany and Italy. There is every reason to believe that EVA will continue to expand and ultimately exist as a globally networked, quality-controlled non-profit archive for the benefit of science. Organizations or individuals who would like to be considered as contributors are invited to contact the EVA coordinator, Jean-Louis Romette, at jean-louis.romette@univmed.fr. © 2012 Elsevier B.V..', 'authors': [{'name': 'Gould E.A.'}, {'name': 'de Lamballerie X.'}, {'name': 'Coutard B.'}, {'name': 'Fooks A.R.'}, {'name': 'Outlaw M.'}, {'name': 'Drosten C.'}, {'name': 'Guenther S.'}, {'name': 'Klempa B.'}, {'name': 'Pinschewer D.'}, {'name': 'Avsic-Zupanc T.'}, {'name': 'Sabeta C.'}, {'name': 'Lukashev A.'}, {'name': 'Eropkin M.'}, {'name': 'Koslov A.'}, {'name': 'Zverev V.'}, {'name': 'Lvov D.'}, {'name': 'Zhebrun A.'}, {'name': 'Shipulin G.'}, {'name': 'Niedrig M.'}, {'name': 'Gao Fu G.'}, {'name': 'Dong Liang G.'}, {'name': 'Ippolito G.'}, {'name': 'Koray E.'}, {'name': 'Romette J.L.'}], 'citationCount': 9, 'date': '2012-08-01T00:00:00Z', 'journal': 'Antiviral Research', 'title': 'The European Virus Archive: A new resource for virology research'}, 'pmid': '22626637', 'type': ['Primary']}]"
140,,rki.de,Institute,,['Provider'],,,,,ictv,,dabrowskiw@rki.de,"[{'doi': '10.1007/s00705-016-2977-6', 'metadata': {'abstract': '© 2016, Springer-Verlag Wien.This article lists the changes to virus taxonomy approved and ratified by the International Committee on Taxonomy of Viruses (ICTV) in April 2016. Changes to virus taxonomy (the Universal Scheme of Virus Classification of the International Committee on Taxonomy of Viruses [ICTV]) now take place annually and are the result of a multi-stage process. In accordance with the ICTV Statutes (http://www.ictvonline.org/statutes.asp), proposals submitted to the ICTV Executive Committee (EC) undergo a review process that involves input from the ICTV Study Groups (SGs) and Subcommittees (SCs), other interested virologists, and the EC. After final approval by the EC, proposals are then presented for ratification to the full ICTV membership by publication on an ICTV web site (http://www.ictvonline.org/) followed by an electronic vote. The latest set of proposals approved by the EC was made available on the ICTV website by January 2016 (https://talk.ictvonline.org/files/proposals/). A list of these proposals was then emailed on 28 March 2016 to the 148 members of ICTV, namely the EC Members, Life Members, ICTV Subcommittee Members (including the SG chairs) and ICTV National Representatives. Members were then requested to vote on whether to ratify the taxonomic proposals (voting closed on 29 April 2016).', 'authors': [{'name': 'Adams M.J.'}, {'name': 'Lefkowitz E.J.'}, {'name': 'King A.M.Q.'}, {'name': 'Harrach B.'}, {'name': 'Harrison R.L.'}, {'name': 'Knowles N.J.'}, {'name': 'Kropinski A.M.'}, {'name': 'Krupovic M.'}, {'name': 'Kuhn J.H.'}, {'name': 'Mushegian A.R.'}, {'name': 'Nibert M.'}, {'name': 'Sabanadzovic S.'}, {'name': 'Sanfacon H.'}, {'name': 'Siddell S.G.'}, {'name': 'Simmonds P.'}, {'name': 'Varsani A.'}, {'name': 'Zerbini F.M.'}, {'name': 'Gorbalenya A.E.'}, {'name': 'Davison A.J.'}], 'citationCount': 179, 'date': '2016-10-01T00:00:00Z', 'journal': 'Archives of Virology', 'title': 'Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2016)'}, 'type': ['Primary']}]"
141,info@ictvonline.org,,Person,,['Primary contact'],,,,,ictv,,dabrowskiw@rki.de,"[{'doi': '10.1007/s00705-016-2977-6', 'metadata': {'abstract': '© 2016, Springer-Verlag Wien.This article lists the changes to virus taxonomy approved and ratified by the International Committee on Taxonomy of Viruses (ICTV) in April 2016. Changes to virus taxonomy (the Universal Scheme of Virus Classification of the International Committee on Taxonomy of Viruses [ICTV]) now take place annually and are the result of a multi-stage process. In accordance with the ICTV Statutes (http://www.ictvonline.org/statutes.asp), proposals submitted to the ICTV Executive Committee (EC) undergo a review process that involves input from the ICTV Study Groups (SGs) and Subcommittees (SCs), other interested virologists, and the EC. After final approval by the EC, proposals are then presented for ratification to the full ICTV membership by publication on an ICTV web site (http://www.ictvonline.org/) followed by an electronic vote. The latest set of proposals approved by the EC was made available on the ICTV website by January 2016 (https://talk.ictvonline.org/files/proposals/). A list of these proposals was then emailed on 28 March 2016 to the 148 members of ICTV, namely the EC Members, Life Members, ICTV Subcommittee Members (including the SG chairs) and ICTV National Representatives. Members were then requested to vote on whether to ratify the taxonomic proposals (voting closed on 29 April 2016).', 'authors': [{'name': 'Adams M.J.'}, {'name': 'Lefkowitz E.J.'}, {'name': 'King A.M.Q.'}, {'name': 'Harrach B.'}, {'name': 'Harrison R.L.'}, {'name': 'Knowles N.J.'}, {'name': 'Kropinski A.M.'}, {'name': 'Krupovic M.'}, {'name': 'Kuhn J.H.'}, {'name': 'Mushegian A.R.'}, {'name': 'Nibert M.'}, {'name': 'Sabanadzovic S.'}, {'name': 'Sanfacon H.'}, {'name': 'Siddell S.G.'}, {'name': 'Simmonds P.'}, {'name': 'Varsani A.'}, {'name': 'Zerbini F.M.'}, {'name': 'Gorbalenya A.E.'}, {'name': 'Davison A.J.'}], 'citationCount': 179, 'date': '2016-10-01T00:00:00Z', 'journal': 'Archives of Virology', 'title': 'Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2016)'}, 'type': ['Primary']}]"
142,xqxia@ihb.ac.cn,,Person,,['Primary contact'],,http://bioinfo.ihb.ac.cn/seq2hosts/,,,seq2hosts,,mbs_import,"[{'metadata': {'abstract': 'Many coronaviruses are capable of interspecies transmission. Some of them have caused worldwide panic as emerging human pathogens in recent years, e.g., severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). In order to assess their threat to humans, we explored to infer the potential hosts of coronaviruses using a dual-model approach based on nineteen parameters computed from spike genes of coronaviruses. Both the support vector machine (SVM) model and the Mahalanobis distance (MD) discriminant model achieved high accuracies in leave-one-out cross-validation of training data consisting of 730 representative coronaviruses (99.86% and 98.08% respectively). Predictions on 47 additional coronaviruses precisely conformed to conclusions or speculations by other researchers. Our approach is implemented as a web server that can be accessed at http://bioinfo.ihb.ac.cn/seq2hosts.', 'authors': [{'name': 'Tang Q.'}, {'name': 'Song Y.'}, {'name': 'Shi M.'}, {'name': 'Cheng Y.'}, {'name': 'Zhang W.'}, {'name': 'Xia X.-Q.'}], 'citationCount': 44, 'date': '2015-11-26T00:00:00Z', 'journal': 'Scientific Reports', 'title': 'Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition'}, 'pmid': '26607834'}]"
143,,Alberto Calderone,Person,,['Developer'],,,,,virusmentha,,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gku830', 'metadata': {'abstract': '© The Author(s) 2014.Viral infections often cause diseases by perturbing several cellular processes in the infected host. Viral proteins target host proteins and either form new complexes or modulate the formation of functional host complexes. Describing and understanding the perturbation of the host interactome following viral infection is essential for basic virology and for the development of antiviral therapies. In order to provide a general overview of such interactions, a few years ago we developed VirusMINT. We have now extended the scope and coverage of VirusMINT and established VirusMentha, a new virus-virus and virus-host interaction resource build on the detailed curation protocols of the IMEx consortium and on the integration strategies developed for mentha. Virus-Mentha is regularly and automatically updated every week by capturing, via the PSICQUIC protocol, interactions curated by five different databases that are part of the IMEx consortium. VirusMentha can be freely browsed at http://virusmentha.uniroma2.it/and its complete data set is available for download.', 'authors': [{'name': 'Calderone A.'}, {'name': 'Licata L.'}, {'name': 'Cesareni G.'}], 'citationCount': 71, 'date': '2015-01-28T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'VirusMentha: A new resource for virus-host protein interactions'}, 'pmcid': 'PMC4384001', 'pmid': '25217587', 'type': ['Primary']}]"
144,,"Molecular Genetic Group, University of Rome ""Tor Vergata"", Rome, Italy",Institute,,['Provider'],,,,,virusmentha,,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gku830', 'metadata': {'abstract': '© The Author(s) 2014.Viral infections often cause diseases by perturbing several cellular processes in the infected host. Viral proteins target host proteins and either form new complexes or modulate the formation of functional host complexes. Describing and understanding the perturbation of the host interactome following viral infection is essential for basic virology and for the development of antiviral therapies. In order to provide a general overview of such interactions, a few years ago we developed VirusMINT. We have now extended the scope and coverage of VirusMINT and established VirusMentha, a new virus-virus and virus-host interaction resource build on the detailed curation protocols of the IMEx consortium and on the integration strategies developed for mentha. Virus-Mentha is regularly and automatically updated every week by capturing, via the PSICQUIC protocol, interactions curated by five different databases that are part of the IMEx consortium. VirusMentha can be freely browsed at http://virusmentha.uniroma2.it/and its complete data set is available for download.', 'authors': [{'name': 'Calderone A.'}, {'name': 'Licata L.'}, {'name': 'Cesareni G.'}], 'citationCount': 71, 'date': '2015-01-28T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'VirusMentha: A new resource for virus-host protein interactions'}, 'pmcid': 'PMC4384001', 'pmid': '25217587', 'type': ['Primary']}]"
145,,ELIXIR-ITA-TORVERGATA,Institute,,['Provider'],,,,,virusmentha,,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gku830', 'metadata': {'abstract': '© The Author(s) 2014.Viral infections often cause diseases by perturbing several cellular processes in the infected host. Viral proteins target host proteins and either form new complexes or modulate the formation of functional host complexes. Describing and understanding the perturbation of the host interactome following viral infection is essential for basic virology and for the development of antiviral therapies. In order to provide a general overview of such interactions, a few years ago we developed VirusMINT. We have now extended the scope and coverage of VirusMINT and established VirusMentha, a new virus-virus and virus-host interaction resource build on the detailed curation protocols of the IMEx consortium and on the integration strategies developed for mentha. Virus-Mentha is regularly and automatically updated every week by capturing, via the PSICQUIC protocol, interactions curated by five different databases that are part of the IMEx consortium. VirusMentha can be freely browsed at http://virusmentha.uniroma2.it/and its complete data set is available for download.', 'authors': [{'name': 'Calderone A.'}, {'name': 'Licata L.'}, {'name': 'Cesareni G.'}], 'citationCount': 71, 'date': '2015-01-28T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'VirusMentha: A new resource for virus-host protein interactions'}, 'pmcid': 'PMC4384001', 'pmid': '25217587', 'type': ['Primary']}]"
146,sinnefa@gmail.com,Alberto Calderone,Person,,['Primary contact'],,,,,virusmentha,,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gku830', 'metadata': {'abstract': '© The Author(s) 2014.Viral infections often cause diseases by perturbing several cellular processes in the infected host. Viral proteins target host proteins and either form new complexes or modulate the formation of functional host complexes. Describing and understanding the perturbation of the host interactome following viral infection is essential for basic virology and for the development of antiviral therapies. In order to provide a general overview of such interactions, a few years ago we developed VirusMINT. We have now extended the scope and coverage of VirusMINT and established VirusMentha, a new virus-virus and virus-host interaction resource build on the detailed curation protocols of the IMEx consortium and on the integration strategies developed for mentha. Virus-Mentha is regularly and automatically updated every week by capturing, via the PSICQUIC protocol, interactions curated by five different databases that are part of the IMEx consortium. VirusMentha can be freely browsed at http://virusmentha.uniroma2.it/and its complete data set is available for download.', 'authors': [{'name': 'Calderone A.'}, {'name': 'Licata L.'}, {'name': 'Cesareni G.'}], 'citationCount': 71, 'date': '2015-01-28T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'VirusMentha: A new resource for virus-host protein interactions'}, 'pmcid': 'PMC4384001', 'pmid': '25217587', 'type': ['Primary']}]"
147,luana.licata@gmail.com,Luana Licata,Person,,['Primary contact'],,,,,virusmentha,,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gku830', 'metadata': {'abstract': '© The Author(s) 2014.Viral infections often cause diseases by perturbing several cellular processes in the infected host. Viral proteins target host proteins and either form new complexes or modulate the formation of functional host complexes. Describing and understanding the perturbation of the host interactome following viral infection is essential for basic virology and for the development of antiviral therapies. In order to provide a general overview of such interactions, a few years ago we developed VirusMINT. We have now extended the scope and coverage of VirusMINT and established VirusMentha, a new virus-virus and virus-host interaction resource build on the detailed curation protocols of the IMEx consortium and on the integration strategies developed for mentha. Virus-Mentha is regularly and automatically updated every week by capturing, via the PSICQUIC protocol, interactions curated by five different databases that are part of the IMEx consortium. VirusMentha can be freely browsed at http://virusmentha.uniroma2.it/and its complete data set is available for download.', 'authors': [{'name': 'Calderone A.'}, {'name': 'Licata L.'}, {'name': 'Cesareni G.'}], 'citationCount': 71, 'date': '2015-01-28T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'VirusMentha: A new resource for virus-host protein interactions'}, 'pmcid': 'PMC4384001', 'pmid': '25217587', 'type': ['Primary']}]"
148,,Gianni Cesareni,Person,,['Contributor'],,,,,virusmentha,,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gku830', 'metadata': {'abstract': '© The Author(s) 2014.Viral infections often cause diseases by perturbing several cellular processes in the infected host. Viral proteins target host proteins and either form new complexes or modulate the formation of functional host complexes. Describing and understanding the perturbation of the host interactome following viral infection is essential for basic virology and for the development of antiviral therapies. In order to provide a general overview of such interactions, a few years ago we developed VirusMINT. We have now extended the scope and coverage of VirusMINT and established VirusMentha, a new virus-virus and virus-host interaction resource build on the detailed curation protocols of the IMEx consortium and on the integration strategies developed for mentha. Virus-Mentha is regularly and automatically updated every week by capturing, via the PSICQUIC protocol, interactions curated by five different databases that are part of the IMEx consortium. VirusMentha can be freely browsed at http://virusmentha.uniroma2.it/and its complete data set is available for download.', 'authors': [{'name': 'Calderone A.'}, {'name': 'Licata L.'}, {'name': 'Cesareni G.'}], 'citationCount': 71, 'date': '2015-01-28T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'VirusMentha: A new resource for virus-host protein interactions'}, 'pmcid': 'PMC4384001', 'pmid': '25217587', 'type': ['Primary']}]"
149,,Torsten Seemann,Person,,['Developer'],,,,,prokka,,griffinp@unimelb.edu.au,"[{'doi': '10.1093/bioinformatics/btu153', 'metadata': {'abstract': 'The multiplex capability and high yield of current day DNA-sequencing instruments has made bacterial whole genome sequencing a routine affair. The subsequent de novo assembly of reads into contigs has been well addressed. The final step of annotating all relevant genomic features on those contigs can be achieved slowly using existing web- and email-based systems, but these are not applicable for sensitive data or integrating into computational pipelines. Here we introduce Prokka, a command line software tool to fully annotate a draft bacterial genome in about 10 min on a typical desktop computer. It produces standards-compliant output files for further analysis or viewing in genome browsers. © 2014 The Author 2014.', 'authors': [{'name': 'Seemann T.'}], 'citationCount': 4834, 'date': '2014-07-15T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'Prokka: Rapid prokaryotic genome annotation'}, 'pmid': '24642063', 'type': ['Primary']}]"
150,,"University of Melbourne, Australia",Institute,,['Provider'],,,,,prokka,,griffinp@unimelb.edu.au,"[{'doi': '10.1093/bioinformatics/btu153', 'metadata': {'abstract': 'The multiplex capability and high yield of current day DNA-sequencing instruments has made bacterial whole genome sequencing a routine affair. The subsequent de novo assembly of reads into contigs has been well addressed. The final step of annotating all relevant genomic features on those contigs can be achieved slowly using existing web- and email-based systems, but these are not applicable for sensitive data or integrating into computational pipelines. Here we introduce Prokka, a command line software tool to fully annotate a draft bacterial genome in about 10 min on a typical desktop computer. It produces standards-compliant output files for further analysis or viewing in genome browsers. © 2014 The Author 2014.', 'authors': [{'name': 'Seemann T.'}], 'citationCount': 4834, 'date': '2014-07-15T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'Prokka: Rapid prokaryotic genome annotation'}, 'pmid': '24642063', 'type': ['Primary']}]"
151,,unimelb.edu.au,Institute,,['Provider'],,,,,prokka,,griffinp@unimelb.edu.au,"[{'doi': '10.1093/bioinformatics/btu153', 'metadata': {'abstract': 'The multiplex capability and high yield of current day DNA-sequencing instruments has made bacterial whole genome sequencing a routine affair. The subsequent de novo assembly of reads into contigs has been well addressed. The final step of annotating all relevant genomic features on those contigs can be achieved slowly using existing web- and email-based systems, but these are not applicable for sensitive data or integrating into computational pipelines. Here we introduce Prokka, a command line software tool to fully annotate a draft bacterial genome in about 10 min on a typical desktop computer. It produces standards-compliant output files for further analysis or viewing in genome browsers. © 2014 The Author 2014.', 'authors': [{'name': 'Seemann T.'}], 'citationCount': 4834, 'date': '2014-07-15T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'Prokka: Rapid prokaryotic genome annotation'}, 'pmid': '24642063', 'type': ['Primary']}]"
152,torsten.seemann@gmail.com,Torsten Seemann,Person,,['Primary contact'],,https://github.com/tseeeman/prokka/issues,,,prokka,,griffinp@unimelb.edu.au,"[{'doi': '10.1093/bioinformatics/btu153', 'metadata': {'abstract': 'The multiplex capability and high yield of current day DNA-sequencing instruments has made bacterial whole genome sequencing a routine affair. The subsequent de novo assembly of reads into contigs has been well addressed. The final step of annotating all relevant genomic features on those contigs can be achieved slowly using existing web- and email-based systems, but these are not applicable for sensitive data or integrating into computational pipelines. Here we introduce Prokka, a command line software tool to fully annotate a draft bacterial genome in about 10 min on a typical desktop computer. It produces standards-compliant output files for further analysis or viewing in genome browsers. © 2014 The Author 2014.', 'authors': [{'name': 'Seemann T.'}], 'citationCount': 4834, 'date': '2014-07-15T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'Prokka: Rapid prokaryotic genome annotation'}, 'pmid': '24642063', 'type': ['Primary']}]"
153,,Australia,Person,,['Primary contact'],,https://github.com/tseeeman/prokka/issues,,,prokka,,griffinp@unimelb.edu.au,"[{'doi': '10.1093/bioinformatics/btu153', 'metadata': {'abstract': 'The multiplex capability and high yield of current day DNA-sequencing instruments has made bacterial whole genome sequencing a routine affair. The subsequent de novo assembly of reads into contigs has been well addressed. The final step of annotating all relevant genomic features on those contigs can be achieved slowly using existing web- and email-based systems, but these are not applicable for sensitive data or integrating into computational pipelines. Here we introduce Prokka, a command line software tool to fully annotate a draft bacterial genome in about 10 min on a typical desktop computer. It produces standards-compliant output files for further analysis or viewing in genome browsers. © 2014 The Author 2014.', 'authors': [{'name': 'Seemann T.'}], 'citationCount': 4834, 'date': '2014-07-15T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'Prokka: Rapid prokaryotic genome annotation'}, 'pmid': '24642063', 'type': ['Primary']}]"
154,cupton@uvic.ca,Viral Bioinformatics Resource Center,Person,,['Primary contact'],,,,,viral_bioinformatics,,ELIXIR-EE,"[{'metadata': {'abstract': 'Background: Since DNA sequencing has become easier and cheaper, an increasing number of closely related viral genomes have been sequenced. However, many of these have been deposited in GenBank without annotations, severely limiting their value to researchers. While maintaining comprehensive genomic databases for a set of virus families at the Viral Bioinformatics Resource Center http://www.biovirus.org and Viral Bioinformatics - Canada http://www.virology.ca, we found that researchers were unnecessarily spending time annotating viral genomes that were close relatives of already annotated viruses. We have therefore designed and implemented a novel tool, Genome Annotation Transfer Utility (GATU), to transfer annotations from a previously annotated reference genome to a new target genome, thereby greatly reducing this laborious task. Results: GATU transfers annotations from a reference genome to a closely related target genome, while still giving the user final control over which annotations should be included. GATU also detects open reading frames present in the target but not the reference genome and provides the user with a variety of bioinformatics tools to quickly determine if these ORFs should also be included in the annotation. After this process is complete, GATU saves the newly annotated genome as a GenBank, EMBL or XML-format file. The software is coded in Java and runs on a variety of computer platforms. Its user-friendly Graphical User Interface is specifically designed for users trained in the biological sciences. Conclusion: GATU greatly simplifies the initial stages of genome annotation by using a closely related genome as a reference. It is not intended to be a gene prediction tool or a ""complete"" annotation system, but we have found that it significantly reduces the time required for annotation of genes and mature peptides as well as helping to standardize gene names between related organisms by transferring reference genome annotations to the target genome. The program is freely available under the General Public License and can be accessed along with documentation and tutorial from http://www.virology.ca/gatu. © 2006 Tcherepanov et al; licensee BioMed Central Ltd.', 'authors': [{'name': 'Tcherepanov V.'}, {'name': 'Ehlers A.'}, {'name': 'Upton C.'}], 'citationCount': 153, 'date': '2006-06-13T00:00:00Z', 'journal': 'BMC Genomics', 'title': 'Genome annotation transfer utility (GATU): Rapid annotation of viral genomes using a closely related reference genome'}, 'pmid': '16772042'}, {'metadata': {'abstract': 'The Viral Genome DataBase (VGDB) contains detailed information of the genes and predicted protein sequences from 15 completely sequenced genomes of large (>100 kb) viruses (2847 genes). The data that is stored includes DNA sequence, protein sequence, Gen-Bank and user-entered notes, molecular weight (MW), isoelectric point (pI), amino acid content, A + T%, nucleotide frequency, dinucleotide frequency and codon use. The VGDB is a mySQL database with a user-friendly JAVA GUI. Results of queries can be easily sorted by any of the individual parameters. Availability: The software and additional figures and information are available at http://athena.bioc.uvic.ca/genomes/index.html.', 'authors': [{'name': 'Hiscock D.'}, {'name': 'Upton C.'}], 'citationCount': 26, 'date': '2000-01-01T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'Viral genome database: Storing and analyzing genes and proteins from complete viral genomes'}, 'pmid': '10871272'}, {'metadata': {'abstract': 'Poxvirus Orthologous Clusters (POCs) is a JAVA client-server application which accesses an updated database containing all complete poxvirus genomes; it automatically groups orthologous genes into families based on BLASTP scores for assessment by a human database curator. POCs has a user-friendly interface permitting complex SQL queries to retrieve interesting groups of DNA and protein sequences as well as gene families for subsequent interrogation by a variety of integrated tools: BLASTP, BLASTX, TBLASTN, Jalview (multiple alignment), Dotlet (Dotplot), Laj (local alignment), and NAP (nucleotide to amino acid alignment). © Oxford University Press 2002.', 'authors': [{'name': 'Ehlers A.'}, {'name': 'Osborne J.'}, {'name': 'Slack S.'}, {'name': 'Roper R.L.'}, {'name': 'Upton C.'}], 'citationCount': 49, 'date': '2002-11-01T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'Poxvirus Orthologous Clusters (POCs)'}, 'pmid': '12424130'}, {'metadata': {'abstract': 'Rabbitpox virus (RPXV) is highly virulent for rabbits and it has long been suspected to be a close relative of vaccinia virus. To explore these questions, the complete coding region of the rabbitpox virus genome was sequenced to permit comparison with sequenced strains of vaccinia virus and other orthopoxviruses. The genome of RPXV strain Utrecht (RPXV-UTR) is 197 731 nucleotides long, excluding the terminal hairpin structures at each end of the genome. The RPXV-UTR genome has 66.5 % A+T content, 184 putative functional genes and 12 fragmented ORF regions that are intact in other orthopoxviruses. The sequence of the RPXV-UTR genome reveals that two RPXV-UTR genes have orthologues in variola virus (VARV; the causative agent of smallpox), but not in vaccinia virus (VACV) strains. These genes are a zinc RING finger protein gene (RPXV-UTR-008) and an ankyrin repeat family protein gene (RPXV-UTR-180). A third gene, encoding a chemokine-binding protein (RPXV-UTR-001/184), is complete in VARV but functional only in some VACV strains. Examination of the evolutionary relationship between RPXV and other orthopoxviruses was carried out using the central 143 kb DNA sequence conserved among all completely sequenced orthopoxviruses and also the protein sequences of 49 gene products present in all completely sequenced chordopoxviruses. The results of these analyses both confirm that RPXV-UTR is most closely related to VACV and suggest that RPXV has not evolved directly from any of the sequenced VACV strains, since RPXV contains a 719 bp region not previously identified in any VACV. © 2005 SGM.', 'authors': [{'name': 'Li G.'}, {'name': 'Chen N.'}, {'name': 'Roper R.L.'}, {'name': 'Feng Z.'}, {'name': 'Hunter A.'}, {'name': 'Danila M.'}, {'name': 'Lefkowitz E.J.'}, {'name': 'Buller R.M.L.'}, {'name': 'Upton C.'}], 'citationCount': 37, 'date': '2005-11-01T00:00:00Z', 'journal': 'Journal of General Virology', 'title': 'Complete coding sequences of the rabbitpox virus genome'}, 'pmid': '16227218'}, {'metadata': {'abstract': 'Background: With ever increasing numbers of closely related virus genomes being sequenced, it has become desirable to be able to compare two genomes at a level more detailed than gene content because two strains of an organism may share the same set of predicted genes but still differ in their pathogenicity profiles. For example, detailed comparison of multiple isolates of the smallpox virus genome (each approximately 200 kb, with 200 genes) is not feasible without new bioinformatics tools. Results: A software package, Base-By-Base, has been developed that provides visualization tools to enable researchers to 1) rapidly identify and correct alignment errors in large, multiple genome alignments; and 2) generate tabular and graphical output of differences between the genomes at the nucleotide level. Base-By-Base uses detailed annotation information about the aligned genomes and can list each predicted gene with nucleotide differences, display whether variations occur within promoter regions or coding regions and whether these changes result in amino acid substitutions. Base-By-Base can connect to our mySQL database (Virus Orthologous Clusters; VOCs) to retrieve detailed annotation information about the aligned genomes or use information from text files. Conclusion: Base-By-Base enables users to quickly and easily compare large viral genomes; it highlights small differences that may be responsible for important phenotypic differences such as virulence. It is available via the Internet using Java Web Start and runs on Macintosh, PC and Linux operating systems with the Java 1.4 virtual machine. © 2004 Brodie et al; licensee BioMed Central Ltd.', 'authors': [{'name': 'Brodie R.'}, {'name': 'Smith A.J.'}, {'name': 'Roper R.L.'}, {'name': 'Tcherepanov V.'}, {'name': 'Upton C.'}], 'citationCount': 59, 'date': '2004-07-14T00:00:00Z', 'journal': 'BMC Bioinformatics', 'title': 'Base-By-Base: Single nucleotide-level analysis of whole viral genome alignments'}, 'pmid': '15253776'}, {'metadata': {'abstract': 'Summary: Java-Dotter (JDotter) is a platform-independent Java interactive interface for the Linux version of Dotter, a widely used program for generating dotplots of large DNA or protein sequences. JDotter runs as a client-server application and can send new sequences to the Dotter program for alignment as well as rapidly access a repository of preprocessed dotplots. JDotter also interfaces with a sequence database or file system to display supplementary feature data. Thus, JDotter greatly simplifies access to dotplot data in laboratories that deal with large numbers of genomes and have a multi-platform organization.', 'authors': [{'name': 'Brodie R.'}, {'name': 'Roper R.L.'}, {'name': 'Upton C.'}], 'citationCount': 85, 'date': '2004-01-22T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'JDotter: A Java interface to multiple dotplots generated by dotter'}, 'pmid': '14734323'}, {'metadata': {'abstract': 'The viral genome organizer (VGO) is designed to simplify the characterization and annotation of complete viral genomes (particularly those of large poxviruses) and to help researchers discover new genes and detect gene fragmentation. VGO is based on Genotator [Harris, N.L., 1997. Genome Res. 7, 754-762], an annotation workbench designed for the analysis of eukaryotic genomic sequences. VGO automates a number of database search routines (FASTA, BLASTP, PSI-BLAST and TBLASTN), processes the results through a multiple-alignment viewer (MView; [Brown, N.P., Leroy, C., Sander, C., 1998. Bioinformatics 14, 380-381]) and serves to manage the hundreds of DNA, protein and database search results files that must be organized when dealing with large complete poxviral genomes. It also directs the generation a self-dotplot of the genome by Dotter [Sonnhammer, E.L.L., Durbin, R., 1995. A dot-matrix program with dynamic threshold control suited for genomic DNA and protein sequence analysis. Gene 167: GC1-10. http://www.sanger.ac.uk/Software/Dotter/] to uncover repeated genes and sequences and provides Internet links to programs for generation of restriction maps and analysis of potential PCR primers. The user-friendly graphical interface displays DNA and protein sequences, links to search results, ORFs, stop-start codons, restriction sites and flags of database searches. Currently, VGO and associated programs run in an X-windows environment on commonly available UNIX machines. (C) 2000 Elsevier Science B.V.', 'authors': [{'name': 'Upton C.'}, {'name': 'Hogg D.'}, {'name': 'Perrin D.'}, {'name': 'Boone M.'}, {'name': 'Harris N.L.'}], 'citationCount': 43, 'date': '2000-11-22T00:00:00Z', 'journal': 'Virus Research', 'title': 'Viral genome organizer: A system for analyzing complete viral genomes'}, 'pmid': '11074125'}, {'metadata': {'abstract': 'The analysis of poxvirus genomes is complex, in part, because of their size (130-360 kb) and the fact that gene content is variable; a common set of 49 genes has been found in all sequenced poxviruses and an additional 41 genes are also present in all sequenced orthopoxviruses. As a group, poxviruses have a very broad range of eukaryotic hosts (including mammals, birds, reptiles and insects) and many poxvirus genes are associated with blocking host anti-viral responses. One consequence of this is that many poxvirus genes are not essential for growth in tissue culture and that extensive passaging in vitro results in the accumulation of mutations, including deletions that result in loss of gene function. Here, we review various comparative analyses of the poxviruses including gene prediction, gene conservation and function, genome organization, and poxvirus taxonomy and evolution. © 2006 Elsevier B.V. All rights reserved.', 'authors': [{'name': 'Lefkowitz E.J.'}, {'name': 'Wang C.'}, {'name': 'Upton C.'}], 'citationCount': 106, 'date': '2006-01-01T00:00:00Z', 'journal': 'Virus Research', 'title': 'Poxviruses: Past, present and future'}, 'pmid': '16503070'}, {'metadata': {'abstract': 'Viruses are much smaller than prokaryotes and eukaryotes, and it is now practical to sequence closely related members of virus families, strains, or even different isolates recovered during the course of an outbreak. However, comparative analysis of viral genomes requires the development of novel bioinformatics tools that allow us to align, edit, compare and interact with these genomes at all levels, from whole genome, to gene family, to single nucleotide polymorphisms. Comparative viral genomics can lead to the identification of the core characteristics that define a virus family, as well as the unique properties of viral species or isolates that contribute to variations in pathogenesis, This paper describes a number of tools, mainly developed for Viral Bioinformatics - Canada, that can be used for annotation and comparative genomic analysis of poxviruses. Nonetheless, these tools are also broadly applicable to other virus families. © 2005 Future Medicine Ltd.', 'authors': [{'name': 'Esteban D.J.'}, {'name': 'Da Silva M.'}, {'name': 'Upton C.'}], 'citationCount': 11, 'date': '2005-04-01T00:00:00Z', 'journal': 'Pharmacogenomics', 'title': 'New bioinformatics tools for viral genome analyses at Viral Bioinformatics - Canada'}, 'pmid': '16013958'}, {'metadata': {'abstract': 'Background: Sequence similarity searching is a powerful tool to help develop hypotheses in the quest to assign functional, structural and evolutionary information to DNA and protein sequences. As sequence databases continue to grow exponentially, it becomes increasingly important to repeat searches at frequent intervals, and similarity searches retrieve larger and larger sets of results. New and potentially significant results may be buried in a long list of previously obtained sequence hits from past searches. Results: ReHAB (Recent Hits Acquired from BLAST) is a tool for finding new protein hits in repeated PSI-BLAST searches. ReHAB compares results from PSI-BLAST searches performed with two versions of a protein sequence database and highlights hits that are present only in the updated database. Results are presented in an easily comprehended table, or in a BLAST-like report, using colors to highlight the new hits. ReHAB is designed to handle large numbers of query sequences, such as whole genomes or sets of genomes. Advanced computer skills are not needed to use ReHAB; the graphics interface is simple to use and was designed with the bench biologist in mind. Conclusions: This software greatly simplifies the problem of evaluating the output of large numbers of protein database searches. © 2005 Whitney et al; licensee BioMed Central Ltd.', 'authors': [{'name': 'Whitney J.'}, {'name': 'Esteban D.J.'}, {'name': 'Upton C.'}], 'citationCount': 11, 'date': '2005-02-08T00:00:00Z', 'journal': 'BMC Bioinformatics', 'title': 'Recent Hits Acquired by BLAST (ReHAB): A tool to indentify new hits in sequence similarity searches'}, 'pmid': '15701178'}, {'metadata': {'abstract': 'Increasingly complex bioinformatic analysis is necessitated by the plethora of sequence information currently available. A total of 21 poxvirus genomes have now been completely sequenced and annotated, and many more genomes will be available in the next few years. First, we describe the creation of a database of continuously corrected and updated genome sequences and an easy-to-use and extremely powerful suite of software tools for the analysis of genomes, genes, and proteins. These tools are available free to all researchers and, in most cases, alleviate the need for using multiple Internet sites for analysis. Further, we describe the use of these programs to identify conserved families of genes (poxvirus orthologous clusters) and have named the software suite POCs, which is available at www.poxvirus.org. Using POCs, we have identified a set of 49 absolutely conserved gene families - those which are conserved between the highly diverged families of insect-infecting entomopoxviruses and vertebrate-infecting chordopoxviruses. An additional set of 41 gene families conserved in chordopoxviruses was also identified. Thus, 90 genes are completely conserved in chordopoxviruses and comprise the minimum essential genome, and these will make excellent drug, antibody, vaccine, and detection targets. Finally, we describe the use of these tools to identify necessary annotation and sequencing updates in poxvirus genomes. For example, using POCs, we identified 19 genes that were widely conserved in poxviruses but missing from the vaccinia virus strain Tian Tan 1998 GenBank file. We have reannotated and resequenced fragments of this genome and verified that these genes are conserved in Tiau Tan. The results for poxvirus genes and genomes are discussed in light of evolutionary processes.', 'authors': [{'name': 'Upton C.'}, {'name': 'Slack S.'}, {'name': 'Hunter A.L.'}, {'name': 'Ehlers A.'}, {'name': 'Roper R.L.'}], 'citationCount': 195, 'date': '2003-07-01T00:00:00Z', 'journal': 'Journal of Virology', 'title': 'Poxvirus orthologous clusters: Toward defining the minimum essential poxvirus genome'}, 'pmid': '12805459'}]"
155,joaomiguelsov@gmail.com,João Carneiro,Person,,['Primary contact'],,,,,cov2id,Open access,fpereira,
156,fpereirapt@gmail.com,Filipe Pereira,,,,,http://portugene.com/fpereira.html,,,cov2id,Open access,fpereira,
157,,Nicholas Loman,Person,https://orcid.org/0000-0002-9843-8988,['Developer'],,,,,artic,Open access,dfornika,
158,,Will Rowe,Person,https://orcid.org/0000-0003-0384-4463,['Developer'],,,,,artic,Open access,dfornika,
159,yuri.pirola@unimib.it,Yuri Pirola,Person,https://orcid.org/0000-0002-8479-7592,['Maintainer'],,https://algolab.eu/pirola,,,malvirus,Open access,yp,"[{'doi': '10.1101/2020.05.05.076992', 'type': ['Primary'], 'version': '1.0.1'}]"
160,covidep@ust.hk,,Person,,['Support'],,,,,covidep,Open access,ahmedaq,"[{'doi': '10.1038/s41596-020-0358-9', 'metadata': {'authors': [{'name': 'Ahmed S.F.'}, {'name': 'Quadeer A.A.'}, {'name': 'McKay M.R.'}], 'citationCount': 16, 'date': '2020-07-01T00:00:00Z', 'journal': 'Nature Protocols', 'title': 'COVIDep: a web-based platform for real-time reporting of vaccine target recommendations for SARS-CoV-2'}, 'note': 'Ahmed, S.F., Quadeer, A.A. & McKay, M.R. COVIDep: a web-based platform for real-time reporting of vaccine target recommendations for SARS-CoV-2. Nature Protocols (2020).', 'pmcid': 'PMC7299140', 'pmid': '32555466', 'type': ['Primary']}]"
161,,Jörn Starruß,Person,https://orcid.org/0000-0003-3649-2433,['Developer'],,,,,morpheus-framework,Open access,lutz.brusch,"[{'doi': '10.1093/bioinformatics/btt772', 'metadata': {'abstract': 'Summary: Morpheus is a modeling environment for the simulation and integration of cell-based models with ordinary differential equations and reaction-diffusion systems. It allows rapid development of multiscale models in biological terms and mathematical expressions rather than programming code. Its graphical user interface supports the entire workflow from model construction and simulation to visualization, archiving and batch processing. © The Author 2013. Published by Oxford University Press.', 'authors': [{'name': 'Starruss J.'}, {'name': 'De Back W.'}, {'name': 'Brusch L.'}, {'name': 'Deutsch A.'}], 'citationCount': 92, 'date': '2014-05-01T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'Morpheus: A user-friendly modeling environment for multiscale and multicellular systems biology'}, 'pmcid': 'PMC3998129', 'pmid': '24443380', 'type': ['Primary']}]"
162,,Walter de Back,Person,https://orcid.org/0000-0003-4641-8472,['Developer'],,,,,morpheus-framework,Open access,lutz.brusch,"[{'doi': '10.1093/bioinformatics/btt772', 'metadata': {'abstract': 'Summary: Morpheus is a modeling environment for the simulation and integration of cell-based models with ordinary differential equations and reaction-diffusion systems. It allows rapid development of multiscale models in biological terms and mathematical expressions rather than programming code. Its graphical user interface supports the entire workflow from model construction and simulation to visualization, archiving and batch processing. © The Author 2013. Published by Oxford University Press.', 'authors': [{'name': 'Starruss J.'}, {'name': 'De Back W.'}, {'name': 'Brusch L.'}, {'name': 'Deutsch A.'}], 'citationCount': 92, 'date': '2014-05-01T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'Morpheus: A user-friendly modeling environment for multiscale and multicellular systems biology'}, 'pmcid': 'PMC3998129', 'pmid': '24443380', 'type': ['Primary']}]"
163,lutz.brusch@tu-dresden.de,Lutz Brusch,Person,https://orcid.org/0000-0003-0137-5106,['Primary contact'],PI and coordinator,https://imc.zih.tu-dresden.de/imc/index.php?page=members&who=brusch,,,morpheus-framework,Open access,lutz.brusch,"[{'doi': '10.1093/bioinformatics/btt772', 'metadata': {'abstract': 'Summary: Morpheus is a modeling environment for the simulation and integration of cell-based models with ordinary differential equations and reaction-diffusion systems. It allows rapid development of multiscale models in biological terms and mathematical expressions rather than programming code. Its graphical user interface supports the entire workflow from model construction and simulation to visualization, archiving and batch processing. © The Author 2013. Published by Oxford University Press.', 'authors': [{'name': 'Starruss J.'}, {'name': 'De Back W.'}, {'name': 'Brusch L.'}, {'name': 'Deutsch A.'}], 'citationCount': 92, 'date': '2014-05-01T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'Morpheus: A user-friendly modeling environment for multiscale and multicellular systems biology'}, 'pmcid': 'PMC3998129', 'pmid': '24443380', 'type': ['Primary']}]"
164,,Andreas Deutsch,Person,https://orcid.org/0000-0002-9005-6897,['Contributor'],,,,,morpheus-framework,Open access,lutz.brusch,"[{'doi': '10.1093/bioinformatics/btt772', 'metadata': {'abstract': 'Summary: Morpheus is a modeling environment for the simulation and integration of cell-based models with ordinary differential equations and reaction-diffusion systems. It allows rapid development of multiscale models in biological terms and mathematical expressions rather than programming code. Its graphical user interface supports the entire workflow from model construction and simulation to visualization, archiving and batch processing. © The Author 2013. Published by Oxford University Press.', 'authors': [{'name': 'Starruss J.'}, {'name': 'De Back W.'}, {'name': 'Brusch L.'}, {'name': 'Deutsch A.'}], 'citationCount': 92, 'date': '2014-05-01T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'Morpheus: A user-friendly modeling environment for multiscale and multicellular systems biology'}, 'pmcid': 'PMC3998129', 'pmid': '24443380', 'type': ['Primary']}]"
165,,Deutsche Forschungsgemeinschaft (DFG),Funding agency,,['Support'],,https://gepris.dfg.de/gepris/projekt/391070520,,,morpheus-framework,Open access,lutz.brusch,"[{'doi': '10.1093/bioinformatics/btt772', 'metadata': {'abstract': 'Summary: Morpheus is a modeling environment for the simulation and integration of cell-based models with ordinary differential equations and reaction-diffusion systems. It allows rapid development of multiscale models in biological terms and mathematical expressions rather than programming code. Its graphical user interface supports the entire workflow from model construction and simulation to visualization, archiving and batch processing. © The Author 2013. Published by Oxford University Press.', 'authors': [{'name': 'Starruss J.'}, {'name': 'De Back W.'}, {'name': 'Brusch L.'}, {'name': 'Deutsch A.'}], 'citationCount': 92, 'date': '2014-05-01T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'Morpheus: A user-friendly modeling environment for multiscale and multicellular systems biology'}, 'pmcid': 'PMC3998129', 'pmid': '24443380', 'type': ['Primary']}]"
166,,Technische Universität Dresden,Institute,,['Support'],,https://tu-dresden.de/,,,morpheus-framework,Open access,lutz.brusch,"[{'doi': '10.1093/bioinformatics/btt772', 'metadata': {'abstract': 'Summary: Morpheus is a modeling environment for the simulation and integration of cell-based models with ordinary differential equations and reaction-diffusion systems. It allows rapid development of multiscale models in biological terms and mathematical expressions rather than programming code. Its graphical user interface supports the entire workflow from model construction and simulation to visualization, archiving and batch processing. © The Author 2013. Published by Oxford University Press.', 'authors': [{'name': 'Starruss J.'}, {'name': 'De Back W.'}, {'name': 'Brusch L.'}, {'name': 'Deutsch A.'}], 'citationCount': 92, 'date': '2014-05-01T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'Morpheus: A user-friendly modeling environment for multiscale and multicellular systems biology'}, 'pmcid': 'PMC3998129', 'pmid': '24443380', 'type': ['Primary']}]"
167,imichalop@bioacademy.gr,Ioannis Michalopoulos,Person,http://orcid.org/0000-0001-8991-8712,['Primary contact'],,https://www.michalopoulos.net/,,,hgca,Open access,imichalop@bioacademy.gr,"[{'doi': '10.1186/1756-0500-5-265', 'metadata': {'abstract': 'Background: Bioinformatics and high-throughput technologies such as microarray studies allow the measure of the expression levels of large numbers of genes simultaneously, thus helping us to understand the molecular mechanisms of various biological processes in a cell. Findings: We calculate the Pearson Correlation Coefficient (r-value) between probe set signal values from Affymetrix Human Genome Microarray samples and cluster the human genes according to the r-value correlation matrix using the Neighbour Joining (NJ) clustering method. A hyper-geometric distribution is applied on the text annotations of the probe sets to quantify the term overrepresentations. The aim of the tool is the identification of closely correlated genes for a given gene of interest and/or the prediction of its biological function, which is based on the annotations of the respective gene cluster. Conclusion: Human Gene Correlation Analysis (HGCA) is a tool to classify human genes according to their coexpression levels and to identify overrepresented annotation terms in correlated gene groups. It is available at: http://biobank-informatics.bioacademy.gr/coexpression/. © 2012 Michalopoulos et al.: licensee BioMed Central Ltd.', 'authors': [{'name': 'Michalopoulos I.'}, {'name': 'Pavlopoulos G.A.'}, {'name': 'Malatras A.'}, {'name': 'Karelas A.'}, {'name': 'Kostadima M.-A.'}, {'name': 'Schneider R.'}, {'name': 'Kossida S.'}], 'citationCount': 18, 'date': '2012-06-08T00:00:00Z', 'journal': 'BMC Research Notes', 'title': 'Human gene correlation analysis (HGCA): A tool for the identification of transcriptionally co-expressed genes'}, 'pmcid': 'PMC3441226', 'pmid': '22672625', 'type': ['Primary']}]"
168,gang.wu@stjude.org,Gang Wu,Person,,,,,,,idcov,,Niclaskn,[{'doi': '10.1101/2020.10.08.330456'}]
169,Ravi.Kant@helsinki.fi,Ravi Kant,Person,,,,,,,havoc,,Niclaskn,[{'doi': '10.1101/2021.02.12.431018'}]
170,Teemu.Smura@helsinki.fi,Teemu Smura,Person,,,,,,,havoc,,Niclaskn,[{'doi': '10.1101/2021.02.12.431018'}]
171,tlb20@cam.ac.uk,Tom L Blundell,Person,,,,,,,sarscov23ddatabase,,zsmag19,"[{'doi': '10.1093/BIB/BBAA404', 'metadata': {'abstract': '© 2021 The Author(s) 2021. Published by Oxford University Press.The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly growing infectious disease, widely spread with high mortality rates. Since the release of the SARS-CoV-2 genome sequence in March 2020, there has been an international focus on developing target-based drug discovery, which also requires knowledge of the 3D structure of the proteome. Where there are no experimentally solved structures, our group has created 3D models with coverage of 97.5% and characterized them using state-of-the-art computational approaches. Models of protomers and oligomers, together with predictions of substrate and allosteric binding sites, protein-ligand docking, SARS-CoV-2 protein interactions with human proteins, impacts of mutations, and mapped solved experimental structures are freely available for download. These are implemented in SARS CoV-2 3D, a comprehensive and user-friendly database, available at https://sars3d.com/. This provides essential information for drug discovery, both to evaluate targets and design new potential therapeutics.', 'authors': [{'name': 'Alsulami A.F.'}, {'name': 'Thomas S.E.'}, {'name': 'Jamasb A.R.'}, {'name': 'Beaudoin C.A.'}, {'name': 'Moghul I.'}, {'name': 'Bannerman B.'}, {'name': 'Copoiu L.'}, {'name': 'Vedithi S.C.'}, {'name': 'Torres P.'}, {'name': 'Blundell T.L.'}], 'citationCount': 1, 'date': '2021-03-01T00:00:00Z', 'journal': 'Briefings in Bioinformatics', 'title': 'SARS-CoV-2 3D database: Understanding the coronavirus proteome and evaluating possible drug targets'}, 'pmcid': 'PMC7929435', 'pmid': '33416848'}]"
172,lucelia.santi@ufrgs.br,Lucélia Santi,Person,,,,,,,sarscovidb,,zsmag19,"[{'doi': '10.1021/ACSOMEGA.0C05701', 'metadata': {'abstract': '© 2021 The Authors. Published by American Chemical Society.The COVID-19 pandemic caused by the new coronavirus (SARS-CoV-2) has become a global emergency issue for public health. This threat has led to an acceleration in related research and, consequently, an unprecedented volume of clinical and experimental data that include changes in gene expression resulting from infection. The SARS-CoV-2 infection database (SARSCOVIDB: https://sarscovidb.org/) was created to mitigate the difficulties related to this scenario. The SARSCOVIDB is an online platform that aims to integrate all differential gene expression data, at messenger RNA and protein levels, helping to speed up analysis and research on the molecular impact of COVID-19. The database can be searched from different experimental perspectives and presents all related information from published data, such as viral strains, hosts, methodological approaches (proteomics or transcriptomics), genes/proteins, and samples (clinical or experimental). All information was taken from 24 articles related to analyses of differential gene expression out of 5,554 COVID-19/SARS-CoV-2-related articles published so far. The database features 12,535 genes whose expression has been identified as altered due to SARS-CoV-2 infection. Thus, the SARSCOVIDB is a new resource to support the health workers and the scientific community in understanding the pathogenesis and molecular impact caused by SARS-CoV-2.', 'authors': [{'name': 'Da Rosa R.L.'}, {'name': 'Yang T.S.'}, {'name': 'Tureta E.F.'}, {'name': 'De Oliveira L.R.S.'}, {'name': 'Moraes A.N.S.'}, {'name': 'Tatara J.M.'}, {'name': 'Costa R.P.'}, {'name': 'Borges J.S.'}, {'name': 'Alves C.I.'}, {'name': 'Berger M.'}, {'name': 'Guimaraes J.A.'}, {'name': 'Santi L.'}, {'name': 'Beys-Da-Silva W.O.'}], 'date': '2021-02-02T00:00:00Z', 'journal': 'ACS Omega', 'title': 'SARSCOVIDB - A New Platform for the Analysis of the Molecular Impact of SARS-CoV-2 Viral Infection'}, 'pmcid': 'PMC7839156', 'pmid': '33553941'}]"
173,walter.beys@ufrgs.br,Walter Orlando Beys-da-Silva,Person,,,,,,,sarscovidb,,zsmag19,"[{'doi': '10.1021/ACSOMEGA.0C05701', 'metadata': {'abstract': '© 2021 The Authors. Published by American Chemical Society.The COVID-19 pandemic caused by the new coronavirus (SARS-CoV-2) has become a global emergency issue for public health. This threat has led to an acceleration in related research and, consequently, an unprecedented volume of clinical and experimental data that include changes in gene expression resulting from infection. The SARS-CoV-2 infection database (SARSCOVIDB: https://sarscovidb.org/) was created to mitigate the difficulties related to this scenario. The SARSCOVIDB is an online platform that aims to integrate all differential gene expression data, at messenger RNA and protein levels, helping to speed up analysis and research on the molecular impact of COVID-19. The database can be searched from different experimental perspectives and presents all related information from published data, such as viral strains, hosts, methodological approaches (proteomics or transcriptomics), genes/proteins, and samples (clinical or experimental). All information was taken from 24 articles related to analyses of differential gene expression out of 5,554 COVID-19/SARS-CoV-2-related articles published so far. The database features 12,535 genes whose expression has been identified as altered due to SARS-CoV-2 infection. Thus, the SARSCOVIDB is a new resource to support the health workers and the scientific community in understanding the pathogenesis and molecular impact caused by SARS-CoV-2.', 'authors': [{'name': 'Da Rosa R.L.'}, {'name': 'Yang T.S.'}, {'name': 'Tureta E.F.'}, {'name': 'De Oliveira L.R.S.'}, {'name': 'Moraes A.N.S.'}, {'name': 'Tatara J.M.'}, {'name': 'Costa R.P.'}, {'name': 'Borges J.S.'}, {'name': 'Alves C.I.'}, {'name': 'Berger M.'}, {'name': 'Guimaraes J.A.'}, {'name': 'Santi L.'}, {'name': 'Beys-Da-Silva W.O.'}], 'date': '2021-02-02T00:00:00Z', 'journal': 'ACS Omega', 'title': 'SARSCOVIDB - A New Platform for the Analysis of the Molecular Impact of SARS-CoV-2 Viral Infection'}, 'pmcid': 'PMC7839156', 'pmid': '33553941'}]"
174,foldxwebmaster@crg.es,Webmaster,Consortium,,['Maintainer'],,,,,foldx,Open access (with restrictions),ELIXIR-EE,"[{'metadata': {'abstract': '© 2019 The Author(s) 2019. Published by Oxford University Press.A new version of FoldX, whose main new features allows running classic FoldX commands on structures containing RNA molecules and includes a module that allows parametrization of ligands or small molecules (ParamX) that were not previously recognized in old versions, has been released. An extended FoldX graphical user interface has also being developed (available as a python plugin for the YASARA molecular viewer) allowing user-friendly parametrization of new custom user molecules encoded using JSON format. Availability and implementation: http://foldxsuite.crg.eu/', 'authors': [{'name': 'Delgado J.'}, {'name': 'Radusky L.G.'}, {'name': 'Cianferoni D.'}, {'name': 'Serrano L.'}], 'citationCount': 38, 'date': '2019-10-15T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'FoldX 5.0: Working with RNA, small molecules and a new graphical interface'}, 'note': 'FoldX 5.0: working with RNA, small molecules and a new graphical interface', 'pmid': '30874800', 'version': '5.0'}]"
175,luis.serrano@crg.eu,Luis Serrano,Person,,['Primary contact'],,,,,foldx,Open access (with restrictions),ELIXIR-EE,"[{'metadata': {'abstract': '© 2019 The Author(s) 2019. Published by Oxford University Press.A new version of FoldX, whose main new features allows running classic FoldX commands on structures containing RNA molecules and includes a module that allows parametrization of ligands or small molecules (ParamX) that were not previously recognized in old versions, has been released. An extended FoldX graphical user interface has also being developed (available as a python plugin for the YASARA molecular viewer) allowing user-friendly parametrization of new custom user molecules encoded using JSON format. Availability and implementation: http://foldxsuite.crg.eu/', 'authors': [{'name': 'Delgado J.'}, {'name': 'Radusky L.G.'}, {'name': 'Cianferoni D.'}, {'name': 'Serrano L.'}], 'citationCount': 38, 'date': '2019-10-15T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'FoldX 5.0: Working with RNA, small molecules and a new graphical interface'}, 'note': 'FoldX 5.0: working with RNA, small molecules and a new graphical interface', 'pmid': '30874800', 'version': '5.0'}]"
176,javier.delgado@crg.eu,Javier Delgado,Person,,"['Support', 'Developer', 'Primary contact']",,,,,foldx,Open access (with restrictions),ELIXIR-EE,"[{'metadata': {'abstract': '© 2019 The Author(s) 2019. Published by Oxford University Press.A new version of FoldX, whose main new features allows running classic FoldX commands on structures containing RNA molecules and includes a module that allows parametrization of ligands or small molecules (ParamX) that were not previously recognized in old versions, has been released. An extended FoldX graphical user interface has also being developed (available as a python plugin for the YASARA molecular viewer) allowing user-friendly parametrization of new custom user molecules encoded using JSON format. Availability and implementation: http://foldxsuite.crg.eu/', 'authors': [{'name': 'Delgado J.'}, {'name': 'Radusky L.G.'}, {'name': 'Cianferoni D.'}, {'name': 'Serrano L.'}], 'citationCount': 38, 'date': '2019-10-15T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'FoldX 5.0: Working with RNA, small molecules and a new graphical interface'}, 'note': 'FoldX 5.0: working with RNA, small molecules and a new graphical interface', 'pmid': '30874800', 'version': '5.0'}]"
177,CRG_BusinessInnovation@crg.eu,License inquiries,Consortium,,['Provider'],Contact for commercial and evaluation licenses (2-weeks free trial). Note: No contact needed for academic users.,http://foldxsuite.crg.eu/licensing-and-services,,,foldx,Open access (with restrictions),ELIXIR-EE,"[{'metadata': {'abstract': '© 2019 The Author(s) 2019. Published by Oxford University Press.A new version of FoldX, whose main new features allows running classic FoldX commands on structures containing RNA molecules and includes a module that allows parametrization of ligands or small molecules (ParamX) that were not previously recognized in old versions, has been released. An extended FoldX graphical user interface has also being developed (available as a python plugin for the YASARA molecular viewer) allowing user-friendly parametrization of new custom user molecules encoded using JSON format. Availability and implementation: http://foldxsuite.crg.eu/', 'authors': [{'name': 'Delgado J.'}, {'name': 'Radusky L.G.'}, {'name': 'Cianferoni D.'}, {'name': 'Serrano L.'}], 'citationCount': 38, 'date': '2019-10-15T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'FoldX 5.0: Working with RNA, small molecules and a new graphical interface'}, 'note': 'FoldX 5.0: working with RNA, small molecules and a new graphical interface', 'pmid': '30874800', 'version': '5.0'}]"
178,ReplaceByFirstName.vercru@gmail.com,Steven Vercruysse,Person,https://orcid.org/0000-0002-3136-7353,"['Primary contact', 'Developer']",,,,,vsm,,stcru,"[{'doi': '10.20944/preprints202007.0486.v2', 'note': 'VSM: Intuitive Representation of Computable Knowledge', 'type': ['Primary']}, {'doi': '10.20944/preprints202007.0557.v1', 'note': 'VSM-box: General-purpose Interface for Biocuration and Knowledge Representation', 'type': ['Usage']}, {'doi': '10.5281/zenodo.4265420', 'note': '[Poster] VSM-box: the general-purpose curation interface as an open-source web-component', 'type': ['Usage']}]"
179,susana.posada@bsse.ethz.ch,Susana Posada Céspedes,Person,https://orcid.org/0000-0002-7459-8186,['Developer'],,https://github.com/sposadac,,,v-pipe,Open access,DrYak,"[{'doi': '10.1093/bioinformatics/btab015', 'pmid': '33471068', 'type': ['Primary'], 'version': '1.0, 2.0'}, {'doi': '10.20944/preprints202005.0376.v1', 'type': ['Review']}, {'doi': '10.1016/j.virusres.2016.09.016', 'metadata': {'abstract': '© 2016 The AuthorsRapidly evolving RNA viruses prevail within a host as a collection of closely related variants, referred to as viral quasispecies. Advances in high-throughput sequencing (HTS) technologies have facilitated the assessment of the genetic diversity of such virus populations at an unprecedented level of detail. However, analysis of HTS data from virus populations is challenging due to short, error-prone reads. In order to account for uncertainties originating from these limitations, several computational and statistical methods have been developed for studying the genetic heterogeneity of virus population. Here, we review methods for the analysis of HTS reads, including approaches to local diversity estimation and global haplotype reconstruction. Challenges posed by aligning reads, as well as the impact of reference biases on diversity estimates are also discussed. In addition, we address some of the experimental approaches designed to improve the biological signal-to-noise ratio. In the future, computational methods for the analysis of heterogeneous virus populations are likely to continue being complemented by technological developments.', 'authors': [{'name': 'Posada-Cespedes S.'}, {'name': 'Seifert D.'}, {'name': 'Beerenwinkel N.'}], 'citationCount': 42, 'date': '2017-07-15T00:00:00Z', 'journal': 'Virus Research', 'title': 'Recent advances in inferring viral diversity from high-throughput sequencing data'}, 'pmid': '27693290', 'type': ['Other']}, {'doi': '10.3390/v10050256', 'metadata': {'abstract': '© 2018 by the authors. Licensee MDPI, Basel, Switzerland.The Second Annual Meeting of the European Virus Bioinformatics Center (EVBC), held in Utrecht, Netherlands, focused on computational approaches in virology, with topics including (but not limited to) virus discovery, diagnostics, (meta-)genomics, modeling, epidemiology, molecular structure, evolution, and viral ecology. The goals of the Second Annual Meeting were threefold: (i) to bring together virologists and bioinformaticians from across the academic, industrial, professional, and training sectors to share best practice; (ii) to provide a meaningful and interactive scientific environment to promote discussion and collaboration between students, postdoctoral fellows, and both new and established investigators; (iii) to inspire and suggest new research directions and questions. Approximately 120 researchers from around the world attended the Second Annual Meeting of the EVBC this year, including 15 renowned international speakers. This report presents an overview of new developments and novel research findings that emerged during the meeting.', 'authors': [{'name': 'Ibrahim B.'}, {'name': 'Arkhipova K.'}, {'name': 'Andeweg A.C.'}, {'name': 'Posada-Cespedes S.'}, {'name': 'Enault F.'}, {'name': 'Gruber A.'}, {'name': 'Koonin E.V.'}, {'name': 'Kupczok A.'}, {'name': 'Lemey P.'}, {'name': 'McHardy A.C.'}, {'name': 'McMahon D.P.'}, {'name': 'Pickett B.E.'}, {'name': 'Robertson D.L.'}, {'name': 'Scheuermann R.H.'}, {'name': 'Zhernakova A.'}, {'name': 'Zwart M.P.'}, {'name': 'Schonhuth A.'}, {'name': 'Dutilh B.E.'}, {'name': 'Marz M.'}], 'citationCount': 3, 'date': '2018-05-14T00:00:00Z', 'journal': 'Viruses', 'title': 'Bioinformatics meets virology: The European virus bioinformatics center’s second annual meeting'}, 'pmcid': 'PMC5977249', 'pmid': '29757994', 'type': ['Other']}, {'doi': '10.1093/infdis/jiz094', 'metadata': {'abstract': '© 2019 The Author(s) 2019.Background: Human immunodeficiency virus type 1 (HIV-1) genetic diversity increases over the course of infection and can be used to infer the time since infection and, consequently, infection recency, which are crucial for HIV-1 surveillance and the understanding of viral pathogenesis. Methods: We considered 313 HIV-infected individuals for whom reliable estimates of infection dates and next-generation sequencing (NGS)-derived nucleotide frequency data were available. Fractions of ambiguous nucleotides, obtained by population sequencing, were available for 207 samples. We assessed whether the average pairwise diversity calculated using NGS sequences provided a more exact prediction of the time since infection and classification of infection recency (<1 year after infection), compared with the fraction of ambiguous nucleotides. Results: NGS-derived average pairwise diversity classified an infection as recent with a sensitivity of 88% and a specificity of 85%. When considering only the 207 samples for which fractions of ambiguous nucleotides were available, the NGS-derived average pairwise diversity exhibited a higher sensitivity (90% vs 78%) and specificity (95% vs 67%) than the fraction of ambiguous nucleotides. Additionally, the average pairwise diversity could be used to estimate the time since infection with a mean absolute error of 0.84 years, compared with 1.03 years for the fraction of ambiguous nucleotides. Conclusions: Viral diversity based on NGS data is more precise than that based on population sequencing in its ability to predict infection recency and provides an estimated time since infection that has a mean absolute error of <1 year.', 'authors': [{'name': 'Carlisle L.A.'}, {'name': 'Turk T.'}, {'name': 'Kusejko K.'}, {'name': 'Metzner K.J.'}, {'name': 'Leemann C.'}, {'name': 'Schenkel C.D.'}, {'name': 'Bachmann N.'}, {'name': 'Posada S.'}, {'name': 'Beerenwinkel N.'}, {'name': 'Boni J.'}, {'name': 'Yerly S.'}, {'name': 'Klimkait T.'}, {'name': 'Perreau M.'}, {'name': 'Braun D.L.'}, {'name': 'Rauch A.'}, {'name': 'Calmy A.'}, {'name': 'Cavassini M.'}, {'name': 'Battegay M.'}, {'name': 'Vernazza P.'}, {'name': 'Bernasconi E.'}, {'name': 'Gunthard H.F.'}, {'name': 'Kouyos R.D.'}, {'name': 'Anagnostopoulos A.'}, {'name': 'Battegay M.'}, {'name': 'Bernasconi E.'}, {'name': 'Boni J.'}, {'name': 'Braun D.L.'}, {'name': 'Bucher H.C.'}, {'name': 'Calmy A.'}, {'name': 'Cavassini M.'}, {'name': 'Ciuffi A.'}, {'name': 'Dollenmaier G.'}, {'name': 'Egger M.'}, {'name': 'Elzi L.'}, {'name': 'Fehr J.'}, {'name': 'Fellay J.'}, {'name': 'Furrer H.'}, {'name': 'Fux C.A.'}, {'name': 'Gunthard H.F.'}, {'name': 'Haerry D.'}, {'name': 'Hasse B.'}, {'name': 'Hirsch H.H.'}, {'name': 'Hoffmann M.'}, {'name': 'Hosli I.'}, {'name': 'Huber M.'}, {'name': 'Kahlert C.'}, {'name': 'Kaiser L.'}, {'name': 'Keiser O.'}, {'name': 'Klimkait T.'}, {'name': 'Kouyos R.D.'}, {'name': 'Kovari H.'}, {'name': 'Ledergerber B.'}, {'name': 'Martinetti G.'}, {'name': 'Martinez De Tejada B.'}, {'name': 'Marzolini C.'}, {'name': 'Metzner K.J.'}, {'name': 'Muller N.'}, {'name': 'Nicca D.'}, {'name': 'Paioni P.'}, {'name': 'Pantaleo G.'}, {'name': 'Perreau M.'}, {'name': 'Rauch A.'}, {'name': 'Rudin C.'}, {'name': 'Scherrer A.U.'}, {'name': 'Schmid P.'}, {'name': 'Speck R.'}, {'name': 'Stockle M.'}, {'name': 'Tarr P.'}, {'name': 'Trkola A.'}, {'name': 'Vernazza P.'}, {'name': 'Wandeler G.'}, {'name': 'Weber R.'}, {'name': 'Yerly S.'}], 'citationCount': 6, 'date': '2019-06-19T00:00:00Z', 'journal': 'Journal of Infectious Diseases', 'title': 'Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time since Infection'}, 'pmid': '30835266', 'type': ['Usage']}, {'doi': '10.2807/1560-7917.es.2020.25.32.2001410', 'metadata': {'abstract': '© 2020 Turkish Society of Cardiology. All rights reserved.We show the distribution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic clades over time and between countries and outline potential genomic surveillance objectives. We applied three genomic nomenclature systems to all sequence data from the World Health Organization European Region available until 10 July 2020. We highlight the importance of real-time sequencing and data dissemination in a pandemic situation, compare the nomenclatures and lay a foundation for future European genomic surveillance of SARS-CoV-2.', 'authors': [{'name': 'Alm E.'}, {'name': 'Broberg E.K.'}, {'name': 'Connor T.'}, {'name': 'Hodcroft E.B.'}, {'name': 'Komissarov A.B.'}, {'name': 'Maurer-Stroh S.'}, {'name': 'Melidou A.'}, {'name': 'Neher R.A.'}, {'name': ""O'Toole A.""}, {'name': 'Pereyaslov D.'}, {'name': 'Beerenwinkel N.'}, {'name': 'Posada-Cespedes S.'}, {'name': 'Jablonski K.P.'}, {'name': 'Ferreira P.F.'}, {'name': 'Topolsky I.'}, {'name': 'Avsic-Zupanc T.'}, {'name': 'Korva M.'}, {'name': 'Poljak M.'}, {'name': 'Zakotnik S.'}, {'name': 'Zorec T.M.'}, {'name': 'Bragstad K.'}, {'name': 'Hungnes O.'}, {'name': 'Stene-Johansen K.'}, {'name': 'Reusken C.'}, {'name': 'Meijer A.'}, {'name': 'Vennema H.'}, {'name': 'Ruiz-Roldan L.'}, {'name': 'Bracho M.A.'}, {'name': 'Garcia-Gonzalez N.'}, {'name': 'Chiner-Oms A.'}, {'name': 'Cancino-Munoz I.'}, {'name': 'Comas I.'}, {'name': 'Goig G.A.'}, {'name': 'Torres-Puente M.'}, {'name': 'Lopez M.G.'}, {'name': 'Martinez-Priego L.'}, {'name': ""D'Auria G.""}, {'name': 'Ruiz-Hueso P.'}, {'name': 'Ferrus-Abad L.'}, {'name': 'de Marco G.'}, {'name': 'Galan-Vendrell I.'}, {'name': 'Carbo-Ramirez S.'}, {'name': 'Ruiz-Rodriguez P.'}, {'name': 'Coscolla M.'}, {'name': 'Polackova K.'}, {'name': 'Kramna L.'}, {'name': 'Cinek O.'}, {'name': 'Richter J.'}, {'name': 'Krashias G.'}, {'name': 'Tryfonos C.'}, {'name': 'Bashiardes S.'}, {'name': 'Koptides D.'}, {'name': 'Christodoulou C.'}, {'name': 'Bartolini B.'}, {'name': 'Gruber C.E.'}, {'name': 'Di Caro A.'}, {'name': 'Castilletti C.'}, {'name': 'Stefani F.'}, {'name': 'Rimoldi S.G.'}, {'name': 'Romeri F.'}, {'name': 'Salerno F.'}, {'name': 'Polesello S.'}, {'name': 'Nagy A.'}, {'name': 'Jirincova H.'}, {'name': 'Vecerova J.'}, {'name': 'Novakova L.'}, {'name': 'Cordey S.'}, {'name': 'Murtskhvaladze M.'}, {'name': 'Kotaria N.'}, {'name': 'Schar T.'}, {'name': 'Beisel C.'}, {'name': 'Vugrek O.'}, {'name': 'Rokic F.'}, {'name': 'Trgovec-Greif L.'}, {'name': 'Jurak I.'}, {'name': 'Rukavina T.'}, {'name': 'Sucic N.'}, {'name': 'Schonning K.'}, {'name': 'Karst S.M.'}, {'name': 'Kirkegaard R.H.'}, {'name': 'Michaelsen T.Y.'}, {'name': 'Sorensen E.A.'}, {'name': 'Knutson S.'}, {'name': 'Brandt J.'}, {'name': 'Le-Quy V.'}, {'name': 'Sorensen T.'}, {'name': 'Petersen C.'}, {'name': 'Pedersen M.S.'}, {'name': 'Larsen S.L.'}, {'name': 'Skov M.N.'}, {'name': 'Rasmussen M.'}, {'name': 'Fonager J.'}, {'name': 'Fomsgaard A.'}, {'name': 'Maksyutov R.A.'}, {'name': 'Gavrilova E.V.'}, {'name': 'Pyankov O.V.'}, {'name': 'Bodnev S.A.'}, {'name': 'Tregubchak T.V.'}, {'name': 'Shvalov A.N.'}, {'name': 'Antonets D.V.'}, {'name': 'Resende P.C.'}, {'name': 'Goya S.'}, {'name': 'Perrin A.'}, {'name': 'Lee R.T.'}, {'name': 'Yadahalli S.'}, {'name': 'Han A.X.'}, {'name': 'Russell C.A.'}, {'name': 'Schmutz S.'}, {'name': 'Zaheri M.'}, {'name': 'Kufner V.'}, {'name': 'Huber M.'}, {'name': 'Trkola A.'}, {'name': 'Antwerpen M.'}, {'name': 'Walter M.C.'}, {'name': 'van der Werf S.'}, {'name': 'Gambaro F.'}, {'name': 'Behillil S.'}, {'name': 'Enouf V.'}, {'name': 'Donati F.'}, {'name': 'Ustinova M.'}, {'name': 'Rovite V.'}, {'name': 'Klovins J.'}, {'name': 'Savicka O.'}, {'name': 'Wienecke-Baldacchino A.K.'}, {'name': 'Ragimbeau C.'}, {'name': 'Fournier G.'}, {'name': 'Mossong J.'}, {'name': 'Aberle S.W.'}, {'name': 'Haukland M.'}, {'name': 'Enkirch T.'}, {'name': 'Advani A.'}, {'name': 'Karlberg M.L.'}, {'name': 'Lindsjo O.K.'}, {'name': 'Broddesson S.'}, {'name': 'Slavikova M.'}, {'name': 'Lickova M.'}, {'name': 'Klempa B.'}, {'name': 'Staronova E.'}, {'name': 'Ticha E.'}, {'name': 'Szemes T.'}, {'name': 'Rusnakova D.'}, {'name': 'Stadler T.'}, {'name': 'Quer J.'}, {'name': 'Anton A.'}, {'name': 'Andres C.'}, {'name': 'Pinana M.'}, {'name': 'Garcia-Cehic D.'}, {'name': 'Pumarola T.'}, {'name': 'Izopet J.'}, {'name': 'Gioula G.'}, {'name': 'Exindari M.'}, {'name': 'Papa A.'}, {'name': 'Chatzidimitriou D.'}, {'name': 'Metallidis S.'}, {'name': 'Pappa S.'}, {'name': 'Macek M.'}, {'name': 'Geryk J.'}, {'name': 'Broz P.'}, {'name': 'Briksi A.'}, {'name': 'Hubacek P.'}, {'name': 'Drevinek P.'}, {'name': 'Zajac M.'}, {'name': 'Kvapil P.'}, {'name': 'Holub M.'}, {'name': 'Kvapilova K.'}, {'name': 'Novotny A.'}, {'name': 'Kasny M.'}, {'name': 'Klempt P.'}, {'name': 'Vapalahti O.'}, {'name': 'Smura T.'}, {'name': 'Sironen T.'}, {'name': 'Selhorst P.'}, {'name': 'Anthony C.'}, {'name': 'Arien K.'}, {'name': 'Simon-Loriere E.'}, {'name': 'Rabalski L.'}, {'name': 'Bienkowska-Szewczyk K.'}, {'name': 'Borges V.'}, {'name': 'Isidro J.'}, {'name': 'Gomes J.P.'}, {'name': 'Guiomar R.'}, {'name': 'Pechirra P.'}, {'name': 'Costa I.'}, {'name': 'Duarte S.'}, {'name': 'Vieira L.'}, {'name': 'Pyrc K.'}, {'name': 'Zuckerman N.S.'}, {'name': 'Turdikulova S.'}, {'name': 'Abdullaev A.'}, {'name': 'Dalimova D.'}, {'name': 'Abdurakhimov A.'}, {'name': 'Tagliabracci A.'}, {'name': 'Alessandrini F.'}, {'name': 'Melchionda F.'}, {'name': 'Onofri V.'}, {'name': 'Turchi C.'}, {'name': 'Bagnarelli P.'}, {'name': 'Menzo S.'}, {'name': 'Caucci S.'}, {'name': 'Di Sante L.'}, {'name': 'Popa A.'}, {'name': 'Genger J.-W.'}, {'name': 'Agerer B.'}, {'name': 'Lercher A.'}, {'name': 'Endler L.'}, {'name': 'Smyth M.'}, {'name': 'Penz T.'}, {'name': 'Schuster M.'}, {'name': 'Senekowitsch M.'}, {'name': 'Laine J.'}, {'name': 'Bock C.'}, {'name': 'Bergthaler A.'}, {'name': 'Shevtsov A.'}, {'name': 'Kalendar R.'}, {'name': 'Ramanculov Y.'}, {'name': 'Graf A.'}, {'name': 'Muenchhoff M.'}, {'name': 'Keppler O.T.'}, {'name': 'Krebs S.'}, {'name': 'Blum H.'}, {'name': 'Marcello A.'}, {'name': 'Licastro D.'}, {'name': ""D'Agaro P.""}, {'name': 'Laubscher F.'}, {'name': 'Vidanovic D.'}, {'name': 'Tesovic B.'}, {'name': 'Volkening J.'}, {'name': 'Clementi N.'}, {'name': 'Mancini N.'}, {'name': 'Rupnik M.'}, {'name': 'Mahnic A.'}, {'name': 'Walker A.'}, {'name': 'Houwaart T.'}, {'name': 'Wienemann T.'}, {'name': 'Vasconcelos M.K.'}, {'name': 'Strelow D.'}, {'name': 'Jensen B.-E.O.'}, {'name': 'Senff T.'}, {'name': 'Hulse L.'}, {'name': 'Adams O.'}, {'name': 'Andree M.'}, {'name': 'Hauka S.'}, {'name': 'Feldt T.'}, {'name': 'Keitel V.'}, {'name': 'Kindgen-Milles D.'}, {'name': 'Timm J.'}, {'name': 'Pfeffer K.'}, {'name': 'Dilthey A.T.'}, {'name': 'Moore C.'}, {'name': 'Ozdarendeli A.'}, {'name': 'Pavel S.T.I.'}, {'name': 'Yetiskin H.'}, {'name': 'Aydin G.'}, {'name': 'Holyavkin C.'}, {'name': 'Uygut M.A.'}, {'name': 'Cevik C.'}, {'name': 'Shchetinin A.'}, {'name': 'Gushchin V.'}, {'name': 'Dinler-Doganay G.'}, {'name': 'Doganay L.'}, {'name': 'Kizilboga-Akgun T.'}, {'name': 'Karacan I.'}, {'name': 'Pancer K.'}, {'name': 'Maes P.'}, {'name': 'Marti-Carreras J.'}, {'name': 'Wawina-Bokalanga T.'}, {'name': 'Vanmechelen B.'}, {'name': 'Thurmer A.'}, {'name': 'Wedde M.'}, {'name': 'Durrwald R.'}, {'name': 'von Kleist M.'}, {'name': 'Drechsel O.'}, {'name': 'Wolff T.'}, {'name': 'Fuchs S.'}, {'name': 'Kmiecinski R.'}, {'name': 'Michel J.'}, {'name': 'Nitsche A.'}, {'name': 'Casas I.'}, {'name': 'Caballero M.I.'}, {'name': 'Zaballos A.'}, {'name': 'Jimenez P.'}, {'name': 'Jimenez M.'}, {'name': 'Fernandez S.M.'}, {'name': 'Fernandez S.V.'}, {'name': 'de la Plaza I.C.'}, {'name': 'Fadeev A.'}, {'name': 'Ivanova A.'}, {'name': 'Sergeeva M.'}, {'name': 'Stefanelli P.'}, {'name': 'Estee Torok M.'}, {'name': 'Hall G.'}, {'name': 'da Silva Filipe A.'}, {'name': 'Turtle L.'}, {'name': 'Afifi S.'}, {'name': 'McCluggage K.'}, {'name': 'Beer R.'}, {'name': 'Ledesma J.'}, {'name': 'Maksimovic J.'}, {'name': 'Spellman K.'}, {'name': 'Hamilton W.L.'}, {'name': 'Marchbank A.'}, {'name': 'Southgate J.A.'}, {'name': 'Underwood A.'}, {'name': 'Taylor B.'}, {'name': 'Yeats C.'}, {'name': 'Abudahab K.'}, {'name': 'Gemmell M.R.'}, {'name': 'Eccles R.'}, {'name': 'Lucaci A.'}, {'name': 'Nelson C.A.'}, {'name': 'Rainbow L.'}, {'name': 'Whitehead M.'}, {'name': 'Gregory R.'}, {'name': 'Haldenby S.'}, {'name': 'Paterson S.'}, {'name': 'Hughes M.A.'}, {'name': 'Curran M.D.'}, {'name': 'Baker D.'}, {'name': 'Tucker R.'}, {'name': 'Green L.R.'}, {'name': 'Feltwell T.'}, {'name': 'Halstead F.D.'}, {'name': 'Wyles M.'}, {'name': 'Jahun A.S.'}, {'name': 'Ahmad S.S.Y.'}, {'name': 'Georgana I.'}, {'name': 'Goodfellow I.'}, {'name': 'Yakovleva A.'}, {'name': 'Meredith L.W.'}, {'name': 'Gavriil A.'}, {'name': 'Awan A.R.'}, {'name': 'Fisher C.'}, {'name': 'Edgeworth J.'}, {'name': 'Lynch J.'}, {'name': 'Moore N.'}, {'name': 'Williams R.'}, {'name': 'Kidd S.P.'}, {'name': 'Cortes N.'}, {'name': 'Brunker K.'}, {'name': 'McCrone J.T.'}, {'name': 'Quick J.'}, {'name': 'Duckworth N.'}, {'name': 'Walsh S.'}, {'name': 'Sloan T.'}, {'name': 'Ludden C.'}, {'name': 'George R.P.'}, {'name': 'Eltringham G.'}, {'name': 'Brown J.R.'}, {'name': 'Aranday-Cortes E.'}, {'name': 'Shepherd J.G.'}, {'name': 'Hughes J.'}, {'name': 'Li K.K.'}, {'name': 'Williams T.C.'}, {'name': 'Johnson N.'}, {'name': 'Jesudason N.'}, {'name': 'Mair D.'}, {'name': 'Thomson E.'}, {'name': 'Shah R.'}, {'name': 'Parr Y.A.'}, {'name': 'Carmichael S.'}, {'name': 'Robertson D.L.'}, {'name': 'Nomikou K.'}, {'name': 'Broos A.'}, {'name': 'Niebel M.'}, {'name': 'Smollett K.'}, {'name': 'Tong L.'}, {'name': 'Miah S.'}, {'name': 'Wittner A.'}, {'name': 'Phillips N.'}, {'name': 'Payne B.'}, {'name': 'Dewar R.'}, {'name': 'Holmes A.'}, {'name': 'Bolt F.'}, {'name': 'Price J.R.'}, {'name': 'Mookerjee S.'}, {'name': 'Sethi D.K.'}, {'name': 'Potter W.'}, {'name': 'Stanley R.'}, {'name': 'Prakash R.'}, {'name': 'Dervisevic S.'}, {'name': 'Graham J.C.'}, {'name': 'Nelson A.'}, {'name': 'Smith D.'}, {'name': 'Young G.R.'}, {'name': 'Yew W.C.'}, {'name': 'Todd J.A.'}, {'name': 'Trebes A.'}, {'name': 'Andersson M.'}, {'name': 'Bull M.'}, {'name': 'Watkins J.'}, {'name': 'Birchley A.'}, {'name': 'Gatica-Wilcox B.'}, {'name': 'Gilbert L.'}, {'name': 'Kumziene-Summerhayes S.'}, {'name': 'Rey S.'}, {'name': 'Chauhan A.'}, {'name': 'Butcher E.'}, {'name': 'Bicknell K.'}, {'name': 'Elliott S.'}, {'name': 'Glaysher S.'}, {'name': 'Lackenby A.'}, {'name': 'Bibby D.'}, {'name': 'Platt S.'}, {'name': 'Mohamed H.'}, {'name': 'Machin N.W.'}, {'name': 'Mbisa J.L.'}, {'name': 'Evans J.'}, {'name': 'Perry M.'}, {'name': 'Pacchiarini N.'}, {'name': 'Corden S.'}, {'name': 'Adams A.G.'}, {'name': 'Gaskin A.'}, {'name': 'Coombs J.'}, {'name': 'Graham L.J.'}, {'name': 'Cottrell S.'}, {'name': 'Morgan M.'}, {'name': 'Gifford L.'}, {'name': 'Kolyva A.'}, {'name': 'Rudder S.J.'}, {'name': 'Trotter A.J.'}, {'name': 'Mather A.E.'}, {'name': 'Aydin A.'}, {'name': 'Page A.J.'}, {'name': 'Kay G.L.'}, {'name': 'de Oliveira Martins L.'}, {'name': 'Yasir M.'}, {'name': 'Alikhan N.-F.'}, {'name': 'Thomson N.M.'}, {'name': 'Gilroy R.'}, {'name': 'Kingsley R.A.'}, {'name': ""O'Grady J.""}, {'name': 'Gutierrez A.V.'}, {'name': 'Diaz M.'}, {'name': 'Viet T.L.'}, {'name': 'Tedim A.P.'}, {'name': 'Adriaenssens E.M.'}, {'name': 'Patrick Mcclure C.'}, {'name': 'Moore C.'}, {'name': 'Sang F.'}, {'name': 'Clark G.'}, {'name': 'Howson-Wells H.C.'}, {'name': 'Debebe J.'}, {'name': 'Ball J.'}, {'name': 'Chappell J.'}, {'name': 'Khakh M.'}, {'name': 'Carlile M.'}, {'name': 'Loose M.'}, {'name': 'Lister M.M.'}, {'name': 'Holmes N.'}, {'name': 'Tsoleridis T.'}, {'name': 'Fleming V.M.'}, {'name': 'Wright V.'}, {'name': 'Smith W.'}, {'name': 'Gallagher M.D.'}, {'name': 'Parker M.'}, {'name': 'Partridge D.G.'}, {'name': 'Evans C.'}, {'name': 'Baker P.'}, {'name': 'Essex S.'}, {'name': 'Liggett S.'}, {'name': 'Keeley A.J.'}, {'name': 'Bashton M.'}, {'name': 'Rooke S.'}, {'name': 'Dervisavic S.'}, {'name': 'Meader E.J.'}, {'name': 'Lopez C.E.B.'}, {'name': 'Angyal A.'}, {'name': 'Kristiansen M.'}, {'name': 'Tutill H.J.'}, {'name': 'Findlay J.'}, {'name': 'Mestek-Boukhibar L.'}, {'name': 'Forrest L.'}, {'name': 'Dyal P.'}, {'name': 'Williams R.J.'}, {'name': 'Panchbhaya Y.'}, {'name': 'Williams C.A.'}, {'name': 'Roy S.'}, {'name': 'Pandey S.'}, {'name': 'Stockton J.'}, {'name': 'Loman N.J.'}, {'name': 'Poplawski R.'}, {'name': 'Nicholls S.'}, {'name': 'Rowe W.P.M.'}, {'name': 'Khokhar F.'}, {'name': 'Pinckert M.L.'}, {'name': 'Hosmillo M.'}, {'name': 'Chaudhry Y.'}, {'name': 'Caller L.G.'}, {'name': 'Davidson R.K.'}, {'name': 'Griffith L.'}, {'name': 'Rambaut A.'}, {'name': 'Jackson B.'}, {'name': 'Colquhoun R.'}, {'name': 'Hill V.'}, {'name': 'Nichols J.'}, {'name': 'Asamaphan P.'}, {'name': 'Darby A.'}, {'name': 'Jackson K.A.'}, {'name': 'Iturriza-Gomara M.'}, {'name': 'Vamos E.E.'}, {'name': 'Green A.'}, {'name': 'Aanensen D.'}, {'name': 'Bonsall D.'}, {'name': 'Buck D.'}, {'name': 'Macintyre-Cockett G.'}, {'name': 'de Cesare M.'}, {'name': 'Pybus O.'}, {'name': 'Golubchik T.'}, {'name': 'Scarlett G.'}, {'name': 'Loveson K.F.'}, {'name': 'Robson S.C.'}, {'name': 'Beckett A.'}, {'name': 'Lindsey B.'}, {'name': 'Groves D.C.'}, {'name': 'Parsons P.J.'}, {'name': 'McHugh M.P.'}, {'name': 'Barnes J.D.'}, {'name': 'Manso C.F.'}, {'name': 'Grammatopoulos D.'}, {'name': 'Menger K.E.'}, {'name': 'Harrison E.'}, {'name': 'Gunson R.'}, {'name': 'Peacock S.J.'}, {'name': 'Gonzalez G.'}, {'name': 'Carr M.'}, {'name': 'Mihaela L.'}, {'name': 'Popovici O.'}, {'name': 'Brytting M.'}, {'name': 'Bresner C.'}, {'name': 'Fuller W.'}, {'name': 'Workman T.'}, {'name': 'Mentis A.F.'}, {'name': 'Kossyvakis A.'}, {'name': 'Karamitros T.'}, {'name': 'Pogka V.'}, {'name': 'Kalliaropoulos A.'}, {'name': 'Horefti E.'}, {'name': 'Kontou A.'}, {'name': 'Martinez-Gonzalez B.'}, {'name': 'Labropoulou V.'}, {'name': 'Voulgari-Kokota A.'}, {'name': 'Evangelidou M.'}, {'name': 'Bizta P.'}, {'name': 'Belimezi M.'}, {'name': 'Lambrechts L.'}, {'name': 'Doymaz M.Z.'}, {'name': 'Yazici M.K.'}, {'name': 'Cetin N.S.'}, {'name': 'Karaaslan E.'}, {'name': 'Kallio-Kokko H.'}, {'name': 'Virtanen J.'}, {'name': 'Suvanto M.'}, {'name': 'Nguyen P.T.'}, {'name': 'Ellonen P.'}, {'name': 'Hannula S.'}, {'name': 'Kangas H.'}, {'name': 'Sreenu V.B.'}, {'name': 'Burian K.'}, {'name': 'Terhes G.'}, {'name': 'Gombos K.'}, {'name': 'Gyenesei A.'}, {'name': 'Urban P.'}, {'name': 'Herczeg R.'}, {'name': 'Jakab F.'}, {'name': 'Kemenesi G.'}, {'name': 'Toth G.E.'}, {'name': 'Somogyi B.'}, {'name': 'Zana B.'}, {'name': 'Zeghbib S.'}, {'name': 'Kuczmog A.'}, {'name': 'Foldes F.'}, {'name': 'Lanszki Z.'}, {'name': 'Madai M.'}, {'name': 'Papp H.'}, {'name': 'Nagy A.'}, {'name': 'Pereszlenyi C.I.'}, {'name': 'Babinszky G.C.'}, {'name': 'Dudas G.'}, {'name': 'Csoma E.'}, {'name': 'Abou Tayoun A.N.'}, {'name': 'Alsheikh-Ali A.A.'}, {'name': 'Loney T.'}, {'name': 'Nowotny N.'}, {'name': 'Abdul-Wahab O.'}, {'name': 'Gonzalez-Candelas F.'}, {'name': 'Andersen M.H.'}, {'name': 'Taylor S.'}], 'citationCount': 42, 'date': '2020-01-01T00:00:00Z', 'journal': 'Eurosurveillance', 'title': 'Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020'}, 'note': 'V-pipe was used to process a major part of the Swiss samples in this pan-European study.', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2020.10.12.335919', 'note': 'Raw reads from SRA public data and Swiss cohort were processed using V-pipe', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2020.10.14.20212621', 'note': 'V-pipe was used to process a major part of the Swiss samples', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2021.01.08.21249379', 'note': 'The waste water samples were analyzed using V-pipe and additional custom scripts.', 'type': ['Usage'], 'version': 'sars-cov2-dev'}, {'doi': '10.1101/2021.03.05.21252520', 'note': 'V-pipe is used within the S3C (Swiss SARS-CoV-2 Sequencing Consortium) to provide sequences.', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.3390/v13030496', 'metadata': {'abstract': '© 2021 by the authors. Licensee MDPI, Basel, Switzerland.Since the emergence of coronavirus disease (COVID-19) in late 2019, domestic cats have been demonstrated to be susceptible to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) under natural and experimental conditions. As pet cats often live in very close contact with their owners, it is essential to investigate SARS-CoV-2 infections in cats in a One-Health context. This study reports the first SARS-CoV-2 infection in a cat in a COVID-19-affected household in Switzerland. The cat (Cat 1) demonstrated signs of an upper respiratory tract infection, including sneezing, inappetence, and apathy, while the cohabiting cat (Cat 2) remained asymptomatic. Nasal, oral, fecal, fur, and environmental swab samples were collected twice from both cats and analyzed by RT-qPCR for the presence of SARS-CoV-2 viral RNA. Both nasal swabs from Cat 1 tested positive. In addition, the first oral swab from Cat 2 and fur and bedding swabs from both cats were RT-qPCR positive. The fecal swabs tested negative. The infection of Cat 1 was confirmed by positive SARS-CoV-2 S1 receptor binding domain (RBD) antibody testing and neutralizing activity in a surrogate assay. The viral genome sequence from Cat 1, obtained by next generation sequencing, showed the closest relation to a human sequence from the B.1.1.39 lineage, with one single nucleotide polymorphism (SNP) difference. This study demonstrates not only SARS-CoV-2 infection of a cat from a COVID-19-affected household but also contamination of the cats’ fur and bed with viral RNA. Our results are important to create awareness that SARS-CoV-2 infected people should observe hygienic measures to avoid infection and contamination of animal cohabitants.', 'authors': [{'name': 'Klaus J.'}, {'name': 'Meli M.L.'}, {'name': 'Willi B.'}, {'name': 'Nadeau S.'}, {'name': 'Beisel C.'}, {'name': 'Stadler T.'}, {'name': 'Egberink H.'}, {'name': 'Zhao S.'}, {'name': 'Lutz H.'}, {'name': 'Riond B.'}, {'name': 'Rosinger N.'}, {'name': 'Stalder H.'}, {'name': 'Renzullo S.'}, {'name': 'Hofmann-Lehmann R.'}], 'citationCount': 2, 'date': '2021-03-01T00:00:00Z', 'journal': 'Viruses', 'title': 'Detection and genome sequencing of sars-cov-2 in a domestic cat with respiratory signs in Switzerland'}, 'note': 'V-pipe and the S3C (Swiss SARS-CoV-2 Sequencing Consortium) infrastructure were used to QA and pre-process the sequencing data.', 'pmcid': 'PMC8002591', 'pmid': '33802899', 'type': ['Usage'], 'version': 'sars-cov2'}]"
180,david.seifert@bsse.ethz.ch,David Seifert,Person,https://orcid.org/0000-0003-4739-5110,['Developer'],,https://github.com/SoapZA,,,v-pipe,Open access,DrYak,"[{'doi': '10.1093/bioinformatics/btab015', 'pmid': '33471068', 'type': ['Primary'], 'version': '1.0, 2.0'}, {'doi': '10.20944/preprints202005.0376.v1', 'type': ['Review']}, {'doi': '10.1016/j.virusres.2016.09.016', 'metadata': {'abstract': '© 2016 The AuthorsRapidly evolving RNA viruses prevail within a host as a collection of closely related variants, referred to as viral quasispecies. Advances in high-throughput sequencing (HTS) technologies have facilitated the assessment of the genetic diversity of such virus populations at an unprecedented level of detail. However, analysis of HTS data from virus populations is challenging due to short, error-prone reads. In order to account for uncertainties originating from these limitations, several computational and statistical methods have been developed for studying the genetic heterogeneity of virus population. Here, we review methods for the analysis of HTS reads, including approaches to local diversity estimation and global haplotype reconstruction. Challenges posed by aligning reads, as well as the impact of reference biases on diversity estimates are also discussed. In addition, we address some of the experimental approaches designed to improve the biological signal-to-noise ratio. In the future, computational methods for the analysis of heterogeneous virus populations are likely to continue being complemented by technological developments.', 'authors': [{'name': 'Posada-Cespedes S.'}, {'name': 'Seifert D.'}, {'name': 'Beerenwinkel N.'}], 'citationCount': 42, 'date': '2017-07-15T00:00:00Z', 'journal': 'Virus Research', 'title': 'Recent advances in inferring viral diversity from high-throughput sequencing data'}, 'pmid': '27693290', 'type': ['Other']}, {'doi': '10.3390/v10050256', 'metadata': {'abstract': '© 2018 by the authors. Licensee MDPI, Basel, Switzerland.The Second Annual Meeting of the European Virus Bioinformatics Center (EVBC), held in Utrecht, Netherlands, focused on computational approaches in virology, with topics including (but not limited to) virus discovery, diagnostics, (meta-)genomics, modeling, epidemiology, molecular structure, evolution, and viral ecology. The goals of the Second Annual Meeting were threefold: (i) to bring together virologists and bioinformaticians from across the academic, industrial, professional, and training sectors to share best practice; (ii) to provide a meaningful and interactive scientific environment to promote discussion and collaboration between students, postdoctoral fellows, and both new and established investigators; (iii) to inspire and suggest new research directions and questions. Approximately 120 researchers from around the world attended the Second Annual Meeting of the EVBC this year, including 15 renowned international speakers. This report presents an overview of new developments and novel research findings that emerged during the meeting.', 'authors': [{'name': 'Ibrahim B.'}, {'name': 'Arkhipova K.'}, {'name': 'Andeweg A.C.'}, {'name': 'Posada-Cespedes S.'}, {'name': 'Enault F.'}, {'name': 'Gruber A.'}, {'name': 'Koonin E.V.'}, {'name': 'Kupczok A.'}, {'name': 'Lemey P.'}, {'name': 'McHardy A.C.'}, {'name': 'McMahon D.P.'}, {'name': 'Pickett B.E.'}, {'name': 'Robertson D.L.'}, {'name': 'Scheuermann R.H.'}, {'name': 'Zhernakova A.'}, {'name': 'Zwart M.P.'}, {'name': 'Schonhuth A.'}, {'name': 'Dutilh B.E.'}, {'name': 'Marz M.'}], 'citationCount': 3, 'date': '2018-05-14T00:00:00Z', 'journal': 'Viruses', 'title': 'Bioinformatics meets virology: The European virus bioinformatics center’s second annual meeting'}, 'pmcid': 'PMC5977249', 'pmid': '29757994', 'type': ['Other']}, {'doi': '10.1093/infdis/jiz094', 'metadata': {'abstract': '© 2019 The Author(s) 2019.Background: Human immunodeficiency virus type 1 (HIV-1) genetic diversity increases over the course of infection and can be used to infer the time since infection and, consequently, infection recency, which are crucial for HIV-1 surveillance and the understanding of viral pathogenesis. Methods: We considered 313 HIV-infected individuals for whom reliable estimates of infection dates and next-generation sequencing (NGS)-derived nucleotide frequency data were available. Fractions of ambiguous nucleotides, obtained by population sequencing, were available for 207 samples. We assessed whether the average pairwise diversity calculated using NGS sequences provided a more exact prediction of the time since infection and classification of infection recency (<1 year after infection), compared with the fraction of ambiguous nucleotides. Results: NGS-derived average pairwise diversity classified an infection as recent with a sensitivity of 88% and a specificity of 85%. When considering only the 207 samples for which fractions of ambiguous nucleotides were available, the NGS-derived average pairwise diversity exhibited a higher sensitivity (90% vs 78%) and specificity (95% vs 67%) than the fraction of ambiguous nucleotides. Additionally, the average pairwise diversity could be used to estimate the time since infection with a mean absolute error of 0.84 years, compared with 1.03 years for the fraction of ambiguous nucleotides. Conclusions: Viral diversity based on NGS data is more precise than that based on population sequencing in its ability to predict infection recency and provides an estimated time since infection that has a mean absolute error of <1 year.', 'authors': [{'name': 'Carlisle L.A.'}, {'name': 'Turk T.'}, {'name': 'Kusejko K.'}, {'name': 'Metzner K.J.'}, {'name': 'Leemann C.'}, {'name': 'Schenkel C.D.'}, {'name': 'Bachmann N.'}, {'name': 'Posada S.'}, {'name': 'Beerenwinkel N.'}, {'name': 'Boni J.'}, {'name': 'Yerly S.'}, {'name': 'Klimkait T.'}, {'name': 'Perreau M.'}, {'name': 'Braun D.L.'}, {'name': 'Rauch A.'}, {'name': 'Calmy A.'}, {'name': 'Cavassini M.'}, {'name': 'Battegay M.'}, {'name': 'Vernazza P.'}, {'name': 'Bernasconi E.'}, {'name': 'Gunthard H.F.'}, {'name': 'Kouyos R.D.'}, {'name': 'Anagnostopoulos A.'}, {'name': 'Battegay M.'}, {'name': 'Bernasconi E.'}, {'name': 'Boni J.'}, {'name': 'Braun D.L.'}, {'name': 'Bucher H.C.'}, {'name': 'Calmy A.'}, {'name': 'Cavassini M.'}, {'name': 'Ciuffi A.'}, {'name': 'Dollenmaier G.'}, {'name': 'Egger M.'}, {'name': 'Elzi L.'}, {'name': 'Fehr J.'}, {'name': 'Fellay J.'}, {'name': 'Furrer H.'}, {'name': 'Fux C.A.'}, {'name': 'Gunthard H.F.'}, {'name': 'Haerry D.'}, {'name': 'Hasse B.'}, {'name': 'Hirsch H.H.'}, {'name': 'Hoffmann M.'}, {'name': 'Hosli I.'}, {'name': 'Huber M.'}, {'name': 'Kahlert C.'}, {'name': 'Kaiser L.'}, {'name': 'Keiser O.'}, {'name': 'Klimkait T.'}, {'name': 'Kouyos R.D.'}, {'name': 'Kovari H.'}, {'name': 'Ledergerber B.'}, {'name': 'Martinetti G.'}, {'name': 'Martinez De Tejada B.'}, {'name': 'Marzolini C.'}, {'name': 'Metzner K.J.'}, {'name': 'Muller N.'}, {'name': 'Nicca D.'}, {'name': 'Paioni P.'}, {'name': 'Pantaleo G.'}, {'name': 'Perreau M.'}, {'name': 'Rauch A.'}, {'name': 'Rudin C.'}, {'name': 'Scherrer A.U.'}, {'name': 'Schmid P.'}, {'name': 'Speck R.'}, {'name': 'Stockle M.'}, {'name': 'Tarr P.'}, {'name': 'Trkola A.'}, {'name': 'Vernazza P.'}, {'name': 'Wandeler G.'}, {'name': 'Weber R.'}, {'name': 'Yerly S.'}], 'citationCount': 6, 'date': '2019-06-19T00:00:00Z', 'journal': 'Journal of Infectious Diseases', 'title': 'Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time since Infection'}, 'pmid': '30835266', 'type': ['Usage']}, {'doi': '10.2807/1560-7917.es.2020.25.32.2001410', 'metadata': {'abstract': '© 2020 Turkish Society of Cardiology. All rights reserved.We show the distribution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic clades over time and between countries and outline potential genomic surveillance objectives. We applied three genomic nomenclature systems to all sequence data from the World Health Organization European Region available until 10 July 2020. We highlight the importance of real-time sequencing and data dissemination in a pandemic situation, compare the nomenclatures and lay a foundation for future European genomic surveillance of SARS-CoV-2.', 'authors': [{'name': 'Alm E.'}, {'name': 'Broberg E.K.'}, {'name': 'Connor T.'}, {'name': 'Hodcroft E.B.'}, {'name': 'Komissarov A.B.'}, {'name': 'Maurer-Stroh S.'}, {'name': 'Melidou A.'}, {'name': 'Neher R.A.'}, {'name': ""O'Toole A.""}, {'name': 'Pereyaslov D.'}, {'name': 'Beerenwinkel N.'}, {'name': 'Posada-Cespedes S.'}, {'name': 'Jablonski K.P.'}, {'name': 'Ferreira P.F.'}, {'name': 'Topolsky I.'}, {'name': 'Avsic-Zupanc T.'}, {'name': 'Korva M.'}, {'name': 'Poljak M.'}, {'name': 'Zakotnik S.'}, {'name': 'Zorec T.M.'}, {'name': 'Bragstad K.'}, {'name': 'Hungnes O.'}, {'name': 'Stene-Johansen K.'}, {'name': 'Reusken C.'}, {'name': 'Meijer A.'}, {'name': 'Vennema H.'}, {'name': 'Ruiz-Roldan L.'}, {'name': 'Bracho M.A.'}, {'name': 'Garcia-Gonzalez N.'}, {'name': 'Chiner-Oms A.'}, {'name': 'Cancino-Munoz I.'}, {'name': 'Comas I.'}, {'name': 'Goig G.A.'}, {'name': 'Torres-Puente M.'}, {'name': 'Lopez M.G.'}, {'name': 'Martinez-Priego L.'}, {'name': ""D'Auria G.""}, {'name': 'Ruiz-Hueso P.'}, {'name': 'Ferrus-Abad L.'}, {'name': 'de Marco G.'}, {'name': 'Galan-Vendrell I.'}, {'name': 'Carbo-Ramirez S.'}, {'name': 'Ruiz-Rodriguez P.'}, {'name': 'Coscolla M.'}, {'name': 'Polackova K.'}, {'name': 'Kramna L.'}, {'name': 'Cinek O.'}, {'name': 'Richter J.'}, {'name': 'Krashias G.'}, {'name': 'Tryfonos C.'}, {'name': 'Bashiardes S.'}, {'name': 'Koptides D.'}, {'name': 'Christodoulou C.'}, {'name': 'Bartolini B.'}, {'name': 'Gruber C.E.'}, {'name': 'Di Caro A.'}, {'name': 'Castilletti C.'}, {'name': 'Stefani F.'}, {'name': 'Rimoldi S.G.'}, {'name': 'Romeri F.'}, {'name': 'Salerno F.'}, {'name': 'Polesello S.'}, {'name': 'Nagy A.'}, {'name': 'Jirincova H.'}, {'name': 'Vecerova J.'}, {'name': 'Novakova L.'}, {'name': 'Cordey S.'}, {'name': 'Murtskhvaladze M.'}, {'name': 'Kotaria N.'}, {'name': 'Schar T.'}, {'name': 'Beisel C.'}, {'name': 'Vugrek O.'}, {'name': 'Rokic F.'}, {'name': 'Trgovec-Greif L.'}, {'name': 'Jurak I.'}, {'name': 'Rukavina T.'}, {'name': 'Sucic N.'}, {'name': 'Schonning K.'}, {'name': 'Karst S.M.'}, {'name': 'Kirkegaard R.H.'}, {'name': 'Michaelsen T.Y.'}, {'name': 'Sorensen E.A.'}, {'name': 'Knutson S.'}, {'name': 'Brandt J.'}, {'name': 'Le-Quy V.'}, {'name': 'Sorensen T.'}, {'name': 'Petersen C.'}, {'name': 'Pedersen M.S.'}, {'name': 'Larsen S.L.'}, {'name': 'Skov M.N.'}, {'name': 'Rasmussen M.'}, {'name': 'Fonager J.'}, {'name': 'Fomsgaard A.'}, {'name': 'Maksyutov R.A.'}, {'name': 'Gavrilova E.V.'}, {'name': 'Pyankov O.V.'}, {'name': 'Bodnev S.A.'}, {'name': 'Tregubchak T.V.'}, {'name': 'Shvalov A.N.'}, {'name': 'Antonets D.V.'}, {'name': 'Resende P.C.'}, {'name': 'Goya S.'}, {'name': 'Perrin A.'}, {'name': 'Lee R.T.'}, {'name': 'Yadahalli S.'}, {'name': 'Han A.X.'}, {'name': 'Russell C.A.'}, {'name': 'Schmutz S.'}, {'name': 'Zaheri M.'}, {'name': 'Kufner V.'}, {'name': 'Huber M.'}, {'name': 'Trkola A.'}, {'name': 'Antwerpen M.'}, {'name': 'Walter M.C.'}, {'name': 'van der Werf S.'}, {'name': 'Gambaro F.'}, {'name': 'Behillil S.'}, {'name': 'Enouf V.'}, {'name': 'Donati F.'}, {'name': 'Ustinova M.'}, {'name': 'Rovite V.'}, {'name': 'Klovins J.'}, {'name': 'Savicka O.'}, {'name': 'Wienecke-Baldacchino A.K.'}, {'name': 'Ragimbeau C.'}, {'name': 'Fournier G.'}, {'name': 'Mossong J.'}, {'name': 'Aberle S.W.'}, {'name': 'Haukland M.'}, {'name': 'Enkirch T.'}, {'name': 'Advani A.'}, {'name': 'Karlberg M.L.'}, {'name': 'Lindsjo O.K.'}, {'name': 'Broddesson S.'}, {'name': 'Slavikova M.'}, {'name': 'Lickova M.'}, {'name': 'Klempa B.'}, {'name': 'Staronova E.'}, {'name': 'Ticha E.'}, {'name': 'Szemes T.'}, {'name': 'Rusnakova D.'}, {'name': 'Stadler T.'}, {'name': 'Quer J.'}, {'name': 'Anton A.'}, {'name': 'Andres C.'}, {'name': 'Pinana M.'}, {'name': 'Garcia-Cehic D.'}, {'name': 'Pumarola T.'}, {'name': 'Izopet J.'}, {'name': 'Gioula G.'}, {'name': 'Exindari M.'}, {'name': 'Papa A.'}, {'name': 'Chatzidimitriou D.'}, {'name': 'Metallidis S.'}, {'name': 'Pappa S.'}, {'name': 'Macek M.'}, {'name': 'Geryk J.'}, {'name': 'Broz P.'}, {'name': 'Briksi A.'}, {'name': 'Hubacek P.'}, {'name': 'Drevinek P.'}, {'name': 'Zajac M.'}, {'name': 'Kvapil P.'}, {'name': 'Holub M.'}, {'name': 'Kvapilova K.'}, {'name': 'Novotny A.'}, {'name': 'Kasny M.'}, {'name': 'Klempt P.'}, {'name': 'Vapalahti O.'}, {'name': 'Smura T.'}, {'name': 'Sironen T.'}, {'name': 'Selhorst P.'}, {'name': 'Anthony C.'}, {'name': 'Arien K.'}, {'name': 'Simon-Loriere E.'}, {'name': 'Rabalski L.'}, {'name': 'Bienkowska-Szewczyk K.'}, {'name': 'Borges V.'}, {'name': 'Isidro J.'}, {'name': 'Gomes J.P.'}, {'name': 'Guiomar R.'}, {'name': 'Pechirra P.'}, {'name': 'Costa I.'}, {'name': 'Duarte S.'}, {'name': 'Vieira L.'}, {'name': 'Pyrc K.'}, {'name': 'Zuckerman N.S.'}, {'name': 'Turdikulova S.'}, {'name': 'Abdullaev A.'}, {'name': 'Dalimova D.'}, {'name': 'Abdurakhimov A.'}, {'name': 'Tagliabracci A.'}, {'name': 'Alessandrini F.'}, {'name': 'Melchionda F.'}, {'name': 'Onofri V.'}, {'name': 'Turchi C.'}, {'name': 'Bagnarelli P.'}, {'name': 'Menzo S.'}, {'name': 'Caucci S.'}, {'name': 'Di Sante L.'}, {'name': 'Popa A.'}, {'name': 'Genger J.-W.'}, {'name': 'Agerer B.'}, {'name': 'Lercher A.'}, {'name': 'Endler L.'}, {'name': 'Smyth M.'}, {'name': 'Penz T.'}, {'name': 'Schuster M.'}, {'name': 'Senekowitsch M.'}, {'name': 'Laine J.'}, {'name': 'Bock C.'}, {'name': 'Bergthaler A.'}, {'name': 'Shevtsov A.'}, {'name': 'Kalendar R.'}, {'name': 'Ramanculov Y.'}, {'name': 'Graf A.'}, {'name': 'Muenchhoff M.'}, {'name': 'Keppler O.T.'}, {'name': 'Krebs S.'}, {'name': 'Blum H.'}, {'name': 'Marcello A.'}, {'name': 'Licastro D.'}, {'name': ""D'Agaro P.""}, {'name': 'Laubscher F.'}, {'name': 'Vidanovic D.'}, {'name': 'Tesovic B.'}, {'name': 'Volkening J.'}, {'name': 'Clementi N.'}, {'name': 'Mancini N.'}, {'name': 'Rupnik M.'}, {'name': 'Mahnic A.'}, {'name': 'Walker A.'}, {'name': 'Houwaart T.'}, {'name': 'Wienemann T.'}, {'name': 'Vasconcelos M.K.'}, {'name': 'Strelow D.'}, {'name': 'Jensen B.-E.O.'}, {'name': 'Senff T.'}, {'name': 'Hulse L.'}, {'name': 'Adams O.'}, {'name': 'Andree M.'}, {'name': 'Hauka S.'}, {'name': 'Feldt T.'}, {'name': 'Keitel V.'}, {'name': 'Kindgen-Milles D.'}, {'name': 'Timm J.'}, {'name': 'Pfeffer K.'}, {'name': 'Dilthey A.T.'}, {'name': 'Moore C.'}, {'name': 'Ozdarendeli A.'}, {'name': 'Pavel S.T.I.'}, {'name': 'Yetiskin H.'}, {'name': 'Aydin G.'}, {'name': 'Holyavkin C.'}, {'name': 'Uygut M.A.'}, {'name': 'Cevik C.'}, {'name': 'Shchetinin A.'}, {'name': 'Gushchin V.'}, {'name': 'Dinler-Doganay G.'}, {'name': 'Doganay L.'}, {'name': 'Kizilboga-Akgun T.'}, {'name': 'Karacan I.'}, {'name': 'Pancer K.'}, {'name': 'Maes P.'}, {'name': 'Marti-Carreras J.'}, {'name': 'Wawina-Bokalanga T.'}, {'name': 'Vanmechelen B.'}, {'name': 'Thurmer A.'}, {'name': 'Wedde M.'}, {'name': 'Durrwald R.'}, {'name': 'von Kleist M.'}, {'name': 'Drechsel O.'}, {'name': 'Wolff T.'}, {'name': 'Fuchs S.'}, {'name': 'Kmiecinski R.'}, {'name': 'Michel J.'}, {'name': 'Nitsche A.'}, {'name': 'Casas I.'}, {'name': 'Caballero M.I.'}, {'name': 'Zaballos A.'}, {'name': 'Jimenez P.'}, {'name': 'Jimenez M.'}, {'name': 'Fernandez S.M.'}, {'name': 'Fernandez S.V.'}, {'name': 'de la Plaza I.C.'}, {'name': 'Fadeev A.'}, {'name': 'Ivanova A.'}, {'name': 'Sergeeva M.'}, {'name': 'Stefanelli P.'}, {'name': 'Estee Torok M.'}, {'name': 'Hall G.'}, {'name': 'da Silva Filipe A.'}, {'name': 'Turtle L.'}, {'name': 'Afifi S.'}, {'name': 'McCluggage K.'}, {'name': 'Beer R.'}, {'name': 'Ledesma J.'}, {'name': 'Maksimovic J.'}, {'name': 'Spellman K.'}, {'name': 'Hamilton W.L.'}, {'name': 'Marchbank A.'}, {'name': 'Southgate J.A.'}, {'name': 'Underwood A.'}, {'name': 'Taylor B.'}, {'name': 'Yeats C.'}, {'name': 'Abudahab K.'}, {'name': 'Gemmell M.R.'}, {'name': 'Eccles R.'}, {'name': 'Lucaci A.'}, {'name': 'Nelson C.A.'}, {'name': 'Rainbow L.'}, {'name': 'Whitehead M.'}, {'name': 'Gregory R.'}, {'name': 'Haldenby S.'}, {'name': 'Paterson S.'}, {'name': 'Hughes M.A.'}, {'name': 'Curran M.D.'}, {'name': 'Baker D.'}, {'name': 'Tucker R.'}, {'name': 'Green L.R.'}, {'name': 'Feltwell T.'}, {'name': 'Halstead F.D.'}, {'name': 'Wyles M.'}, {'name': 'Jahun A.S.'}, {'name': 'Ahmad S.S.Y.'}, {'name': 'Georgana I.'}, {'name': 'Goodfellow I.'}, {'name': 'Yakovleva A.'}, {'name': 'Meredith L.W.'}, {'name': 'Gavriil A.'}, {'name': 'Awan A.R.'}, {'name': 'Fisher C.'}, {'name': 'Edgeworth J.'}, {'name': 'Lynch J.'}, {'name': 'Moore N.'}, {'name': 'Williams R.'}, {'name': 'Kidd S.P.'}, {'name': 'Cortes N.'}, {'name': 'Brunker K.'}, {'name': 'McCrone J.T.'}, {'name': 'Quick J.'}, {'name': 'Duckworth N.'}, {'name': 'Walsh S.'}, {'name': 'Sloan T.'}, {'name': 'Ludden C.'}, {'name': 'George R.P.'}, {'name': 'Eltringham G.'}, {'name': 'Brown J.R.'}, {'name': 'Aranday-Cortes E.'}, {'name': 'Shepherd J.G.'}, {'name': 'Hughes J.'}, {'name': 'Li K.K.'}, {'name': 'Williams T.C.'}, {'name': 'Johnson N.'}, {'name': 'Jesudason N.'}, {'name': 'Mair D.'}, {'name': 'Thomson E.'}, {'name': 'Shah R.'}, {'name': 'Parr Y.A.'}, {'name': 'Carmichael S.'}, {'name': 'Robertson D.L.'}, {'name': 'Nomikou K.'}, {'name': 'Broos A.'}, {'name': 'Niebel M.'}, {'name': 'Smollett K.'}, {'name': 'Tong L.'}, {'name': 'Miah S.'}, {'name': 'Wittner A.'}, {'name': 'Phillips N.'}, {'name': 'Payne B.'}, {'name': 'Dewar R.'}, {'name': 'Holmes A.'}, {'name': 'Bolt F.'}, {'name': 'Price J.R.'}, {'name': 'Mookerjee S.'}, {'name': 'Sethi D.K.'}, {'name': 'Potter W.'}, {'name': 'Stanley R.'}, {'name': 'Prakash R.'}, {'name': 'Dervisevic S.'}, {'name': 'Graham J.C.'}, {'name': 'Nelson A.'}, {'name': 'Smith D.'}, {'name': 'Young G.R.'}, {'name': 'Yew W.C.'}, {'name': 'Todd J.A.'}, {'name': 'Trebes A.'}, {'name': 'Andersson M.'}, {'name': 'Bull M.'}, {'name': 'Watkins J.'}, {'name': 'Birchley A.'}, {'name': 'Gatica-Wilcox B.'}, {'name': 'Gilbert L.'}, {'name': 'Kumziene-Summerhayes S.'}, {'name': 'Rey S.'}, {'name': 'Chauhan A.'}, {'name': 'Butcher E.'}, {'name': 'Bicknell K.'}, {'name': 'Elliott S.'}, {'name': 'Glaysher S.'}, {'name': 'Lackenby A.'}, {'name': 'Bibby D.'}, {'name': 'Platt S.'}, {'name': 'Mohamed H.'}, {'name': 'Machin N.W.'}, {'name': 'Mbisa J.L.'}, {'name': 'Evans J.'}, {'name': 'Perry M.'}, {'name': 'Pacchiarini N.'}, {'name': 'Corden S.'}, {'name': 'Adams A.G.'}, {'name': 'Gaskin A.'}, {'name': 'Coombs J.'}, {'name': 'Graham L.J.'}, {'name': 'Cottrell S.'}, {'name': 'Morgan M.'}, {'name': 'Gifford L.'}, {'name': 'Kolyva A.'}, {'name': 'Rudder S.J.'}, {'name': 'Trotter A.J.'}, {'name': 'Mather A.E.'}, {'name': 'Aydin A.'}, {'name': 'Page A.J.'}, {'name': 'Kay G.L.'}, {'name': 'de Oliveira Martins L.'}, {'name': 'Yasir M.'}, {'name': 'Alikhan N.-F.'}, {'name': 'Thomson N.M.'}, {'name': 'Gilroy R.'}, {'name': 'Kingsley R.A.'}, {'name': ""O'Grady J.""}, {'name': 'Gutierrez A.V.'}, {'name': 'Diaz M.'}, {'name': 'Viet T.L.'}, {'name': 'Tedim A.P.'}, {'name': 'Adriaenssens E.M.'}, {'name': 'Patrick Mcclure C.'}, {'name': 'Moore C.'}, {'name': 'Sang F.'}, {'name': 'Clark G.'}, {'name': 'Howson-Wells H.C.'}, {'name': 'Debebe J.'}, {'name': 'Ball J.'}, {'name': 'Chappell J.'}, {'name': 'Khakh M.'}, {'name': 'Carlile M.'}, {'name': 'Loose M.'}, {'name': 'Lister M.M.'}, {'name': 'Holmes N.'}, {'name': 'Tsoleridis T.'}, {'name': 'Fleming V.M.'}, {'name': 'Wright V.'}, {'name': 'Smith W.'}, {'name': 'Gallagher M.D.'}, {'name': 'Parker M.'}, {'name': 'Partridge D.G.'}, {'name': 'Evans C.'}, {'name': 'Baker P.'}, {'name': 'Essex S.'}, {'name': 'Liggett S.'}, {'name': 'Keeley A.J.'}, {'name': 'Bashton M.'}, {'name': 'Rooke S.'}, {'name': 'Dervisavic S.'}, {'name': 'Meader E.J.'}, {'name': 'Lopez C.E.B.'}, {'name': 'Angyal A.'}, {'name': 'Kristiansen M.'}, {'name': 'Tutill H.J.'}, {'name': 'Findlay J.'}, {'name': 'Mestek-Boukhibar L.'}, {'name': 'Forrest L.'}, {'name': 'Dyal P.'}, {'name': 'Williams R.J.'}, {'name': 'Panchbhaya Y.'}, {'name': 'Williams C.A.'}, {'name': 'Roy S.'}, {'name': 'Pandey S.'}, {'name': 'Stockton J.'}, {'name': 'Loman N.J.'}, {'name': 'Poplawski R.'}, {'name': 'Nicholls S.'}, {'name': 'Rowe W.P.M.'}, {'name': 'Khokhar F.'}, {'name': 'Pinckert M.L.'}, {'name': 'Hosmillo M.'}, {'name': 'Chaudhry Y.'}, {'name': 'Caller L.G.'}, {'name': 'Davidson R.K.'}, {'name': 'Griffith L.'}, {'name': 'Rambaut A.'}, {'name': 'Jackson B.'}, {'name': 'Colquhoun R.'}, {'name': 'Hill V.'}, {'name': 'Nichols J.'}, {'name': 'Asamaphan P.'}, {'name': 'Darby A.'}, {'name': 'Jackson K.A.'}, {'name': 'Iturriza-Gomara M.'}, {'name': 'Vamos E.E.'}, {'name': 'Green A.'}, {'name': 'Aanensen D.'}, {'name': 'Bonsall D.'}, {'name': 'Buck D.'}, {'name': 'Macintyre-Cockett G.'}, {'name': 'de Cesare M.'}, {'name': 'Pybus O.'}, {'name': 'Golubchik T.'}, {'name': 'Scarlett G.'}, {'name': 'Loveson K.F.'}, {'name': 'Robson S.C.'}, {'name': 'Beckett A.'}, {'name': 'Lindsey B.'}, {'name': 'Groves D.C.'}, {'name': 'Parsons P.J.'}, {'name': 'McHugh M.P.'}, {'name': 'Barnes J.D.'}, {'name': 'Manso C.F.'}, {'name': 'Grammatopoulos D.'}, {'name': 'Menger K.E.'}, {'name': 'Harrison E.'}, {'name': 'Gunson R.'}, {'name': 'Peacock S.J.'}, {'name': 'Gonzalez G.'}, {'name': 'Carr M.'}, {'name': 'Mihaela L.'}, {'name': 'Popovici O.'}, {'name': 'Brytting M.'}, {'name': 'Bresner C.'}, {'name': 'Fuller W.'}, {'name': 'Workman T.'}, {'name': 'Mentis A.F.'}, {'name': 'Kossyvakis A.'}, {'name': 'Karamitros T.'}, {'name': 'Pogka V.'}, {'name': 'Kalliaropoulos A.'}, {'name': 'Horefti E.'}, {'name': 'Kontou A.'}, {'name': 'Martinez-Gonzalez B.'}, {'name': 'Labropoulou V.'}, {'name': 'Voulgari-Kokota A.'}, {'name': 'Evangelidou M.'}, {'name': 'Bizta P.'}, {'name': 'Belimezi M.'}, {'name': 'Lambrechts L.'}, {'name': 'Doymaz M.Z.'}, {'name': 'Yazici M.K.'}, {'name': 'Cetin N.S.'}, {'name': 'Karaaslan E.'}, {'name': 'Kallio-Kokko H.'}, {'name': 'Virtanen J.'}, {'name': 'Suvanto M.'}, {'name': 'Nguyen P.T.'}, {'name': 'Ellonen P.'}, {'name': 'Hannula S.'}, {'name': 'Kangas H.'}, {'name': 'Sreenu V.B.'}, {'name': 'Burian K.'}, {'name': 'Terhes G.'}, {'name': 'Gombos K.'}, {'name': 'Gyenesei A.'}, {'name': 'Urban P.'}, {'name': 'Herczeg R.'}, {'name': 'Jakab F.'}, {'name': 'Kemenesi G.'}, {'name': 'Toth G.E.'}, {'name': 'Somogyi B.'}, {'name': 'Zana B.'}, {'name': 'Zeghbib S.'}, {'name': 'Kuczmog A.'}, {'name': 'Foldes F.'}, {'name': 'Lanszki Z.'}, {'name': 'Madai M.'}, {'name': 'Papp H.'}, {'name': 'Nagy A.'}, {'name': 'Pereszlenyi C.I.'}, {'name': 'Babinszky G.C.'}, {'name': 'Dudas G.'}, {'name': 'Csoma E.'}, {'name': 'Abou Tayoun A.N.'}, {'name': 'Alsheikh-Ali A.A.'}, {'name': 'Loney T.'}, {'name': 'Nowotny N.'}, {'name': 'Abdul-Wahab O.'}, {'name': 'Gonzalez-Candelas F.'}, {'name': 'Andersen M.H.'}, {'name': 'Taylor S.'}], 'citationCount': 42, 'date': '2020-01-01T00:00:00Z', 'journal': 'Eurosurveillance', 'title': 'Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020'}, 'note': 'V-pipe was used to process a major part of the Swiss samples in this pan-European study.', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2020.10.12.335919', 'note': 'Raw reads from SRA public data and Swiss cohort were processed using V-pipe', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2020.10.14.20212621', 'note': 'V-pipe was used to process a major part of the Swiss samples', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2021.01.08.21249379', 'note': 'The waste water samples were analyzed using V-pipe and additional custom scripts.', 'type': ['Usage'], 'version': 'sars-cov2-dev'}, {'doi': '10.1101/2021.03.05.21252520', 'note': 'V-pipe is used within the S3C (Swiss SARS-CoV-2 Sequencing Consortium) to provide sequences.', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.3390/v13030496', 'metadata': {'abstract': '© 2021 by the authors. Licensee MDPI, Basel, Switzerland.Since the emergence of coronavirus disease (COVID-19) in late 2019, domestic cats have been demonstrated to be susceptible to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) under natural and experimental conditions. As pet cats often live in very close contact with their owners, it is essential to investigate SARS-CoV-2 infections in cats in a One-Health context. This study reports the first SARS-CoV-2 infection in a cat in a COVID-19-affected household in Switzerland. The cat (Cat 1) demonstrated signs of an upper respiratory tract infection, including sneezing, inappetence, and apathy, while the cohabiting cat (Cat 2) remained asymptomatic. Nasal, oral, fecal, fur, and environmental swab samples were collected twice from both cats and analyzed by RT-qPCR for the presence of SARS-CoV-2 viral RNA. Both nasal swabs from Cat 1 tested positive. In addition, the first oral swab from Cat 2 and fur and bedding swabs from both cats were RT-qPCR positive. The fecal swabs tested negative. The infection of Cat 1 was confirmed by positive SARS-CoV-2 S1 receptor binding domain (RBD) antibody testing and neutralizing activity in a surrogate assay. The viral genome sequence from Cat 1, obtained by next generation sequencing, showed the closest relation to a human sequence from the B.1.1.39 lineage, with one single nucleotide polymorphism (SNP) difference. This study demonstrates not only SARS-CoV-2 infection of a cat from a COVID-19-affected household but also contamination of the cats’ fur and bed with viral RNA. Our results are important to create awareness that SARS-CoV-2 infected people should observe hygienic measures to avoid infection and contamination of animal cohabitants.', 'authors': [{'name': 'Klaus J.'}, {'name': 'Meli M.L.'}, {'name': 'Willi B.'}, {'name': 'Nadeau S.'}, {'name': 'Beisel C.'}, {'name': 'Stadler T.'}, {'name': 'Egberink H.'}, {'name': 'Zhao S.'}, {'name': 'Lutz H.'}, {'name': 'Riond B.'}, {'name': 'Rosinger N.'}, {'name': 'Stalder H.'}, {'name': 'Renzullo S.'}, {'name': 'Hofmann-Lehmann R.'}], 'citationCount': 2, 'date': '2021-03-01T00:00:00Z', 'journal': 'Viruses', 'title': 'Detection and genome sequencing of sars-cov-2 in a domestic cat with respiratory signs in Switzerland'}, 'note': 'V-pipe and the S3C (Swiss SARS-CoV-2 Sequencing Consortium) infrastructure were used to QA and pre-process the sequencing data.', 'pmcid': 'PMC8002591', 'pmid': '33802899', 'type': ['Usage'], 'version': 'sars-cov2'}]"
181,niko.beerenwinkel@bsse.ethz.ch,Niko Beerenwinkel,Person,https://orcid.org/0000-0002-0573-6119,['Contributor'],,https://www.bsse.ethz.ch/cbg/group/people/person-detail.html?persid=149417,,,v-pipe,Open access,DrYak,"[{'doi': '10.1093/bioinformatics/btab015', 'pmid': '33471068', 'type': ['Primary'], 'version': '1.0, 2.0'}, {'doi': '10.20944/preprints202005.0376.v1', 'type': ['Review']}, {'doi': '10.1016/j.virusres.2016.09.016', 'metadata': {'abstract': '© 2016 The AuthorsRapidly evolving RNA viruses prevail within a host as a collection of closely related variants, referred to as viral quasispecies. Advances in high-throughput sequencing (HTS) technologies have facilitated the assessment of the genetic diversity of such virus populations at an unprecedented level of detail. However, analysis of HTS data from virus populations is challenging due to short, error-prone reads. In order to account for uncertainties originating from these limitations, several computational and statistical methods have been developed for studying the genetic heterogeneity of virus population. Here, we review methods for the analysis of HTS reads, including approaches to local diversity estimation and global haplotype reconstruction. Challenges posed by aligning reads, as well as the impact of reference biases on diversity estimates are also discussed. In addition, we address some of the experimental approaches designed to improve the biological signal-to-noise ratio. In the future, computational methods for the analysis of heterogeneous virus populations are likely to continue being complemented by technological developments.', 'authors': [{'name': 'Posada-Cespedes S.'}, {'name': 'Seifert D.'}, {'name': 'Beerenwinkel N.'}], 'citationCount': 42, 'date': '2017-07-15T00:00:00Z', 'journal': 'Virus Research', 'title': 'Recent advances in inferring viral diversity from high-throughput sequencing data'}, 'pmid': '27693290', 'type': ['Other']}, {'doi': '10.3390/v10050256', 'metadata': {'abstract': '© 2018 by the authors. Licensee MDPI, Basel, Switzerland.The Second Annual Meeting of the European Virus Bioinformatics Center (EVBC), held in Utrecht, Netherlands, focused on computational approaches in virology, with topics including (but not limited to) virus discovery, diagnostics, (meta-)genomics, modeling, epidemiology, molecular structure, evolution, and viral ecology. The goals of the Second Annual Meeting were threefold: (i) to bring together virologists and bioinformaticians from across the academic, industrial, professional, and training sectors to share best practice; (ii) to provide a meaningful and interactive scientific environment to promote discussion and collaboration between students, postdoctoral fellows, and both new and established investigators; (iii) to inspire and suggest new research directions and questions. Approximately 120 researchers from around the world attended the Second Annual Meeting of the EVBC this year, including 15 renowned international speakers. This report presents an overview of new developments and novel research findings that emerged during the meeting.', 'authors': [{'name': 'Ibrahim B.'}, {'name': 'Arkhipova K.'}, {'name': 'Andeweg A.C.'}, {'name': 'Posada-Cespedes S.'}, {'name': 'Enault F.'}, {'name': 'Gruber A.'}, {'name': 'Koonin E.V.'}, {'name': 'Kupczok A.'}, {'name': 'Lemey P.'}, {'name': 'McHardy A.C.'}, {'name': 'McMahon D.P.'}, {'name': 'Pickett B.E.'}, {'name': 'Robertson D.L.'}, {'name': 'Scheuermann R.H.'}, {'name': 'Zhernakova A.'}, {'name': 'Zwart M.P.'}, {'name': 'Schonhuth A.'}, {'name': 'Dutilh B.E.'}, {'name': 'Marz M.'}], 'citationCount': 3, 'date': '2018-05-14T00:00:00Z', 'journal': 'Viruses', 'title': 'Bioinformatics meets virology: The European virus bioinformatics center’s second annual meeting'}, 'pmcid': 'PMC5977249', 'pmid': '29757994', 'type': ['Other']}, {'doi': '10.1093/infdis/jiz094', 'metadata': {'abstract': '© 2019 The Author(s) 2019.Background: Human immunodeficiency virus type 1 (HIV-1) genetic diversity increases over the course of infection and can be used to infer the time since infection and, consequently, infection recency, which are crucial for HIV-1 surveillance and the understanding of viral pathogenesis. Methods: We considered 313 HIV-infected individuals for whom reliable estimates of infection dates and next-generation sequencing (NGS)-derived nucleotide frequency data were available. Fractions of ambiguous nucleotides, obtained by population sequencing, were available for 207 samples. We assessed whether the average pairwise diversity calculated using NGS sequences provided a more exact prediction of the time since infection and classification of infection recency (<1 year after infection), compared with the fraction of ambiguous nucleotides. Results: NGS-derived average pairwise diversity classified an infection as recent with a sensitivity of 88% and a specificity of 85%. When considering only the 207 samples for which fractions of ambiguous nucleotides were available, the NGS-derived average pairwise diversity exhibited a higher sensitivity (90% vs 78%) and specificity (95% vs 67%) than the fraction of ambiguous nucleotides. Additionally, the average pairwise diversity could be used to estimate the time since infection with a mean absolute error of 0.84 years, compared with 1.03 years for the fraction of ambiguous nucleotides. Conclusions: Viral diversity based on NGS data is more precise than that based on population sequencing in its ability to predict infection recency and provides an estimated time since infection that has a mean absolute error of <1 year.', 'authors': [{'name': 'Carlisle L.A.'}, {'name': 'Turk T.'}, {'name': 'Kusejko K.'}, {'name': 'Metzner K.J.'}, {'name': 'Leemann C.'}, {'name': 'Schenkel C.D.'}, {'name': 'Bachmann N.'}, {'name': 'Posada S.'}, {'name': 'Beerenwinkel N.'}, {'name': 'Boni J.'}, {'name': 'Yerly S.'}, {'name': 'Klimkait T.'}, {'name': 'Perreau M.'}, {'name': 'Braun D.L.'}, {'name': 'Rauch A.'}, {'name': 'Calmy A.'}, {'name': 'Cavassini M.'}, {'name': 'Battegay M.'}, {'name': 'Vernazza P.'}, {'name': 'Bernasconi E.'}, {'name': 'Gunthard H.F.'}, {'name': 'Kouyos R.D.'}, {'name': 'Anagnostopoulos A.'}, {'name': 'Battegay M.'}, {'name': 'Bernasconi E.'}, {'name': 'Boni J.'}, {'name': 'Braun D.L.'}, {'name': 'Bucher H.C.'}, {'name': 'Calmy A.'}, {'name': 'Cavassini M.'}, {'name': 'Ciuffi A.'}, {'name': 'Dollenmaier G.'}, {'name': 'Egger M.'}, {'name': 'Elzi L.'}, {'name': 'Fehr J.'}, {'name': 'Fellay J.'}, {'name': 'Furrer H.'}, {'name': 'Fux C.A.'}, {'name': 'Gunthard H.F.'}, {'name': 'Haerry D.'}, {'name': 'Hasse B.'}, {'name': 'Hirsch H.H.'}, {'name': 'Hoffmann M.'}, {'name': 'Hosli I.'}, {'name': 'Huber M.'}, {'name': 'Kahlert C.'}, {'name': 'Kaiser L.'}, {'name': 'Keiser O.'}, {'name': 'Klimkait T.'}, {'name': 'Kouyos R.D.'}, {'name': 'Kovari H.'}, {'name': 'Ledergerber B.'}, {'name': 'Martinetti G.'}, {'name': 'Martinez De Tejada B.'}, {'name': 'Marzolini C.'}, {'name': 'Metzner K.J.'}, {'name': 'Muller N.'}, {'name': 'Nicca D.'}, {'name': 'Paioni P.'}, {'name': 'Pantaleo G.'}, {'name': 'Perreau M.'}, {'name': 'Rauch A.'}, {'name': 'Rudin C.'}, {'name': 'Scherrer A.U.'}, {'name': 'Schmid P.'}, {'name': 'Speck R.'}, {'name': 'Stockle M.'}, {'name': 'Tarr P.'}, {'name': 'Trkola A.'}, {'name': 'Vernazza P.'}, {'name': 'Wandeler G.'}, {'name': 'Weber R.'}, {'name': 'Yerly S.'}], 'citationCount': 6, 'date': '2019-06-19T00:00:00Z', 'journal': 'Journal of Infectious Diseases', 'title': 'Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time since Infection'}, 'pmid': '30835266', 'type': ['Usage']}, {'doi': '10.2807/1560-7917.es.2020.25.32.2001410', 'metadata': {'abstract': '© 2020 Turkish Society of Cardiology. All rights reserved.We show the distribution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic clades over time and between countries and outline potential genomic surveillance objectives. We applied three genomic nomenclature systems to all sequence data from the World Health Organization European Region available until 10 July 2020. We highlight the importance of real-time sequencing and data dissemination in a pandemic situation, compare the nomenclatures and lay a foundation for future European genomic surveillance of SARS-CoV-2.', 'authors': [{'name': 'Alm E.'}, {'name': 'Broberg E.K.'}, {'name': 'Connor T.'}, {'name': 'Hodcroft E.B.'}, {'name': 'Komissarov A.B.'}, {'name': 'Maurer-Stroh S.'}, {'name': 'Melidou A.'}, {'name': 'Neher R.A.'}, {'name': ""O'Toole A.""}, {'name': 'Pereyaslov D.'}, {'name': 'Beerenwinkel N.'}, {'name': 'Posada-Cespedes S.'}, {'name': 'Jablonski K.P.'}, {'name': 'Ferreira P.F.'}, {'name': 'Topolsky I.'}, {'name': 'Avsic-Zupanc T.'}, {'name': 'Korva M.'}, {'name': 'Poljak M.'}, {'name': 'Zakotnik S.'}, {'name': 'Zorec T.M.'}, {'name': 'Bragstad K.'}, {'name': 'Hungnes O.'}, {'name': 'Stene-Johansen K.'}, {'name': 'Reusken C.'}, {'name': 'Meijer A.'}, {'name': 'Vennema H.'}, {'name': 'Ruiz-Roldan L.'}, {'name': 'Bracho M.A.'}, {'name': 'Garcia-Gonzalez N.'}, {'name': 'Chiner-Oms A.'}, {'name': 'Cancino-Munoz I.'}, {'name': 'Comas I.'}, {'name': 'Goig G.A.'}, {'name': 'Torres-Puente M.'}, {'name': 'Lopez M.G.'}, {'name': 'Martinez-Priego L.'}, {'name': ""D'Auria G.""}, {'name': 'Ruiz-Hueso P.'}, {'name': 'Ferrus-Abad L.'}, {'name': 'de Marco G.'}, {'name': 'Galan-Vendrell I.'}, {'name': 'Carbo-Ramirez S.'}, {'name': 'Ruiz-Rodriguez P.'}, {'name': 'Coscolla M.'}, {'name': 'Polackova K.'}, {'name': 'Kramna L.'}, {'name': 'Cinek O.'}, {'name': 'Richter J.'}, {'name': 'Krashias G.'}, {'name': 'Tryfonos C.'}, {'name': 'Bashiardes S.'}, {'name': 'Koptides D.'}, {'name': 'Christodoulou C.'}, {'name': 'Bartolini B.'}, {'name': 'Gruber C.E.'}, {'name': 'Di Caro A.'}, {'name': 'Castilletti C.'}, {'name': 'Stefani F.'}, {'name': 'Rimoldi S.G.'}, {'name': 'Romeri F.'}, {'name': 'Salerno F.'}, {'name': 'Polesello S.'}, {'name': 'Nagy A.'}, {'name': 'Jirincova H.'}, {'name': 'Vecerova J.'}, {'name': 'Novakova L.'}, {'name': 'Cordey S.'}, {'name': 'Murtskhvaladze M.'}, {'name': 'Kotaria N.'}, {'name': 'Schar T.'}, {'name': 'Beisel C.'}, {'name': 'Vugrek O.'}, {'name': 'Rokic F.'}, {'name': 'Trgovec-Greif L.'}, {'name': 'Jurak I.'}, {'name': 'Rukavina T.'}, {'name': 'Sucic N.'}, {'name': 'Schonning K.'}, {'name': 'Karst S.M.'}, {'name': 'Kirkegaard R.H.'}, {'name': 'Michaelsen T.Y.'}, {'name': 'Sorensen E.A.'}, {'name': 'Knutson S.'}, {'name': 'Brandt J.'}, {'name': 'Le-Quy V.'}, {'name': 'Sorensen T.'}, {'name': 'Petersen C.'}, {'name': 'Pedersen M.S.'}, {'name': 'Larsen S.L.'}, {'name': 'Skov M.N.'}, {'name': 'Rasmussen M.'}, {'name': 'Fonager J.'}, {'name': 'Fomsgaard A.'}, {'name': 'Maksyutov R.A.'}, {'name': 'Gavrilova E.V.'}, {'name': 'Pyankov O.V.'}, {'name': 'Bodnev S.A.'}, {'name': 'Tregubchak T.V.'}, {'name': 'Shvalov A.N.'}, {'name': 'Antonets D.V.'}, {'name': 'Resende P.C.'}, {'name': 'Goya S.'}, {'name': 'Perrin A.'}, {'name': 'Lee R.T.'}, {'name': 'Yadahalli S.'}, {'name': 'Han A.X.'}, {'name': 'Russell C.A.'}, {'name': 'Schmutz S.'}, {'name': 'Zaheri M.'}, {'name': 'Kufner V.'}, {'name': 'Huber M.'}, {'name': 'Trkola A.'}, {'name': 'Antwerpen M.'}, {'name': 'Walter M.C.'}, {'name': 'van der Werf S.'}, {'name': 'Gambaro F.'}, {'name': 'Behillil S.'}, {'name': 'Enouf V.'}, {'name': 'Donati F.'}, {'name': 'Ustinova M.'}, {'name': 'Rovite V.'}, {'name': 'Klovins J.'}, {'name': 'Savicka O.'}, {'name': 'Wienecke-Baldacchino A.K.'}, {'name': 'Ragimbeau C.'}, {'name': 'Fournier G.'}, {'name': 'Mossong J.'}, {'name': 'Aberle S.W.'}, {'name': 'Haukland M.'}, {'name': 'Enkirch T.'}, {'name': 'Advani A.'}, {'name': 'Karlberg M.L.'}, {'name': 'Lindsjo O.K.'}, {'name': 'Broddesson S.'}, {'name': 'Slavikova M.'}, {'name': 'Lickova M.'}, {'name': 'Klempa B.'}, {'name': 'Staronova E.'}, {'name': 'Ticha E.'}, {'name': 'Szemes T.'}, {'name': 'Rusnakova D.'}, {'name': 'Stadler T.'}, {'name': 'Quer J.'}, {'name': 'Anton A.'}, {'name': 'Andres C.'}, {'name': 'Pinana M.'}, {'name': 'Garcia-Cehic D.'}, {'name': 'Pumarola T.'}, {'name': 'Izopet J.'}, {'name': 'Gioula G.'}, {'name': 'Exindari M.'}, {'name': 'Papa A.'}, {'name': 'Chatzidimitriou D.'}, {'name': 'Metallidis S.'}, {'name': 'Pappa S.'}, {'name': 'Macek M.'}, {'name': 'Geryk J.'}, {'name': 'Broz P.'}, {'name': 'Briksi A.'}, {'name': 'Hubacek P.'}, {'name': 'Drevinek P.'}, {'name': 'Zajac M.'}, {'name': 'Kvapil P.'}, {'name': 'Holub M.'}, {'name': 'Kvapilova K.'}, {'name': 'Novotny A.'}, {'name': 'Kasny M.'}, {'name': 'Klempt P.'}, {'name': 'Vapalahti O.'}, {'name': 'Smura T.'}, {'name': 'Sironen T.'}, {'name': 'Selhorst P.'}, {'name': 'Anthony C.'}, {'name': 'Arien K.'}, {'name': 'Simon-Loriere E.'}, {'name': 'Rabalski L.'}, {'name': 'Bienkowska-Szewczyk K.'}, {'name': 'Borges V.'}, {'name': 'Isidro J.'}, {'name': 'Gomes J.P.'}, {'name': 'Guiomar R.'}, {'name': 'Pechirra P.'}, {'name': 'Costa I.'}, {'name': 'Duarte S.'}, {'name': 'Vieira L.'}, {'name': 'Pyrc K.'}, {'name': 'Zuckerman N.S.'}, {'name': 'Turdikulova S.'}, {'name': 'Abdullaev A.'}, {'name': 'Dalimova D.'}, {'name': 'Abdurakhimov A.'}, {'name': 'Tagliabracci A.'}, {'name': 'Alessandrini F.'}, {'name': 'Melchionda F.'}, {'name': 'Onofri V.'}, {'name': 'Turchi C.'}, {'name': 'Bagnarelli P.'}, {'name': 'Menzo S.'}, {'name': 'Caucci S.'}, {'name': 'Di Sante L.'}, {'name': 'Popa A.'}, {'name': 'Genger J.-W.'}, {'name': 'Agerer B.'}, {'name': 'Lercher A.'}, {'name': 'Endler L.'}, {'name': 'Smyth M.'}, {'name': 'Penz T.'}, {'name': 'Schuster M.'}, {'name': 'Senekowitsch M.'}, {'name': 'Laine J.'}, {'name': 'Bock C.'}, {'name': 'Bergthaler A.'}, {'name': 'Shevtsov A.'}, {'name': 'Kalendar R.'}, {'name': 'Ramanculov Y.'}, {'name': 'Graf A.'}, {'name': 'Muenchhoff M.'}, {'name': 'Keppler O.T.'}, {'name': 'Krebs S.'}, {'name': 'Blum H.'}, {'name': 'Marcello A.'}, {'name': 'Licastro D.'}, {'name': ""D'Agaro P.""}, {'name': 'Laubscher F.'}, {'name': 'Vidanovic D.'}, {'name': 'Tesovic B.'}, {'name': 'Volkening J.'}, {'name': 'Clementi N.'}, {'name': 'Mancini N.'}, {'name': 'Rupnik M.'}, {'name': 'Mahnic A.'}, {'name': 'Walker A.'}, {'name': 'Houwaart T.'}, {'name': 'Wienemann T.'}, {'name': 'Vasconcelos M.K.'}, {'name': 'Strelow D.'}, {'name': 'Jensen B.-E.O.'}, {'name': 'Senff T.'}, {'name': 'Hulse L.'}, {'name': 'Adams O.'}, {'name': 'Andree M.'}, {'name': 'Hauka S.'}, {'name': 'Feldt T.'}, {'name': 'Keitel V.'}, {'name': 'Kindgen-Milles D.'}, {'name': 'Timm J.'}, {'name': 'Pfeffer K.'}, {'name': 'Dilthey A.T.'}, {'name': 'Moore C.'}, {'name': 'Ozdarendeli A.'}, {'name': 'Pavel S.T.I.'}, {'name': 'Yetiskin H.'}, {'name': 'Aydin G.'}, {'name': 'Holyavkin C.'}, {'name': 'Uygut M.A.'}, {'name': 'Cevik C.'}, {'name': 'Shchetinin A.'}, {'name': 'Gushchin V.'}, {'name': 'Dinler-Doganay G.'}, {'name': 'Doganay L.'}, {'name': 'Kizilboga-Akgun T.'}, {'name': 'Karacan I.'}, {'name': 'Pancer K.'}, {'name': 'Maes P.'}, {'name': 'Marti-Carreras J.'}, {'name': 'Wawina-Bokalanga T.'}, {'name': 'Vanmechelen B.'}, {'name': 'Thurmer A.'}, {'name': 'Wedde M.'}, {'name': 'Durrwald R.'}, {'name': 'von Kleist M.'}, {'name': 'Drechsel O.'}, {'name': 'Wolff T.'}, {'name': 'Fuchs S.'}, {'name': 'Kmiecinski R.'}, {'name': 'Michel J.'}, {'name': 'Nitsche A.'}, {'name': 'Casas I.'}, {'name': 'Caballero M.I.'}, {'name': 'Zaballos A.'}, {'name': 'Jimenez P.'}, {'name': 'Jimenez M.'}, {'name': 'Fernandez S.M.'}, {'name': 'Fernandez S.V.'}, {'name': 'de la Plaza I.C.'}, {'name': 'Fadeev A.'}, {'name': 'Ivanova A.'}, {'name': 'Sergeeva M.'}, {'name': 'Stefanelli P.'}, {'name': 'Estee Torok M.'}, {'name': 'Hall G.'}, {'name': 'da Silva Filipe A.'}, {'name': 'Turtle L.'}, {'name': 'Afifi S.'}, {'name': 'McCluggage K.'}, {'name': 'Beer R.'}, {'name': 'Ledesma J.'}, {'name': 'Maksimovic J.'}, {'name': 'Spellman K.'}, {'name': 'Hamilton W.L.'}, {'name': 'Marchbank A.'}, {'name': 'Southgate J.A.'}, {'name': 'Underwood A.'}, {'name': 'Taylor B.'}, {'name': 'Yeats C.'}, {'name': 'Abudahab K.'}, {'name': 'Gemmell M.R.'}, {'name': 'Eccles R.'}, {'name': 'Lucaci A.'}, {'name': 'Nelson C.A.'}, {'name': 'Rainbow L.'}, {'name': 'Whitehead M.'}, {'name': 'Gregory R.'}, {'name': 'Haldenby S.'}, {'name': 'Paterson S.'}, {'name': 'Hughes M.A.'}, {'name': 'Curran M.D.'}, {'name': 'Baker D.'}, {'name': 'Tucker R.'}, {'name': 'Green L.R.'}, {'name': 'Feltwell T.'}, {'name': 'Halstead F.D.'}, {'name': 'Wyles M.'}, {'name': 'Jahun A.S.'}, {'name': 'Ahmad S.S.Y.'}, {'name': 'Georgana I.'}, {'name': 'Goodfellow I.'}, {'name': 'Yakovleva A.'}, {'name': 'Meredith L.W.'}, {'name': 'Gavriil A.'}, {'name': 'Awan A.R.'}, {'name': 'Fisher C.'}, {'name': 'Edgeworth J.'}, {'name': 'Lynch J.'}, {'name': 'Moore N.'}, {'name': 'Williams R.'}, {'name': 'Kidd S.P.'}, {'name': 'Cortes N.'}, {'name': 'Brunker K.'}, {'name': 'McCrone J.T.'}, {'name': 'Quick J.'}, {'name': 'Duckworth N.'}, {'name': 'Walsh S.'}, {'name': 'Sloan T.'}, {'name': 'Ludden C.'}, {'name': 'George R.P.'}, {'name': 'Eltringham G.'}, {'name': 'Brown J.R.'}, {'name': 'Aranday-Cortes E.'}, {'name': 'Shepherd J.G.'}, {'name': 'Hughes J.'}, {'name': 'Li K.K.'}, {'name': 'Williams T.C.'}, {'name': 'Johnson N.'}, {'name': 'Jesudason N.'}, {'name': 'Mair D.'}, {'name': 'Thomson E.'}, {'name': 'Shah R.'}, {'name': 'Parr Y.A.'}, {'name': 'Carmichael S.'}, {'name': 'Robertson D.L.'}, {'name': 'Nomikou K.'}, {'name': 'Broos A.'}, {'name': 'Niebel M.'}, {'name': 'Smollett K.'}, {'name': 'Tong L.'}, {'name': 'Miah S.'}, {'name': 'Wittner A.'}, {'name': 'Phillips N.'}, {'name': 'Payne B.'}, {'name': 'Dewar R.'}, {'name': 'Holmes A.'}, {'name': 'Bolt F.'}, {'name': 'Price J.R.'}, {'name': 'Mookerjee S.'}, {'name': 'Sethi D.K.'}, {'name': 'Potter W.'}, {'name': 'Stanley R.'}, {'name': 'Prakash R.'}, {'name': 'Dervisevic S.'}, {'name': 'Graham J.C.'}, {'name': 'Nelson A.'}, {'name': 'Smith D.'}, {'name': 'Young G.R.'}, {'name': 'Yew W.C.'}, {'name': 'Todd J.A.'}, {'name': 'Trebes A.'}, {'name': 'Andersson M.'}, {'name': 'Bull M.'}, {'name': 'Watkins J.'}, {'name': 'Birchley A.'}, {'name': 'Gatica-Wilcox B.'}, {'name': 'Gilbert L.'}, {'name': 'Kumziene-Summerhayes S.'}, {'name': 'Rey S.'}, {'name': 'Chauhan A.'}, {'name': 'Butcher E.'}, {'name': 'Bicknell K.'}, {'name': 'Elliott S.'}, {'name': 'Glaysher S.'}, {'name': 'Lackenby A.'}, {'name': 'Bibby D.'}, {'name': 'Platt S.'}, {'name': 'Mohamed H.'}, {'name': 'Machin N.W.'}, {'name': 'Mbisa J.L.'}, {'name': 'Evans J.'}, {'name': 'Perry M.'}, {'name': 'Pacchiarini N.'}, {'name': 'Corden S.'}, {'name': 'Adams A.G.'}, {'name': 'Gaskin A.'}, {'name': 'Coombs J.'}, {'name': 'Graham L.J.'}, {'name': 'Cottrell S.'}, {'name': 'Morgan M.'}, {'name': 'Gifford L.'}, {'name': 'Kolyva A.'}, {'name': 'Rudder S.J.'}, {'name': 'Trotter A.J.'}, {'name': 'Mather A.E.'}, {'name': 'Aydin A.'}, {'name': 'Page A.J.'}, {'name': 'Kay G.L.'}, {'name': 'de Oliveira Martins L.'}, {'name': 'Yasir M.'}, {'name': 'Alikhan N.-F.'}, {'name': 'Thomson N.M.'}, {'name': 'Gilroy R.'}, {'name': 'Kingsley R.A.'}, {'name': ""O'Grady J.""}, {'name': 'Gutierrez A.V.'}, {'name': 'Diaz M.'}, {'name': 'Viet T.L.'}, {'name': 'Tedim A.P.'}, {'name': 'Adriaenssens E.M.'}, {'name': 'Patrick Mcclure C.'}, {'name': 'Moore C.'}, {'name': 'Sang F.'}, {'name': 'Clark G.'}, {'name': 'Howson-Wells H.C.'}, {'name': 'Debebe J.'}, {'name': 'Ball J.'}, {'name': 'Chappell J.'}, {'name': 'Khakh M.'}, {'name': 'Carlile M.'}, {'name': 'Loose M.'}, {'name': 'Lister M.M.'}, {'name': 'Holmes N.'}, {'name': 'Tsoleridis T.'}, {'name': 'Fleming V.M.'}, {'name': 'Wright V.'}, {'name': 'Smith W.'}, {'name': 'Gallagher M.D.'}, {'name': 'Parker M.'}, {'name': 'Partridge D.G.'}, {'name': 'Evans C.'}, {'name': 'Baker P.'}, {'name': 'Essex S.'}, {'name': 'Liggett S.'}, {'name': 'Keeley A.J.'}, {'name': 'Bashton M.'}, {'name': 'Rooke S.'}, {'name': 'Dervisavic S.'}, {'name': 'Meader E.J.'}, {'name': 'Lopez C.E.B.'}, {'name': 'Angyal A.'}, {'name': 'Kristiansen M.'}, {'name': 'Tutill H.J.'}, {'name': 'Findlay J.'}, {'name': 'Mestek-Boukhibar L.'}, {'name': 'Forrest L.'}, {'name': 'Dyal P.'}, {'name': 'Williams R.J.'}, {'name': 'Panchbhaya Y.'}, {'name': 'Williams C.A.'}, {'name': 'Roy S.'}, {'name': 'Pandey S.'}, {'name': 'Stockton J.'}, {'name': 'Loman N.J.'}, {'name': 'Poplawski R.'}, {'name': 'Nicholls S.'}, {'name': 'Rowe W.P.M.'}, {'name': 'Khokhar F.'}, {'name': 'Pinckert M.L.'}, {'name': 'Hosmillo M.'}, {'name': 'Chaudhry Y.'}, {'name': 'Caller L.G.'}, {'name': 'Davidson R.K.'}, {'name': 'Griffith L.'}, {'name': 'Rambaut A.'}, {'name': 'Jackson B.'}, {'name': 'Colquhoun R.'}, {'name': 'Hill V.'}, {'name': 'Nichols J.'}, {'name': 'Asamaphan P.'}, {'name': 'Darby A.'}, {'name': 'Jackson K.A.'}, {'name': 'Iturriza-Gomara M.'}, {'name': 'Vamos E.E.'}, {'name': 'Green A.'}, {'name': 'Aanensen D.'}, {'name': 'Bonsall D.'}, {'name': 'Buck D.'}, {'name': 'Macintyre-Cockett G.'}, {'name': 'de Cesare M.'}, {'name': 'Pybus O.'}, {'name': 'Golubchik T.'}, {'name': 'Scarlett G.'}, {'name': 'Loveson K.F.'}, {'name': 'Robson S.C.'}, {'name': 'Beckett A.'}, {'name': 'Lindsey B.'}, {'name': 'Groves D.C.'}, {'name': 'Parsons P.J.'}, {'name': 'McHugh M.P.'}, {'name': 'Barnes J.D.'}, {'name': 'Manso C.F.'}, {'name': 'Grammatopoulos D.'}, {'name': 'Menger K.E.'}, {'name': 'Harrison E.'}, {'name': 'Gunson R.'}, {'name': 'Peacock S.J.'}, {'name': 'Gonzalez G.'}, {'name': 'Carr M.'}, {'name': 'Mihaela L.'}, {'name': 'Popovici O.'}, {'name': 'Brytting M.'}, {'name': 'Bresner C.'}, {'name': 'Fuller W.'}, {'name': 'Workman T.'}, {'name': 'Mentis A.F.'}, {'name': 'Kossyvakis A.'}, {'name': 'Karamitros T.'}, {'name': 'Pogka V.'}, {'name': 'Kalliaropoulos A.'}, {'name': 'Horefti E.'}, {'name': 'Kontou A.'}, {'name': 'Martinez-Gonzalez B.'}, {'name': 'Labropoulou V.'}, {'name': 'Voulgari-Kokota A.'}, {'name': 'Evangelidou M.'}, {'name': 'Bizta P.'}, {'name': 'Belimezi M.'}, {'name': 'Lambrechts L.'}, {'name': 'Doymaz M.Z.'}, {'name': 'Yazici M.K.'}, {'name': 'Cetin N.S.'}, {'name': 'Karaaslan E.'}, {'name': 'Kallio-Kokko H.'}, {'name': 'Virtanen J.'}, {'name': 'Suvanto M.'}, {'name': 'Nguyen P.T.'}, {'name': 'Ellonen P.'}, {'name': 'Hannula S.'}, {'name': 'Kangas H.'}, {'name': 'Sreenu V.B.'}, {'name': 'Burian K.'}, {'name': 'Terhes G.'}, {'name': 'Gombos K.'}, {'name': 'Gyenesei A.'}, {'name': 'Urban P.'}, {'name': 'Herczeg R.'}, {'name': 'Jakab F.'}, {'name': 'Kemenesi G.'}, {'name': 'Toth G.E.'}, {'name': 'Somogyi B.'}, {'name': 'Zana B.'}, {'name': 'Zeghbib S.'}, {'name': 'Kuczmog A.'}, {'name': 'Foldes F.'}, {'name': 'Lanszki Z.'}, {'name': 'Madai M.'}, {'name': 'Papp H.'}, {'name': 'Nagy A.'}, {'name': 'Pereszlenyi C.I.'}, {'name': 'Babinszky G.C.'}, {'name': 'Dudas G.'}, {'name': 'Csoma E.'}, {'name': 'Abou Tayoun A.N.'}, {'name': 'Alsheikh-Ali A.A.'}, {'name': 'Loney T.'}, {'name': 'Nowotny N.'}, {'name': 'Abdul-Wahab O.'}, {'name': 'Gonzalez-Candelas F.'}, {'name': 'Andersen M.H.'}, {'name': 'Taylor S.'}], 'citationCount': 42, 'date': '2020-01-01T00:00:00Z', 'journal': 'Eurosurveillance', 'title': 'Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020'}, 'note': 'V-pipe was used to process a major part of the Swiss samples in this pan-European study.', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2020.10.12.335919', 'note': 'Raw reads from SRA public data and Swiss cohort were processed using V-pipe', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2020.10.14.20212621', 'note': 'V-pipe was used to process a major part of the Swiss samples', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2021.01.08.21249379', 'note': 'The waste water samples were analyzed using V-pipe and additional custom scripts.', 'type': ['Usage'], 'version': 'sars-cov2-dev'}, {'doi': '10.1101/2021.03.05.21252520', 'note': 'V-pipe is used within the S3C (Swiss SARS-CoV-2 Sequencing Consortium) to provide sequences.', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.3390/v13030496', 'metadata': {'abstract': '© 2021 by the authors. Licensee MDPI, Basel, Switzerland.Since the emergence of coronavirus disease (COVID-19) in late 2019, domestic cats have been demonstrated to be susceptible to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) under natural and experimental conditions. As pet cats often live in very close contact with their owners, it is essential to investigate SARS-CoV-2 infections in cats in a One-Health context. This study reports the first SARS-CoV-2 infection in a cat in a COVID-19-affected household in Switzerland. The cat (Cat 1) demonstrated signs of an upper respiratory tract infection, including sneezing, inappetence, and apathy, while the cohabiting cat (Cat 2) remained asymptomatic. Nasal, oral, fecal, fur, and environmental swab samples were collected twice from both cats and analyzed by RT-qPCR for the presence of SARS-CoV-2 viral RNA. Both nasal swabs from Cat 1 tested positive. In addition, the first oral swab from Cat 2 and fur and bedding swabs from both cats were RT-qPCR positive. The fecal swabs tested negative. The infection of Cat 1 was confirmed by positive SARS-CoV-2 S1 receptor binding domain (RBD) antibody testing and neutralizing activity in a surrogate assay. The viral genome sequence from Cat 1, obtained by next generation sequencing, showed the closest relation to a human sequence from the B.1.1.39 lineage, with one single nucleotide polymorphism (SNP) difference. This study demonstrates not only SARS-CoV-2 infection of a cat from a COVID-19-affected household but also contamination of the cats’ fur and bed with viral RNA. Our results are important to create awareness that SARS-CoV-2 infected people should observe hygienic measures to avoid infection and contamination of animal cohabitants.', 'authors': [{'name': 'Klaus J.'}, {'name': 'Meli M.L.'}, {'name': 'Willi B.'}, {'name': 'Nadeau S.'}, {'name': 'Beisel C.'}, {'name': 'Stadler T.'}, {'name': 'Egberink H.'}, {'name': 'Zhao S.'}, {'name': 'Lutz H.'}, {'name': 'Riond B.'}, {'name': 'Rosinger N.'}, {'name': 'Stalder H.'}, {'name': 'Renzullo S.'}, {'name': 'Hofmann-Lehmann R.'}], 'citationCount': 2, 'date': '2021-03-01T00:00:00Z', 'journal': 'Viruses', 'title': 'Detection and genome sequencing of sars-cov-2 in a domestic cat with respiratory signs in Switzerland'}, 'note': 'V-pipe and the S3C (Swiss SARS-CoV-2 Sequencing Consortium) infrastructure were used to QA and pre-process the sequencing data.', 'pmcid': 'PMC8002591', 'pmid': '33802899', 'type': ['Usage'], 'version': 'sars-cov2'}]"
182,ivan.topolsky@sib.swiss,Ivan Topolsky,Person,https://orcid.org/0000-0002-7561-0810,['Maintainer'],,https://www.sib.swiss/directory?cn=ivan%20topolsky,,,v-pipe,Open access,DrYak,"[{'doi': '10.1093/bioinformatics/btab015', 'pmid': '33471068', 'type': ['Primary'], 'version': '1.0, 2.0'}, {'doi': '10.20944/preprints202005.0376.v1', 'type': ['Review']}, {'doi': '10.1016/j.virusres.2016.09.016', 'metadata': {'abstract': '© 2016 The AuthorsRapidly evolving RNA viruses prevail within a host as a collection of closely related variants, referred to as viral quasispecies. Advances in high-throughput sequencing (HTS) technologies have facilitated the assessment of the genetic diversity of such virus populations at an unprecedented level of detail. However, analysis of HTS data from virus populations is challenging due to short, error-prone reads. In order to account for uncertainties originating from these limitations, several computational and statistical methods have been developed for studying the genetic heterogeneity of virus population. Here, we review methods for the analysis of HTS reads, including approaches to local diversity estimation and global haplotype reconstruction. Challenges posed by aligning reads, as well as the impact of reference biases on diversity estimates are also discussed. In addition, we address some of the experimental approaches designed to improve the biological signal-to-noise ratio. In the future, computational methods for the analysis of heterogeneous virus populations are likely to continue being complemented by technological developments.', 'authors': [{'name': 'Posada-Cespedes S.'}, {'name': 'Seifert D.'}, {'name': 'Beerenwinkel N.'}], 'citationCount': 42, 'date': '2017-07-15T00:00:00Z', 'journal': 'Virus Research', 'title': 'Recent advances in inferring viral diversity from high-throughput sequencing data'}, 'pmid': '27693290', 'type': ['Other']}, {'doi': '10.3390/v10050256', 'metadata': {'abstract': '© 2018 by the authors. Licensee MDPI, Basel, Switzerland.The Second Annual Meeting of the European Virus Bioinformatics Center (EVBC), held in Utrecht, Netherlands, focused on computational approaches in virology, with topics including (but not limited to) virus discovery, diagnostics, (meta-)genomics, modeling, epidemiology, molecular structure, evolution, and viral ecology. The goals of the Second Annual Meeting were threefold: (i) to bring together virologists and bioinformaticians from across the academic, industrial, professional, and training sectors to share best practice; (ii) to provide a meaningful and interactive scientific environment to promote discussion and collaboration between students, postdoctoral fellows, and both new and established investigators; (iii) to inspire and suggest new research directions and questions. Approximately 120 researchers from around the world attended the Second Annual Meeting of the EVBC this year, including 15 renowned international speakers. This report presents an overview of new developments and novel research findings that emerged during the meeting.', 'authors': [{'name': 'Ibrahim B.'}, {'name': 'Arkhipova K.'}, {'name': 'Andeweg A.C.'}, {'name': 'Posada-Cespedes S.'}, {'name': 'Enault F.'}, {'name': 'Gruber A.'}, {'name': 'Koonin E.V.'}, {'name': 'Kupczok A.'}, {'name': 'Lemey P.'}, {'name': 'McHardy A.C.'}, {'name': 'McMahon D.P.'}, {'name': 'Pickett B.E.'}, {'name': 'Robertson D.L.'}, {'name': 'Scheuermann R.H.'}, {'name': 'Zhernakova A.'}, {'name': 'Zwart M.P.'}, {'name': 'Schonhuth A.'}, {'name': 'Dutilh B.E.'}, {'name': 'Marz M.'}], 'citationCount': 3, 'date': '2018-05-14T00:00:00Z', 'journal': 'Viruses', 'title': 'Bioinformatics meets virology: The European virus bioinformatics center’s second annual meeting'}, 'pmcid': 'PMC5977249', 'pmid': '29757994', 'type': ['Other']}, {'doi': '10.1093/infdis/jiz094', 'metadata': {'abstract': '© 2019 The Author(s) 2019.Background: Human immunodeficiency virus type 1 (HIV-1) genetic diversity increases over the course of infection and can be used to infer the time since infection and, consequently, infection recency, which are crucial for HIV-1 surveillance and the understanding of viral pathogenesis. Methods: We considered 313 HIV-infected individuals for whom reliable estimates of infection dates and next-generation sequencing (NGS)-derived nucleotide frequency data were available. Fractions of ambiguous nucleotides, obtained by population sequencing, were available for 207 samples. We assessed whether the average pairwise diversity calculated using NGS sequences provided a more exact prediction of the time since infection and classification of infection recency (<1 year after infection), compared with the fraction of ambiguous nucleotides. Results: NGS-derived average pairwise diversity classified an infection as recent with a sensitivity of 88% and a specificity of 85%. When considering only the 207 samples for which fractions of ambiguous nucleotides were available, the NGS-derived average pairwise diversity exhibited a higher sensitivity (90% vs 78%) and specificity (95% vs 67%) than the fraction of ambiguous nucleotides. Additionally, the average pairwise diversity could be used to estimate the time since infection with a mean absolute error of 0.84 years, compared with 1.03 years for the fraction of ambiguous nucleotides. Conclusions: Viral diversity based on NGS data is more precise than that based on population sequencing in its ability to predict infection recency and provides an estimated time since infection that has a mean absolute error of <1 year.', 'authors': [{'name': 'Carlisle L.A.'}, {'name': 'Turk T.'}, {'name': 'Kusejko K.'}, {'name': 'Metzner K.J.'}, {'name': 'Leemann C.'}, {'name': 'Schenkel C.D.'}, {'name': 'Bachmann N.'}, {'name': 'Posada S.'}, {'name': 'Beerenwinkel N.'}, {'name': 'Boni J.'}, {'name': 'Yerly S.'}, {'name': 'Klimkait T.'}, {'name': 'Perreau M.'}, {'name': 'Braun D.L.'}, {'name': 'Rauch A.'}, {'name': 'Calmy A.'}, {'name': 'Cavassini M.'}, {'name': 'Battegay M.'}, {'name': 'Vernazza P.'}, {'name': 'Bernasconi E.'}, {'name': 'Gunthard H.F.'}, {'name': 'Kouyos R.D.'}, {'name': 'Anagnostopoulos A.'}, {'name': 'Battegay M.'}, {'name': 'Bernasconi E.'}, {'name': 'Boni J.'}, {'name': 'Braun D.L.'}, {'name': 'Bucher H.C.'}, {'name': 'Calmy A.'}, {'name': 'Cavassini M.'}, {'name': 'Ciuffi A.'}, {'name': 'Dollenmaier G.'}, {'name': 'Egger M.'}, {'name': 'Elzi L.'}, {'name': 'Fehr J.'}, {'name': 'Fellay J.'}, {'name': 'Furrer H.'}, {'name': 'Fux C.A.'}, {'name': 'Gunthard H.F.'}, {'name': 'Haerry D.'}, {'name': 'Hasse B.'}, {'name': 'Hirsch H.H.'}, {'name': 'Hoffmann M.'}, {'name': 'Hosli I.'}, {'name': 'Huber M.'}, {'name': 'Kahlert C.'}, {'name': 'Kaiser L.'}, {'name': 'Keiser O.'}, {'name': 'Klimkait T.'}, {'name': 'Kouyos R.D.'}, {'name': 'Kovari H.'}, {'name': 'Ledergerber B.'}, {'name': 'Martinetti G.'}, {'name': 'Martinez De Tejada B.'}, {'name': 'Marzolini C.'}, {'name': 'Metzner K.J.'}, {'name': 'Muller N.'}, {'name': 'Nicca D.'}, {'name': 'Paioni P.'}, {'name': 'Pantaleo G.'}, {'name': 'Perreau M.'}, {'name': 'Rauch A.'}, {'name': 'Rudin C.'}, {'name': 'Scherrer A.U.'}, {'name': 'Schmid P.'}, {'name': 'Speck R.'}, {'name': 'Stockle M.'}, {'name': 'Tarr P.'}, {'name': 'Trkola A.'}, {'name': 'Vernazza P.'}, {'name': 'Wandeler G.'}, {'name': 'Weber R.'}, {'name': 'Yerly S.'}], 'citationCount': 6, 'date': '2019-06-19T00:00:00Z', 'journal': 'Journal of Infectious Diseases', 'title': 'Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time since Infection'}, 'pmid': '30835266', 'type': ['Usage']}, {'doi': '10.2807/1560-7917.es.2020.25.32.2001410', 'metadata': {'abstract': '© 2020 Turkish Society of Cardiology. All rights reserved.We show the distribution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic clades over time and between countries and outline potential genomic surveillance objectives. We applied three genomic nomenclature systems to all sequence data from the World Health Organization European Region available until 10 July 2020. We highlight the importance of real-time sequencing and data dissemination in a pandemic situation, compare the nomenclatures and lay a foundation for future European genomic surveillance of SARS-CoV-2.', 'authors': [{'name': 'Alm E.'}, {'name': 'Broberg E.K.'}, {'name': 'Connor T.'}, {'name': 'Hodcroft E.B.'}, {'name': 'Komissarov A.B.'}, {'name': 'Maurer-Stroh S.'}, {'name': 'Melidou A.'}, {'name': 'Neher R.A.'}, {'name': ""O'Toole A.""}, {'name': 'Pereyaslov D.'}, {'name': 'Beerenwinkel N.'}, {'name': 'Posada-Cespedes S.'}, {'name': 'Jablonski K.P.'}, {'name': 'Ferreira P.F.'}, {'name': 'Topolsky I.'}, {'name': 'Avsic-Zupanc T.'}, {'name': 'Korva M.'}, {'name': 'Poljak M.'}, {'name': 'Zakotnik S.'}, {'name': 'Zorec T.M.'}, {'name': 'Bragstad K.'}, {'name': 'Hungnes O.'}, {'name': 'Stene-Johansen K.'}, {'name': 'Reusken C.'}, {'name': 'Meijer A.'}, {'name': 'Vennema H.'}, {'name': 'Ruiz-Roldan L.'}, {'name': 'Bracho M.A.'}, {'name': 'Garcia-Gonzalez N.'}, {'name': 'Chiner-Oms A.'}, {'name': 'Cancino-Munoz I.'}, {'name': 'Comas I.'}, {'name': 'Goig G.A.'}, {'name': 'Torres-Puente M.'}, {'name': 'Lopez M.G.'}, {'name': 'Martinez-Priego L.'}, {'name': ""D'Auria G.""}, {'name': 'Ruiz-Hueso P.'}, {'name': 'Ferrus-Abad L.'}, {'name': 'de Marco G.'}, {'name': 'Galan-Vendrell I.'}, {'name': 'Carbo-Ramirez S.'}, {'name': 'Ruiz-Rodriguez P.'}, {'name': 'Coscolla M.'}, {'name': 'Polackova K.'}, {'name': 'Kramna L.'}, {'name': 'Cinek O.'}, {'name': 'Richter J.'}, {'name': 'Krashias G.'}, {'name': 'Tryfonos C.'}, {'name': 'Bashiardes S.'}, {'name': 'Koptides D.'}, {'name': 'Christodoulou C.'}, {'name': 'Bartolini B.'}, {'name': 'Gruber C.E.'}, {'name': 'Di Caro A.'}, {'name': 'Castilletti C.'}, {'name': 'Stefani F.'}, {'name': 'Rimoldi S.G.'}, {'name': 'Romeri F.'}, {'name': 'Salerno F.'}, {'name': 'Polesello S.'}, {'name': 'Nagy A.'}, {'name': 'Jirincova H.'}, {'name': 'Vecerova J.'}, {'name': 'Novakova L.'}, {'name': 'Cordey S.'}, {'name': 'Murtskhvaladze M.'}, {'name': 'Kotaria N.'}, {'name': 'Schar T.'}, {'name': 'Beisel C.'}, {'name': 'Vugrek O.'}, {'name': 'Rokic F.'}, {'name': 'Trgovec-Greif L.'}, {'name': 'Jurak I.'}, {'name': 'Rukavina T.'}, {'name': 'Sucic N.'}, {'name': 'Schonning K.'}, {'name': 'Karst S.M.'}, {'name': 'Kirkegaard R.H.'}, {'name': 'Michaelsen T.Y.'}, {'name': 'Sorensen E.A.'}, {'name': 'Knutson S.'}, {'name': 'Brandt J.'}, {'name': 'Le-Quy V.'}, {'name': 'Sorensen T.'}, {'name': 'Petersen C.'}, {'name': 'Pedersen M.S.'}, {'name': 'Larsen S.L.'}, {'name': 'Skov M.N.'}, {'name': 'Rasmussen M.'}, {'name': 'Fonager J.'}, {'name': 'Fomsgaard A.'}, {'name': 'Maksyutov R.A.'}, {'name': 'Gavrilova E.V.'}, {'name': 'Pyankov O.V.'}, {'name': 'Bodnev S.A.'}, {'name': 'Tregubchak T.V.'}, {'name': 'Shvalov A.N.'}, {'name': 'Antonets D.V.'}, {'name': 'Resende P.C.'}, {'name': 'Goya S.'}, {'name': 'Perrin A.'}, {'name': 'Lee R.T.'}, {'name': 'Yadahalli S.'}, {'name': 'Han A.X.'}, {'name': 'Russell C.A.'}, {'name': 'Schmutz S.'}, {'name': 'Zaheri M.'}, {'name': 'Kufner V.'}, {'name': 'Huber M.'}, {'name': 'Trkola A.'}, {'name': 'Antwerpen M.'}, {'name': 'Walter M.C.'}, {'name': 'van der Werf S.'}, {'name': 'Gambaro F.'}, {'name': 'Behillil S.'}, {'name': 'Enouf V.'}, {'name': 'Donati F.'}, {'name': 'Ustinova M.'}, {'name': 'Rovite V.'}, {'name': 'Klovins J.'}, {'name': 'Savicka O.'}, {'name': 'Wienecke-Baldacchino A.K.'}, {'name': 'Ragimbeau C.'}, {'name': 'Fournier G.'}, {'name': 'Mossong J.'}, {'name': 'Aberle S.W.'}, {'name': 'Haukland M.'}, {'name': 'Enkirch T.'}, {'name': 'Advani A.'}, {'name': 'Karlberg M.L.'}, {'name': 'Lindsjo O.K.'}, {'name': 'Broddesson S.'}, {'name': 'Slavikova M.'}, {'name': 'Lickova M.'}, {'name': 'Klempa B.'}, {'name': 'Staronova E.'}, {'name': 'Ticha E.'}, {'name': 'Szemes T.'}, {'name': 'Rusnakova D.'}, {'name': 'Stadler T.'}, {'name': 'Quer J.'}, {'name': 'Anton A.'}, {'name': 'Andres C.'}, {'name': 'Pinana M.'}, {'name': 'Garcia-Cehic D.'}, {'name': 'Pumarola T.'}, {'name': 'Izopet J.'}, {'name': 'Gioula G.'}, {'name': 'Exindari M.'}, {'name': 'Papa A.'}, {'name': 'Chatzidimitriou D.'}, {'name': 'Metallidis S.'}, {'name': 'Pappa S.'}, {'name': 'Macek M.'}, {'name': 'Geryk J.'}, {'name': 'Broz P.'}, {'name': 'Briksi A.'}, {'name': 'Hubacek P.'}, {'name': 'Drevinek P.'}, {'name': 'Zajac M.'}, {'name': 'Kvapil P.'}, {'name': 'Holub M.'}, {'name': 'Kvapilova K.'}, {'name': 'Novotny A.'}, {'name': 'Kasny M.'}, {'name': 'Klempt P.'}, {'name': 'Vapalahti O.'}, {'name': 'Smura T.'}, {'name': 'Sironen T.'}, {'name': 'Selhorst P.'}, {'name': 'Anthony C.'}, {'name': 'Arien K.'}, {'name': 'Simon-Loriere E.'}, {'name': 'Rabalski L.'}, {'name': 'Bienkowska-Szewczyk K.'}, {'name': 'Borges V.'}, {'name': 'Isidro J.'}, {'name': 'Gomes J.P.'}, {'name': 'Guiomar R.'}, {'name': 'Pechirra P.'}, {'name': 'Costa I.'}, {'name': 'Duarte S.'}, {'name': 'Vieira L.'}, {'name': 'Pyrc K.'}, {'name': 'Zuckerman N.S.'}, {'name': 'Turdikulova S.'}, {'name': 'Abdullaev A.'}, {'name': 'Dalimova D.'}, {'name': 'Abdurakhimov A.'}, {'name': 'Tagliabracci A.'}, {'name': 'Alessandrini F.'}, {'name': 'Melchionda F.'}, {'name': 'Onofri V.'}, {'name': 'Turchi C.'}, {'name': 'Bagnarelli P.'}, {'name': 'Menzo S.'}, {'name': 'Caucci S.'}, {'name': 'Di Sante L.'}, {'name': 'Popa A.'}, {'name': 'Genger J.-W.'}, {'name': 'Agerer B.'}, {'name': 'Lercher A.'}, {'name': 'Endler L.'}, {'name': 'Smyth M.'}, {'name': 'Penz T.'}, {'name': 'Schuster M.'}, {'name': 'Senekowitsch M.'}, {'name': 'Laine J.'}, {'name': 'Bock C.'}, {'name': 'Bergthaler A.'}, {'name': 'Shevtsov A.'}, {'name': 'Kalendar R.'}, {'name': 'Ramanculov Y.'}, {'name': 'Graf A.'}, {'name': 'Muenchhoff M.'}, {'name': 'Keppler O.T.'}, {'name': 'Krebs S.'}, {'name': 'Blum H.'}, {'name': 'Marcello A.'}, {'name': 'Licastro D.'}, {'name': ""D'Agaro P.""}, {'name': 'Laubscher F.'}, {'name': 'Vidanovic D.'}, {'name': 'Tesovic B.'}, {'name': 'Volkening J.'}, {'name': 'Clementi N.'}, {'name': 'Mancini N.'}, {'name': 'Rupnik M.'}, {'name': 'Mahnic A.'}, {'name': 'Walker A.'}, {'name': 'Houwaart T.'}, {'name': 'Wienemann T.'}, {'name': 'Vasconcelos M.K.'}, {'name': 'Strelow D.'}, {'name': 'Jensen B.-E.O.'}, {'name': 'Senff T.'}, {'name': 'Hulse L.'}, {'name': 'Adams O.'}, {'name': 'Andree M.'}, {'name': 'Hauka S.'}, {'name': 'Feldt T.'}, {'name': 'Keitel V.'}, {'name': 'Kindgen-Milles D.'}, {'name': 'Timm J.'}, {'name': 'Pfeffer K.'}, {'name': 'Dilthey A.T.'}, {'name': 'Moore C.'}, {'name': 'Ozdarendeli A.'}, {'name': 'Pavel S.T.I.'}, {'name': 'Yetiskin H.'}, {'name': 'Aydin G.'}, {'name': 'Holyavkin C.'}, {'name': 'Uygut M.A.'}, {'name': 'Cevik C.'}, {'name': 'Shchetinin A.'}, {'name': 'Gushchin V.'}, {'name': 'Dinler-Doganay G.'}, {'name': 'Doganay L.'}, {'name': 'Kizilboga-Akgun T.'}, {'name': 'Karacan I.'}, {'name': 'Pancer K.'}, {'name': 'Maes P.'}, {'name': 'Marti-Carreras J.'}, {'name': 'Wawina-Bokalanga T.'}, {'name': 'Vanmechelen B.'}, {'name': 'Thurmer A.'}, {'name': 'Wedde M.'}, {'name': 'Durrwald R.'}, {'name': 'von Kleist M.'}, {'name': 'Drechsel O.'}, {'name': 'Wolff T.'}, {'name': 'Fuchs S.'}, {'name': 'Kmiecinski R.'}, {'name': 'Michel J.'}, {'name': 'Nitsche A.'}, {'name': 'Casas I.'}, {'name': 'Caballero M.I.'}, {'name': 'Zaballos A.'}, {'name': 'Jimenez P.'}, {'name': 'Jimenez M.'}, {'name': 'Fernandez S.M.'}, {'name': 'Fernandez S.V.'}, {'name': 'de la Plaza I.C.'}, {'name': 'Fadeev A.'}, {'name': 'Ivanova A.'}, {'name': 'Sergeeva M.'}, {'name': 'Stefanelli P.'}, {'name': 'Estee Torok M.'}, {'name': 'Hall G.'}, {'name': 'da Silva Filipe A.'}, {'name': 'Turtle L.'}, {'name': 'Afifi S.'}, {'name': 'McCluggage K.'}, {'name': 'Beer R.'}, {'name': 'Ledesma J.'}, {'name': 'Maksimovic J.'}, {'name': 'Spellman K.'}, {'name': 'Hamilton W.L.'}, {'name': 'Marchbank A.'}, {'name': 'Southgate J.A.'}, {'name': 'Underwood A.'}, {'name': 'Taylor B.'}, {'name': 'Yeats C.'}, {'name': 'Abudahab K.'}, {'name': 'Gemmell M.R.'}, {'name': 'Eccles R.'}, {'name': 'Lucaci A.'}, {'name': 'Nelson C.A.'}, {'name': 'Rainbow L.'}, {'name': 'Whitehead M.'}, {'name': 'Gregory R.'}, {'name': 'Haldenby S.'}, {'name': 'Paterson S.'}, {'name': 'Hughes M.A.'}, {'name': 'Curran M.D.'}, {'name': 'Baker D.'}, {'name': 'Tucker R.'}, {'name': 'Green L.R.'}, {'name': 'Feltwell T.'}, {'name': 'Halstead F.D.'}, {'name': 'Wyles M.'}, {'name': 'Jahun A.S.'}, {'name': 'Ahmad S.S.Y.'}, {'name': 'Georgana I.'}, {'name': 'Goodfellow I.'}, {'name': 'Yakovleva A.'}, {'name': 'Meredith L.W.'}, {'name': 'Gavriil A.'}, {'name': 'Awan A.R.'}, {'name': 'Fisher C.'}, {'name': 'Edgeworth J.'}, {'name': 'Lynch J.'}, {'name': 'Moore N.'}, {'name': 'Williams R.'}, {'name': 'Kidd S.P.'}, {'name': 'Cortes N.'}, {'name': 'Brunker K.'}, {'name': 'McCrone J.T.'}, {'name': 'Quick J.'}, {'name': 'Duckworth N.'}, {'name': 'Walsh S.'}, {'name': 'Sloan T.'}, {'name': 'Ludden C.'}, {'name': 'George R.P.'}, {'name': 'Eltringham G.'}, {'name': 'Brown J.R.'}, {'name': 'Aranday-Cortes E.'}, {'name': 'Shepherd J.G.'}, {'name': 'Hughes J.'}, {'name': 'Li K.K.'}, {'name': 'Williams T.C.'}, {'name': 'Johnson N.'}, {'name': 'Jesudason N.'}, {'name': 'Mair D.'}, {'name': 'Thomson E.'}, {'name': 'Shah R.'}, {'name': 'Parr Y.A.'}, {'name': 'Carmichael S.'}, {'name': 'Robertson D.L.'}, {'name': 'Nomikou K.'}, {'name': 'Broos A.'}, {'name': 'Niebel M.'}, {'name': 'Smollett K.'}, {'name': 'Tong L.'}, {'name': 'Miah S.'}, {'name': 'Wittner A.'}, {'name': 'Phillips N.'}, {'name': 'Payne B.'}, {'name': 'Dewar R.'}, {'name': 'Holmes A.'}, {'name': 'Bolt F.'}, {'name': 'Price J.R.'}, {'name': 'Mookerjee S.'}, {'name': 'Sethi D.K.'}, {'name': 'Potter W.'}, {'name': 'Stanley R.'}, {'name': 'Prakash R.'}, {'name': 'Dervisevic S.'}, {'name': 'Graham J.C.'}, {'name': 'Nelson A.'}, {'name': 'Smith D.'}, {'name': 'Young G.R.'}, {'name': 'Yew W.C.'}, {'name': 'Todd J.A.'}, {'name': 'Trebes A.'}, {'name': 'Andersson M.'}, {'name': 'Bull M.'}, {'name': 'Watkins J.'}, {'name': 'Birchley A.'}, {'name': 'Gatica-Wilcox B.'}, {'name': 'Gilbert L.'}, {'name': 'Kumziene-Summerhayes S.'}, {'name': 'Rey S.'}, {'name': 'Chauhan A.'}, {'name': 'Butcher E.'}, {'name': 'Bicknell K.'}, {'name': 'Elliott S.'}, {'name': 'Glaysher S.'}, {'name': 'Lackenby A.'}, {'name': 'Bibby D.'}, {'name': 'Platt S.'}, {'name': 'Mohamed H.'}, {'name': 'Machin N.W.'}, {'name': 'Mbisa J.L.'}, {'name': 'Evans J.'}, {'name': 'Perry M.'}, {'name': 'Pacchiarini N.'}, {'name': 'Corden S.'}, {'name': 'Adams A.G.'}, {'name': 'Gaskin A.'}, {'name': 'Coombs J.'}, {'name': 'Graham L.J.'}, {'name': 'Cottrell S.'}, {'name': 'Morgan M.'}, {'name': 'Gifford L.'}, {'name': 'Kolyva A.'}, {'name': 'Rudder S.J.'}, {'name': 'Trotter A.J.'}, {'name': 'Mather A.E.'}, {'name': 'Aydin A.'}, {'name': 'Page A.J.'}, {'name': 'Kay G.L.'}, {'name': 'de Oliveira Martins L.'}, {'name': 'Yasir M.'}, {'name': 'Alikhan N.-F.'}, {'name': 'Thomson N.M.'}, {'name': 'Gilroy R.'}, {'name': 'Kingsley R.A.'}, {'name': ""O'Grady J.""}, {'name': 'Gutierrez A.V.'}, {'name': 'Diaz M.'}, {'name': 'Viet T.L.'}, {'name': 'Tedim A.P.'}, {'name': 'Adriaenssens E.M.'}, {'name': 'Patrick Mcclure C.'}, {'name': 'Moore C.'}, {'name': 'Sang F.'}, {'name': 'Clark G.'}, {'name': 'Howson-Wells H.C.'}, {'name': 'Debebe J.'}, {'name': 'Ball J.'}, {'name': 'Chappell J.'}, {'name': 'Khakh M.'}, {'name': 'Carlile M.'}, {'name': 'Loose M.'}, {'name': 'Lister M.M.'}, {'name': 'Holmes N.'}, {'name': 'Tsoleridis T.'}, {'name': 'Fleming V.M.'}, {'name': 'Wright V.'}, {'name': 'Smith W.'}, {'name': 'Gallagher M.D.'}, {'name': 'Parker M.'}, {'name': 'Partridge D.G.'}, {'name': 'Evans C.'}, {'name': 'Baker P.'}, {'name': 'Essex S.'}, {'name': 'Liggett S.'}, {'name': 'Keeley A.J.'}, {'name': 'Bashton M.'}, {'name': 'Rooke S.'}, {'name': 'Dervisavic S.'}, {'name': 'Meader E.J.'}, {'name': 'Lopez C.E.B.'}, {'name': 'Angyal A.'}, {'name': 'Kristiansen M.'}, {'name': 'Tutill H.J.'}, {'name': 'Findlay J.'}, {'name': 'Mestek-Boukhibar L.'}, {'name': 'Forrest L.'}, {'name': 'Dyal P.'}, {'name': 'Williams R.J.'}, {'name': 'Panchbhaya Y.'}, {'name': 'Williams C.A.'}, {'name': 'Roy S.'}, {'name': 'Pandey S.'}, {'name': 'Stockton J.'}, {'name': 'Loman N.J.'}, {'name': 'Poplawski R.'}, {'name': 'Nicholls S.'}, {'name': 'Rowe W.P.M.'}, {'name': 'Khokhar F.'}, {'name': 'Pinckert M.L.'}, {'name': 'Hosmillo M.'}, {'name': 'Chaudhry Y.'}, {'name': 'Caller L.G.'}, {'name': 'Davidson R.K.'}, {'name': 'Griffith L.'}, {'name': 'Rambaut A.'}, {'name': 'Jackson B.'}, {'name': 'Colquhoun R.'}, {'name': 'Hill V.'}, {'name': 'Nichols J.'}, {'name': 'Asamaphan P.'}, {'name': 'Darby A.'}, {'name': 'Jackson K.A.'}, {'name': 'Iturriza-Gomara M.'}, {'name': 'Vamos E.E.'}, {'name': 'Green A.'}, {'name': 'Aanensen D.'}, {'name': 'Bonsall D.'}, {'name': 'Buck D.'}, {'name': 'Macintyre-Cockett G.'}, {'name': 'de Cesare M.'}, {'name': 'Pybus O.'}, {'name': 'Golubchik T.'}, {'name': 'Scarlett G.'}, {'name': 'Loveson K.F.'}, {'name': 'Robson S.C.'}, {'name': 'Beckett A.'}, {'name': 'Lindsey B.'}, {'name': 'Groves D.C.'}, {'name': 'Parsons P.J.'}, {'name': 'McHugh M.P.'}, {'name': 'Barnes J.D.'}, {'name': 'Manso C.F.'}, {'name': 'Grammatopoulos D.'}, {'name': 'Menger K.E.'}, {'name': 'Harrison E.'}, {'name': 'Gunson R.'}, {'name': 'Peacock S.J.'}, {'name': 'Gonzalez G.'}, {'name': 'Carr M.'}, {'name': 'Mihaela L.'}, {'name': 'Popovici O.'}, {'name': 'Brytting M.'}, {'name': 'Bresner C.'}, {'name': 'Fuller W.'}, {'name': 'Workman T.'}, {'name': 'Mentis A.F.'}, {'name': 'Kossyvakis A.'}, {'name': 'Karamitros T.'}, {'name': 'Pogka V.'}, {'name': 'Kalliaropoulos A.'}, {'name': 'Horefti E.'}, {'name': 'Kontou A.'}, {'name': 'Martinez-Gonzalez B.'}, {'name': 'Labropoulou V.'}, {'name': 'Voulgari-Kokota A.'}, {'name': 'Evangelidou M.'}, {'name': 'Bizta P.'}, {'name': 'Belimezi M.'}, {'name': 'Lambrechts L.'}, {'name': 'Doymaz M.Z.'}, {'name': 'Yazici M.K.'}, {'name': 'Cetin N.S.'}, {'name': 'Karaaslan E.'}, {'name': 'Kallio-Kokko H.'}, {'name': 'Virtanen J.'}, {'name': 'Suvanto M.'}, {'name': 'Nguyen P.T.'}, {'name': 'Ellonen P.'}, {'name': 'Hannula S.'}, {'name': 'Kangas H.'}, {'name': 'Sreenu V.B.'}, {'name': 'Burian K.'}, {'name': 'Terhes G.'}, {'name': 'Gombos K.'}, {'name': 'Gyenesei A.'}, {'name': 'Urban P.'}, {'name': 'Herczeg R.'}, {'name': 'Jakab F.'}, {'name': 'Kemenesi G.'}, {'name': 'Toth G.E.'}, {'name': 'Somogyi B.'}, {'name': 'Zana B.'}, {'name': 'Zeghbib S.'}, {'name': 'Kuczmog A.'}, {'name': 'Foldes F.'}, {'name': 'Lanszki Z.'}, {'name': 'Madai M.'}, {'name': 'Papp H.'}, {'name': 'Nagy A.'}, {'name': 'Pereszlenyi C.I.'}, {'name': 'Babinszky G.C.'}, {'name': 'Dudas G.'}, {'name': 'Csoma E.'}, {'name': 'Abou Tayoun A.N.'}, {'name': 'Alsheikh-Ali A.A.'}, {'name': 'Loney T.'}, {'name': 'Nowotny N.'}, {'name': 'Abdul-Wahab O.'}, {'name': 'Gonzalez-Candelas F.'}, {'name': 'Andersen M.H.'}, {'name': 'Taylor S.'}], 'citationCount': 42, 'date': '2020-01-01T00:00:00Z', 'journal': 'Eurosurveillance', 'title': 'Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020'}, 'note': 'V-pipe was used to process a major part of the Swiss samples in this pan-European study.', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2020.10.12.335919', 'note': 'Raw reads from SRA public data and Swiss cohort were processed using V-pipe', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2020.10.14.20212621', 'note': 'V-pipe was used to process a major part of the Swiss samples', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2021.01.08.21249379', 'note': 'The waste water samples were analyzed using V-pipe and additional custom scripts.', 'type': ['Usage'], 'version': 'sars-cov2-dev'}, {'doi': '10.1101/2021.03.05.21252520', 'note': 'V-pipe is used within the S3C (Swiss SARS-CoV-2 Sequencing Consortium) to provide sequences.', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.3390/v13030496', 'metadata': {'abstract': '© 2021 by the authors. Licensee MDPI, Basel, Switzerland.Since the emergence of coronavirus disease (COVID-19) in late 2019, domestic cats have been demonstrated to be susceptible to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) under natural and experimental conditions. As pet cats often live in very close contact with their owners, it is essential to investigate SARS-CoV-2 infections in cats in a One-Health context. This study reports the first SARS-CoV-2 infection in a cat in a COVID-19-affected household in Switzerland. The cat (Cat 1) demonstrated signs of an upper respiratory tract infection, including sneezing, inappetence, and apathy, while the cohabiting cat (Cat 2) remained asymptomatic. Nasal, oral, fecal, fur, and environmental swab samples were collected twice from both cats and analyzed by RT-qPCR for the presence of SARS-CoV-2 viral RNA. Both nasal swabs from Cat 1 tested positive. In addition, the first oral swab from Cat 2 and fur and bedding swabs from both cats were RT-qPCR positive. The fecal swabs tested negative. The infection of Cat 1 was confirmed by positive SARS-CoV-2 S1 receptor binding domain (RBD) antibody testing and neutralizing activity in a surrogate assay. The viral genome sequence from Cat 1, obtained by next generation sequencing, showed the closest relation to a human sequence from the B.1.1.39 lineage, with one single nucleotide polymorphism (SNP) difference. This study demonstrates not only SARS-CoV-2 infection of a cat from a COVID-19-affected household but also contamination of the cats’ fur and bed with viral RNA. Our results are important to create awareness that SARS-CoV-2 infected people should observe hygienic measures to avoid infection and contamination of animal cohabitants.', 'authors': [{'name': 'Klaus J.'}, {'name': 'Meli M.L.'}, {'name': 'Willi B.'}, {'name': 'Nadeau S.'}, {'name': 'Beisel C.'}, {'name': 'Stadler T.'}, {'name': 'Egberink H.'}, {'name': 'Zhao S.'}, {'name': 'Lutz H.'}, {'name': 'Riond B.'}, {'name': 'Rosinger N.'}, {'name': 'Stalder H.'}, {'name': 'Renzullo S.'}, {'name': 'Hofmann-Lehmann R.'}], 'citationCount': 2, 'date': '2021-03-01T00:00:00Z', 'journal': 'Viruses', 'title': 'Detection and genome sequencing of sars-cov-2 in a domestic cat with respiratory signs in Switzerland'}, 'note': 'V-pipe and the S3C (Swiss SARS-CoV-2 Sequencing Consortium) infrastructure were used to QA and pre-process the sequencing data.', 'pmcid': 'PMC8002591', 'pmid': '33802899', 'type': ['Usage'], 'version': 'sars-cov2'}]"
183,,Computational Biology Group,Division,,,,https://www.bsse.ethz.ch/cbg,,,v-pipe,Open access,DrYak,"[{'doi': '10.1093/bioinformatics/btab015', 'pmid': '33471068', 'type': ['Primary'], 'version': '1.0, 2.0'}, {'doi': '10.20944/preprints202005.0376.v1', 'type': ['Review']}, {'doi': '10.1016/j.virusres.2016.09.016', 'metadata': {'abstract': '© 2016 The AuthorsRapidly evolving RNA viruses prevail within a host as a collection of closely related variants, referred to as viral quasispecies. Advances in high-throughput sequencing (HTS) technologies have facilitated the assessment of the genetic diversity of such virus populations at an unprecedented level of detail. However, analysis of HTS data from virus populations is challenging due to short, error-prone reads. In order to account for uncertainties originating from these limitations, several computational and statistical methods have been developed for studying the genetic heterogeneity of virus population. Here, we review methods for the analysis of HTS reads, including approaches to local diversity estimation and global haplotype reconstruction. Challenges posed by aligning reads, as well as the impact of reference biases on diversity estimates are also discussed. In addition, we address some of the experimental approaches designed to improve the biological signal-to-noise ratio. In the future, computational methods for the analysis of heterogeneous virus populations are likely to continue being complemented by technological developments.', 'authors': [{'name': 'Posada-Cespedes S.'}, {'name': 'Seifert D.'}, {'name': 'Beerenwinkel N.'}], 'citationCount': 42, 'date': '2017-07-15T00:00:00Z', 'journal': 'Virus Research', 'title': 'Recent advances in inferring viral diversity from high-throughput sequencing data'}, 'pmid': '27693290', 'type': ['Other']}, {'doi': '10.3390/v10050256', 'metadata': {'abstract': '© 2018 by the authors. Licensee MDPI, Basel, Switzerland.The Second Annual Meeting of the European Virus Bioinformatics Center (EVBC), held in Utrecht, Netherlands, focused on computational approaches in virology, with topics including (but not limited to) virus discovery, diagnostics, (meta-)genomics, modeling, epidemiology, molecular structure, evolution, and viral ecology. The goals of the Second Annual Meeting were threefold: (i) to bring together virologists and bioinformaticians from across the academic, industrial, professional, and training sectors to share best practice; (ii) to provide a meaningful and interactive scientific environment to promote discussion and collaboration between students, postdoctoral fellows, and both new and established investigators; (iii) to inspire and suggest new research directions and questions. Approximately 120 researchers from around the world attended the Second Annual Meeting of the EVBC this year, including 15 renowned international speakers. This report presents an overview of new developments and novel research findings that emerged during the meeting.', 'authors': [{'name': 'Ibrahim B.'}, {'name': 'Arkhipova K.'}, {'name': 'Andeweg A.C.'}, {'name': 'Posada-Cespedes S.'}, {'name': 'Enault F.'}, {'name': 'Gruber A.'}, {'name': 'Koonin E.V.'}, {'name': 'Kupczok A.'}, {'name': 'Lemey P.'}, {'name': 'McHardy A.C.'}, {'name': 'McMahon D.P.'}, {'name': 'Pickett B.E.'}, {'name': 'Robertson D.L.'}, {'name': 'Scheuermann R.H.'}, {'name': 'Zhernakova A.'}, {'name': 'Zwart M.P.'}, {'name': 'Schonhuth A.'}, {'name': 'Dutilh B.E.'}, {'name': 'Marz M.'}], 'citationCount': 3, 'date': '2018-05-14T00:00:00Z', 'journal': 'Viruses', 'title': 'Bioinformatics meets virology: The European virus bioinformatics center’s second annual meeting'}, 'pmcid': 'PMC5977249', 'pmid': '29757994', 'type': ['Other']}, {'doi': '10.1093/infdis/jiz094', 'metadata': {'abstract': '© 2019 The Author(s) 2019.Background: Human immunodeficiency virus type 1 (HIV-1) genetic diversity increases over the course of infection and can be used to infer the time since infection and, consequently, infection recency, which are crucial for HIV-1 surveillance and the understanding of viral pathogenesis. Methods: We considered 313 HIV-infected individuals for whom reliable estimates of infection dates and next-generation sequencing (NGS)-derived nucleotide frequency data were available. Fractions of ambiguous nucleotides, obtained by population sequencing, were available for 207 samples. We assessed whether the average pairwise diversity calculated using NGS sequences provided a more exact prediction of the time since infection and classification of infection recency (<1 year after infection), compared with the fraction of ambiguous nucleotides. Results: NGS-derived average pairwise diversity classified an infection as recent with a sensitivity of 88% and a specificity of 85%. When considering only the 207 samples for which fractions of ambiguous nucleotides were available, the NGS-derived average pairwise diversity exhibited a higher sensitivity (90% vs 78%) and specificity (95% vs 67%) than the fraction of ambiguous nucleotides. Additionally, the average pairwise diversity could be used to estimate the time since infection with a mean absolute error of 0.84 years, compared with 1.03 years for the fraction of ambiguous nucleotides. Conclusions: Viral diversity based on NGS data is more precise than that based on population sequencing in its ability to predict infection recency and provides an estimated time since infection that has a mean absolute error of <1 year.', 'authors': [{'name': 'Carlisle L.A.'}, {'name': 'Turk T.'}, {'name': 'Kusejko K.'}, {'name': 'Metzner K.J.'}, {'name': 'Leemann C.'}, {'name': 'Schenkel C.D.'}, {'name': 'Bachmann N.'}, {'name': 'Posada S.'}, {'name': 'Beerenwinkel N.'}, {'name': 'Boni J.'}, {'name': 'Yerly S.'}, {'name': 'Klimkait T.'}, {'name': 'Perreau M.'}, {'name': 'Braun D.L.'}, {'name': 'Rauch A.'}, {'name': 'Calmy A.'}, {'name': 'Cavassini M.'}, {'name': 'Battegay M.'}, {'name': 'Vernazza P.'}, {'name': 'Bernasconi E.'}, {'name': 'Gunthard H.F.'}, {'name': 'Kouyos R.D.'}, {'name': 'Anagnostopoulos A.'}, {'name': 'Battegay M.'}, {'name': 'Bernasconi E.'}, {'name': 'Boni J.'}, {'name': 'Braun D.L.'}, {'name': 'Bucher H.C.'}, {'name': 'Calmy A.'}, {'name': 'Cavassini M.'}, {'name': 'Ciuffi A.'}, {'name': 'Dollenmaier G.'}, {'name': 'Egger M.'}, {'name': 'Elzi L.'}, {'name': 'Fehr J.'}, {'name': 'Fellay J.'}, {'name': 'Furrer H.'}, {'name': 'Fux C.A.'}, {'name': 'Gunthard H.F.'}, {'name': 'Haerry D.'}, {'name': 'Hasse B.'}, {'name': 'Hirsch H.H.'}, {'name': 'Hoffmann M.'}, {'name': 'Hosli I.'}, {'name': 'Huber M.'}, {'name': 'Kahlert C.'}, {'name': 'Kaiser L.'}, {'name': 'Keiser O.'}, {'name': 'Klimkait T.'}, {'name': 'Kouyos R.D.'}, {'name': 'Kovari H.'}, {'name': 'Ledergerber B.'}, {'name': 'Martinetti G.'}, {'name': 'Martinez De Tejada B.'}, {'name': 'Marzolini C.'}, {'name': 'Metzner K.J.'}, {'name': 'Muller N.'}, {'name': 'Nicca D.'}, {'name': 'Paioni P.'}, {'name': 'Pantaleo G.'}, {'name': 'Perreau M.'}, {'name': 'Rauch A.'}, {'name': 'Rudin C.'}, {'name': 'Scherrer A.U.'}, {'name': 'Schmid P.'}, {'name': 'Speck R.'}, {'name': 'Stockle M.'}, {'name': 'Tarr P.'}, {'name': 'Trkola A.'}, {'name': 'Vernazza P.'}, {'name': 'Wandeler G.'}, {'name': 'Weber R.'}, {'name': 'Yerly S.'}], 'citationCount': 6, 'date': '2019-06-19T00:00:00Z', 'journal': 'Journal of Infectious Diseases', 'title': 'Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time since Infection'}, 'pmid': '30835266', 'type': ['Usage']}, {'doi': '10.2807/1560-7917.es.2020.25.32.2001410', 'metadata': {'abstract': '© 2020 Turkish Society of Cardiology. All rights reserved.We show the distribution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic clades over time and between countries and outline potential genomic surveillance objectives. We applied three genomic nomenclature systems to all sequence data from the World Health Organization European Region available until 10 July 2020. We highlight the importance of real-time sequencing and data dissemination in a pandemic situation, compare the nomenclatures and lay a foundation for future European genomic surveillance of SARS-CoV-2.', 'authors': [{'name': 'Alm E.'}, {'name': 'Broberg E.K.'}, {'name': 'Connor T.'}, {'name': 'Hodcroft E.B.'}, {'name': 'Komissarov A.B.'}, {'name': 'Maurer-Stroh S.'}, {'name': 'Melidou A.'}, {'name': 'Neher R.A.'}, {'name': ""O'Toole A.""}, {'name': 'Pereyaslov D.'}, {'name': 'Beerenwinkel N.'}, {'name': 'Posada-Cespedes S.'}, {'name': 'Jablonski K.P.'}, {'name': 'Ferreira P.F.'}, {'name': 'Topolsky I.'}, {'name': 'Avsic-Zupanc T.'}, {'name': 'Korva M.'}, {'name': 'Poljak M.'}, {'name': 'Zakotnik S.'}, {'name': 'Zorec T.M.'}, {'name': 'Bragstad K.'}, {'name': 'Hungnes O.'}, {'name': 'Stene-Johansen K.'}, {'name': 'Reusken C.'}, {'name': 'Meijer A.'}, {'name': 'Vennema H.'}, {'name': 'Ruiz-Roldan L.'}, {'name': 'Bracho M.A.'}, {'name': 'Garcia-Gonzalez N.'}, {'name': 'Chiner-Oms A.'}, {'name': 'Cancino-Munoz I.'}, {'name': 'Comas I.'}, {'name': 'Goig G.A.'}, {'name': 'Torres-Puente M.'}, {'name': 'Lopez M.G.'}, {'name': 'Martinez-Priego L.'}, {'name': ""D'Auria G.""}, {'name': 'Ruiz-Hueso P.'}, {'name': 'Ferrus-Abad L.'}, {'name': 'de Marco G.'}, {'name': 'Galan-Vendrell I.'}, {'name': 'Carbo-Ramirez S.'}, {'name': 'Ruiz-Rodriguez P.'}, {'name': 'Coscolla M.'}, {'name': 'Polackova K.'}, {'name': 'Kramna L.'}, {'name': 'Cinek O.'}, {'name': 'Richter J.'}, {'name': 'Krashias G.'}, {'name': 'Tryfonos C.'}, {'name': 'Bashiardes S.'}, {'name': 'Koptides D.'}, {'name': 'Christodoulou C.'}, {'name': 'Bartolini B.'}, {'name': 'Gruber C.E.'}, {'name': 'Di Caro A.'}, {'name': 'Castilletti C.'}, {'name': 'Stefani F.'}, {'name': 'Rimoldi S.G.'}, {'name': 'Romeri F.'}, {'name': 'Salerno F.'}, {'name': 'Polesello S.'}, {'name': 'Nagy A.'}, {'name': 'Jirincova H.'}, {'name': 'Vecerova J.'}, {'name': 'Novakova L.'}, {'name': 'Cordey S.'}, {'name': 'Murtskhvaladze M.'}, {'name': 'Kotaria N.'}, {'name': 'Schar T.'}, {'name': 'Beisel C.'}, {'name': 'Vugrek O.'}, {'name': 'Rokic F.'}, {'name': 'Trgovec-Greif L.'}, {'name': 'Jurak I.'}, {'name': 'Rukavina T.'}, {'name': 'Sucic N.'}, {'name': 'Schonning K.'}, {'name': 'Karst S.M.'}, {'name': 'Kirkegaard R.H.'}, {'name': 'Michaelsen T.Y.'}, {'name': 'Sorensen E.A.'}, {'name': 'Knutson S.'}, {'name': 'Brandt J.'}, {'name': 'Le-Quy V.'}, {'name': 'Sorensen T.'}, {'name': 'Petersen C.'}, {'name': 'Pedersen M.S.'}, {'name': 'Larsen S.L.'}, {'name': 'Skov M.N.'}, {'name': 'Rasmussen M.'}, {'name': 'Fonager J.'}, {'name': 'Fomsgaard A.'}, {'name': 'Maksyutov R.A.'}, {'name': 'Gavrilova E.V.'}, {'name': 'Pyankov O.V.'}, {'name': 'Bodnev S.A.'}, {'name': 'Tregubchak T.V.'}, {'name': 'Shvalov A.N.'}, {'name': 'Antonets D.V.'}, {'name': 'Resende P.C.'}, {'name': 'Goya S.'}, {'name': 'Perrin A.'}, {'name': 'Lee R.T.'}, {'name': 'Yadahalli S.'}, {'name': 'Han A.X.'}, {'name': 'Russell C.A.'}, {'name': 'Schmutz S.'}, {'name': 'Zaheri M.'}, {'name': 'Kufner V.'}, {'name': 'Huber M.'}, {'name': 'Trkola A.'}, {'name': 'Antwerpen M.'}, {'name': 'Walter M.C.'}, {'name': 'van der Werf S.'}, {'name': 'Gambaro F.'}, {'name': 'Behillil S.'}, {'name': 'Enouf V.'}, {'name': 'Donati F.'}, {'name': 'Ustinova M.'}, {'name': 'Rovite V.'}, {'name': 'Klovins J.'}, {'name': 'Savicka O.'}, {'name': 'Wienecke-Baldacchino A.K.'}, {'name': 'Ragimbeau C.'}, {'name': 'Fournier G.'}, {'name': 'Mossong J.'}, {'name': 'Aberle S.W.'}, {'name': 'Haukland M.'}, {'name': 'Enkirch T.'}, {'name': 'Advani A.'}, {'name': 'Karlberg M.L.'}, {'name': 'Lindsjo O.K.'}, {'name': 'Broddesson S.'}, {'name': 'Slavikova M.'}, {'name': 'Lickova M.'}, {'name': 'Klempa B.'}, {'name': 'Staronova E.'}, {'name': 'Ticha E.'}, {'name': 'Szemes T.'}, {'name': 'Rusnakova D.'}, {'name': 'Stadler T.'}, {'name': 'Quer J.'}, {'name': 'Anton A.'}, {'name': 'Andres C.'}, {'name': 'Pinana M.'}, {'name': 'Garcia-Cehic D.'}, {'name': 'Pumarola T.'}, {'name': 'Izopet J.'}, {'name': 'Gioula G.'}, {'name': 'Exindari M.'}, {'name': 'Papa A.'}, {'name': 'Chatzidimitriou D.'}, {'name': 'Metallidis S.'}, {'name': 'Pappa S.'}, {'name': 'Macek M.'}, {'name': 'Geryk J.'}, {'name': 'Broz P.'}, {'name': 'Briksi A.'}, {'name': 'Hubacek P.'}, {'name': 'Drevinek P.'}, {'name': 'Zajac M.'}, {'name': 'Kvapil P.'}, {'name': 'Holub M.'}, {'name': 'Kvapilova K.'}, {'name': 'Novotny A.'}, {'name': 'Kasny M.'}, {'name': 'Klempt P.'}, {'name': 'Vapalahti O.'}, {'name': 'Smura T.'}, {'name': 'Sironen T.'}, {'name': 'Selhorst P.'}, {'name': 'Anthony C.'}, {'name': 'Arien K.'}, {'name': 'Simon-Loriere E.'}, {'name': 'Rabalski L.'}, {'name': 'Bienkowska-Szewczyk K.'}, {'name': 'Borges V.'}, {'name': 'Isidro J.'}, {'name': 'Gomes J.P.'}, {'name': 'Guiomar R.'}, {'name': 'Pechirra P.'}, {'name': 'Costa I.'}, {'name': 'Duarte S.'}, {'name': 'Vieira L.'}, {'name': 'Pyrc K.'}, {'name': 'Zuckerman N.S.'}, {'name': 'Turdikulova S.'}, {'name': 'Abdullaev A.'}, {'name': 'Dalimova D.'}, {'name': 'Abdurakhimov A.'}, {'name': 'Tagliabracci A.'}, {'name': 'Alessandrini F.'}, {'name': 'Melchionda F.'}, {'name': 'Onofri V.'}, {'name': 'Turchi C.'}, {'name': 'Bagnarelli P.'}, {'name': 'Menzo S.'}, {'name': 'Caucci S.'}, {'name': 'Di Sante L.'}, {'name': 'Popa A.'}, {'name': 'Genger J.-W.'}, {'name': 'Agerer B.'}, {'name': 'Lercher A.'}, {'name': 'Endler L.'}, {'name': 'Smyth M.'}, {'name': 'Penz T.'}, {'name': 'Schuster M.'}, {'name': 'Senekowitsch M.'}, {'name': 'Laine J.'}, {'name': 'Bock C.'}, {'name': 'Bergthaler A.'}, {'name': 'Shevtsov A.'}, {'name': 'Kalendar R.'}, {'name': 'Ramanculov Y.'}, {'name': 'Graf A.'}, {'name': 'Muenchhoff M.'}, {'name': 'Keppler O.T.'}, {'name': 'Krebs S.'}, {'name': 'Blum H.'}, {'name': 'Marcello A.'}, {'name': 'Licastro D.'}, {'name': ""D'Agaro P.""}, {'name': 'Laubscher F.'}, {'name': 'Vidanovic D.'}, {'name': 'Tesovic B.'}, {'name': 'Volkening J.'}, {'name': 'Clementi N.'}, {'name': 'Mancini N.'}, {'name': 'Rupnik M.'}, {'name': 'Mahnic A.'}, {'name': 'Walker A.'}, {'name': 'Houwaart T.'}, {'name': 'Wienemann T.'}, {'name': 'Vasconcelos M.K.'}, {'name': 'Strelow D.'}, {'name': 'Jensen B.-E.O.'}, {'name': 'Senff T.'}, {'name': 'Hulse L.'}, {'name': 'Adams O.'}, {'name': 'Andree M.'}, {'name': 'Hauka S.'}, {'name': 'Feldt T.'}, {'name': 'Keitel V.'}, {'name': 'Kindgen-Milles D.'}, {'name': 'Timm J.'}, {'name': 'Pfeffer K.'}, {'name': 'Dilthey A.T.'}, {'name': 'Moore C.'}, {'name': 'Ozdarendeli A.'}, {'name': 'Pavel S.T.I.'}, {'name': 'Yetiskin H.'}, {'name': 'Aydin G.'}, {'name': 'Holyavkin C.'}, {'name': 'Uygut M.A.'}, {'name': 'Cevik C.'}, {'name': 'Shchetinin A.'}, {'name': 'Gushchin V.'}, {'name': 'Dinler-Doganay G.'}, {'name': 'Doganay L.'}, {'name': 'Kizilboga-Akgun T.'}, {'name': 'Karacan I.'}, {'name': 'Pancer K.'}, {'name': 'Maes P.'}, {'name': 'Marti-Carreras J.'}, {'name': 'Wawina-Bokalanga T.'}, {'name': 'Vanmechelen B.'}, {'name': 'Thurmer A.'}, {'name': 'Wedde M.'}, {'name': 'Durrwald R.'}, {'name': 'von Kleist M.'}, {'name': 'Drechsel O.'}, {'name': 'Wolff T.'}, {'name': 'Fuchs S.'}, {'name': 'Kmiecinski R.'}, {'name': 'Michel J.'}, {'name': 'Nitsche A.'}, {'name': 'Casas I.'}, {'name': 'Caballero M.I.'}, {'name': 'Zaballos A.'}, {'name': 'Jimenez P.'}, {'name': 'Jimenez M.'}, {'name': 'Fernandez S.M.'}, {'name': 'Fernandez S.V.'}, {'name': 'de la Plaza I.C.'}, {'name': 'Fadeev A.'}, {'name': 'Ivanova A.'}, {'name': 'Sergeeva M.'}, {'name': 'Stefanelli P.'}, {'name': 'Estee Torok M.'}, {'name': 'Hall G.'}, {'name': 'da Silva Filipe A.'}, {'name': 'Turtle L.'}, {'name': 'Afifi S.'}, {'name': 'McCluggage K.'}, {'name': 'Beer R.'}, {'name': 'Ledesma J.'}, {'name': 'Maksimovic J.'}, {'name': 'Spellman K.'}, {'name': 'Hamilton W.L.'}, {'name': 'Marchbank A.'}, {'name': 'Southgate J.A.'}, {'name': 'Underwood A.'}, {'name': 'Taylor B.'}, {'name': 'Yeats C.'}, {'name': 'Abudahab K.'}, {'name': 'Gemmell M.R.'}, {'name': 'Eccles R.'}, {'name': 'Lucaci A.'}, {'name': 'Nelson C.A.'}, {'name': 'Rainbow L.'}, {'name': 'Whitehead M.'}, {'name': 'Gregory R.'}, {'name': 'Haldenby S.'}, {'name': 'Paterson S.'}, {'name': 'Hughes M.A.'}, {'name': 'Curran M.D.'}, {'name': 'Baker D.'}, {'name': 'Tucker R.'}, {'name': 'Green L.R.'}, {'name': 'Feltwell T.'}, {'name': 'Halstead F.D.'}, {'name': 'Wyles M.'}, {'name': 'Jahun A.S.'}, {'name': 'Ahmad S.S.Y.'}, {'name': 'Georgana I.'}, {'name': 'Goodfellow I.'}, {'name': 'Yakovleva A.'}, {'name': 'Meredith L.W.'}, {'name': 'Gavriil A.'}, {'name': 'Awan A.R.'}, {'name': 'Fisher C.'}, {'name': 'Edgeworth J.'}, {'name': 'Lynch J.'}, {'name': 'Moore N.'}, {'name': 'Williams R.'}, {'name': 'Kidd S.P.'}, {'name': 'Cortes N.'}, {'name': 'Brunker K.'}, {'name': 'McCrone J.T.'}, {'name': 'Quick J.'}, {'name': 'Duckworth N.'}, {'name': 'Walsh S.'}, {'name': 'Sloan T.'}, {'name': 'Ludden C.'}, {'name': 'George R.P.'}, {'name': 'Eltringham G.'}, {'name': 'Brown J.R.'}, {'name': 'Aranday-Cortes E.'}, {'name': 'Shepherd J.G.'}, {'name': 'Hughes J.'}, {'name': 'Li K.K.'}, {'name': 'Williams T.C.'}, {'name': 'Johnson N.'}, {'name': 'Jesudason N.'}, {'name': 'Mair D.'}, {'name': 'Thomson E.'}, {'name': 'Shah R.'}, {'name': 'Parr Y.A.'}, {'name': 'Carmichael S.'}, {'name': 'Robertson D.L.'}, {'name': 'Nomikou K.'}, {'name': 'Broos A.'}, {'name': 'Niebel M.'}, {'name': 'Smollett K.'}, {'name': 'Tong L.'}, {'name': 'Miah S.'}, {'name': 'Wittner A.'}, {'name': 'Phillips N.'}, {'name': 'Payne B.'}, {'name': 'Dewar R.'}, {'name': 'Holmes A.'}, {'name': 'Bolt F.'}, {'name': 'Price J.R.'}, {'name': 'Mookerjee S.'}, {'name': 'Sethi D.K.'}, {'name': 'Potter W.'}, {'name': 'Stanley R.'}, {'name': 'Prakash R.'}, {'name': 'Dervisevic S.'}, {'name': 'Graham J.C.'}, {'name': 'Nelson A.'}, {'name': 'Smith D.'}, {'name': 'Young G.R.'}, {'name': 'Yew W.C.'}, {'name': 'Todd J.A.'}, {'name': 'Trebes A.'}, {'name': 'Andersson M.'}, {'name': 'Bull M.'}, {'name': 'Watkins J.'}, {'name': 'Birchley A.'}, {'name': 'Gatica-Wilcox B.'}, {'name': 'Gilbert L.'}, {'name': 'Kumziene-Summerhayes S.'}, {'name': 'Rey S.'}, {'name': 'Chauhan A.'}, {'name': 'Butcher E.'}, {'name': 'Bicknell K.'}, {'name': 'Elliott S.'}, {'name': 'Glaysher S.'}, {'name': 'Lackenby A.'}, {'name': 'Bibby D.'}, {'name': 'Platt S.'}, {'name': 'Mohamed H.'}, {'name': 'Machin N.W.'}, {'name': 'Mbisa J.L.'}, {'name': 'Evans J.'}, {'name': 'Perry M.'}, {'name': 'Pacchiarini N.'}, {'name': 'Corden S.'}, {'name': 'Adams A.G.'}, {'name': 'Gaskin A.'}, {'name': 'Coombs J.'}, {'name': 'Graham L.J.'}, {'name': 'Cottrell S.'}, {'name': 'Morgan M.'}, {'name': 'Gifford L.'}, {'name': 'Kolyva A.'}, {'name': 'Rudder S.J.'}, {'name': 'Trotter A.J.'}, {'name': 'Mather A.E.'}, {'name': 'Aydin A.'}, {'name': 'Page A.J.'}, {'name': 'Kay G.L.'}, {'name': 'de Oliveira Martins L.'}, {'name': 'Yasir M.'}, {'name': 'Alikhan N.-F.'}, {'name': 'Thomson N.M.'}, {'name': 'Gilroy R.'}, {'name': 'Kingsley R.A.'}, {'name': ""O'Grady J.""}, {'name': 'Gutierrez A.V.'}, {'name': 'Diaz M.'}, {'name': 'Viet T.L.'}, {'name': 'Tedim A.P.'}, {'name': 'Adriaenssens E.M.'}, {'name': 'Patrick Mcclure C.'}, {'name': 'Moore C.'}, {'name': 'Sang F.'}, {'name': 'Clark G.'}, {'name': 'Howson-Wells H.C.'}, {'name': 'Debebe J.'}, {'name': 'Ball J.'}, {'name': 'Chappell J.'}, {'name': 'Khakh M.'}, {'name': 'Carlile M.'}, {'name': 'Loose M.'}, {'name': 'Lister M.M.'}, {'name': 'Holmes N.'}, {'name': 'Tsoleridis T.'}, {'name': 'Fleming V.M.'}, {'name': 'Wright V.'}, {'name': 'Smith W.'}, {'name': 'Gallagher M.D.'}, {'name': 'Parker M.'}, {'name': 'Partridge D.G.'}, {'name': 'Evans C.'}, {'name': 'Baker P.'}, {'name': 'Essex S.'}, {'name': 'Liggett S.'}, {'name': 'Keeley A.J.'}, {'name': 'Bashton M.'}, {'name': 'Rooke S.'}, {'name': 'Dervisavic S.'}, {'name': 'Meader E.J.'}, {'name': 'Lopez C.E.B.'}, {'name': 'Angyal A.'}, {'name': 'Kristiansen M.'}, {'name': 'Tutill H.J.'}, {'name': 'Findlay J.'}, {'name': 'Mestek-Boukhibar L.'}, {'name': 'Forrest L.'}, {'name': 'Dyal P.'}, {'name': 'Williams R.J.'}, {'name': 'Panchbhaya Y.'}, {'name': 'Williams C.A.'}, {'name': 'Roy S.'}, {'name': 'Pandey S.'}, {'name': 'Stockton J.'}, {'name': 'Loman N.J.'}, {'name': 'Poplawski R.'}, {'name': 'Nicholls S.'}, {'name': 'Rowe W.P.M.'}, {'name': 'Khokhar F.'}, {'name': 'Pinckert M.L.'}, {'name': 'Hosmillo M.'}, {'name': 'Chaudhry Y.'}, {'name': 'Caller L.G.'}, {'name': 'Davidson R.K.'}, {'name': 'Griffith L.'}, {'name': 'Rambaut A.'}, {'name': 'Jackson B.'}, {'name': 'Colquhoun R.'}, {'name': 'Hill V.'}, {'name': 'Nichols J.'}, {'name': 'Asamaphan P.'}, {'name': 'Darby A.'}, {'name': 'Jackson K.A.'}, {'name': 'Iturriza-Gomara M.'}, {'name': 'Vamos E.E.'}, {'name': 'Green A.'}, {'name': 'Aanensen D.'}, {'name': 'Bonsall D.'}, {'name': 'Buck D.'}, {'name': 'Macintyre-Cockett G.'}, {'name': 'de Cesare M.'}, {'name': 'Pybus O.'}, {'name': 'Golubchik T.'}, {'name': 'Scarlett G.'}, {'name': 'Loveson K.F.'}, {'name': 'Robson S.C.'}, {'name': 'Beckett A.'}, {'name': 'Lindsey B.'}, {'name': 'Groves D.C.'}, {'name': 'Parsons P.J.'}, {'name': 'McHugh M.P.'}, {'name': 'Barnes J.D.'}, {'name': 'Manso C.F.'}, {'name': 'Grammatopoulos D.'}, {'name': 'Menger K.E.'}, {'name': 'Harrison E.'}, {'name': 'Gunson R.'}, {'name': 'Peacock S.J.'}, {'name': 'Gonzalez G.'}, {'name': 'Carr M.'}, {'name': 'Mihaela L.'}, {'name': 'Popovici O.'}, {'name': 'Brytting M.'}, {'name': 'Bresner C.'}, {'name': 'Fuller W.'}, {'name': 'Workman T.'}, {'name': 'Mentis A.F.'}, {'name': 'Kossyvakis A.'}, {'name': 'Karamitros T.'}, {'name': 'Pogka V.'}, {'name': 'Kalliaropoulos A.'}, {'name': 'Horefti E.'}, {'name': 'Kontou A.'}, {'name': 'Martinez-Gonzalez B.'}, {'name': 'Labropoulou V.'}, {'name': 'Voulgari-Kokota A.'}, {'name': 'Evangelidou M.'}, {'name': 'Bizta P.'}, {'name': 'Belimezi M.'}, {'name': 'Lambrechts L.'}, {'name': 'Doymaz M.Z.'}, {'name': 'Yazici M.K.'}, {'name': 'Cetin N.S.'}, {'name': 'Karaaslan E.'}, {'name': 'Kallio-Kokko H.'}, {'name': 'Virtanen J.'}, {'name': 'Suvanto M.'}, {'name': 'Nguyen P.T.'}, {'name': 'Ellonen P.'}, {'name': 'Hannula S.'}, {'name': 'Kangas H.'}, {'name': 'Sreenu V.B.'}, {'name': 'Burian K.'}, {'name': 'Terhes G.'}, {'name': 'Gombos K.'}, {'name': 'Gyenesei A.'}, {'name': 'Urban P.'}, {'name': 'Herczeg R.'}, {'name': 'Jakab F.'}, {'name': 'Kemenesi G.'}, {'name': 'Toth G.E.'}, {'name': 'Somogyi B.'}, {'name': 'Zana B.'}, {'name': 'Zeghbib S.'}, {'name': 'Kuczmog A.'}, {'name': 'Foldes F.'}, {'name': 'Lanszki Z.'}, {'name': 'Madai M.'}, {'name': 'Papp H.'}, {'name': 'Nagy A.'}, {'name': 'Pereszlenyi C.I.'}, {'name': 'Babinszky G.C.'}, {'name': 'Dudas G.'}, {'name': 'Csoma E.'}, {'name': 'Abou Tayoun A.N.'}, {'name': 'Alsheikh-Ali A.A.'}, {'name': 'Loney T.'}, {'name': 'Nowotny N.'}, {'name': 'Abdul-Wahab O.'}, {'name': 'Gonzalez-Candelas F.'}, {'name': 'Andersen M.H.'}, {'name': 'Taylor S.'}], 'citationCount': 42, 'date': '2020-01-01T00:00:00Z', 'journal': 'Eurosurveillance', 'title': 'Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020'}, 'note': 'V-pipe was used to process a major part of the Swiss samples in this pan-European study.', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2020.10.12.335919', 'note': 'Raw reads from SRA public data and Swiss cohort were processed using V-pipe', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2020.10.14.20212621', 'note': 'V-pipe was used to process a major part of the Swiss samples', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2021.01.08.21249379', 'note': 'The waste water samples were analyzed using V-pipe and additional custom scripts.', 'type': ['Usage'], 'version': 'sars-cov2-dev'}, {'doi': '10.1101/2021.03.05.21252520', 'note': 'V-pipe is used within the S3C (Swiss SARS-CoV-2 Sequencing Consortium) to provide sequences.', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.3390/v13030496', 'metadata': {'abstract': '© 2021 by the authors. Licensee MDPI, Basel, Switzerland.Since the emergence of coronavirus disease (COVID-19) in late 2019, domestic cats have been demonstrated to be susceptible to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) under natural and experimental conditions. As pet cats often live in very close contact with their owners, it is essential to investigate SARS-CoV-2 infections in cats in a One-Health context. This study reports the first SARS-CoV-2 infection in a cat in a COVID-19-affected household in Switzerland. The cat (Cat 1) demonstrated signs of an upper respiratory tract infection, including sneezing, inappetence, and apathy, while the cohabiting cat (Cat 2) remained asymptomatic. Nasal, oral, fecal, fur, and environmental swab samples were collected twice from both cats and analyzed by RT-qPCR for the presence of SARS-CoV-2 viral RNA. Both nasal swabs from Cat 1 tested positive. In addition, the first oral swab from Cat 2 and fur and bedding swabs from both cats were RT-qPCR positive. The fecal swabs tested negative. The infection of Cat 1 was confirmed by positive SARS-CoV-2 S1 receptor binding domain (RBD) antibody testing and neutralizing activity in a surrogate assay. The viral genome sequence from Cat 1, obtained by next generation sequencing, showed the closest relation to a human sequence from the B.1.1.39 lineage, with one single nucleotide polymorphism (SNP) difference. This study demonstrates not only SARS-CoV-2 infection of a cat from a COVID-19-affected household but also contamination of the cats’ fur and bed with viral RNA. Our results are important to create awareness that SARS-CoV-2 infected people should observe hygienic measures to avoid infection and contamination of animal cohabitants.', 'authors': [{'name': 'Klaus J.'}, {'name': 'Meli M.L.'}, {'name': 'Willi B.'}, {'name': 'Nadeau S.'}, {'name': 'Beisel C.'}, {'name': 'Stadler T.'}, {'name': 'Egberink H.'}, {'name': 'Zhao S.'}, {'name': 'Lutz H.'}, {'name': 'Riond B.'}, {'name': 'Rosinger N.'}, {'name': 'Stalder H.'}, {'name': 'Renzullo S.'}, {'name': 'Hofmann-Lehmann R.'}], 'citationCount': 2, 'date': '2021-03-01T00:00:00Z', 'journal': 'Viruses', 'title': 'Detection and genome sequencing of sars-cov-2 in a domestic cat with respiratory signs in Switzerland'}, 'note': 'V-pipe and the S3C (Swiss SARS-CoV-2 Sequencing Consortium) infrastructure were used to QA and pre-process the sequencing data.', 'pmcid': 'PMC8002591', 'pmid': '33802899', 'type': ['Usage'], 'version': 'sars-cov2'}]"
184,,D-BSSE,Division,,,,https://www.bsse.ethz.ch/,,,v-pipe,Open access,DrYak,"[{'doi': '10.1093/bioinformatics/btab015', 'pmid': '33471068', 'type': ['Primary'], 'version': '1.0, 2.0'}, {'doi': '10.20944/preprints202005.0376.v1', 'type': ['Review']}, {'doi': '10.1016/j.virusres.2016.09.016', 'metadata': {'abstract': '© 2016 The AuthorsRapidly evolving RNA viruses prevail within a host as a collection of closely related variants, referred to as viral quasispecies. Advances in high-throughput sequencing (HTS) technologies have facilitated the assessment of the genetic diversity of such virus populations at an unprecedented level of detail. However, analysis of HTS data from virus populations is challenging due to short, error-prone reads. In order to account for uncertainties originating from these limitations, several computational and statistical methods have been developed for studying the genetic heterogeneity of virus population. Here, we review methods for the analysis of HTS reads, including approaches to local diversity estimation and global haplotype reconstruction. Challenges posed by aligning reads, as well as the impact of reference biases on diversity estimates are also discussed. In addition, we address some of the experimental approaches designed to improve the biological signal-to-noise ratio. In the future, computational methods for the analysis of heterogeneous virus populations are likely to continue being complemented by technological developments.', 'authors': [{'name': 'Posada-Cespedes S.'}, {'name': 'Seifert D.'}, {'name': 'Beerenwinkel N.'}], 'citationCount': 42, 'date': '2017-07-15T00:00:00Z', 'journal': 'Virus Research', 'title': 'Recent advances in inferring viral diversity from high-throughput sequencing data'}, 'pmid': '27693290', 'type': ['Other']}, {'doi': '10.3390/v10050256', 'metadata': {'abstract': '© 2018 by the authors. Licensee MDPI, Basel, Switzerland.The Second Annual Meeting of the European Virus Bioinformatics Center (EVBC), held in Utrecht, Netherlands, focused on computational approaches in virology, with topics including (but not limited to) virus discovery, diagnostics, (meta-)genomics, modeling, epidemiology, molecular structure, evolution, and viral ecology. The goals of the Second Annual Meeting were threefold: (i) to bring together virologists and bioinformaticians from across the academic, industrial, professional, and training sectors to share best practice; (ii) to provide a meaningful and interactive scientific environment to promote discussion and collaboration between students, postdoctoral fellows, and both new and established investigators; (iii) to inspire and suggest new research directions and questions. Approximately 120 researchers from around the world attended the Second Annual Meeting of the EVBC this year, including 15 renowned international speakers. This report presents an overview of new developments and novel research findings that emerged during the meeting.', 'authors': [{'name': 'Ibrahim B.'}, {'name': 'Arkhipova K.'}, {'name': 'Andeweg A.C.'}, {'name': 'Posada-Cespedes S.'}, {'name': 'Enault F.'}, {'name': 'Gruber A.'}, {'name': 'Koonin E.V.'}, {'name': 'Kupczok A.'}, {'name': 'Lemey P.'}, {'name': 'McHardy A.C.'}, {'name': 'McMahon D.P.'}, {'name': 'Pickett B.E.'}, {'name': 'Robertson D.L.'}, {'name': 'Scheuermann R.H.'}, {'name': 'Zhernakova A.'}, {'name': 'Zwart M.P.'}, {'name': 'Schonhuth A.'}, {'name': 'Dutilh B.E.'}, {'name': 'Marz M.'}], 'citationCount': 3, 'date': '2018-05-14T00:00:00Z', 'journal': 'Viruses', 'title': 'Bioinformatics meets virology: The European virus bioinformatics center’s second annual meeting'}, 'pmcid': 'PMC5977249', 'pmid': '29757994', 'type': ['Other']}, {'doi': '10.1093/infdis/jiz094', 'metadata': {'abstract': '© 2019 The Author(s) 2019.Background: Human immunodeficiency virus type 1 (HIV-1) genetic diversity increases over the course of infection and can be used to infer the time since infection and, consequently, infection recency, which are crucial for HIV-1 surveillance and the understanding of viral pathogenesis. Methods: We considered 313 HIV-infected individuals for whom reliable estimates of infection dates and next-generation sequencing (NGS)-derived nucleotide frequency data were available. Fractions of ambiguous nucleotides, obtained by population sequencing, were available for 207 samples. We assessed whether the average pairwise diversity calculated using NGS sequences provided a more exact prediction of the time since infection and classification of infection recency (<1 year after infection), compared with the fraction of ambiguous nucleotides. Results: NGS-derived average pairwise diversity classified an infection as recent with a sensitivity of 88% and a specificity of 85%. When considering only the 207 samples for which fractions of ambiguous nucleotides were available, the NGS-derived average pairwise diversity exhibited a higher sensitivity (90% vs 78%) and specificity (95% vs 67%) than the fraction of ambiguous nucleotides. Additionally, the average pairwise diversity could be used to estimate the time since infection with a mean absolute error of 0.84 years, compared with 1.03 years for the fraction of ambiguous nucleotides. Conclusions: Viral diversity based on NGS data is more precise than that based on population sequencing in its ability to predict infection recency and provides an estimated time since infection that has a mean absolute error of <1 year.', 'authors': [{'name': 'Carlisle L.A.'}, {'name': 'Turk T.'}, {'name': 'Kusejko K.'}, {'name': 'Metzner K.J.'}, {'name': 'Leemann C.'}, {'name': 'Schenkel C.D.'}, {'name': 'Bachmann N.'}, {'name': 'Posada S.'}, {'name': 'Beerenwinkel N.'}, {'name': 'Boni J.'}, {'name': 'Yerly S.'}, {'name': 'Klimkait T.'}, {'name': 'Perreau M.'}, {'name': 'Braun D.L.'}, {'name': 'Rauch A.'}, {'name': 'Calmy A.'}, {'name': 'Cavassini M.'}, {'name': 'Battegay M.'}, {'name': 'Vernazza P.'}, {'name': 'Bernasconi E.'}, {'name': 'Gunthard H.F.'}, {'name': 'Kouyos R.D.'}, {'name': 'Anagnostopoulos A.'}, {'name': 'Battegay M.'}, {'name': 'Bernasconi E.'}, {'name': 'Boni J.'}, {'name': 'Braun D.L.'}, {'name': 'Bucher H.C.'}, {'name': 'Calmy A.'}, {'name': 'Cavassini M.'}, {'name': 'Ciuffi A.'}, {'name': 'Dollenmaier G.'}, {'name': 'Egger M.'}, {'name': 'Elzi L.'}, {'name': 'Fehr J.'}, {'name': 'Fellay J.'}, {'name': 'Furrer H.'}, {'name': 'Fux C.A.'}, {'name': 'Gunthard H.F.'}, {'name': 'Haerry D.'}, {'name': 'Hasse B.'}, {'name': 'Hirsch H.H.'}, {'name': 'Hoffmann M.'}, {'name': 'Hosli I.'}, {'name': 'Huber M.'}, {'name': 'Kahlert C.'}, {'name': 'Kaiser L.'}, {'name': 'Keiser O.'}, {'name': 'Klimkait T.'}, {'name': 'Kouyos R.D.'}, {'name': 'Kovari H.'}, {'name': 'Ledergerber B.'}, {'name': 'Martinetti G.'}, {'name': 'Martinez De Tejada B.'}, {'name': 'Marzolini C.'}, {'name': 'Metzner K.J.'}, {'name': 'Muller N.'}, {'name': 'Nicca D.'}, {'name': 'Paioni P.'}, {'name': 'Pantaleo G.'}, {'name': 'Perreau M.'}, {'name': 'Rauch A.'}, {'name': 'Rudin C.'}, {'name': 'Scherrer A.U.'}, {'name': 'Schmid P.'}, {'name': 'Speck R.'}, {'name': 'Stockle M.'}, {'name': 'Tarr P.'}, {'name': 'Trkola A.'}, {'name': 'Vernazza P.'}, {'name': 'Wandeler G.'}, {'name': 'Weber R.'}, {'name': 'Yerly S.'}], 'citationCount': 6, 'date': '2019-06-19T00:00:00Z', 'journal': 'Journal of Infectious Diseases', 'title': 'Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time since Infection'}, 'pmid': '30835266', 'type': ['Usage']}, {'doi': '10.2807/1560-7917.es.2020.25.32.2001410', 'metadata': {'abstract': '© 2020 Turkish Society of Cardiology. All rights reserved.We show the distribution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic clades over time and between countries and outline potential genomic surveillance objectives. We applied three genomic nomenclature systems to all sequence data from the World Health Organization European Region available until 10 July 2020. We highlight the importance of real-time sequencing and data dissemination in a pandemic situation, compare the nomenclatures and lay a foundation for future European genomic surveillance of SARS-CoV-2.', 'authors': [{'name': 'Alm E.'}, {'name': 'Broberg E.K.'}, {'name': 'Connor T.'}, {'name': 'Hodcroft E.B.'}, {'name': 'Komissarov A.B.'}, {'name': 'Maurer-Stroh S.'}, {'name': 'Melidou A.'}, {'name': 'Neher R.A.'}, {'name': ""O'Toole A.""}, {'name': 'Pereyaslov D.'}, {'name': 'Beerenwinkel N.'}, {'name': 'Posada-Cespedes S.'}, {'name': 'Jablonski K.P.'}, {'name': 'Ferreira P.F.'}, {'name': 'Topolsky I.'}, {'name': 'Avsic-Zupanc T.'}, {'name': 'Korva M.'}, {'name': 'Poljak M.'}, {'name': 'Zakotnik S.'}, {'name': 'Zorec T.M.'}, {'name': 'Bragstad K.'}, {'name': 'Hungnes O.'}, {'name': 'Stene-Johansen K.'}, {'name': 'Reusken C.'}, {'name': 'Meijer A.'}, {'name': 'Vennema H.'}, {'name': 'Ruiz-Roldan L.'}, {'name': 'Bracho M.A.'}, {'name': 'Garcia-Gonzalez N.'}, {'name': 'Chiner-Oms A.'}, {'name': 'Cancino-Munoz I.'}, {'name': 'Comas I.'}, {'name': 'Goig G.A.'}, {'name': 'Torres-Puente M.'}, {'name': 'Lopez M.G.'}, {'name': 'Martinez-Priego L.'}, {'name': ""D'Auria G.""}, {'name': 'Ruiz-Hueso P.'}, {'name': 'Ferrus-Abad L.'}, {'name': 'de Marco G.'}, {'name': 'Galan-Vendrell I.'}, {'name': 'Carbo-Ramirez S.'}, {'name': 'Ruiz-Rodriguez P.'}, {'name': 'Coscolla M.'}, {'name': 'Polackova K.'}, {'name': 'Kramna L.'}, {'name': 'Cinek O.'}, {'name': 'Richter J.'}, {'name': 'Krashias G.'}, {'name': 'Tryfonos C.'}, {'name': 'Bashiardes S.'}, {'name': 'Koptides D.'}, {'name': 'Christodoulou C.'}, {'name': 'Bartolini B.'}, {'name': 'Gruber C.E.'}, {'name': 'Di Caro A.'}, {'name': 'Castilletti C.'}, {'name': 'Stefani F.'}, {'name': 'Rimoldi S.G.'}, {'name': 'Romeri F.'}, {'name': 'Salerno F.'}, {'name': 'Polesello S.'}, {'name': 'Nagy A.'}, {'name': 'Jirincova H.'}, {'name': 'Vecerova J.'}, {'name': 'Novakova L.'}, {'name': 'Cordey S.'}, {'name': 'Murtskhvaladze M.'}, {'name': 'Kotaria N.'}, {'name': 'Schar T.'}, {'name': 'Beisel C.'}, {'name': 'Vugrek O.'}, {'name': 'Rokic F.'}, {'name': 'Trgovec-Greif L.'}, {'name': 'Jurak I.'}, {'name': 'Rukavina T.'}, {'name': 'Sucic N.'}, {'name': 'Schonning K.'}, {'name': 'Karst S.M.'}, {'name': 'Kirkegaard R.H.'}, {'name': 'Michaelsen T.Y.'}, {'name': 'Sorensen E.A.'}, {'name': 'Knutson S.'}, {'name': 'Brandt J.'}, {'name': 'Le-Quy V.'}, {'name': 'Sorensen T.'}, {'name': 'Petersen C.'}, {'name': 'Pedersen M.S.'}, {'name': 'Larsen S.L.'}, {'name': 'Skov M.N.'}, {'name': 'Rasmussen M.'}, {'name': 'Fonager J.'}, {'name': 'Fomsgaard A.'}, {'name': 'Maksyutov R.A.'}, {'name': 'Gavrilova E.V.'}, {'name': 'Pyankov O.V.'}, {'name': 'Bodnev S.A.'}, {'name': 'Tregubchak T.V.'}, {'name': 'Shvalov A.N.'}, {'name': 'Antonets D.V.'}, {'name': 'Resende P.C.'}, {'name': 'Goya S.'}, {'name': 'Perrin A.'}, {'name': 'Lee R.T.'}, {'name': 'Yadahalli S.'}, {'name': 'Han A.X.'}, {'name': 'Russell C.A.'}, {'name': 'Schmutz S.'}, {'name': 'Zaheri M.'}, {'name': 'Kufner V.'}, {'name': 'Huber M.'}, {'name': 'Trkola A.'}, {'name': 'Antwerpen M.'}, {'name': 'Walter M.C.'}, {'name': 'van der Werf S.'}, {'name': 'Gambaro F.'}, {'name': 'Behillil S.'}, {'name': 'Enouf V.'}, {'name': 'Donati F.'}, {'name': 'Ustinova M.'}, {'name': 'Rovite V.'}, {'name': 'Klovins J.'}, {'name': 'Savicka O.'}, {'name': 'Wienecke-Baldacchino A.K.'}, {'name': 'Ragimbeau C.'}, {'name': 'Fournier G.'}, {'name': 'Mossong J.'}, {'name': 'Aberle S.W.'}, {'name': 'Haukland M.'}, {'name': 'Enkirch T.'}, {'name': 'Advani A.'}, {'name': 'Karlberg M.L.'}, {'name': 'Lindsjo O.K.'}, {'name': 'Broddesson S.'}, {'name': 'Slavikova M.'}, {'name': 'Lickova M.'}, {'name': 'Klempa B.'}, {'name': 'Staronova E.'}, {'name': 'Ticha E.'}, {'name': 'Szemes T.'}, {'name': 'Rusnakova D.'}, {'name': 'Stadler T.'}, {'name': 'Quer J.'}, {'name': 'Anton A.'}, {'name': 'Andres C.'}, {'name': 'Pinana M.'}, {'name': 'Garcia-Cehic D.'}, {'name': 'Pumarola T.'}, {'name': 'Izopet J.'}, {'name': 'Gioula G.'}, {'name': 'Exindari M.'}, {'name': 'Papa A.'}, {'name': 'Chatzidimitriou D.'}, {'name': 'Metallidis S.'}, {'name': 'Pappa S.'}, {'name': 'Macek M.'}, {'name': 'Geryk J.'}, {'name': 'Broz P.'}, {'name': 'Briksi A.'}, {'name': 'Hubacek P.'}, {'name': 'Drevinek P.'}, {'name': 'Zajac M.'}, {'name': 'Kvapil P.'}, {'name': 'Holub M.'}, {'name': 'Kvapilova K.'}, {'name': 'Novotny A.'}, {'name': 'Kasny M.'}, {'name': 'Klempt P.'}, {'name': 'Vapalahti O.'}, {'name': 'Smura T.'}, {'name': 'Sironen T.'}, {'name': 'Selhorst P.'}, {'name': 'Anthony C.'}, {'name': 'Arien K.'}, {'name': 'Simon-Loriere E.'}, {'name': 'Rabalski L.'}, {'name': 'Bienkowska-Szewczyk K.'}, {'name': 'Borges V.'}, {'name': 'Isidro J.'}, {'name': 'Gomes J.P.'}, {'name': 'Guiomar R.'}, {'name': 'Pechirra P.'}, {'name': 'Costa I.'}, {'name': 'Duarte S.'}, {'name': 'Vieira L.'}, {'name': 'Pyrc K.'}, {'name': 'Zuckerman N.S.'}, {'name': 'Turdikulova S.'}, {'name': 'Abdullaev A.'}, {'name': 'Dalimova D.'}, {'name': 'Abdurakhimov A.'}, {'name': 'Tagliabracci A.'}, {'name': 'Alessandrini F.'}, {'name': 'Melchionda F.'}, {'name': 'Onofri V.'}, {'name': 'Turchi C.'}, {'name': 'Bagnarelli P.'}, {'name': 'Menzo S.'}, {'name': 'Caucci S.'}, {'name': 'Di Sante L.'}, {'name': 'Popa A.'}, {'name': 'Genger J.-W.'}, {'name': 'Agerer B.'}, {'name': 'Lercher A.'}, {'name': 'Endler L.'}, {'name': 'Smyth M.'}, {'name': 'Penz T.'}, {'name': 'Schuster M.'}, {'name': 'Senekowitsch M.'}, {'name': 'Laine J.'}, {'name': 'Bock C.'}, {'name': 'Bergthaler A.'}, {'name': 'Shevtsov A.'}, {'name': 'Kalendar R.'}, {'name': 'Ramanculov Y.'}, {'name': 'Graf A.'}, {'name': 'Muenchhoff M.'}, {'name': 'Keppler O.T.'}, {'name': 'Krebs S.'}, {'name': 'Blum H.'}, {'name': 'Marcello A.'}, {'name': 'Licastro D.'}, {'name': ""D'Agaro P.""}, {'name': 'Laubscher F.'}, {'name': 'Vidanovic D.'}, {'name': 'Tesovic B.'}, {'name': 'Volkening J.'}, {'name': 'Clementi N.'}, {'name': 'Mancini N.'}, {'name': 'Rupnik M.'}, {'name': 'Mahnic A.'}, {'name': 'Walker A.'}, {'name': 'Houwaart T.'}, {'name': 'Wienemann T.'}, {'name': 'Vasconcelos M.K.'}, {'name': 'Strelow D.'}, {'name': 'Jensen B.-E.O.'}, {'name': 'Senff T.'}, {'name': 'Hulse L.'}, {'name': 'Adams O.'}, {'name': 'Andree M.'}, {'name': 'Hauka S.'}, {'name': 'Feldt T.'}, {'name': 'Keitel V.'}, {'name': 'Kindgen-Milles D.'}, {'name': 'Timm J.'}, {'name': 'Pfeffer K.'}, {'name': 'Dilthey A.T.'}, {'name': 'Moore C.'}, {'name': 'Ozdarendeli A.'}, {'name': 'Pavel S.T.I.'}, {'name': 'Yetiskin H.'}, {'name': 'Aydin G.'}, {'name': 'Holyavkin C.'}, {'name': 'Uygut M.A.'}, {'name': 'Cevik C.'}, {'name': 'Shchetinin A.'}, {'name': 'Gushchin V.'}, {'name': 'Dinler-Doganay G.'}, {'name': 'Doganay L.'}, {'name': 'Kizilboga-Akgun T.'}, {'name': 'Karacan I.'}, {'name': 'Pancer K.'}, {'name': 'Maes P.'}, {'name': 'Marti-Carreras J.'}, {'name': 'Wawina-Bokalanga T.'}, {'name': 'Vanmechelen B.'}, {'name': 'Thurmer A.'}, {'name': 'Wedde M.'}, {'name': 'Durrwald R.'}, {'name': 'von Kleist M.'}, {'name': 'Drechsel O.'}, {'name': 'Wolff T.'}, {'name': 'Fuchs S.'}, {'name': 'Kmiecinski R.'}, {'name': 'Michel J.'}, {'name': 'Nitsche A.'}, {'name': 'Casas I.'}, {'name': 'Caballero M.I.'}, {'name': 'Zaballos A.'}, {'name': 'Jimenez P.'}, {'name': 'Jimenez M.'}, {'name': 'Fernandez S.M.'}, {'name': 'Fernandez S.V.'}, {'name': 'de la Plaza I.C.'}, {'name': 'Fadeev A.'}, {'name': 'Ivanova A.'}, {'name': 'Sergeeva M.'}, {'name': 'Stefanelli P.'}, {'name': 'Estee Torok M.'}, {'name': 'Hall G.'}, {'name': 'da Silva Filipe A.'}, {'name': 'Turtle L.'}, {'name': 'Afifi S.'}, {'name': 'McCluggage K.'}, {'name': 'Beer R.'}, {'name': 'Ledesma J.'}, {'name': 'Maksimovic J.'}, {'name': 'Spellman K.'}, {'name': 'Hamilton W.L.'}, {'name': 'Marchbank A.'}, {'name': 'Southgate J.A.'}, {'name': 'Underwood A.'}, {'name': 'Taylor B.'}, {'name': 'Yeats C.'}, {'name': 'Abudahab K.'}, {'name': 'Gemmell M.R.'}, {'name': 'Eccles R.'}, {'name': 'Lucaci A.'}, {'name': 'Nelson C.A.'}, {'name': 'Rainbow L.'}, {'name': 'Whitehead M.'}, {'name': 'Gregory R.'}, {'name': 'Haldenby S.'}, {'name': 'Paterson S.'}, {'name': 'Hughes M.A.'}, {'name': 'Curran M.D.'}, {'name': 'Baker D.'}, {'name': 'Tucker R.'}, {'name': 'Green L.R.'}, {'name': 'Feltwell T.'}, {'name': 'Halstead F.D.'}, {'name': 'Wyles M.'}, {'name': 'Jahun A.S.'}, {'name': 'Ahmad S.S.Y.'}, {'name': 'Georgana I.'}, {'name': 'Goodfellow I.'}, {'name': 'Yakovleva A.'}, {'name': 'Meredith L.W.'}, {'name': 'Gavriil A.'}, {'name': 'Awan A.R.'}, {'name': 'Fisher C.'}, {'name': 'Edgeworth J.'}, {'name': 'Lynch J.'}, {'name': 'Moore N.'}, {'name': 'Williams R.'}, {'name': 'Kidd S.P.'}, {'name': 'Cortes N.'}, {'name': 'Brunker K.'}, {'name': 'McCrone J.T.'}, {'name': 'Quick J.'}, {'name': 'Duckworth N.'}, {'name': 'Walsh S.'}, {'name': 'Sloan T.'}, {'name': 'Ludden C.'}, {'name': 'George R.P.'}, {'name': 'Eltringham G.'}, {'name': 'Brown J.R.'}, {'name': 'Aranday-Cortes E.'}, {'name': 'Shepherd J.G.'}, {'name': 'Hughes J.'}, {'name': 'Li K.K.'}, {'name': 'Williams T.C.'}, {'name': 'Johnson N.'}, {'name': 'Jesudason N.'}, {'name': 'Mair D.'}, {'name': 'Thomson E.'}, {'name': 'Shah R.'}, {'name': 'Parr Y.A.'}, {'name': 'Carmichael S.'}, {'name': 'Robertson D.L.'}, {'name': 'Nomikou K.'}, {'name': 'Broos A.'}, {'name': 'Niebel M.'}, {'name': 'Smollett K.'}, {'name': 'Tong L.'}, {'name': 'Miah S.'}, {'name': 'Wittner A.'}, {'name': 'Phillips N.'}, {'name': 'Payne B.'}, {'name': 'Dewar R.'}, {'name': 'Holmes A.'}, {'name': 'Bolt F.'}, {'name': 'Price J.R.'}, {'name': 'Mookerjee S.'}, {'name': 'Sethi D.K.'}, {'name': 'Potter W.'}, {'name': 'Stanley R.'}, {'name': 'Prakash R.'}, {'name': 'Dervisevic S.'}, {'name': 'Graham J.C.'}, {'name': 'Nelson A.'}, {'name': 'Smith D.'}, {'name': 'Young G.R.'}, {'name': 'Yew W.C.'}, {'name': 'Todd J.A.'}, {'name': 'Trebes A.'}, {'name': 'Andersson M.'}, {'name': 'Bull M.'}, {'name': 'Watkins J.'}, {'name': 'Birchley A.'}, {'name': 'Gatica-Wilcox B.'}, {'name': 'Gilbert L.'}, {'name': 'Kumziene-Summerhayes S.'}, {'name': 'Rey S.'}, {'name': 'Chauhan A.'}, {'name': 'Butcher E.'}, {'name': 'Bicknell K.'}, {'name': 'Elliott S.'}, {'name': 'Glaysher S.'}, {'name': 'Lackenby A.'}, {'name': 'Bibby D.'}, {'name': 'Platt S.'}, {'name': 'Mohamed H.'}, {'name': 'Machin N.W.'}, {'name': 'Mbisa J.L.'}, {'name': 'Evans J.'}, {'name': 'Perry M.'}, {'name': 'Pacchiarini N.'}, {'name': 'Corden S.'}, {'name': 'Adams A.G.'}, {'name': 'Gaskin A.'}, {'name': 'Coombs J.'}, {'name': 'Graham L.J.'}, {'name': 'Cottrell S.'}, {'name': 'Morgan M.'}, {'name': 'Gifford L.'}, {'name': 'Kolyva A.'}, {'name': 'Rudder S.J.'}, {'name': 'Trotter A.J.'}, {'name': 'Mather A.E.'}, {'name': 'Aydin A.'}, {'name': 'Page A.J.'}, {'name': 'Kay G.L.'}, {'name': 'de Oliveira Martins L.'}, {'name': 'Yasir M.'}, {'name': 'Alikhan N.-F.'}, {'name': 'Thomson N.M.'}, {'name': 'Gilroy R.'}, {'name': 'Kingsley R.A.'}, {'name': ""O'Grady J.""}, {'name': 'Gutierrez A.V.'}, {'name': 'Diaz M.'}, {'name': 'Viet T.L.'}, {'name': 'Tedim A.P.'}, {'name': 'Adriaenssens E.M.'}, {'name': 'Patrick Mcclure C.'}, {'name': 'Moore C.'}, {'name': 'Sang F.'}, {'name': 'Clark G.'}, {'name': 'Howson-Wells H.C.'}, {'name': 'Debebe J.'}, {'name': 'Ball J.'}, {'name': 'Chappell J.'}, {'name': 'Khakh M.'}, {'name': 'Carlile M.'}, {'name': 'Loose M.'}, {'name': 'Lister M.M.'}, {'name': 'Holmes N.'}, {'name': 'Tsoleridis T.'}, {'name': 'Fleming V.M.'}, {'name': 'Wright V.'}, {'name': 'Smith W.'}, {'name': 'Gallagher M.D.'}, {'name': 'Parker M.'}, {'name': 'Partridge D.G.'}, {'name': 'Evans C.'}, {'name': 'Baker P.'}, {'name': 'Essex S.'}, {'name': 'Liggett S.'}, {'name': 'Keeley A.J.'}, {'name': 'Bashton M.'}, {'name': 'Rooke S.'}, {'name': 'Dervisavic S.'}, {'name': 'Meader E.J.'}, {'name': 'Lopez C.E.B.'}, {'name': 'Angyal A.'}, {'name': 'Kristiansen M.'}, {'name': 'Tutill H.J.'}, {'name': 'Findlay J.'}, {'name': 'Mestek-Boukhibar L.'}, {'name': 'Forrest L.'}, {'name': 'Dyal P.'}, {'name': 'Williams R.J.'}, {'name': 'Panchbhaya Y.'}, {'name': 'Williams C.A.'}, {'name': 'Roy S.'}, {'name': 'Pandey S.'}, {'name': 'Stockton J.'}, {'name': 'Loman N.J.'}, {'name': 'Poplawski R.'}, {'name': 'Nicholls S.'}, {'name': 'Rowe W.P.M.'}, {'name': 'Khokhar F.'}, {'name': 'Pinckert M.L.'}, {'name': 'Hosmillo M.'}, {'name': 'Chaudhry Y.'}, {'name': 'Caller L.G.'}, {'name': 'Davidson R.K.'}, {'name': 'Griffith L.'}, {'name': 'Rambaut A.'}, {'name': 'Jackson B.'}, {'name': 'Colquhoun R.'}, {'name': 'Hill V.'}, {'name': 'Nichols J.'}, {'name': 'Asamaphan P.'}, {'name': 'Darby A.'}, {'name': 'Jackson K.A.'}, {'name': 'Iturriza-Gomara M.'}, {'name': 'Vamos E.E.'}, {'name': 'Green A.'}, {'name': 'Aanensen D.'}, {'name': 'Bonsall D.'}, {'name': 'Buck D.'}, {'name': 'Macintyre-Cockett G.'}, {'name': 'de Cesare M.'}, {'name': 'Pybus O.'}, {'name': 'Golubchik T.'}, {'name': 'Scarlett G.'}, {'name': 'Loveson K.F.'}, {'name': 'Robson S.C.'}, {'name': 'Beckett A.'}, {'name': 'Lindsey B.'}, {'name': 'Groves D.C.'}, {'name': 'Parsons P.J.'}, {'name': 'McHugh M.P.'}, {'name': 'Barnes J.D.'}, {'name': 'Manso C.F.'}, {'name': 'Grammatopoulos D.'}, {'name': 'Menger K.E.'}, {'name': 'Harrison E.'}, {'name': 'Gunson R.'}, {'name': 'Peacock S.J.'}, {'name': 'Gonzalez G.'}, {'name': 'Carr M.'}, {'name': 'Mihaela L.'}, {'name': 'Popovici O.'}, {'name': 'Brytting M.'}, {'name': 'Bresner C.'}, {'name': 'Fuller W.'}, {'name': 'Workman T.'}, {'name': 'Mentis A.F.'}, {'name': 'Kossyvakis A.'}, {'name': 'Karamitros T.'}, {'name': 'Pogka V.'}, {'name': 'Kalliaropoulos A.'}, {'name': 'Horefti E.'}, {'name': 'Kontou A.'}, {'name': 'Martinez-Gonzalez B.'}, {'name': 'Labropoulou V.'}, {'name': 'Voulgari-Kokota A.'}, {'name': 'Evangelidou M.'}, {'name': 'Bizta P.'}, {'name': 'Belimezi M.'}, {'name': 'Lambrechts L.'}, {'name': 'Doymaz M.Z.'}, {'name': 'Yazici M.K.'}, {'name': 'Cetin N.S.'}, {'name': 'Karaaslan E.'}, {'name': 'Kallio-Kokko H.'}, {'name': 'Virtanen J.'}, {'name': 'Suvanto M.'}, {'name': 'Nguyen P.T.'}, {'name': 'Ellonen P.'}, {'name': 'Hannula S.'}, {'name': 'Kangas H.'}, {'name': 'Sreenu V.B.'}, {'name': 'Burian K.'}, {'name': 'Terhes G.'}, {'name': 'Gombos K.'}, {'name': 'Gyenesei A.'}, {'name': 'Urban P.'}, {'name': 'Herczeg R.'}, {'name': 'Jakab F.'}, {'name': 'Kemenesi G.'}, {'name': 'Toth G.E.'}, {'name': 'Somogyi B.'}, {'name': 'Zana B.'}, {'name': 'Zeghbib S.'}, {'name': 'Kuczmog A.'}, {'name': 'Foldes F.'}, {'name': 'Lanszki Z.'}, {'name': 'Madai M.'}, {'name': 'Papp H.'}, {'name': 'Nagy A.'}, {'name': 'Pereszlenyi C.I.'}, {'name': 'Babinszky G.C.'}, {'name': 'Dudas G.'}, {'name': 'Csoma E.'}, {'name': 'Abou Tayoun A.N.'}, {'name': 'Alsheikh-Ali A.A.'}, {'name': 'Loney T.'}, {'name': 'Nowotny N.'}, {'name': 'Abdul-Wahab O.'}, {'name': 'Gonzalez-Candelas F.'}, {'name': 'Andersen M.H.'}, {'name': 'Taylor S.'}], 'citationCount': 42, 'date': '2020-01-01T00:00:00Z', 'journal': 'Eurosurveillance', 'title': 'Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020'}, 'note': 'V-pipe was used to process a major part of the Swiss samples in this pan-European study.', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2020.10.12.335919', 'note': 'Raw reads from SRA public data and Swiss cohort were processed using V-pipe', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2020.10.14.20212621', 'note': 'V-pipe was used to process a major part of the Swiss samples', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2021.01.08.21249379', 'note': 'The waste water samples were analyzed using V-pipe and additional custom scripts.', 'type': ['Usage'], 'version': 'sars-cov2-dev'}, {'doi': '10.1101/2021.03.05.21252520', 'note': 'V-pipe is used within the S3C (Swiss SARS-CoV-2 Sequencing Consortium) to provide sequences.', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.3390/v13030496', 'metadata': {'abstract': '© 2021 by the authors. Licensee MDPI, Basel, Switzerland.Since the emergence of coronavirus disease (COVID-19) in late 2019, domestic cats have been demonstrated to be susceptible to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) under natural and experimental conditions. As pet cats often live in very close contact with their owners, it is essential to investigate SARS-CoV-2 infections in cats in a One-Health context. This study reports the first SARS-CoV-2 infection in a cat in a COVID-19-affected household in Switzerland. The cat (Cat 1) demonstrated signs of an upper respiratory tract infection, including sneezing, inappetence, and apathy, while the cohabiting cat (Cat 2) remained asymptomatic. Nasal, oral, fecal, fur, and environmental swab samples were collected twice from both cats and analyzed by RT-qPCR for the presence of SARS-CoV-2 viral RNA. Both nasal swabs from Cat 1 tested positive. In addition, the first oral swab from Cat 2 and fur and bedding swabs from both cats were RT-qPCR positive. The fecal swabs tested negative. The infection of Cat 1 was confirmed by positive SARS-CoV-2 S1 receptor binding domain (RBD) antibody testing and neutralizing activity in a surrogate assay. The viral genome sequence from Cat 1, obtained by next generation sequencing, showed the closest relation to a human sequence from the B.1.1.39 lineage, with one single nucleotide polymorphism (SNP) difference. This study demonstrates not only SARS-CoV-2 infection of a cat from a COVID-19-affected household but also contamination of the cats’ fur and bed with viral RNA. Our results are important to create awareness that SARS-CoV-2 infected people should observe hygienic measures to avoid infection and contamination of animal cohabitants.', 'authors': [{'name': 'Klaus J.'}, {'name': 'Meli M.L.'}, {'name': 'Willi B.'}, {'name': 'Nadeau S.'}, {'name': 'Beisel C.'}, {'name': 'Stadler T.'}, {'name': 'Egberink H.'}, {'name': 'Zhao S.'}, {'name': 'Lutz H.'}, {'name': 'Riond B.'}, {'name': 'Rosinger N.'}, {'name': 'Stalder H.'}, {'name': 'Renzullo S.'}, {'name': 'Hofmann-Lehmann R.'}], 'citationCount': 2, 'date': '2021-03-01T00:00:00Z', 'journal': 'Viruses', 'title': 'Detection and genome sequencing of sars-cov-2 in a domestic cat with respiratory signs in Switzerland'}, 'note': 'V-pipe and the S3C (Swiss SARS-CoV-2 Sequencing Consortium) infrastructure were used to QA and pre-process the sequencing data.', 'pmcid': 'PMC8002591', 'pmid': '33802899', 'type': ['Usage'], 'version': 'sars-cov2'}]"
185,,ETHZ,Institute,,,,https://www.ethz.ch/,grid.5801.c,05a28rw58,v-pipe,Open access,DrYak,"[{'doi': '10.1093/bioinformatics/btab015', 'pmid': '33471068', 'type': ['Primary'], 'version': '1.0, 2.0'}, {'doi': '10.20944/preprints202005.0376.v1', 'type': ['Review']}, {'doi': '10.1016/j.virusres.2016.09.016', 'metadata': {'abstract': '© 2016 The AuthorsRapidly evolving RNA viruses prevail within a host as a collection of closely related variants, referred to as viral quasispecies. Advances in high-throughput sequencing (HTS) technologies have facilitated the assessment of the genetic diversity of such virus populations at an unprecedented level of detail. However, analysis of HTS data from virus populations is challenging due to short, error-prone reads. In order to account for uncertainties originating from these limitations, several computational and statistical methods have been developed for studying the genetic heterogeneity of virus population. Here, we review methods for the analysis of HTS reads, including approaches to local diversity estimation and global haplotype reconstruction. Challenges posed by aligning reads, as well as the impact of reference biases on diversity estimates are also discussed. In addition, we address some of the experimental approaches designed to improve the biological signal-to-noise ratio. In the future, computational methods for the analysis of heterogeneous virus populations are likely to continue being complemented by technological developments.', 'authors': [{'name': 'Posada-Cespedes S.'}, {'name': 'Seifert D.'}, {'name': 'Beerenwinkel N.'}], 'citationCount': 42, 'date': '2017-07-15T00:00:00Z', 'journal': 'Virus Research', 'title': 'Recent advances in inferring viral diversity from high-throughput sequencing data'}, 'pmid': '27693290', 'type': ['Other']}, {'doi': '10.3390/v10050256', 'metadata': {'abstract': '© 2018 by the authors. Licensee MDPI, Basel, Switzerland.The Second Annual Meeting of the European Virus Bioinformatics Center (EVBC), held in Utrecht, Netherlands, focused on computational approaches in virology, with topics including (but not limited to) virus discovery, diagnostics, (meta-)genomics, modeling, epidemiology, molecular structure, evolution, and viral ecology. The goals of the Second Annual Meeting were threefold: (i) to bring together virologists and bioinformaticians from across the academic, industrial, professional, and training sectors to share best practice; (ii) to provide a meaningful and interactive scientific environment to promote discussion and collaboration between students, postdoctoral fellows, and both new and established investigators; (iii) to inspire and suggest new research directions and questions. Approximately 120 researchers from around the world attended the Second Annual Meeting of the EVBC this year, including 15 renowned international speakers. This report presents an overview of new developments and novel research findings that emerged during the meeting.', 'authors': [{'name': 'Ibrahim B.'}, {'name': 'Arkhipova K.'}, {'name': 'Andeweg A.C.'}, {'name': 'Posada-Cespedes S.'}, {'name': 'Enault F.'}, {'name': 'Gruber A.'}, {'name': 'Koonin E.V.'}, {'name': 'Kupczok A.'}, {'name': 'Lemey P.'}, {'name': 'McHardy A.C.'}, {'name': 'McMahon D.P.'}, {'name': 'Pickett B.E.'}, {'name': 'Robertson D.L.'}, {'name': 'Scheuermann R.H.'}, {'name': 'Zhernakova A.'}, {'name': 'Zwart M.P.'}, {'name': 'Schonhuth A.'}, {'name': 'Dutilh B.E.'}, {'name': 'Marz M.'}], 'citationCount': 3, 'date': '2018-05-14T00:00:00Z', 'journal': 'Viruses', 'title': 'Bioinformatics meets virology: The European virus bioinformatics center’s second annual meeting'}, 'pmcid': 'PMC5977249', 'pmid': '29757994', 'type': ['Other']}, {'doi': '10.1093/infdis/jiz094', 'metadata': {'abstract': '© 2019 The Author(s) 2019.Background: Human immunodeficiency virus type 1 (HIV-1) genetic diversity increases over the course of infection and can be used to infer the time since infection and, consequently, infection recency, which are crucial for HIV-1 surveillance and the understanding of viral pathogenesis. Methods: We considered 313 HIV-infected individuals for whom reliable estimates of infection dates and next-generation sequencing (NGS)-derived nucleotide frequency data were available. Fractions of ambiguous nucleotides, obtained by population sequencing, were available for 207 samples. We assessed whether the average pairwise diversity calculated using NGS sequences provided a more exact prediction of the time since infection and classification of infection recency (<1 year after infection), compared with the fraction of ambiguous nucleotides. Results: NGS-derived average pairwise diversity classified an infection as recent with a sensitivity of 88% and a specificity of 85%. When considering only the 207 samples for which fractions of ambiguous nucleotides were available, the NGS-derived average pairwise diversity exhibited a higher sensitivity (90% vs 78%) and specificity (95% vs 67%) than the fraction of ambiguous nucleotides. Additionally, the average pairwise diversity could be used to estimate the time since infection with a mean absolute error of 0.84 years, compared with 1.03 years for the fraction of ambiguous nucleotides. Conclusions: Viral diversity based on NGS data is more precise than that based on population sequencing in its ability to predict infection recency and provides an estimated time since infection that has a mean absolute error of <1 year.', 'authors': [{'name': 'Carlisle L.A.'}, {'name': 'Turk T.'}, {'name': 'Kusejko K.'}, {'name': 'Metzner K.J.'}, {'name': 'Leemann C.'}, {'name': 'Schenkel C.D.'}, {'name': 'Bachmann N.'}, {'name': 'Posada S.'}, {'name': 'Beerenwinkel N.'}, {'name': 'Boni J.'}, {'name': 'Yerly S.'}, {'name': 'Klimkait T.'}, {'name': 'Perreau M.'}, {'name': 'Braun D.L.'}, {'name': 'Rauch A.'}, {'name': 'Calmy A.'}, {'name': 'Cavassini M.'}, {'name': 'Battegay M.'}, {'name': 'Vernazza P.'}, {'name': 'Bernasconi E.'}, {'name': 'Gunthard H.F.'}, {'name': 'Kouyos R.D.'}, {'name': 'Anagnostopoulos A.'}, {'name': 'Battegay M.'}, {'name': 'Bernasconi E.'}, {'name': 'Boni J.'}, {'name': 'Braun D.L.'}, {'name': 'Bucher H.C.'}, {'name': 'Calmy A.'}, {'name': 'Cavassini M.'}, {'name': 'Ciuffi A.'}, {'name': 'Dollenmaier G.'}, {'name': 'Egger M.'}, {'name': 'Elzi L.'}, {'name': 'Fehr J.'}, {'name': 'Fellay J.'}, {'name': 'Furrer H.'}, {'name': 'Fux C.A.'}, {'name': 'Gunthard H.F.'}, {'name': 'Haerry D.'}, {'name': 'Hasse B.'}, {'name': 'Hirsch H.H.'}, {'name': 'Hoffmann M.'}, {'name': 'Hosli I.'}, {'name': 'Huber M.'}, {'name': 'Kahlert C.'}, {'name': 'Kaiser L.'}, {'name': 'Keiser O.'}, {'name': 'Klimkait T.'}, {'name': 'Kouyos R.D.'}, {'name': 'Kovari H.'}, {'name': 'Ledergerber B.'}, {'name': 'Martinetti G.'}, {'name': 'Martinez De Tejada B.'}, {'name': 'Marzolini C.'}, {'name': 'Metzner K.J.'}, {'name': 'Muller N.'}, {'name': 'Nicca D.'}, {'name': 'Paioni P.'}, {'name': 'Pantaleo G.'}, {'name': 'Perreau M.'}, {'name': 'Rauch A.'}, {'name': 'Rudin C.'}, {'name': 'Scherrer A.U.'}, {'name': 'Schmid P.'}, {'name': 'Speck R.'}, {'name': 'Stockle M.'}, {'name': 'Tarr P.'}, {'name': 'Trkola A.'}, {'name': 'Vernazza P.'}, {'name': 'Wandeler G.'}, {'name': 'Weber R.'}, {'name': 'Yerly S.'}], 'citationCount': 6, 'date': '2019-06-19T00:00:00Z', 'journal': 'Journal of Infectious Diseases', 'title': 'Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time since Infection'}, 'pmid': '30835266', 'type': ['Usage']}, {'doi': '10.2807/1560-7917.es.2020.25.32.2001410', 'metadata': {'abstract': '© 2020 Turkish Society of Cardiology. All rights reserved.We show the distribution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic clades over time and between countries and outline potential genomic surveillance objectives. We applied three genomic nomenclature systems to all sequence data from the World Health Organization European Region available until 10 July 2020. We highlight the importance of real-time sequencing and data dissemination in a pandemic situation, compare the nomenclatures and lay a foundation for future European genomic surveillance of SARS-CoV-2.', 'authors': [{'name': 'Alm E.'}, {'name': 'Broberg E.K.'}, {'name': 'Connor T.'}, {'name': 'Hodcroft E.B.'}, {'name': 'Komissarov A.B.'}, {'name': 'Maurer-Stroh S.'}, {'name': 'Melidou A.'}, {'name': 'Neher R.A.'}, {'name': ""O'Toole A.""}, {'name': 'Pereyaslov D.'}, {'name': 'Beerenwinkel N.'}, {'name': 'Posada-Cespedes S.'}, {'name': 'Jablonski K.P.'}, {'name': 'Ferreira P.F.'}, {'name': 'Topolsky I.'}, {'name': 'Avsic-Zupanc T.'}, {'name': 'Korva M.'}, {'name': 'Poljak M.'}, {'name': 'Zakotnik S.'}, {'name': 'Zorec T.M.'}, {'name': 'Bragstad K.'}, {'name': 'Hungnes O.'}, {'name': 'Stene-Johansen K.'}, {'name': 'Reusken C.'}, {'name': 'Meijer A.'}, {'name': 'Vennema H.'}, {'name': 'Ruiz-Roldan L.'}, {'name': 'Bracho M.A.'}, {'name': 'Garcia-Gonzalez N.'}, {'name': 'Chiner-Oms A.'}, {'name': 'Cancino-Munoz I.'}, {'name': 'Comas I.'}, {'name': 'Goig G.A.'}, {'name': 'Torres-Puente M.'}, {'name': 'Lopez M.G.'}, {'name': 'Martinez-Priego L.'}, {'name': ""D'Auria G.""}, {'name': 'Ruiz-Hueso P.'}, {'name': 'Ferrus-Abad L.'}, {'name': 'de Marco G.'}, {'name': 'Galan-Vendrell I.'}, {'name': 'Carbo-Ramirez S.'}, {'name': 'Ruiz-Rodriguez P.'}, {'name': 'Coscolla M.'}, {'name': 'Polackova K.'}, {'name': 'Kramna L.'}, {'name': 'Cinek O.'}, {'name': 'Richter J.'}, {'name': 'Krashias G.'}, {'name': 'Tryfonos C.'}, {'name': 'Bashiardes S.'}, {'name': 'Koptides D.'}, {'name': 'Christodoulou C.'}, {'name': 'Bartolini B.'}, {'name': 'Gruber C.E.'}, {'name': 'Di Caro A.'}, {'name': 'Castilletti C.'}, {'name': 'Stefani F.'}, {'name': 'Rimoldi S.G.'}, {'name': 'Romeri F.'}, {'name': 'Salerno F.'}, {'name': 'Polesello S.'}, {'name': 'Nagy A.'}, {'name': 'Jirincova H.'}, {'name': 'Vecerova J.'}, {'name': 'Novakova L.'}, {'name': 'Cordey S.'}, {'name': 'Murtskhvaladze M.'}, {'name': 'Kotaria N.'}, {'name': 'Schar T.'}, {'name': 'Beisel C.'}, {'name': 'Vugrek O.'}, {'name': 'Rokic F.'}, {'name': 'Trgovec-Greif L.'}, {'name': 'Jurak I.'}, {'name': 'Rukavina T.'}, {'name': 'Sucic N.'}, {'name': 'Schonning K.'}, {'name': 'Karst S.M.'}, {'name': 'Kirkegaard R.H.'}, {'name': 'Michaelsen T.Y.'}, {'name': 'Sorensen E.A.'}, {'name': 'Knutson S.'}, {'name': 'Brandt J.'}, {'name': 'Le-Quy V.'}, {'name': 'Sorensen T.'}, {'name': 'Petersen C.'}, {'name': 'Pedersen M.S.'}, {'name': 'Larsen S.L.'}, {'name': 'Skov M.N.'}, {'name': 'Rasmussen M.'}, {'name': 'Fonager J.'}, {'name': 'Fomsgaard A.'}, {'name': 'Maksyutov R.A.'}, {'name': 'Gavrilova E.V.'}, {'name': 'Pyankov O.V.'}, {'name': 'Bodnev S.A.'}, {'name': 'Tregubchak T.V.'}, {'name': 'Shvalov A.N.'}, {'name': 'Antonets D.V.'}, {'name': 'Resende P.C.'}, {'name': 'Goya S.'}, {'name': 'Perrin A.'}, {'name': 'Lee R.T.'}, {'name': 'Yadahalli S.'}, {'name': 'Han A.X.'}, {'name': 'Russell C.A.'}, {'name': 'Schmutz S.'}, {'name': 'Zaheri M.'}, {'name': 'Kufner V.'}, {'name': 'Huber M.'}, {'name': 'Trkola A.'}, {'name': 'Antwerpen M.'}, {'name': 'Walter M.C.'}, {'name': 'van der Werf S.'}, {'name': 'Gambaro F.'}, {'name': 'Behillil S.'}, {'name': 'Enouf V.'}, {'name': 'Donati F.'}, {'name': 'Ustinova M.'}, {'name': 'Rovite V.'}, {'name': 'Klovins J.'}, {'name': 'Savicka O.'}, {'name': 'Wienecke-Baldacchino A.K.'}, {'name': 'Ragimbeau C.'}, {'name': 'Fournier G.'}, {'name': 'Mossong J.'}, {'name': 'Aberle S.W.'}, {'name': 'Haukland M.'}, {'name': 'Enkirch T.'}, {'name': 'Advani A.'}, {'name': 'Karlberg M.L.'}, {'name': 'Lindsjo O.K.'}, {'name': 'Broddesson S.'}, {'name': 'Slavikova M.'}, {'name': 'Lickova M.'}, {'name': 'Klempa B.'}, {'name': 'Staronova E.'}, {'name': 'Ticha E.'}, {'name': 'Szemes T.'}, {'name': 'Rusnakova D.'}, {'name': 'Stadler T.'}, {'name': 'Quer J.'}, {'name': 'Anton A.'}, {'name': 'Andres C.'}, {'name': 'Pinana M.'}, {'name': 'Garcia-Cehic D.'}, {'name': 'Pumarola T.'}, {'name': 'Izopet J.'}, {'name': 'Gioula G.'}, {'name': 'Exindari M.'}, {'name': 'Papa A.'}, {'name': 'Chatzidimitriou D.'}, {'name': 'Metallidis S.'}, {'name': 'Pappa S.'}, {'name': 'Macek M.'}, {'name': 'Geryk J.'}, {'name': 'Broz P.'}, {'name': 'Briksi A.'}, {'name': 'Hubacek P.'}, {'name': 'Drevinek P.'}, {'name': 'Zajac M.'}, {'name': 'Kvapil P.'}, {'name': 'Holub M.'}, {'name': 'Kvapilova K.'}, {'name': 'Novotny A.'}, {'name': 'Kasny M.'}, {'name': 'Klempt P.'}, {'name': 'Vapalahti O.'}, {'name': 'Smura T.'}, {'name': 'Sironen T.'}, {'name': 'Selhorst P.'}, {'name': 'Anthony C.'}, {'name': 'Arien K.'}, {'name': 'Simon-Loriere E.'}, {'name': 'Rabalski L.'}, {'name': 'Bienkowska-Szewczyk K.'}, {'name': 'Borges V.'}, {'name': 'Isidro J.'}, {'name': 'Gomes J.P.'}, {'name': 'Guiomar R.'}, {'name': 'Pechirra P.'}, {'name': 'Costa I.'}, {'name': 'Duarte S.'}, {'name': 'Vieira L.'}, {'name': 'Pyrc K.'}, {'name': 'Zuckerman N.S.'}, {'name': 'Turdikulova S.'}, {'name': 'Abdullaev A.'}, {'name': 'Dalimova D.'}, {'name': 'Abdurakhimov A.'}, {'name': 'Tagliabracci A.'}, {'name': 'Alessandrini F.'}, {'name': 'Melchionda F.'}, {'name': 'Onofri V.'}, {'name': 'Turchi C.'}, {'name': 'Bagnarelli P.'}, {'name': 'Menzo S.'}, {'name': 'Caucci S.'}, {'name': 'Di Sante L.'}, {'name': 'Popa A.'}, {'name': 'Genger J.-W.'}, {'name': 'Agerer B.'}, {'name': 'Lercher A.'}, {'name': 'Endler L.'}, {'name': 'Smyth M.'}, {'name': 'Penz T.'}, {'name': 'Schuster M.'}, {'name': 'Senekowitsch M.'}, {'name': 'Laine J.'}, {'name': 'Bock C.'}, {'name': 'Bergthaler A.'}, {'name': 'Shevtsov A.'}, {'name': 'Kalendar R.'}, {'name': 'Ramanculov Y.'}, {'name': 'Graf A.'}, {'name': 'Muenchhoff M.'}, {'name': 'Keppler O.T.'}, {'name': 'Krebs S.'}, {'name': 'Blum H.'}, {'name': 'Marcello A.'}, {'name': 'Licastro D.'}, {'name': ""D'Agaro P.""}, {'name': 'Laubscher F.'}, {'name': 'Vidanovic D.'}, {'name': 'Tesovic B.'}, {'name': 'Volkening J.'}, {'name': 'Clementi N.'}, {'name': 'Mancini N.'}, {'name': 'Rupnik M.'}, {'name': 'Mahnic A.'}, {'name': 'Walker A.'}, {'name': 'Houwaart T.'}, {'name': 'Wienemann T.'}, {'name': 'Vasconcelos M.K.'}, {'name': 'Strelow D.'}, {'name': 'Jensen B.-E.O.'}, {'name': 'Senff T.'}, {'name': 'Hulse L.'}, {'name': 'Adams O.'}, {'name': 'Andree M.'}, {'name': 'Hauka S.'}, {'name': 'Feldt T.'}, {'name': 'Keitel V.'}, {'name': 'Kindgen-Milles D.'}, {'name': 'Timm J.'}, {'name': 'Pfeffer K.'}, {'name': 'Dilthey A.T.'}, {'name': 'Moore C.'}, {'name': 'Ozdarendeli A.'}, {'name': 'Pavel S.T.I.'}, {'name': 'Yetiskin H.'}, {'name': 'Aydin G.'}, {'name': 'Holyavkin C.'}, {'name': 'Uygut M.A.'}, {'name': 'Cevik C.'}, {'name': 'Shchetinin A.'}, {'name': 'Gushchin V.'}, {'name': 'Dinler-Doganay G.'}, {'name': 'Doganay L.'}, {'name': 'Kizilboga-Akgun T.'}, {'name': 'Karacan I.'}, {'name': 'Pancer K.'}, {'name': 'Maes P.'}, {'name': 'Marti-Carreras J.'}, {'name': 'Wawina-Bokalanga T.'}, {'name': 'Vanmechelen B.'}, {'name': 'Thurmer A.'}, {'name': 'Wedde M.'}, {'name': 'Durrwald R.'}, {'name': 'von Kleist M.'}, {'name': 'Drechsel O.'}, {'name': 'Wolff T.'}, {'name': 'Fuchs S.'}, {'name': 'Kmiecinski R.'}, {'name': 'Michel J.'}, {'name': 'Nitsche A.'}, {'name': 'Casas I.'}, {'name': 'Caballero M.I.'}, {'name': 'Zaballos A.'}, {'name': 'Jimenez P.'}, {'name': 'Jimenez M.'}, {'name': 'Fernandez S.M.'}, {'name': 'Fernandez S.V.'}, {'name': 'de la Plaza I.C.'}, {'name': 'Fadeev A.'}, {'name': 'Ivanova A.'}, {'name': 'Sergeeva M.'}, {'name': 'Stefanelli P.'}, {'name': 'Estee Torok M.'}, {'name': 'Hall G.'}, {'name': 'da Silva Filipe A.'}, {'name': 'Turtle L.'}, {'name': 'Afifi S.'}, {'name': 'McCluggage K.'}, {'name': 'Beer R.'}, {'name': 'Ledesma J.'}, {'name': 'Maksimovic J.'}, {'name': 'Spellman K.'}, {'name': 'Hamilton W.L.'}, {'name': 'Marchbank A.'}, {'name': 'Southgate J.A.'}, {'name': 'Underwood A.'}, {'name': 'Taylor B.'}, {'name': 'Yeats C.'}, {'name': 'Abudahab K.'}, {'name': 'Gemmell M.R.'}, {'name': 'Eccles R.'}, {'name': 'Lucaci A.'}, {'name': 'Nelson C.A.'}, {'name': 'Rainbow L.'}, {'name': 'Whitehead M.'}, {'name': 'Gregory R.'}, {'name': 'Haldenby S.'}, {'name': 'Paterson S.'}, {'name': 'Hughes M.A.'}, {'name': 'Curran M.D.'}, {'name': 'Baker D.'}, {'name': 'Tucker R.'}, {'name': 'Green L.R.'}, {'name': 'Feltwell T.'}, {'name': 'Halstead F.D.'}, {'name': 'Wyles M.'}, {'name': 'Jahun A.S.'}, {'name': 'Ahmad S.S.Y.'}, {'name': 'Georgana I.'}, {'name': 'Goodfellow I.'}, {'name': 'Yakovleva A.'}, {'name': 'Meredith L.W.'}, {'name': 'Gavriil A.'}, {'name': 'Awan A.R.'}, {'name': 'Fisher C.'}, {'name': 'Edgeworth J.'}, {'name': 'Lynch J.'}, {'name': 'Moore N.'}, {'name': 'Williams R.'}, {'name': 'Kidd S.P.'}, {'name': 'Cortes N.'}, {'name': 'Brunker K.'}, {'name': 'McCrone J.T.'}, {'name': 'Quick J.'}, {'name': 'Duckworth N.'}, {'name': 'Walsh S.'}, {'name': 'Sloan T.'}, {'name': 'Ludden C.'}, {'name': 'George R.P.'}, {'name': 'Eltringham G.'}, {'name': 'Brown J.R.'}, {'name': 'Aranday-Cortes E.'}, {'name': 'Shepherd J.G.'}, {'name': 'Hughes J.'}, {'name': 'Li K.K.'}, {'name': 'Williams T.C.'}, {'name': 'Johnson N.'}, {'name': 'Jesudason N.'}, {'name': 'Mair D.'}, {'name': 'Thomson E.'}, {'name': 'Shah R.'}, {'name': 'Parr Y.A.'}, {'name': 'Carmichael S.'}, {'name': 'Robertson D.L.'}, {'name': 'Nomikou K.'}, {'name': 'Broos A.'}, {'name': 'Niebel M.'}, {'name': 'Smollett K.'}, {'name': 'Tong L.'}, {'name': 'Miah S.'}, {'name': 'Wittner A.'}, {'name': 'Phillips N.'}, {'name': 'Payne B.'}, {'name': 'Dewar R.'}, {'name': 'Holmes A.'}, {'name': 'Bolt F.'}, {'name': 'Price J.R.'}, {'name': 'Mookerjee S.'}, {'name': 'Sethi D.K.'}, {'name': 'Potter W.'}, {'name': 'Stanley R.'}, {'name': 'Prakash R.'}, {'name': 'Dervisevic S.'}, {'name': 'Graham J.C.'}, {'name': 'Nelson A.'}, {'name': 'Smith D.'}, {'name': 'Young G.R.'}, {'name': 'Yew W.C.'}, {'name': 'Todd J.A.'}, {'name': 'Trebes A.'}, {'name': 'Andersson M.'}, {'name': 'Bull M.'}, {'name': 'Watkins J.'}, {'name': 'Birchley A.'}, {'name': 'Gatica-Wilcox B.'}, {'name': 'Gilbert L.'}, {'name': 'Kumziene-Summerhayes S.'}, {'name': 'Rey S.'}, {'name': 'Chauhan A.'}, {'name': 'Butcher E.'}, {'name': 'Bicknell K.'}, {'name': 'Elliott S.'}, {'name': 'Glaysher S.'}, {'name': 'Lackenby A.'}, {'name': 'Bibby D.'}, {'name': 'Platt S.'}, {'name': 'Mohamed H.'}, {'name': 'Machin N.W.'}, {'name': 'Mbisa J.L.'}, {'name': 'Evans J.'}, {'name': 'Perry M.'}, {'name': 'Pacchiarini N.'}, {'name': 'Corden S.'}, {'name': 'Adams A.G.'}, {'name': 'Gaskin A.'}, {'name': 'Coombs J.'}, {'name': 'Graham L.J.'}, {'name': 'Cottrell S.'}, {'name': 'Morgan M.'}, {'name': 'Gifford L.'}, {'name': 'Kolyva A.'}, {'name': 'Rudder S.J.'}, {'name': 'Trotter A.J.'}, {'name': 'Mather A.E.'}, {'name': 'Aydin A.'}, {'name': 'Page A.J.'}, {'name': 'Kay G.L.'}, {'name': 'de Oliveira Martins L.'}, {'name': 'Yasir M.'}, {'name': 'Alikhan N.-F.'}, {'name': 'Thomson N.M.'}, {'name': 'Gilroy R.'}, {'name': 'Kingsley R.A.'}, {'name': ""O'Grady J.""}, {'name': 'Gutierrez A.V.'}, {'name': 'Diaz M.'}, {'name': 'Viet T.L.'}, {'name': 'Tedim A.P.'}, {'name': 'Adriaenssens E.M.'}, {'name': 'Patrick Mcclure C.'}, {'name': 'Moore C.'}, {'name': 'Sang F.'}, {'name': 'Clark G.'}, {'name': 'Howson-Wells H.C.'}, {'name': 'Debebe J.'}, {'name': 'Ball J.'}, {'name': 'Chappell J.'}, {'name': 'Khakh M.'}, {'name': 'Carlile M.'}, {'name': 'Loose M.'}, {'name': 'Lister M.M.'}, {'name': 'Holmes N.'}, {'name': 'Tsoleridis T.'}, {'name': 'Fleming V.M.'}, {'name': 'Wright V.'}, {'name': 'Smith W.'}, {'name': 'Gallagher M.D.'}, {'name': 'Parker M.'}, {'name': 'Partridge D.G.'}, {'name': 'Evans C.'}, {'name': 'Baker P.'}, {'name': 'Essex S.'}, {'name': 'Liggett S.'}, {'name': 'Keeley A.J.'}, {'name': 'Bashton M.'}, {'name': 'Rooke S.'}, {'name': 'Dervisavic S.'}, {'name': 'Meader E.J.'}, {'name': 'Lopez C.E.B.'}, {'name': 'Angyal A.'}, {'name': 'Kristiansen M.'}, {'name': 'Tutill H.J.'}, {'name': 'Findlay J.'}, {'name': 'Mestek-Boukhibar L.'}, {'name': 'Forrest L.'}, {'name': 'Dyal P.'}, {'name': 'Williams R.J.'}, {'name': 'Panchbhaya Y.'}, {'name': 'Williams C.A.'}, {'name': 'Roy S.'}, {'name': 'Pandey S.'}, {'name': 'Stockton J.'}, {'name': 'Loman N.J.'}, {'name': 'Poplawski R.'}, {'name': 'Nicholls S.'}, {'name': 'Rowe W.P.M.'}, {'name': 'Khokhar F.'}, {'name': 'Pinckert M.L.'}, {'name': 'Hosmillo M.'}, {'name': 'Chaudhry Y.'}, {'name': 'Caller L.G.'}, {'name': 'Davidson R.K.'}, {'name': 'Griffith L.'}, {'name': 'Rambaut A.'}, {'name': 'Jackson B.'}, {'name': 'Colquhoun R.'}, {'name': 'Hill V.'}, {'name': 'Nichols J.'}, {'name': 'Asamaphan P.'}, {'name': 'Darby A.'}, {'name': 'Jackson K.A.'}, {'name': 'Iturriza-Gomara M.'}, {'name': 'Vamos E.E.'}, {'name': 'Green A.'}, {'name': 'Aanensen D.'}, {'name': 'Bonsall D.'}, {'name': 'Buck D.'}, {'name': 'Macintyre-Cockett G.'}, {'name': 'de Cesare M.'}, {'name': 'Pybus O.'}, {'name': 'Golubchik T.'}, {'name': 'Scarlett G.'}, {'name': 'Loveson K.F.'}, {'name': 'Robson S.C.'}, {'name': 'Beckett A.'}, {'name': 'Lindsey B.'}, {'name': 'Groves D.C.'}, {'name': 'Parsons P.J.'}, {'name': 'McHugh M.P.'}, {'name': 'Barnes J.D.'}, {'name': 'Manso C.F.'}, {'name': 'Grammatopoulos D.'}, {'name': 'Menger K.E.'}, {'name': 'Harrison E.'}, {'name': 'Gunson R.'}, {'name': 'Peacock S.J.'}, {'name': 'Gonzalez G.'}, {'name': 'Carr M.'}, {'name': 'Mihaela L.'}, {'name': 'Popovici O.'}, {'name': 'Brytting M.'}, {'name': 'Bresner C.'}, {'name': 'Fuller W.'}, {'name': 'Workman T.'}, {'name': 'Mentis A.F.'}, {'name': 'Kossyvakis A.'}, {'name': 'Karamitros T.'}, {'name': 'Pogka V.'}, {'name': 'Kalliaropoulos A.'}, {'name': 'Horefti E.'}, {'name': 'Kontou A.'}, {'name': 'Martinez-Gonzalez B.'}, {'name': 'Labropoulou V.'}, {'name': 'Voulgari-Kokota A.'}, {'name': 'Evangelidou M.'}, {'name': 'Bizta P.'}, {'name': 'Belimezi M.'}, {'name': 'Lambrechts L.'}, {'name': 'Doymaz M.Z.'}, {'name': 'Yazici M.K.'}, {'name': 'Cetin N.S.'}, {'name': 'Karaaslan E.'}, {'name': 'Kallio-Kokko H.'}, {'name': 'Virtanen J.'}, {'name': 'Suvanto M.'}, {'name': 'Nguyen P.T.'}, {'name': 'Ellonen P.'}, {'name': 'Hannula S.'}, {'name': 'Kangas H.'}, {'name': 'Sreenu V.B.'}, {'name': 'Burian K.'}, {'name': 'Terhes G.'}, {'name': 'Gombos K.'}, {'name': 'Gyenesei A.'}, {'name': 'Urban P.'}, {'name': 'Herczeg R.'}, {'name': 'Jakab F.'}, {'name': 'Kemenesi G.'}, {'name': 'Toth G.E.'}, {'name': 'Somogyi B.'}, {'name': 'Zana B.'}, {'name': 'Zeghbib S.'}, {'name': 'Kuczmog A.'}, {'name': 'Foldes F.'}, {'name': 'Lanszki Z.'}, {'name': 'Madai M.'}, {'name': 'Papp H.'}, {'name': 'Nagy A.'}, {'name': 'Pereszlenyi C.I.'}, {'name': 'Babinszky G.C.'}, {'name': 'Dudas G.'}, {'name': 'Csoma E.'}, {'name': 'Abou Tayoun A.N.'}, {'name': 'Alsheikh-Ali A.A.'}, {'name': 'Loney T.'}, {'name': 'Nowotny N.'}, {'name': 'Abdul-Wahab O.'}, {'name': 'Gonzalez-Candelas F.'}, {'name': 'Andersen M.H.'}, {'name': 'Taylor S.'}], 'citationCount': 42, 'date': '2020-01-01T00:00:00Z', 'journal': 'Eurosurveillance', 'title': 'Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020'}, 'note': 'V-pipe was used to process a major part of the Swiss samples in this pan-European study.', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2020.10.12.335919', 'note': 'Raw reads from SRA public data and Swiss cohort were processed using V-pipe', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2020.10.14.20212621', 'note': 'V-pipe was used to process a major part of the Swiss samples', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2021.01.08.21249379', 'note': 'The waste water samples were analyzed using V-pipe and additional custom scripts.', 'type': ['Usage'], 'version': 'sars-cov2-dev'}, {'doi': '10.1101/2021.03.05.21252520', 'note': 'V-pipe is used within the S3C (Swiss SARS-CoV-2 Sequencing Consortium) to provide sequences.', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.3390/v13030496', 'metadata': {'abstract': '© 2021 by the authors. Licensee MDPI, Basel, Switzerland.Since the emergence of coronavirus disease (COVID-19) in late 2019, domestic cats have been demonstrated to be susceptible to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) under natural and experimental conditions. As pet cats often live in very close contact with their owners, it is essential to investigate SARS-CoV-2 infections in cats in a One-Health context. This study reports the first SARS-CoV-2 infection in a cat in a COVID-19-affected household in Switzerland. The cat (Cat 1) demonstrated signs of an upper respiratory tract infection, including sneezing, inappetence, and apathy, while the cohabiting cat (Cat 2) remained asymptomatic. Nasal, oral, fecal, fur, and environmental swab samples were collected twice from both cats and analyzed by RT-qPCR for the presence of SARS-CoV-2 viral RNA. Both nasal swabs from Cat 1 tested positive. In addition, the first oral swab from Cat 2 and fur and bedding swabs from both cats were RT-qPCR positive. The fecal swabs tested negative. The infection of Cat 1 was confirmed by positive SARS-CoV-2 S1 receptor binding domain (RBD) antibody testing and neutralizing activity in a surrogate assay. The viral genome sequence from Cat 1, obtained by next generation sequencing, showed the closest relation to a human sequence from the B.1.1.39 lineage, with one single nucleotide polymorphism (SNP) difference. This study demonstrates not only SARS-CoV-2 infection of a cat from a COVID-19-affected household but also contamination of the cats’ fur and bed with viral RNA. Our results are important to create awareness that SARS-CoV-2 infected people should observe hygienic measures to avoid infection and contamination of animal cohabitants.', 'authors': [{'name': 'Klaus J.'}, {'name': 'Meli M.L.'}, {'name': 'Willi B.'}, {'name': 'Nadeau S.'}, {'name': 'Beisel C.'}, {'name': 'Stadler T.'}, {'name': 'Egberink H.'}, {'name': 'Zhao S.'}, {'name': 'Lutz H.'}, {'name': 'Riond B.'}, {'name': 'Rosinger N.'}, {'name': 'Stalder H.'}, {'name': 'Renzullo S.'}, {'name': 'Hofmann-Lehmann R.'}], 'citationCount': 2, 'date': '2021-03-01T00:00:00Z', 'journal': 'Viruses', 'title': 'Detection and genome sequencing of sars-cov-2 in a domestic cat with respiratory signs in Switzerland'}, 'note': 'V-pipe and the S3C (Swiss SARS-CoV-2 Sequencing Consortium) infrastructure were used to QA and pre-process the sequencing data.', 'pmcid': 'PMC8002591', 'pmid': '33802899', 'type': ['Usage'], 'version': 'sars-cov2'}]"
186,,SIB Swiss Institute of Bioinformatics,Institute,,,,https://www.sib.swiss/,grid.419765.8,002n09z45,v-pipe,Open access,DrYak,"[{'doi': '10.1093/bioinformatics/btab015', 'pmid': '33471068', 'type': ['Primary'], 'version': '1.0, 2.0'}, {'doi': '10.20944/preprints202005.0376.v1', 'type': ['Review']}, {'doi': '10.1016/j.virusres.2016.09.016', 'metadata': {'abstract': '© 2016 The AuthorsRapidly evolving RNA viruses prevail within a host as a collection of closely related variants, referred to as viral quasispecies. Advances in high-throughput sequencing (HTS) technologies have facilitated the assessment of the genetic diversity of such virus populations at an unprecedented level of detail. However, analysis of HTS data from virus populations is challenging due to short, error-prone reads. In order to account for uncertainties originating from these limitations, several computational and statistical methods have been developed for studying the genetic heterogeneity of virus population. Here, we review methods for the analysis of HTS reads, including approaches to local diversity estimation and global haplotype reconstruction. Challenges posed by aligning reads, as well as the impact of reference biases on diversity estimates are also discussed. In addition, we address some of the experimental approaches designed to improve the biological signal-to-noise ratio. In the future, computational methods for the analysis of heterogeneous virus populations are likely to continue being complemented by technological developments.', 'authors': [{'name': 'Posada-Cespedes S.'}, {'name': 'Seifert D.'}, {'name': 'Beerenwinkel N.'}], 'citationCount': 42, 'date': '2017-07-15T00:00:00Z', 'journal': 'Virus Research', 'title': 'Recent advances in inferring viral diversity from high-throughput sequencing data'}, 'pmid': '27693290', 'type': ['Other']}, {'doi': '10.3390/v10050256', 'metadata': {'abstract': '© 2018 by the authors. Licensee MDPI, Basel, Switzerland.The Second Annual Meeting of the European Virus Bioinformatics Center (EVBC), held in Utrecht, Netherlands, focused on computational approaches in virology, with topics including (but not limited to) virus discovery, diagnostics, (meta-)genomics, modeling, epidemiology, molecular structure, evolution, and viral ecology. The goals of the Second Annual Meeting were threefold: (i) to bring together virologists and bioinformaticians from across the academic, industrial, professional, and training sectors to share best practice; (ii) to provide a meaningful and interactive scientific environment to promote discussion and collaboration between students, postdoctoral fellows, and both new and established investigators; (iii) to inspire and suggest new research directions and questions. Approximately 120 researchers from around the world attended the Second Annual Meeting of the EVBC this year, including 15 renowned international speakers. This report presents an overview of new developments and novel research findings that emerged during the meeting.', 'authors': [{'name': 'Ibrahim B.'}, {'name': 'Arkhipova K.'}, {'name': 'Andeweg A.C.'}, {'name': 'Posada-Cespedes S.'}, {'name': 'Enault F.'}, {'name': 'Gruber A.'}, {'name': 'Koonin E.V.'}, {'name': 'Kupczok A.'}, {'name': 'Lemey P.'}, {'name': 'McHardy A.C.'}, {'name': 'McMahon D.P.'}, {'name': 'Pickett B.E.'}, {'name': 'Robertson D.L.'}, {'name': 'Scheuermann R.H.'}, {'name': 'Zhernakova A.'}, {'name': 'Zwart M.P.'}, {'name': 'Schonhuth A.'}, {'name': 'Dutilh B.E.'}, {'name': 'Marz M.'}], 'citationCount': 3, 'date': '2018-05-14T00:00:00Z', 'journal': 'Viruses', 'title': 'Bioinformatics meets virology: The European virus bioinformatics center’s second annual meeting'}, 'pmcid': 'PMC5977249', 'pmid': '29757994', 'type': ['Other']}, {'doi': '10.1093/infdis/jiz094', 'metadata': {'abstract': '© 2019 The Author(s) 2019.Background: Human immunodeficiency virus type 1 (HIV-1) genetic diversity increases over the course of infection and can be used to infer the time since infection and, consequently, infection recency, which are crucial for HIV-1 surveillance and the understanding of viral pathogenesis. Methods: We considered 313 HIV-infected individuals for whom reliable estimates of infection dates and next-generation sequencing (NGS)-derived nucleotide frequency data were available. Fractions of ambiguous nucleotides, obtained by population sequencing, were available for 207 samples. We assessed whether the average pairwise diversity calculated using NGS sequences provided a more exact prediction of the time since infection and classification of infection recency (<1 year after infection), compared with the fraction of ambiguous nucleotides. Results: NGS-derived average pairwise diversity classified an infection as recent with a sensitivity of 88% and a specificity of 85%. When considering only the 207 samples for which fractions of ambiguous nucleotides were available, the NGS-derived average pairwise diversity exhibited a higher sensitivity (90% vs 78%) and specificity (95% vs 67%) than the fraction of ambiguous nucleotides. Additionally, the average pairwise diversity could be used to estimate the time since infection with a mean absolute error of 0.84 years, compared with 1.03 years for the fraction of ambiguous nucleotides. Conclusions: Viral diversity based on NGS data is more precise than that based on population sequencing in its ability to predict infection recency and provides an estimated time since infection that has a mean absolute error of <1 year.', 'authors': [{'name': 'Carlisle L.A.'}, {'name': 'Turk T.'}, {'name': 'Kusejko K.'}, {'name': 'Metzner K.J.'}, {'name': 'Leemann C.'}, {'name': 'Schenkel C.D.'}, {'name': 'Bachmann N.'}, {'name': 'Posada S.'}, {'name': 'Beerenwinkel N.'}, {'name': 'Boni J.'}, {'name': 'Yerly S.'}, {'name': 'Klimkait T.'}, {'name': 'Perreau M.'}, {'name': 'Braun D.L.'}, {'name': 'Rauch A.'}, {'name': 'Calmy A.'}, {'name': 'Cavassini M.'}, {'name': 'Battegay M.'}, {'name': 'Vernazza P.'}, {'name': 'Bernasconi E.'}, {'name': 'Gunthard H.F.'}, {'name': 'Kouyos R.D.'}, {'name': 'Anagnostopoulos A.'}, {'name': 'Battegay M.'}, {'name': 'Bernasconi E.'}, {'name': 'Boni J.'}, {'name': 'Braun D.L.'}, {'name': 'Bucher H.C.'}, {'name': 'Calmy A.'}, {'name': 'Cavassini M.'}, {'name': 'Ciuffi A.'}, {'name': 'Dollenmaier G.'}, {'name': 'Egger M.'}, {'name': 'Elzi L.'}, {'name': 'Fehr J.'}, {'name': 'Fellay J.'}, {'name': 'Furrer H.'}, {'name': 'Fux C.A.'}, {'name': 'Gunthard H.F.'}, {'name': 'Haerry D.'}, {'name': 'Hasse B.'}, {'name': 'Hirsch H.H.'}, {'name': 'Hoffmann M.'}, {'name': 'Hosli I.'}, {'name': 'Huber M.'}, {'name': 'Kahlert C.'}, {'name': 'Kaiser L.'}, {'name': 'Keiser O.'}, {'name': 'Klimkait T.'}, {'name': 'Kouyos R.D.'}, {'name': 'Kovari H.'}, {'name': 'Ledergerber B.'}, {'name': 'Martinetti G.'}, {'name': 'Martinez De Tejada B.'}, {'name': 'Marzolini C.'}, {'name': 'Metzner K.J.'}, {'name': 'Muller N.'}, {'name': 'Nicca D.'}, {'name': 'Paioni P.'}, {'name': 'Pantaleo G.'}, {'name': 'Perreau M.'}, {'name': 'Rauch A.'}, {'name': 'Rudin C.'}, {'name': 'Scherrer A.U.'}, {'name': 'Schmid P.'}, {'name': 'Speck R.'}, {'name': 'Stockle M.'}, {'name': 'Tarr P.'}, {'name': 'Trkola A.'}, {'name': 'Vernazza P.'}, {'name': 'Wandeler G.'}, {'name': 'Weber R.'}, {'name': 'Yerly S.'}], 'citationCount': 6, 'date': '2019-06-19T00:00:00Z', 'journal': 'Journal of Infectious Diseases', 'title': 'Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time since Infection'}, 'pmid': '30835266', 'type': ['Usage']}, {'doi': '10.2807/1560-7917.es.2020.25.32.2001410', 'metadata': {'abstract': '© 2020 Turkish Society of Cardiology. All rights reserved.We show the distribution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic clades over time and between countries and outline potential genomic surveillance objectives. We applied three genomic nomenclature systems to all sequence data from the World Health Organization European Region available until 10 July 2020. We highlight the importance of real-time sequencing and data dissemination in a pandemic situation, compare the nomenclatures and lay a foundation for future European genomic surveillance of SARS-CoV-2.', 'authors': [{'name': 'Alm E.'}, {'name': 'Broberg E.K.'}, {'name': 'Connor T.'}, {'name': 'Hodcroft E.B.'}, {'name': 'Komissarov A.B.'}, {'name': 'Maurer-Stroh S.'}, {'name': 'Melidou A.'}, {'name': 'Neher R.A.'}, {'name': ""O'Toole A.""}, {'name': 'Pereyaslov D.'}, {'name': 'Beerenwinkel N.'}, {'name': 'Posada-Cespedes S.'}, {'name': 'Jablonski K.P.'}, {'name': 'Ferreira P.F.'}, {'name': 'Topolsky I.'}, {'name': 'Avsic-Zupanc T.'}, {'name': 'Korva M.'}, {'name': 'Poljak M.'}, {'name': 'Zakotnik S.'}, {'name': 'Zorec T.M.'}, {'name': 'Bragstad K.'}, {'name': 'Hungnes O.'}, {'name': 'Stene-Johansen K.'}, {'name': 'Reusken C.'}, {'name': 'Meijer A.'}, {'name': 'Vennema H.'}, {'name': 'Ruiz-Roldan L.'}, {'name': 'Bracho M.A.'}, {'name': 'Garcia-Gonzalez N.'}, {'name': 'Chiner-Oms A.'}, {'name': 'Cancino-Munoz I.'}, {'name': 'Comas I.'}, {'name': 'Goig G.A.'}, {'name': 'Torres-Puente M.'}, {'name': 'Lopez M.G.'}, {'name': 'Martinez-Priego L.'}, {'name': ""D'Auria G.""}, {'name': 'Ruiz-Hueso P.'}, {'name': 'Ferrus-Abad L.'}, {'name': 'de Marco G.'}, {'name': 'Galan-Vendrell I.'}, {'name': 'Carbo-Ramirez S.'}, {'name': 'Ruiz-Rodriguez P.'}, {'name': 'Coscolla M.'}, {'name': 'Polackova K.'}, {'name': 'Kramna L.'}, {'name': 'Cinek O.'}, {'name': 'Richter J.'}, {'name': 'Krashias G.'}, {'name': 'Tryfonos C.'}, {'name': 'Bashiardes S.'}, {'name': 'Koptides D.'}, {'name': 'Christodoulou C.'}, {'name': 'Bartolini B.'}, {'name': 'Gruber C.E.'}, {'name': 'Di Caro A.'}, {'name': 'Castilletti C.'}, {'name': 'Stefani F.'}, {'name': 'Rimoldi S.G.'}, {'name': 'Romeri F.'}, {'name': 'Salerno F.'}, {'name': 'Polesello S.'}, {'name': 'Nagy A.'}, {'name': 'Jirincova H.'}, {'name': 'Vecerova J.'}, {'name': 'Novakova L.'}, {'name': 'Cordey S.'}, {'name': 'Murtskhvaladze M.'}, {'name': 'Kotaria N.'}, {'name': 'Schar T.'}, {'name': 'Beisel C.'}, {'name': 'Vugrek O.'}, {'name': 'Rokic F.'}, {'name': 'Trgovec-Greif L.'}, {'name': 'Jurak I.'}, {'name': 'Rukavina T.'}, {'name': 'Sucic N.'}, {'name': 'Schonning K.'}, {'name': 'Karst S.M.'}, {'name': 'Kirkegaard R.H.'}, {'name': 'Michaelsen T.Y.'}, {'name': 'Sorensen E.A.'}, {'name': 'Knutson S.'}, {'name': 'Brandt J.'}, {'name': 'Le-Quy V.'}, {'name': 'Sorensen T.'}, {'name': 'Petersen C.'}, {'name': 'Pedersen M.S.'}, {'name': 'Larsen S.L.'}, {'name': 'Skov M.N.'}, {'name': 'Rasmussen M.'}, {'name': 'Fonager J.'}, {'name': 'Fomsgaard A.'}, {'name': 'Maksyutov R.A.'}, {'name': 'Gavrilova E.V.'}, {'name': 'Pyankov O.V.'}, {'name': 'Bodnev S.A.'}, {'name': 'Tregubchak T.V.'}, {'name': 'Shvalov A.N.'}, {'name': 'Antonets D.V.'}, {'name': 'Resende P.C.'}, {'name': 'Goya S.'}, {'name': 'Perrin A.'}, {'name': 'Lee R.T.'}, {'name': 'Yadahalli S.'}, {'name': 'Han A.X.'}, {'name': 'Russell C.A.'}, {'name': 'Schmutz S.'}, {'name': 'Zaheri M.'}, {'name': 'Kufner V.'}, {'name': 'Huber M.'}, {'name': 'Trkola A.'}, {'name': 'Antwerpen M.'}, {'name': 'Walter M.C.'}, {'name': 'van der Werf S.'}, {'name': 'Gambaro F.'}, {'name': 'Behillil S.'}, {'name': 'Enouf V.'}, {'name': 'Donati F.'}, {'name': 'Ustinova M.'}, {'name': 'Rovite V.'}, {'name': 'Klovins J.'}, {'name': 'Savicka O.'}, {'name': 'Wienecke-Baldacchino A.K.'}, {'name': 'Ragimbeau C.'}, {'name': 'Fournier G.'}, {'name': 'Mossong J.'}, {'name': 'Aberle S.W.'}, {'name': 'Haukland M.'}, {'name': 'Enkirch T.'}, {'name': 'Advani A.'}, {'name': 'Karlberg M.L.'}, {'name': 'Lindsjo O.K.'}, {'name': 'Broddesson S.'}, {'name': 'Slavikova M.'}, {'name': 'Lickova M.'}, {'name': 'Klempa B.'}, {'name': 'Staronova E.'}, {'name': 'Ticha E.'}, {'name': 'Szemes T.'}, {'name': 'Rusnakova D.'}, {'name': 'Stadler T.'}, {'name': 'Quer J.'}, {'name': 'Anton A.'}, {'name': 'Andres C.'}, {'name': 'Pinana M.'}, {'name': 'Garcia-Cehic D.'}, {'name': 'Pumarola T.'}, {'name': 'Izopet J.'}, {'name': 'Gioula G.'}, {'name': 'Exindari M.'}, {'name': 'Papa A.'}, {'name': 'Chatzidimitriou D.'}, {'name': 'Metallidis S.'}, {'name': 'Pappa S.'}, {'name': 'Macek M.'}, {'name': 'Geryk J.'}, {'name': 'Broz P.'}, {'name': 'Briksi A.'}, {'name': 'Hubacek P.'}, {'name': 'Drevinek P.'}, {'name': 'Zajac M.'}, {'name': 'Kvapil P.'}, {'name': 'Holub M.'}, {'name': 'Kvapilova K.'}, {'name': 'Novotny A.'}, {'name': 'Kasny M.'}, {'name': 'Klempt P.'}, {'name': 'Vapalahti O.'}, {'name': 'Smura T.'}, {'name': 'Sironen T.'}, {'name': 'Selhorst P.'}, {'name': 'Anthony C.'}, {'name': 'Arien K.'}, {'name': 'Simon-Loriere E.'}, {'name': 'Rabalski L.'}, {'name': 'Bienkowska-Szewczyk K.'}, {'name': 'Borges V.'}, {'name': 'Isidro J.'}, {'name': 'Gomes J.P.'}, {'name': 'Guiomar R.'}, {'name': 'Pechirra P.'}, {'name': 'Costa I.'}, {'name': 'Duarte S.'}, {'name': 'Vieira L.'}, {'name': 'Pyrc K.'}, {'name': 'Zuckerman N.S.'}, {'name': 'Turdikulova S.'}, {'name': 'Abdullaev A.'}, {'name': 'Dalimova D.'}, {'name': 'Abdurakhimov A.'}, {'name': 'Tagliabracci A.'}, {'name': 'Alessandrini F.'}, {'name': 'Melchionda F.'}, {'name': 'Onofri V.'}, {'name': 'Turchi C.'}, {'name': 'Bagnarelli P.'}, {'name': 'Menzo S.'}, {'name': 'Caucci S.'}, {'name': 'Di Sante L.'}, {'name': 'Popa A.'}, {'name': 'Genger J.-W.'}, {'name': 'Agerer B.'}, {'name': 'Lercher A.'}, {'name': 'Endler L.'}, {'name': 'Smyth M.'}, {'name': 'Penz T.'}, {'name': 'Schuster M.'}, {'name': 'Senekowitsch M.'}, {'name': 'Laine J.'}, {'name': 'Bock C.'}, {'name': 'Bergthaler A.'}, {'name': 'Shevtsov A.'}, {'name': 'Kalendar R.'}, {'name': 'Ramanculov Y.'}, {'name': 'Graf A.'}, {'name': 'Muenchhoff M.'}, {'name': 'Keppler O.T.'}, {'name': 'Krebs S.'}, {'name': 'Blum H.'}, {'name': 'Marcello A.'}, {'name': 'Licastro D.'}, {'name': ""D'Agaro P.""}, {'name': 'Laubscher F.'}, {'name': 'Vidanovic D.'}, {'name': 'Tesovic B.'}, {'name': 'Volkening J.'}, {'name': 'Clementi N.'}, {'name': 'Mancini N.'}, {'name': 'Rupnik M.'}, {'name': 'Mahnic A.'}, {'name': 'Walker A.'}, {'name': 'Houwaart T.'}, {'name': 'Wienemann T.'}, {'name': 'Vasconcelos M.K.'}, {'name': 'Strelow D.'}, {'name': 'Jensen B.-E.O.'}, {'name': 'Senff T.'}, {'name': 'Hulse L.'}, {'name': 'Adams O.'}, {'name': 'Andree M.'}, {'name': 'Hauka S.'}, {'name': 'Feldt T.'}, {'name': 'Keitel V.'}, {'name': 'Kindgen-Milles D.'}, {'name': 'Timm J.'}, {'name': 'Pfeffer K.'}, {'name': 'Dilthey A.T.'}, {'name': 'Moore C.'}, {'name': 'Ozdarendeli A.'}, {'name': 'Pavel S.T.I.'}, {'name': 'Yetiskin H.'}, {'name': 'Aydin G.'}, {'name': 'Holyavkin C.'}, {'name': 'Uygut M.A.'}, {'name': 'Cevik C.'}, {'name': 'Shchetinin A.'}, {'name': 'Gushchin V.'}, {'name': 'Dinler-Doganay G.'}, {'name': 'Doganay L.'}, {'name': 'Kizilboga-Akgun T.'}, {'name': 'Karacan I.'}, {'name': 'Pancer K.'}, {'name': 'Maes P.'}, {'name': 'Marti-Carreras J.'}, {'name': 'Wawina-Bokalanga T.'}, {'name': 'Vanmechelen B.'}, {'name': 'Thurmer A.'}, {'name': 'Wedde M.'}, {'name': 'Durrwald R.'}, {'name': 'von Kleist M.'}, {'name': 'Drechsel O.'}, {'name': 'Wolff T.'}, {'name': 'Fuchs S.'}, {'name': 'Kmiecinski R.'}, {'name': 'Michel J.'}, {'name': 'Nitsche A.'}, {'name': 'Casas I.'}, {'name': 'Caballero M.I.'}, {'name': 'Zaballos A.'}, {'name': 'Jimenez P.'}, {'name': 'Jimenez M.'}, {'name': 'Fernandez S.M.'}, {'name': 'Fernandez S.V.'}, {'name': 'de la Plaza I.C.'}, {'name': 'Fadeev A.'}, {'name': 'Ivanova A.'}, {'name': 'Sergeeva M.'}, {'name': 'Stefanelli P.'}, {'name': 'Estee Torok M.'}, {'name': 'Hall G.'}, {'name': 'da Silva Filipe A.'}, {'name': 'Turtle L.'}, {'name': 'Afifi S.'}, {'name': 'McCluggage K.'}, {'name': 'Beer R.'}, {'name': 'Ledesma J.'}, {'name': 'Maksimovic J.'}, {'name': 'Spellman K.'}, {'name': 'Hamilton W.L.'}, {'name': 'Marchbank A.'}, {'name': 'Southgate J.A.'}, {'name': 'Underwood A.'}, {'name': 'Taylor B.'}, {'name': 'Yeats C.'}, {'name': 'Abudahab K.'}, {'name': 'Gemmell M.R.'}, {'name': 'Eccles R.'}, {'name': 'Lucaci A.'}, {'name': 'Nelson C.A.'}, {'name': 'Rainbow L.'}, {'name': 'Whitehead M.'}, {'name': 'Gregory R.'}, {'name': 'Haldenby S.'}, {'name': 'Paterson S.'}, {'name': 'Hughes M.A.'}, {'name': 'Curran M.D.'}, {'name': 'Baker D.'}, {'name': 'Tucker R.'}, {'name': 'Green L.R.'}, {'name': 'Feltwell T.'}, {'name': 'Halstead F.D.'}, {'name': 'Wyles M.'}, {'name': 'Jahun A.S.'}, {'name': 'Ahmad S.S.Y.'}, {'name': 'Georgana I.'}, {'name': 'Goodfellow I.'}, {'name': 'Yakovleva A.'}, {'name': 'Meredith L.W.'}, {'name': 'Gavriil A.'}, {'name': 'Awan A.R.'}, {'name': 'Fisher C.'}, {'name': 'Edgeworth J.'}, {'name': 'Lynch J.'}, {'name': 'Moore N.'}, {'name': 'Williams R.'}, {'name': 'Kidd S.P.'}, {'name': 'Cortes N.'}, {'name': 'Brunker K.'}, {'name': 'McCrone J.T.'}, {'name': 'Quick J.'}, {'name': 'Duckworth N.'}, {'name': 'Walsh S.'}, {'name': 'Sloan T.'}, {'name': 'Ludden C.'}, {'name': 'George R.P.'}, {'name': 'Eltringham G.'}, {'name': 'Brown J.R.'}, {'name': 'Aranday-Cortes E.'}, {'name': 'Shepherd J.G.'}, {'name': 'Hughes J.'}, {'name': 'Li K.K.'}, {'name': 'Williams T.C.'}, {'name': 'Johnson N.'}, {'name': 'Jesudason N.'}, {'name': 'Mair D.'}, {'name': 'Thomson E.'}, {'name': 'Shah R.'}, {'name': 'Parr Y.A.'}, {'name': 'Carmichael S.'}, {'name': 'Robertson D.L.'}, {'name': 'Nomikou K.'}, {'name': 'Broos A.'}, {'name': 'Niebel M.'}, {'name': 'Smollett K.'}, {'name': 'Tong L.'}, {'name': 'Miah S.'}, {'name': 'Wittner A.'}, {'name': 'Phillips N.'}, {'name': 'Payne B.'}, {'name': 'Dewar R.'}, {'name': 'Holmes A.'}, {'name': 'Bolt F.'}, {'name': 'Price J.R.'}, {'name': 'Mookerjee S.'}, {'name': 'Sethi D.K.'}, {'name': 'Potter W.'}, {'name': 'Stanley R.'}, {'name': 'Prakash R.'}, {'name': 'Dervisevic S.'}, {'name': 'Graham J.C.'}, {'name': 'Nelson A.'}, {'name': 'Smith D.'}, {'name': 'Young G.R.'}, {'name': 'Yew W.C.'}, {'name': 'Todd J.A.'}, {'name': 'Trebes A.'}, {'name': 'Andersson M.'}, {'name': 'Bull M.'}, {'name': 'Watkins J.'}, {'name': 'Birchley A.'}, {'name': 'Gatica-Wilcox B.'}, {'name': 'Gilbert L.'}, {'name': 'Kumziene-Summerhayes S.'}, {'name': 'Rey S.'}, {'name': 'Chauhan A.'}, {'name': 'Butcher E.'}, {'name': 'Bicknell K.'}, {'name': 'Elliott S.'}, {'name': 'Glaysher S.'}, {'name': 'Lackenby A.'}, {'name': 'Bibby D.'}, {'name': 'Platt S.'}, {'name': 'Mohamed H.'}, {'name': 'Machin N.W.'}, {'name': 'Mbisa J.L.'}, {'name': 'Evans J.'}, {'name': 'Perry M.'}, {'name': 'Pacchiarini N.'}, {'name': 'Corden S.'}, {'name': 'Adams A.G.'}, {'name': 'Gaskin A.'}, {'name': 'Coombs J.'}, {'name': 'Graham L.J.'}, {'name': 'Cottrell S.'}, {'name': 'Morgan M.'}, {'name': 'Gifford L.'}, {'name': 'Kolyva A.'}, {'name': 'Rudder S.J.'}, {'name': 'Trotter A.J.'}, {'name': 'Mather A.E.'}, {'name': 'Aydin A.'}, {'name': 'Page A.J.'}, {'name': 'Kay G.L.'}, {'name': 'de Oliveira Martins L.'}, {'name': 'Yasir M.'}, {'name': 'Alikhan N.-F.'}, {'name': 'Thomson N.M.'}, {'name': 'Gilroy R.'}, {'name': 'Kingsley R.A.'}, {'name': ""O'Grady J.""}, {'name': 'Gutierrez A.V.'}, {'name': 'Diaz M.'}, {'name': 'Viet T.L.'}, {'name': 'Tedim A.P.'}, {'name': 'Adriaenssens E.M.'}, {'name': 'Patrick Mcclure C.'}, {'name': 'Moore C.'}, {'name': 'Sang F.'}, {'name': 'Clark G.'}, {'name': 'Howson-Wells H.C.'}, {'name': 'Debebe J.'}, {'name': 'Ball J.'}, {'name': 'Chappell J.'}, {'name': 'Khakh M.'}, {'name': 'Carlile M.'}, {'name': 'Loose M.'}, {'name': 'Lister M.M.'}, {'name': 'Holmes N.'}, {'name': 'Tsoleridis T.'}, {'name': 'Fleming V.M.'}, {'name': 'Wright V.'}, {'name': 'Smith W.'}, {'name': 'Gallagher M.D.'}, {'name': 'Parker M.'}, {'name': 'Partridge D.G.'}, {'name': 'Evans C.'}, {'name': 'Baker P.'}, {'name': 'Essex S.'}, {'name': 'Liggett S.'}, {'name': 'Keeley A.J.'}, {'name': 'Bashton M.'}, {'name': 'Rooke S.'}, {'name': 'Dervisavic S.'}, {'name': 'Meader E.J.'}, {'name': 'Lopez C.E.B.'}, {'name': 'Angyal A.'}, {'name': 'Kristiansen M.'}, {'name': 'Tutill H.J.'}, {'name': 'Findlay J.'}, {'name': 'Mestek-Boukhibar L.'}, {'name': 'Forrest L.'}, {'name': 'Dyal P.'}, {'name': 'Williams R.J.'}, {'name': 'Panchbhaya Y.'}, {'name': 'Williams C.A.'}, {'name': 'Roy S.'}, {'name': 'Pandey S.'}, {'name': 'Stockton J.'}, {'name': 'Loman N.J.'}, {'name': 'Poplawski R.'}, {'name': 'Nicholls S.'}, {'name': 'Rowe W.P.M.'}, {'name': 'Khokhar F.'}, {'name': 'Pinckert M.L.'}, {'name': 'Hosmillo M.'}, {'name': 'Chaudhry Y.'}, {'name': 'Caller L.G.'}, {'name': 'Davidson R.K.'}, {'name': 'Griffith L.'}, {'name': 'Rambaut A.'}, {'name': 'Jackson B.'}, {'name': 'Colquhoun R.'}, {'name': 'Hill V.'}, {'name': 'Nichols J.'}, {'name': 'Asamaphan P.'}, {'name': 'Darby A.'}, {'name': 'Jackson K.A.'}, {'name': 'Iturriza-Gomara M.'}, {'name': 'Vamos E.E.'}, {'name': 'Green A.'}, {'name': 'Aanensen D.'}, {'name': 'Bonsall D.'}, {'name': 'Buck D.'}, {'name': 'Macintyre-Cockett G.'}, {'name': 'de Cesare M.'}, {'name': 'Pybus O.'}, {'name': 'Golubchik T.'}, {'name': 'Scarlett G.'}, {'name': 'Loveson K.F.'}, {'name': 'Robson S.C.'}, {'name': 'Beckett A.'}, {'name': 'Lindsey B.'}, {'name': 'Groves D.C.'}, {'name': 'Parsons P.J.'}, {'name': 'McHugh M.P.'}, {'name': 'Barnes J.D.'}, {'name': 'Manso C.F.'}, {'name': 'Grammatopoulos D.'}, {'name': 'Menger K.E.'}, {'name': 'Harrison E.'}, {'name': 'Gunson R.'}, {'name': 'Peacock S.J.'}, {'name': 'Gonzalez G.'}, {'name': 'Carr M.'}, {'name': 'Mihaela L.'}, {'name': 'Popovici O.'}, {'name': 'Brytting M.'}, {'name': 'Bresner C.'}, {'name': 'Fuller W.'}, {'name': 'Workman T.'}, {'name': 'Mentis A.F.'}, {'name': 'Kossyvakis A.'}, {'name': 'Karamitros T.'}, {'name': 'Pogka V.'}, {'name': 'Kalliaropoulos A.'}, {'name': 'Horefti E.'}, {'name': 'Kontou A.'}, {'name': 'Martinez-Gonzalez B.'}, {'name': 'Labropoulou V.'}, {'name': 'Voulgari-Kokota A.'}, {'name': 'Evangelidou M.'}, {'name': 'Bizta P.'}, {'name': 'Belimezi M.'}, {'name': 'Lambrechts L.'}, {'name': 'Doymaz M.Z.'}, {'name': 'Yazici M.K.'}, {'name': 'Cetin N.S.'}, {'name': 'Karaaslan E.'}, {'name': 'Kallio-Kokko H.'}, {'name': 'Virtanen J.'}, {'name': 'Suvanto M.'}, {'name': 'Nguyen P.T.'}, {'name': 'Ellonen P.'}, {'name': 'Hannula S.'}, {'name': 'Kangas H.'}, {'name': 'Sreenu V.B.'}, {'name': 'Burian K.'}, {'name': 'Terhes G.'}, {'name': 'Gombos K.'}, {'name': 'Gyenesei A.'}, {'name': 'Urban P.'}, {'name': 'Herczeg R.'}, {'name': 'Jakab F.'}, {'name': 'Kemenesi G.'}, {'name': 'Toth G.E.'}, {'name': 'Somogyi B.'}, {'name': 'Zana B.'}, {'name': 'Zeghbib S.'}, {'name': 'Kuczmog A.'}, {'name': 'Foldes F.'}, {'name': 'Lanszki Z.'}, {'name': 'Madai M.'}, {'name': 'Papp H.'}, {'name': 'Nagy A.'}, {'name': 'Pereszlenyi C.I.'}, {'name': 'Babinszky G.C.'}, {'name': 'Dudas G.'}, {'name': 'Csoma E.'}, {'name': 'Abou Tayoun A.N.'}, {'name': 'Alsheikh-Ali A.A.'}, {'name': 'Loney T.'}, {'name': 'Nowotny N.'}, {'name': 'Abdul-Wahab O.'}, {'name': 'Gonzalez-Candelas F.'}, {'name': 'Andersen M.H.'}, {'name': 'Taylor S.'}], 'citationCount': 42, 'date': '2020-01-01T00:00:00Z', 'journal': 'Eurosurveillance', 'title': 'Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020'}, 'note': 'V-pipe was used to process a major part of the Swiss samples in this pan-European study.', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2020.10.12.335919', 'note': 'Raw reads from SRA public data and Swiss cohort were processed using V-pipe', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2020.10.14.20212621', 'note': 'V-pipe was used to process a major part of the Swiss samples', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2021.01.08.21249379', 'note': 'The waste water samples were analyzed using V-pipe and additional custom scripts.', 'type': ['Usage'], 'version': 'sars-cov2-dev'}, {'doi': '10.1101/2021.03.05.21252520', 'note': 'V-pipe is used within the S3C (Swiss SARS-CoV-2 Sequencing Consortium) to provide sequences.', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.3390/v13030496', 'metadata': {'abstract': '© 2021 by the authors. Licensee MDPI, Basel, Switzerland.Since the emergence of coronavirus disease (COVID-19) in late 2019, domestic cats have been demonstrated to be susceptible to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) under natural and experimental conditions. As pet cats often live in very close contact with their owners, it is essential to investigate SARS-CoV-2 infections in cats in a One-Health context. This study reports the first SARS-CoV-2 infection in a cat in a COVID-19-affected household in Switzerland. The cat (Cat 1) demonstrated signs of an upper respiratory tract infection, including sneezing, inappetence, and apathy, while the cohabiting cat (Cat 2) remained asymptomatic. Nasal, oral, fecal, fur, and environmental swab samples were collected twice from both cats and analyzed by RT-qPCR for the presence of SARS-CoV-2 viral RNA. Both nasal swabs from Cat 1 tested positive. In addition, the first oral swab from Cat 2 and fur and bedding swabs from both cats were RT-qPCR positive. The fecal swabs tested negative. The infection of Cat 1 was confirmed by positive SARS-CoV-2 S1 receptor binding domain (RBD) antibody testing and neutralizing activity in a surrogate assay. The viral genome sequence from Cat 1, obtained by next generation sequencing, showed the closest relation to a human sequence from the B.1.1.39 lineage, with one single nucleotide polymorphism (SNP) difference. This study demonstrates not only SARS-CoV-2 infection of a cat from a COVID-19-affected household but also contamination of the cats’ fur and bed with viral RNA. Our results are important to create awareness that SARS-CoV-2 infected people should observe hygienic measures to avoid infection and contamination of animal cohabitants.', 'authors': [{'name': 'Klaus J.'}, {'name': 'Meli M.L.'}, {'name': 'Willi B.'}, {'name': 'Nadeau S.'}, {'name': 'Beisel C.'}, {'name': 'Stadler T.'}, {'name': 'Egberink H.'}, {'name': 'Zhao S.'}, {'name': 'Lutz H.'}, {'name': 'Riond B.'}, {'name': 'Rosinger N.'}, {'name': 'Stalder H.'}, {'name': 'Renzullo S.'}, {'name': 'Hofmann-Lehmann R.'}], 'citationCount': 2, 'date': '2021-03-01T00:00:00Z', 'journal': 'Viruses', 'title': 'Detection and genome sequencing of sars-cov-2 in a domestic cat with respiratory signs in Switzerland'}, 'note': 'V-pipe and the S3C (Swiss SARS-CoV-2 Sequencing Consortium) infrastructure were used to QA and pre-process the sequencing data.', 'pmcid': 'PMC8002591', 'pmid': '33802899', 'type': ['Usage'], 'version': 'sars-cov2'}]"
187,v-pipe@bsse.ethz.ch,V-pipe Dev Team,Person,,['Primary contact'],,,,,v-pipe,Open access,DrYak,"[{'doi': '10.1093/bioinformatics/btab015', 'pmid': '33471068', 'type': ['Primary'], 'version': '1.0, 2.0'}, {'doi': '10.20944/preprints202005.0376.v1', 'type': ['Review']}, {'doi': '10.1016/j.virusres.2016.09.016', 'metadata': {'abstract': '© 2016 The AuthorsRapidly evolving RNA viruses prevail within a host as a collection of closely related variants, referred to as viral quasispecies. Advances in high-throughput sequencing (HTS) technologies have facilitated the assessment of the genetic diversity of such virus populations at an unprecedented level of detail. However, analysis of HTS data from virus populations is challenging due to short, error-prone reads. In order to account for uncertainties originating from these limitations, several computational and statistical methods have been developed for studying the genetic heterogeneity of virus population. Here, we review methods for the analysis of HTS reads, including approaches to local diversity estimation and global haplotype reconstruction. Challenges posed by aligning reads, as well as the impact of reference biases on diversity estimates are also discussed. In addition, we address some of the experimental approaches designed to improve the biological signal-to-noise ratio. In the future, computational methods for the analysis of heterogeneous virus populations are likely to continue being complemented by technological developments.', 'authors': [{'name': 'Posada-Cespedes S.'}, {'name': 'Seifert D.'}, {'name': 'Beerenwinkel N.'}], 'citationCount': 42, 'date': '2017-07-15T00:00:00Z', 'journal': 'Virus Research', 'title': 'Recent advances in inferring viral diversity from high-throughput sequencing data'}, 'pmid': '27693290', 'type': ['Other']}, {'doi': '10.3390/v10050256', 'metadata': {'abstract': '© 2018 by the authors. Licensee MDPI, Basel, Switzerland.The Second Annual Meeting of the European Virus Bioinformatics Center (EVBC), held in Utrecht, Netherlands, focused on computational approaches in virology, with topics including (but not limited to) virus discovery, diagnostics, (meta-)genomics, modeling, epidemiology, molecular structure, evolution, and viral ecology. The goals of the Second Annual Meeting were threefold: (i) to bring together virologists and bioinformaticians from across the academic, industrial, professional, and training sectors to share best practice; (ii) to provide a meaningful and interactive scientific environment to promote discussion and collaboration between students, postdoctoral fellows, and both new and established investigators; (iii) to inspire and suggest new research directions and questions. Approximately 120 researchers from around the world attended the Second Annual Meeting of the EVBC this year, including 15 renowned international speakers. This report presents an overview of new developments and novel research findings that emerged during the meeting.', 'authors': [{'name': 'Ibrahim B.'}, {'name': 'Arkhipova K.'}, {'name': 'Andeweg A.C.'}, {'name': 'Posada-Cespedes S.'}, {'name': 'Enault F.'}, {'name': 'Gruber A.'}, {'name': 'Koonin E.V.'}, {'name': 'Kupczok A.'}, {'name': 'Lemey P.'}, {'name': 'McHardy A.C.'}, {'name': 'McMahon D.P.'}, {'name': 'Pickett B.E.'}, {'name': 'Robertson D.L.'}, {'name': 'Scheuermann R.H.'}, {'name': 'Zhernakova A.'}, {'name': 'Zwart M.P.'}, {'name': 'Schonhuth A.'}, {'name': 'Dutilh B.E.'}, {'name': 'Marz M.'}], 'citationCount': 3, 'date': '2018-05-14T00:00:00Z', 'journal': 'Viruses', 'title': 'Bioinformatics meets virology: The European virus bioinformatics center’s second annual meeting'}, 'pmcid': 'PMC5977249', 'pmid': '29757994', 'type': ['Other']}, {'doi': '10.1093/infdis/jiz094', 'metadata': {'abstract': '© 2019 The Author(s) 2019.Background: Human immunodeficiency virus type 1 (HIV-1) genetic diversity increases over the course of infection and can be used to infer the time since infection and, consequently, infection recency, which are crucial for HIV-1 surveillance and the understanding of viral pathogenesis. Methods: We considered 313 HIV-infected individuals for whom reliable estimates of infection dates and next-generation sequencing (NGS)-derived nucleotide frequency data were available. Fractions of ambiguous nucleotides, obtained by population sequencing, were available for 207 samples. We assessed whether the average pairwise diversity calculated using NGS sequences provided a more exact prediction of the time since infection and classification of infection recency (<1 year after infection), compared with the fraction of ambiguous nucleotides. Results: NGS-derived average pairwise diversity classified an infection as recent with a sensitivity of 88% and a specificity of 85%. When considering only the 207 samples for which fractions of ambiguous nucleotides were available, the NGS-derived average pairwise diversity exhibited a higher sensitivity (90% vs 78%) and specificity (95% vs 67%) than the fraction of ambiguous nucleotides. Additionally, the average pairwise diversity could be used to estimate the time since infection with a mean absolute error of 0.84 years, compared with 1.03 years for the fraction of ambiguous nucleotides. Conclusions: Viral diversity based on NGS data is more precise than that based on population sequencing in its ability to predict infection recency and provides an estimated time since infection that has a mean absolute error of <1 year.', 'authors': [{'name': 'Carlisle L.A.'}, {'name': 'Turk T.'}, {'name': 'Kusejko K.'}, {'name': 'Metzner K.J.'}, {'name': 'Leemann C.'}, {'name': 'Schenkel C.D.'}, {'name': 'Bachmann N.'}, {'name': 'Posada S.'}, {'name': 'Beerenwinkel N.'}, {'name': 'Boni J.'}, {'name': 'Yerly S.'}, {'name': 'Klimkait T.'}, {'name': 'Perreau M.'}, {'name': 'Braun D.L.'}, {'name': 'Rauch A.'}, {'name': 'Calmy A.'}, {'name': 'Cavassini M.'}, {'name': 'Battegay M.'}, {'name': 'Vernazza P.'}, {'name': 'Bernasconi E.'}, {'name': 'Gunthard H.F.'}, {'name': 'Kouyos R.D.'}, {'name': 'Anagnostopoulos A.'}, {'name': 'Battegay M.'}, {'name': 'Bernasconi E.'}, {'name': 'Boni J.'}, {'name': 'Braun D.L.'}, {'name': 'Bucher H.C.'}, {'name': 'Calmy A.'}, {'name': 'Cavassini M.'}, {'name': 'Ciuffi A.'}, {'name': 'Dollenmaier G.'}, {'name': 'Egger M.'}, {'name': 'Elzi L.'}, {'name': 'Fehr J.'}, {'name': 'Fellay J.'}, {'name': 'Furrer H.'}, {'name': 'Fux C.A.'}, {'name': 'Gunthard H.F.'}, {'name': 'Haerry D.'}, {'name': 'Hasse B.'}, {'name': 'Hirsch H.H.'}, {'name': 'Hoffmann M.'}, {'name': 'Hosli I.'}, {'name': 'Huber M.'}, {'name': 'Kahlert C.'}, {'name': 'Kaiser L.'}, {'name': 'Keiser O.'}, {'name': 'Klimkait T.'}, {'name': 'Kouyos R.D.'}, {'name': 'Kovari H.'}, {'name': 'Ledergerber B.'}, {'name': 'Martinetti G.'}, {'name': 'Martinez De Tejada B.'}, {'name': 'Marzolini C.'}, {'name': 'Metzner K.J.'}, {'name': 'Muller N.'}, {'name': 'Nicca D.'}, {'name': 'Paioni P.'}, {'name': 'Pantaleo G.'}, {'name': 'Perreau M.'}, {'name': 'Rauch A.'}, {'name': 'Rudin C.'}, {'name': 'Scherrer A.U.'}, {'name': 'Schmid P.'}, {'name': 'Speck R.'}, {'name': 'Stockle M.'}, {'name': 'Tarr P.'}, {'name': 'Trkola A.'}, {'name': 'Vernazza P.'}, {'name': 'Wandeler G.'}, {'name': 'Weber R.'}, {'name': 'Yerly S.'}], 'citationCount': 6, 'date': '2019-06-19T00:00:00Z', 'journal': 'Journal of Infectious Diseases', 'title': 'Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time since Infection'}, 'pmid': '30835266', 'type': ['Usage']}, {'doi': '10.2807/1560-7917.es.2020.25.32.2001410', 'metadata': {'abstract': '© 2020 Turkish Society of Cardiology. All rights reserved.We show the distribution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic clades over time and between countries and outline potential genomic surveillance objectives. We applied three genomic nomenclature systems to all sequence data from the World Health Organization European Region available until 10 July 2020. We highlight the importance of real-time sequencing and data dissemination in a pandemic situation, compare the nomenclatures and lay a foundation for future European genomic surveillance of SARS-CoV-2.', 'authors': [{'name': 'Alm E.'}, {'name': 'Broberg E.K.'}, {'name': 'Connor T.'}, {'name': 'Hodcroft E.B.'}, {'name': 'Komissarov A.B.'}, {'name': 'Maurer-Stroh S.'}, {'name': 'Melidou A.'}, {'name': 'Neher R.A.'}, {'name': ""O'Toole A.""}, {'name': 'Pereyaslov D.'}, {'name': 'Beerenwinkel N.'}, {'name': 'Posada-Cespedes S.'}, {'name': 'Jablonski K.P.'}, {'name': 'Ferreira P.F.'}, {'name': 'Topolsky I.'}, {'name': 'Avsic-Zupanc T.'}, {'name': 'Korva M.'}, {'name': 'Poljak M.'}, {'name': 'Zakotnik S.'}, {'name': 'Zorec T.M.'}, {'name': 'Bragstad K.'}, {'name': 'Hungnes O.'}, {'name': 'Stene-Johansen K.'}, {'name': 'Reusken C.'}, {'name': 'Meijer A.'}, {'name': 'Vennema H.'}, {'name': 'Ruiz-Roldan L.'}, {'name': 'Bracho M.A.'}, {'name': 'Garcia-Gonzalez N.'}, {'name': 'Chiner-Oms A.'}, {'name': 'Cancino-Munoz I.'}, {'name': 'Comas I.'}, {'name': 'Goig G.A.'}, {'name': 'Torres-Puente M.'}, {'name': 'Lopez M.G.'}, {'name': 'Martinez-Priego L.'}, {'name': ""D'Auria G.""}, {'name': 'Ruiz-Hueso P.'}, {'name': 'Ferrus-Abad L.'}, {'name': 'de Marco G.'}, {'name': 'Galan-Vendrell I.'}, {'name': 'Carbo-Ramirez S.'}, {'name': 'Ruiz-Rodriguez P.'}, {'name': 'Coscolla M.'}, {'name': 'Polackova K.'}, {'name': 'Kramna L.'}, {'name': 'Cinek O.'}, {'name': 'Richter J.'}, {'name': 'Krashias G.'}, {'name': 'Tryfonos C.'}, {'name': 'Bashiardes S.'}, {'name': 'Koptides D.'}, {'name': 'Christodoulou C.'}, {'name': 'Bartolini B.'}, {'name': 'Gruber C.E.'}, {'name': 'Di Caro A.'}, {'name': 'Castilletti C.'}, {'name': 'Stefani F.'}, {'name': 'Rimoldi S.G.'}, {'name': 'Romeri F.'}, {'name': 'Salerno F.'}, {'name': 'Polesello S.'}, {'name': 'Nagy A.'}, {'name': 'Jirincova H.'}, {'name': 'Vecerova J.'}, {'name': 'Novakova L.'}, {'name': 'Cordey S.'}, {'name': 'Murtskhvaladze M.'}, {'name': 'Kotaria N.'}, {'name': 'Schar T.'}, {'name': 'Beisel C.'}, {'name': 'Vugrek O.'}, {'name': 'Rokic F.'}, {'name': 'Trgovec-Greif L.'}, {'name': 'Jurak I.'}, {'name': 'Rukavina T.'}, {'name': 'Sucic N.'}, {'name': 'Schonning K.'}, {'name': 'Karst S.M.'}, {'name': 'Kirkegaard R.H.'}, {'name': 'Michaelsen T.Y.'}, {'name': 'Sorensen E.A.'}, {'name': 'Knutson S.'}, {'name': 'Brandt J.'}, {'name': 'Le-Quy V.'}, {'name': 'Sorensen T.'}, {'name': 'Petersen C.'}, {'name': 'Pedersen M.S.'}, {'name': 'Larsen S.L.'}, {'name': 'Skov M.N.'}, {'name': 'Rasmussen M.'}, {'name': 'Fonager J.'}, {'name': 'Fomsgaard A.'}, {'name': 'Maksyutov R.A.'}, {'name': 'Gavrilova E.V.'}, {'name': 'Pyankov O.V.'}, {'name': 'Bodnev S.A.'}, {'name': 'Tregubchak T.V.'}, {'name': 'Shvalov A.N.'}, {'name': 'Antonets D.V.'}, {'name': 'Resende P.C.'}, {'name': 'Goya S.'}, {'name': 'Perrin A.'}, {'name': 'Lee R.T.'}, {'name': 'Yadahalli S.'}, {'name': 'Han A.X.'}, {'name': 'Russell C.A.'}, {'name': 'Schmutz S.'}, {'name': 'Zaheri M.'}, {'name': 'Kufner V.'}, {'name': 'Huber M.'}, {'name': 'Trkola A.'}, {'name': 'Antwerpen M.'}, {'name': 'Walter M.C.'}, {'name': 'van der Werf S.'}, {'name': 'Gambaro F.'}, {'name': 'Behillil S.'}, {'name': 'Enouf V.'}, {'name': 'Donati F.'}, {'name': 'Ustinova M.'}, {'name': 'Rovite V.'}, {'name': 'Klovins J.'}, {'name': 'Savicka O.'}, {'name': 'Wienecke-Baldacchino A.K.'}, {'name': 'Ragimbeau C.'}, {'name': 'Fournier G.'}, {'name': 'Mossong J.'}, {'name': 'Aberle S.W.'}, {'name': 'Haukland M.'}, {'name': 'Enkirch T.'}, {'name': 'Advani A.'}, {'name': 'Karlberg M.L.'}, {'name': 'Lindsjo O.K.'}, {'name': 'Broddesson S.'}, {'name': 'Slavikova M.'}, {'name': 'Lickova M.'}, {'name': 'Klempa B.'}, {'name': 'Staronova E.'}, {'name': 'Ticha E.'}, {'name': 'Szemes T.'}, {'name': 'Rusnakova D.'}, {'name': 'Stadler T.'}, {'name': 'Quer J.'}, {'name': 'Anton A.'}, {'name': 'Andres C.'}, {'name': 'Pinana M.'}, {'name': 'Garcia-Cehic D.'}, {'name': 'Pumarola T.'}, {'name': 'Izopet J.'}, {'name': 'Gioula G.'}, {'name': 'Exindari M.'}, {'name': 'Papa A.'}, {'name': 'Chatzidimitriou D.'}, {'name': 'Metallidis S.'}, {'name': 'Pappa S.'}, {'name': 'Macek M.'}, {'name': 'Geryk J.'}, {'name': 'Broz P.'}, {'name': 'Briksi A.'}, {'name': 'Hubacek P.'}, {'name': 'Drevinek P.'}, {'name': 'Zajac M.'}, {'name': 'Kvapil P.'}, {'name': 'Holub M.'}, {'name': 'Kvapilova K.'}, {'name': 'Novotny A.'}, {'name': 'Kasny M.'}, {'name': 'Klempt P.'}, {'name': 'Vapalahti O.'}, {'name': 'Smura T.'}, {'name': 'Sironen T.'}, {'name': 'Selhorst P.'}, {'name': 'Anthony C.'}, {'name': 'Arien K.'}, {'name': 'Simon-Loriere E.'}, {'name': 'Rabalski L.'}, {'name': 'Bienkowska-Szewczyk K.'}, {'name': 'Borges V.'}, {'name': 'Isidro J.'}, {'name': 'Gomes J.P.'}, {'name': 'Guiomar R.'}, {'name': 'Pechirra P.'}, {'name': 'Costa I.'}, {'name': 'Duarte S.'}, {'name': 'Vieira L.'}, {'name': 'Pyrc K.'}, {'name': 'Zuckerman N.S.'}, {'name': 'Turdikulova S.'}, {'name': 'Abdullaev A.'}, {'name': 'Dalimova D.'}, {'name': 'Abdurakhimov A.'}, {'name': 'Tagliabracci A.'}, {'name': 'Alessandrini F.'}, {'name': 'Melchionda F.'}, {'name': 'Onofri V.'}, {'name': 'Turchi C.'}, {'name': 'Bagnarelli P.'}, {'name': 'Menzo S.'}, {'name': 'Caucci S.'}, {'name': 'Di Sante L.'}, {'name': 'Popa A.'}, {'name': 'Genger J.-W.'}, {'name': 'Agerer B.'}, {'name': 'Lercher A.'}, {'name': 'Endler L.'}, {'name': 'Smyth M.'}, {'name': 'Penz T.'}, {'name': 'Schuster M.'}, {'name': 'Senekowitsch M.'}, {'name': 'Laine J.'}, {'name': 'Bock C.'}, {'name': 'Bergthaler A.'}, {'name': 'Shevtsov A.'}, {'name': 'Kalendar R.'}, {'name': 'Ramanculov Y.'}, {'name': 'Graf A.'}, {'name': 'Muenchhoff M.'}, {'name': 'Keppler O.T.'}, {'name': 'Krebs S.'}, {'name': 'Blum H.'}, {'name': 'Marcello A.'}, {'name': 'Licastro D.'}, {'name': ""D'Agaro P.""}, {'name': 'Laubscher F.'}, {'name': 'Vidanovic D.'}, {'name': 'Tesovic B.'}, {'name': 'Volkening J.'}, {'name': 'Clementi N.'}, {'name': 'Mancini N.'}, {'name': 'Rupnik M.'}, {'name': 'Mahnic A.'}, {'name': 'Walker A.'}, {'name': 'Houwaart T.'}, {'name': 'Wienemann T.'}, {'name': 'Vasconcelos M.K.'}, {'name': 'Strelow D.'}, {'name': 'Jensen B.-E.O.'}, {'name': 'Senff T.'}, {'name': 'Hulse L.'}, {'name': 'Adams O.'}, {'name': 'Andree M.'}, {'name': 'Hauka S.'}, {'name': 'Feldt T.'}, {'name': 'Keitel V.'}, {'name': 'Kindgen-Milles D.'}, {'name': 'Timm J.'}, {'name': 'Pfeffer K.'}, {'name': 'Dilthey A.T.'}, {'name': 'Moore C.'}, {'name': 'Ozdarendeli A.'}, {'name': 'Pavel S.T.I.'}, {'name': 'Yetiskin H.'}, {'name': 'Aydin G.'}, {'name': 'Holyavkin C.'}, {'name': 'Uygut M.A.'}, {'name': 'Cevik C.'}, {'name': 'Shchetinin A.'}, {'name': 'Gushchin V.'}, {'name': 'Dinler-Doganay G.'}, {'name': 'Doganay L.'}, {'name': 'Kizilboga-Akgun T.'}, {'name': 'Karacan I.'}, {'name': 'Pancer K.'}, {'name': 'Maes P.'}, {'name': 'Marti-Carreras J.'}, {'name': 'Wawina-Bokalanga T.'}, {'name': 'Vanmechelen B.'}, {'name': 'Thurmer A.'}, {'name': 'Wedde M.'}, {'name': 'Durrwald R.'}, {'name': 'von Kleist M.'}, {'name': 'Drechsel O.'}, {'name': 'Wolff T.'}, {'name': 'Fuchs S.'}, {'name': 'Kmiecinski R.'}, {'name': 'Michel J.'}, {'name': 'Nitsche A.'}, {'name': 'Casas I.'}, {'name': 'Caballero M.I.'}, {'name': 'Zaballos A.'}, {'name': 'Jimenez P.'}, {'name': 'Jimenez M.'}, {'name': 'Fernandez S.M.'}, {'name': 'Fernandez S.V.'}, {'name': 'de la Plaza I.C.'}, {'name': 'Fadeev A.'}, {'name': 'Ivanova A.'}, {'name': 'Sergeeva M.'}, {'name': 'Stefanelli P.'}, {'name': 'Estee Torok M.'}, {'name': 'Hall G.'}, {'name': 'da Silva Filipe A.'}, {'name': 'Turtle L.'}, {'name': 'Afifi S.'}, {'name': 'McCluggage K.'}, {'name': 'Beer R.'}, {'name': 'Ledesma J.'}, {'name': 'Maksimovic J.'}, {'name': 'Spellman K.'}, {'name': 'Hamilton W.L.'}, {'name': 'Marchbank A.'}, {'name': 'Southgate J.A.'}, {'name': 'Underwood A.'}, {'name': 'Taylor B.'}, {'name': 'Yeats C.'}, {'name': 'Abudahab K.'}, {'name': 'Gemmell M.R.'}, {'name': 'Eccles R.'}, {'name': 'Lucaci A.'}, {'name': 'Nelson C.A.'}, {'name': 'Rainbow L.'}, {'name': 'Whitehead M.'}, {'name': 'Gregory R.'}, {'name': 'Haldenby S.'}, {'name': 'Paterson S.'}, {'name': 'Hughes M.A.'}, {'name': 'Curran M.D.'}, {'name': 'Baker D.'}, {'name': 'Tucker R.'}, {'name': 'Green L.R.'}, {'name': 'Feltwell T.'}, {'name': 'Halstead F.D.'}, {'name': 'Wyles M.'}, {'name': 'Jahun A.S.'}, {'name': 'Ahmad S.S.Y.'}, {'name': 'Georgana I.'}, {'name': 'Goodfellow I.'}, {'name': 'Yakovleva A.'}, {'name': 'Meredith L.W.'}, {'name': 'Gavriil A.'}, {'name': 'Awan A.R.'}, {'name': 'Fisher C.'}, {'name': 'Edgeworth J.'}, {'name': 'Lynch J.'}, {'name': 'Moore N.'}, {'name': 'Williams R.'}, {'name': 'Kidd S.P.'}, {'name': 'Cortes N.'}, {'name': 'Brunker K.'}, {'name': 'McCrone J.T.'}, {'name': 'Quick J.'}, {'name': 'Duckworth N.'}, {'name': 'Walsh S.'}, {'name': 'Sloan T.'}, {'name': 'Ludden C.'}, {'name': 'George R.P.'}, {'name': 'Eltringham G.'}, {'name': 'Brown J.R.'}, {'name': 'Aranday-Cortes E.'}, {'name': 'Shepherd J.G.'}, {'name': 'Hughes J.'}, {'name': 'Li K.K.'}, {'name': 'Williams T.C.'}, {'name': 'Johnson N.'}, {'name': 'Jesudason N.'}, {'name': 'Mair D.'}, {'name': 'Thomson E.'}, {'name': 'Shah R.'}, {'name': 'Parr Y.A.'}, {'name': 'Carmichael S.'}, {'name': 'Robertson D.L.'}, {'name': 'Nomikou K.'}, {'name': 'Broos A.'}, {'name': 'Niebel M.'}, {'name': 'Smollett K.'}, {'name': 'Tong L.'}, {'name': 'Miah S.'}, {'name': 'Wittner A.'}, {'name': 'Phillips N.'}, {'name': 'Payne B.'}, {'name': 'Dewar R.'}, {'name': 'Holmes A.'}, {'name': 'Bolt F.'}, {'name': 'Price J.R.'}, {'name': 'Mookerjee S.'}, {'name': 'Sethi D.K.'}, {'name': 'Potter W.'}, {'name': 'Stanley R.'}, {'name': 'Prakash R.'}, {'name': 'Dervisevic S.'}, {'name': 'Graham J.C.'}, {'name': 'Nelson A.'}, {'name': 'Smith D.'}, {'name': 'Young G.R.'}, {'name': 'Yew W.C.'}, {'name': 'Todd J.A.'}, {'name': 'Trebes A.'}, {'name': 'Andersson M.'}, {'name': 'Bull M.'}, {'name': 'Watkins J.'}, {'name': 'Birchley A.'}, {'name': 'Gatica-Wilcox B.'}, {'name': 'Gilbert L.'}, {'name': 'Kumziene-Summerhayes S.'}, {'name': 'Rey S.'}, {'name': 'Chauhan A.'}, {'name': 'Butcher E.'}, {'name': 'Bicknell K.'}, {'name': 'Elliott S.'}, {'name': 'Glaysher S.'}, {'name': 'Lackenby A.'}, {'name': 'Bibby D.'}, {'name': 'Platt S.'}, {'name': 'Mohamed H.'}, {'name': 'Machin N.W.'}, {'name': 'Mbisa J.L.'}, {'name': 'Evans J.'}, {'name': 'Perry M.'}, {'name': 'Pacchiarini N.'}, {'name': 'Corden S.'}, {'name': 'Adams A.G.'}, {'name': 'Gaskin A.'}, {'name': 'Coombs J.'}, {'name': 'Graham L.J.'}, {'name': 'Cottrell S.'}, {'name': 'Morgan M.'}, {'name': 'Gifford L.'}, {'name': 'Kolyva A.'}, {'name': 'Rudder S.J.'}, {'name': 'Trotter A.J.'}, {'name': 'Mather A.E.'}, {'name': 'Aydin A.'}, {'name': 'Page A.J.'}, {'name': 'Kay G.L.'}, {'name': 'de Oliveira Martins L.'}, {'name': 'Yasir M.'}, {'name': 'Alikhan N.-F.'}, {'name': 'Thomson N.M.'}, {'name': 'Gilroy R.'}, {'name': 'Kingsley R.A.'}, {'name': ""O'Grady J.""}, {'name': 'Gutierrez A.V.'}, {'name': 'Diaz M.'}, {'name': 'Viet T.L.'}, {'name': 'Tedim A.P.'}, {'name': 'Adriaenssens E.M.'}, {'name': 'Patrick Mcclure C.'}, {'name': 'Moore C.'}, {'name': 'Sang F.'}, {'name': 'Clark G.'}, {'name': 'Howson-Wells H.C.'}, {'name': 'Debebe J.'}, {'name': 'Ball J.'}, {'name': 'Chappell J.'}, {'name': 'Khakh M.'}, {'name': 'Carlile M.'}, {'name': 'Loose M.'}, {'name': 'Lister M.M.'}, {'name': 'Holmes N.'}, {'name': 'Tsoleridis T.'}, {'name': 'Fleming V.M.'}, {'name': 'Wright V.'}, {'name': 'Smith W.'}, {'name': 'Gallagher M.D.'}, {'name': 'Parker M.'}, {'name': 'Partridge D.G.'}, {'name': 'Evans C.'}, {'name': 'Baker P.'}, {'name': 'Essex S.'}, {'name': 'Liggett S.'}, {'name': 'Keeley A.J.'}, {'name': 'Bashton M.'}, {'name': 'Rooke S.'}, {'name': 'Dervisavic S.'}, {'name': 'Meader E.J.'}, {'name': 'Lopez C.E.B.'}, {'name': 'Angyal A.'}, {'name': 'Kristiansen M.'}, {'name': 'Tutill H.J.'}, {'name': 'Findlay J.'}, {'name': 'Mestek-Boukhibar L.'}, {'name': 'Forrest L.'}, {'name': 'Dyal P.'}, {'name': 'Williams R.J.'}, {'name': 'Panchbhaya Y.'}, {'name': 'Williams C.A.'}, {'name': 'Roy S.'}, {'name': 'Pandey S.'}, {'name': 'Stockton J.'}, {'name': 'Loman N.J.'}, {'name': 'Poplawski R.'}, {'name': 'Nicholls S.'}, {'name': 'Rowe W.P.M.'}, {'name': 'Khokhar F.'}, {'name': 'Pinckert M.L.'}, {'name': 'Hosmillo M.'}, {'name': 'Chaudhry Y.'}, {'name': 'Caller L.G.'}, {'name': 'Davidson R.K.'}, {'name': 'Griffith L.'}, {'name': 'Rambaut A.'}, {'name': 'Jackson B.'}, {'name': 'Colquhoun R.'}, {'name': 'Hill V.'}, {'name': 'Nichols J.'}, {'name': 'Asamaphan P.'}, {'name': 'Darby A.'}, {'name': 'Jackson K.A.'}, {'name': 'Iturriza-Gomara M.'}, {'name': 'Vamos E.E.'}, {'name': 'Green A.'}, {'name': 'Aanensen D.'}, {'name': 'Bonsall D.'}, {'name': 'Buck D.'}, {'name': 'Macintyre-Cockett G.'}, {'name': 'de Cesare M.'}, {'name': 'Pybus O.'}, {'name': 'Golubchik T.'}, {'name': 'Scarlett G.'}, {'name': 'Loveson K.F.'}, {'name': 'Robson S.C.'}, {'name': 'Beckett A.'}, {'name': 'Lindsey B.'}, {'name': 'Groves D.C.'}, {'name': 'Parsons P.J.'}, {'name': 'McHugh M.P.'}, {'name': 'Barnes J.D.'}, {'name': 'Manso C.F.'}, {'name': 'Grammatopoulos D.'}, {'name': 'Menger K.E.'}, {'name': 'Harrison E.'}, {'name': 'Gunson R.'}, {'name': 'Peacock S.J.'}, {'name': 'Gonzalez G.'}, {'name': 'Carr M.'}, {'name': 'Mihaela L.'}, {'name': 'Popovici O.'}, {'name': 'Brytting M.'}, {'name': 'Bresner C.'}, {'name': 'Fuller W.'}, {'name': 'Workman T.'}, {'name': 'Mentis A.F.'}, {'name': 'Kossyvakis A.'}, {'name': 'Karamitros T.'}, {'name': 'Pogka V.'}, {'name': 'Kalliaropoulos A.'}, {'name': 'Horefti E.'}, {'name': 'Kontou A.'}, {'name': 'Martinez-Gonzalez B.'}, {'name': 'Labropoulou V.'}, {'name': 'Voulgari-Kokota A.'}, {'name': 'Evangelidou M.'}, {'name': 'Bizta P.'}, {'name': 'Belimezi M.'}, {'name': 'Lambrechts L.'}, {'name': 'Doymaz M.Z.'}, {'name': 'Yazici M.K.'}, {'name': 'Cetin N.S.'}, {'name': 'Karaaslan E.'}, {'name': 'Kallio-Kokko H.'}, {'name': 'Virtanen J.'}, {'name': 'Suvanto M.'}, {'name': 'Nguyen P.T.'}, {'name': 'Ellonen P.'}, {'name': 'Hannula S.'}, {'name': 'Kangas H.'}, {'name': 'Sreenu V.B.'}, {'name': 'Burian K.'}, {'name': 'Terhes G.'}, {'name': 'Gombos K.'}, {'name': 'Gyenesei A.'}, {'name': 'Urban P.'}, {'name': 'Herczeg R.'}, {'name': 'Jakab F.'}, {'name': 'Kemenesi G.'}, {'name': 'Toth G.E.'}, {'name': 'Somogyi B.'}, {'name': 'Zana B.'}, {'name': 'Zeghbib S.'}, {'name': 'Kuczmog A.'}, {'name': 'Foldes F.'}, {'name': 'Lanszki Z.'}, {'name': 'Madai M.'}, {'name': 'Papp H.'}, {'name': 'Nagy A.'}, {'name': 'Pereszlenyi C.I.'}, {'name': 'Babinszky G.C.'}, {'name': 'Dudas G.'}, {'name': 'Csoma E.'}, {'name': 'Abou Tayoun A.N.'}, {'name': 'Alsheikh-Ali A.A.'}, {'name': 'Loney T.'}, {'name': 'Nowotny N.'}, {'name': 'Abdul-Wahab O.'}, {'name': 'Gonzalez-Candelas F.'}, {'name': 'Andersen M.H.'}, {'name': 'Taylor S.'}], 'citationCount': 42, 'date': '2020-01-01T00:00:00Z', 'journal': 'Eurosurveillance', 'title': 'Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020'}, 'note': 'V-pipe was used to process a major part of the Swiss samples in this pan-European study.', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2020.10.12.335919', 'note': 'Raw reads from SRA public data and Swiss cohort were processed using V-pipe', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2020.10.14.20212621', 'note': 'V-pipe was used to process a major part of the Swiss samples', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.1101/2021.01.08.21249379', 'note': 'The waste water samples were analyzed using V-pipe and additional custom scripts.', 'type': ['Usage'], 'version': 'sars-cov2-dev'}, {'doi': '10.1101/2021.03.05.21252520', 'note': 'V-pipe is used within the S3C (Swiss SARS-CoV-2 Sequencing Consortium) to provide sequences.', 'type': ['Usage'], 'version': 'sars-cov2'}, {'doi': '10.3390/v13030496', 'metadata': {'abstract': '© 2021 by the authors. Licensee MDPI, Basel, Switzerland.Since the emergence of coronavirus disease (COVID-19) in late 2019, domestic cats have been demonstrated to be susceptible to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) under natural and experimental conditions. As pet cats often live in very close contact with their owners, it is essential to investigate SARS-CoV-2 infections in cats in a One-Health context. This study reports the first SARS-CoV-2 infection in a cat in a COVID-19-affected household in Switzerland. The cat (Cat 1) demonstrated signs of an upper respiratory tract infection, including sneezing, inappetence, and apathy, while the cohabiting cat (Cat 2) remained asymptomatic. Nasal, oral, fecal, fur, and environmental swab samples were collected twice from both cats and analyzed by RT-qPCR for the presence of SARS-CoV-2 viral RNA. Both nasal swabs from Cat 1 tested positive. In addition, the first oral swab from Cat 2 and fur and bedding swabs from both cats were RT-qPCR positive. The fecal swabs tested negative. The infection of Cat 1 was confirmed by positive SARS-CoV-2 S1 receptor binding domain (RBD) antibody testing and neutralizing activity in a surrogate assay. The viral genome sequence from Cat 1, obtained by next generation sequencing, showed the closest relation to a human sequence from the B.1.1.39 lineage, with one single nucleotide polymorphism (SNP) difference. This study demonstrates not only SARS-CoV-2 infection of a cat from a COVID-19-affected household but also contamination of the cats’ fur and bed with viral RNA. Our results are important to create awareness that SARS-CoV-2 infected people should observe hygienic measures to avoid infection and contamination of animal cohabitants.', 'authors': [{'name': 'Klaus J.'}, {'name': 'Meli M.L.'}, {'name': 'Willi B.'}, {'name': 'Nadeau S.'}, {'name': 'Beisel C.'}, {'name': 'Stadler T.'}, {'name': 'Egberink H.'}, {'name': 'Zhao S.'}, {'name': 'Lutz H.'}, {'name': 'Riond B.'}, {'name': 'Rosinger N.'}, {'name': 'Stalder H.'}, {'name': 'Renzullo S.'}, {'name': 'Hofmann-Lehmann R.'}], 'citationCount': 2, 'date': '2021-03-01T00:00:00Z', 'journal': 'Viruses', 'title': 'Detection and genome sequencing of sars-cov-2 in a domestic cat with respiratory signs in Switzerland'}, 'note': 'V-pipe and the S3C (Swiss SARS-CoV-2 Sequencing Consortium) infrastructure were used to QA and pre-process the sequencing data.', 'pmcid': 'PMC8002591', 'pmid': '33802899', 'type': ['Usage'], 'version': 'sars-cov2'}]"
188,alice.wittig@hpi.de,Alice Wittig,Person,https://orcid.org/0000-0002-0578-8752,['Primary contact'],,,,,covradar,,Kigaard,[{'doi': '10.1101/2021.02.03.429146'}]
189,Bernhard.Renard@hpi.de,Bernhard Renard,Person,https://orcid.org/0000-0003-4589-9809,['Primary contact'],,,,,covradar,,Kigaard,[{'doi': '10.1101/2021.02.03.429146'}]
190,fuchss@rki.de,Stephan Fuchs,Person,https://orcid.org/0000-0002-1338-2699,['Primary contact'],,,,,covradar,,Kigaard,[{'doi': '10.1101/2021.02.03.429146'}]
191,vinods@igib.in,Vinod Scaria,Person,https://orcid.org/0000-0001-7644-7181,['Primary contact'],,,,,esc,,Kigaard,[{'doi': '10.1101/2021.02.18.431922'}]
192,leetzongyi@cuhk.edu.cn,Tzong-Yi Lee,Person,,,,,,,preanticov,,Kigaard,"[{'doi': '10.1093/BIB/BBAA423', 'metadata': {'abstract': '© 2021 The Author(s) 2021. Published by Oxford University Press. All rights reserved.As the current worldwide outbreaks of the SARS-CoV-2, it is urgently needed to develop effective therapeutic agents for inhibiting the pathogens or treating the related diseases. Antimicrobial peptides (AMP) with functional activity against coronavirus could be a considerable solution, yet there is no research for identifying anti-coronavirus (anti-CoV) peptides with the computational approach. In this study, we first investigated the physiochemical and compositional properties of the collected anti-CoV peptides by comparing against three other negative sets: Antivirus peptides without anti-CoV function (antivirus), regular AMP without antivirus functions (non-AVP) and peptides without antimicrobial functions (non-AMP). Then, we established classifiers for identifying anti-CoV peptides between different negative sets based on random forest. Imbalanced learning strategies were adopted due to the severe class-imbalance within the datasets. The geometric mean of the sensitivity and specificity (GMean) under the identification from antivirus, non-AVP and non-AMP reaches 83.07%, 85.51% and 98.82%, respectively. Then, to pursue identifying anti-CoV peptides from broad-spectrum peptides, we designed a double-stages classifier based on the collected datasets. In the first stage, the classifier characterizes AMPs from regular peptides. It achieves an area under the receiver operating curve (AUCROC) value of 97.31%. The second stage is to identify the anti-CoV peptides between the combined negatives of other AMPs. Here, the GMean of evaluation on the independent test set is 79.42%. The proposed approach is considered as an applicable scheme for assisting the development of novel anti-CoV peptides. The datasets and source codes used in this study are available at https://github.com/poncey/PreAntiCoV.', 'authors': [{'name': 'Pang Y.'}, {'name': 'Wang Z.'}, {'name': 'Jhong J.-H.'}, {'name': 'Lee T.-Y.'}], 'date': '2021-03-01T00:00:00Z', 'journal': 'Briefings in Bioinformatics', 'title': 'Identifying anti-coronavirus peptides by incorporating different negative datasets and imbalanced learning strategies'}, 'pmcid': 'PMC7929366', 'pmid': '33497434'}]"
193,federico.giorgi@unibo.it,Federico M. Giorgi,Person,https://orcid.org/0000-0002-7325-9908,,,,,,coronapp,Open access,Kigaard,"[{'doi': '10.1002/JMV.26678', 'metadata': {'abstract': '© 2020 Wiley Periodicals LLCThe avalanche of genomic data generated from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus requires the development of tools to detect and monitor its mutations across the world. Here, we present a webtool, coronapp, dedicated to easily processing user-provided SARS-CoV-2 genomic sequences and visualizing the current worldwide status of SARS-CoV-2 mutations. The webtool allows users to highlight mutations and categorize them by frequency, country, genomic location and effect on protein sequences, and to monitor their presence in the population over time. The tool is available at http://giorgilab.unibo.it/coronannotator/ for the annotation of user-provided sequences. The full code is freely shared at https://github.com/federicogiorgi/giorgilab/tree/master/coronannotator.', 'authors': [{'name': 'Mercatelli D.'}, {'name': 'Triboli L.'}, {'name': 'Fornasari E.'}, {'name': 'Ray F.'}, {'name': 'Giorgi F.M.'}], 'citationCount': 12, 'date': '2021-05-01T00:00:00Z', 'journal': 'Journal of Medical Virology', 'title': 'Coronapp: A web application to annotate and monitor SARS-CoV-2 mutations'}, 'pmcid': 'PMC7753722', 'pmid': '33205830', 'type': ['Primary']}, {'doi': '10.1002/jmv.26678', 'metadata': {'abstract': '© 2020 Wiley Periodicals LLCThe avalanche of genomic data generated from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus requires the development of tools to detect and monitor its mutations across the world. Here, we present a webtool, coronapp, dedicated to easily processing user-provided SARS-CoV-2 genomic sequences and visualizing the current worldwide status of SARS-CoV-2 mutations. The webtool allows users to highlight mutations and categorize them by frequency, country, genomic location and effect on protein sequences, and to monitor their presence in the population over time. The tool is available at http://giorgilab.unibo.it/coronannotator/ for the annotation of user-provided sequences. The full code is freely shared at https://github.com/federicogiorgi/giorgilab/tree/master/coronannotator.', 'authors': [{'name': 'Mercatelli D.'}, {'name': 'Triboli L.'}, {'name': 'Fornasari E.'}, {'name': 'Ray F.'}, {'name': 'Giorgi F.M.'}], 'citationCount': 12, 'date': '2021-05-01T00:00:00Z', 'journal': 'Journal of Medical Virology', 'title': 'Coronapp: A web application to annotate and monitor SARS-CoV-2 mutations'}}]"
194,manojk@imtech.res.in,Manoj Kumar,Person,,,,,,,coronavr,,Kigaard,"[{'doi': '10.3389/FMICB.2020.01858', 'metadata': {'abstract': '© Copyright © 2020 Gupta, Khan, Choudhury, Mukhopadhyay, Sakshi, Rastogi, Thakur, Kumari, Kaur, Shalu, Saini, Sapehia, Barkha, Patel, Bhamare and Kumar.In December 2019, the Chinese city of Wuhan was the center of origin of a pneumonia-like disease outbreak with an unknown causative pathogen. The CDC, China, managed to track the source of infection to a novel coronavirus (2019-nCoV; SARS-CoV-2) that shares approximately 79.6% of its genome with SARS-CoV. The World Health Organization (WHO) initially declared COVID-19 as a Public Health Emergency of International Concern (PHEIC) and later characterized it as a global pandemic on March 11, 2020. Due to the novel nature of this virus, there is an urgent need for vaccines and therapeutics to control the spread of SARS-CoV-2 and its associated disease, COVID-19. Global efforts are underway to circumvent its further spread and treat COVID-19 patients through experimental vaccine formulations and therapeutic interventions, respectively. In the absence of any effective therapeutics, we have devised h bioinformatics-based approaches to accelerate global efforts in the fight against SARS-CoV-2 and to assist researchers in the initial phase of vaccine and therapeutics development. In this study, we have performed comprehensive meta-analyses and developed an integrative resource, “CoronaVR” (http://bioinfo.imtech.res.in/manojk/coronavr/). Predominantly, we identified potential epitope-based vaccine candidates, siRNA-based therapeutic regimens, and diagnostic primers. The resource is categorized into the main sections “Genomes,” “Epitopes,” “Therapeutics,” and Primers.” The genome section harbors different components, viz, genomes, a genome browser, phylogenetic analysis, codon usage, glycosylation sites, and structural analysis. Under the umbrella of epitopes, sub-divisions, namely cross-protective epitopes, B-cell (linear/discontinuous), T-cell (CD4+/CD8+), CTL, and MHC binders, are presented. The therapeutics section has different sub-sections like siRNA, miRNAs, and sgRNAs. Further, experimentally confirmed and designed diagnostic primers are earmarked in the primers section. Our study provided a set of shortlisted B-cell and T-cell (CD4+ and CD8+) epitopes that can be experimentally tested for their incorporation in vaccine formulations. The list of selected primers can be used in testing kits to identify SARS-CoV-2, while the recommended siRNAs, sgRNAs, and miRNAs can be used in therapeutic regimens. We foresee that this resource will help in advancing the research against coronaviruses.', 'authors': [{'name': 'Gupta A.K.'}, {'name': 'Khan M.S.'}, {'name': 'Choudhury S.'}, {'name': 'Mukhopadhyay A.'}, {'name': 'Sakshi'}, {'name': 'Rastogi A.'}, {'name': 'Thakur A.'}, {'name': 'Kumari P.'}, {'name': 'Kaur M.'}, {'name': 'Shalu'}, {'name': 'Saini C.'}, {'name': 'Sapehia V.'}, {'name': 'Barkha'}, {'name': 'Patel P.K.'}, {'name': 'Bhamare K.T.'}, {'name': 'Kumar M.'}], 'citationCount': 9, 'date': '2020-07-31T00:00:00Z', 'journal': 'Frontiers in Microbiology', 'title': 'CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2'}, 'pmcid': 'PMC7412965', 'pmid': '32849449'}]"
195,pierce@umd.edu,Brian G. Pierce,Person,,,,,,,cov3d,,Kigaard,[{'doi': '10.1101/2020.05.12.091983'}]
196,zhuzl@cqu.edu.cn,Zhenglin Zhu,Person,,,,,,,covdb,,Kigaard,[{'doi': '10.1101/2020.02.05.920009'}]
197,mg@cau.edu.cn,Geng Meng,Person,,,,,,,covdb,,Kigaard,[{'doi': '10.1101/2020.02.05.920009'}]
198,jan.baumbach@wzw.tum.de,Jan Baumbach,Person,https://orcid.org/0000-0002-0282-0462,,,,,,covex,,Kigaard,"[{'doi': '10.1038/S41467-020-17189-2', 'metadata': {'abstract': '© 2020, The Author(s).Coronavirus Disease-2019 (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Various studies exist about the molecular mechanisms of viral infection. However, such information is spread across many publications and it is very time-consuming to integrate, and exploit. We develop CoVex, an interactive online platform for SARS-CoV-2 host interactome exploration and drug (target) identification. CoVex integrates virus-human protein interactions, human protein-protein interactions, and drug-target interactions. It allows visual exploration of the virus-host interactome and implements systems medicine algorithms for network-based prediction of drug candidates. Thus, CoVex is a resource to understand molecular mechanisms of pathogenicity and to prioritize candidate therapeutics. We investigate recent hypotheses on a systems biology level to explore mechanistic virus life cycle drivers, and to extract drug repurposing candidates. CoVex renders COVID-19 drug research systems-medicine-ready by giving the scientific community direct access to network medicine algorithms. It is available at https://exbio.wzw.tum.de/covex/.', 'authors': [{'name': 'Sadegh S.'}, {'name': 'Matschinske J.'}, {'name': 'Blumenthal D.B.'}, {'name': 'Galindez G.'}, {'name': 'Kacprowski T.'}, {'name': 'List M.'}, {'name': 'Nasirigerdeh R.'}, {'name': 'Oubounyt M.'}, {'name': 'Pichlmair A.'}, {'name': 'Rose T.D.'}, {'name': 'Salgado-Albarran M.'}, {'name': 'Spath J.'}, {'name': 'Stukalov A.'}, {'name': 'Wenke N.K.'}, {'name': 'Yuan K.'}, {'name': 'Pauling J.K.'}, {'name': 'Baumbach J.'}], 'citationCount': 42, 'date': '2020-12-01T00:00:00Z', 'journal': 'Nature Communications', 'title': 'Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing'}, 'pmcid': 'PMC7360763', 'pmid': '32665542'}]"
199,mirzaatifadnan@gmail.com,Atif Adnan,Person,,,,,,,covid-19-mutation-browser,,Kigaard,[{'doi': '10.1101/2020.06.10.145292'}]
200,3624108@qq.com,Jiang Du,Person,,,,,,,covid-19-mutation-browser,,Kigaard,[{'doi': '10.1101/2020.06.10.145292'}]
201,marcocacciabue@yahoo.com,Marco Cacciabue,Person,,,,,,,covidex,,Kigaard,[{'doi': '10.1101/2020.08.21.261347'}]
202,kleistm@rki.de,,Person,,,,,,,covidstrategycalculator,,Kigaard,[{'doi': '10.1101/2020.11.18.20233825'}]
203,zhanzhou@zju.edu.cn,Zhan Zhou,Person,,,,,,,coviedb,,Kigaard,[{'doi': '10.1101/2020.05.24.096164'}]
204,tuncadogan@gmail.com,Tunca Doğan,Person,,,,,,,crossbar,,Kigaard,[{'doi': '10.1101/2020.09.14.296889'}]
205,,Gajendra P. S. Raghava,,https://orcid.org/0000-0002-8902-2876,,,,,,stat3in,,Jennifer,[{'doi': '10.21203/RS.3.RS-495671/V1'}]
206,,Anjali Dhall,,,,,,,,stat3in,,Jennifer,[{'doi': '10.21203/RS.3.RS-495671/V1'}]
207,,Sumeet Patiyal,,,,,,,,stat3in,,Jennifer,[{'doi': '10.21203/RS.3.RS-495671/V1'}]
208,,Neelam Sharma,,,,,,,,stat3in,,Jennifer,[{'doi': '10.21203/RS.3.RS-495671/V1'}]
209,,Naorem Leimarembi Devi,,,,,,,,stat3in,,Jennifer,[{'doi': '10.21203/RS.3.RS-495671/V1'}]
210,chen@haplox.com,Shifu Chen,Person,,,,,,,fastv,,Kigaard,[{'doi': '10.1101/2020.05.12.092163'}]
211,hardip.patel@anu.edu.au,Eduardo Eyras,Person,,,,,,,pacific,,Niclaskn,[{'doi': '10.1101/2020.07.24.219097'}]
212,eduardo.eyras@anu.edu.au,Hardip R. Patel,Person,,,,,,,pacific,,Niclaskn,[{'doi': '10.1101/2020.07.24.219097'}]
213,jakechen@uab.edu,Jake Y Chen,Person,,,,,,,pager-cov,,Niclaskn,"[{'doi': '10.1093/NAR/GKAA1094', 'metadata': {'abstract': '© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.PAGER-CoV (http://discovery.informatics.uab.edu/PAGER-CoV/) is a new web-based database that can help biomedical researchers interpret coronavirus-related functional genomic study results in the context of curated knowledge of host viral infection, inflammatory response, organ damage, and tissue repair. The new database consists of 11 835 PAGs (Pathways, Annotated gene-lists, or Gene signatures) from 33 public data sources. Through the web user interface, users can search by a query gene or a query term and retrieve significantly matched PAGs with all the curated information. Users can navigate from a PAG of interest to other related PAGs through either shared PAG-to-PAG co-membership relationships or PAG-to-PAG regulatory relationships, totaling 19 996 993. Users can also retrieve enriched PAGs from an input list of COVID-19 functional study result genes, customize the search data sources, and export all results for subsequent offline data analysis. In a case study, we performed a gene set enrichment analysis (GSEA) of a COVID-19 RNA-seq data set from the Gene Expression Omnibus database. Compared with the results using the standard PAGER database, PAGER-CoV allows for more sensitive matching of known immune-related gene signatures. We expect PAGER-CoV to be invaluable for biomedical researchers to find molecular biology mechanisms and tailored therapeutics to treat COVID-19 patients.', 'authors': [{'name': 'Yue Z.'}, {'name': 'Zhang E.'}, {'name': 'Xu C.'}, {'name': 'Khurana S.'}, {'name': 'Batra N.'}, {'name': 'Dang S.D.H.'}, {'name': 'Cimino J.J.'}, {'name': 'Chen J.Y.'}], 'citationCount': 4, 'date': '2021-01-08T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'PAGER-CoV: A comprehensive collection of pathways, annotated gene-lists and gene signatures for coronavirus disease studies'}, 'pmid': '33245774'}]"
214,,Mrutyunjay Suar,Person,,,,,,,dbcovp,,Kigaard,"[{'doi': '10.1016/J.COMPBIOMED.2020.104131', 'metadata': {'abstract': '© 2020Since the emergence of SARS-CoV-1 (2002), novel coronaviruses have emerged periodically like the MERS- CoV (2012) and now, the SARS-CoV-2 outbreak which has posed a global threat to public health. Although, this is the third zoonotic coronavirus breakout within the last two decades, there are only a few platforms that provide information about coronavirus genomes. None of them is specific for the virulence glycoproteins and complete sequence-structural features of these virulence factors across the betacoronavirus family including SARS-CoV-2 strains are lacking. Against this backdrop, we present DBCOVP (http://covp.immt.res.in/), the first manually-curated, web-based resource to provide extensive information on the complete repertoire of structural virulent glycoproteins from coronavirus genomes belonging to betacoronavirus genera. The database provides various sequence-structural properties in which users can browse and analyze information in different ways. Furthermore, many conserved T-cell and B-cell epitopes predicted for each protein are present that may perform a significant role in eliciting the humoral and cellular immune response. The tertiary structure of the epitopes together with the docked epitope-HLA binding-complex is made available to facilitate further analysis. DBCOVP presents an easy-to-use interface with in-built tools for similarity search, cross-genome comparison, phylogenetic, and multiple sequence alignment. DBCOVP will certainly be an important resource for experimental biologists engaged in coronavirus research studies and will aid in vaccine development.', 'authors': [{'name': 'Sahoo S.'}, {'name': 'Mahapatra S.R.'}, {'name': 'Parida B.K.'}, {'name': 'Rath S.'}, {'name': 'Dehury B.'}, {'name': 'Raina V.'}, {'name': 'Mohakud N.K.'}, {'name': 'Misra N.'}, {'name': 'Suar M.'}], 'citationCount': 3, 'date': '2021-02-01T00:00:00Z', 'journal': 'Computers in Biology and Medicine', 'title': 'DBCOVP: A database of coronavirus virulent glycoproteins'}, 'pmcid': 'PMC7679231', 'pmid': '33276297'}]"
215,dongsi@uw.edu,Dong Si,Person,,,,,,,deeptracer,Open access (with restrictions),Kigaard,[{'doi': '10.1101/2020.07.21.214064'}]
216,chienyuchen@ntu.edu.tw,Chien-Yu Chen,Person,,,,,,,dockcov2,Open access,Kigaard,"[{'doi': '10.1093/NAR/GKAA861', 'metadata': {'abstract': '© 2021 The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.The current state of the COVID-19 pandemic is a global health crisis. To fight the novel coronavirus, one of the best-known ways is to block enzymes essential for virus replication. Currently, we know that the SARS-CoV-2 virus encodes about 29 proteins such as spike protein, 3C-like protease (3CLpro), RNA-dependent RNA polymerase (RdRp), Papain-like protease (PLpro), and nucleocapsid (N) protein. SARS-CoV-2 uses human angiotensin-converting enzyme 2 (ACE2) for viral entry and transmembrane serine protease family member II (TMPRSS2) for spike protein priming. Thus in order to speed up the discovery of potential drugs, we develop DockCoV2, a drug database for SARS-CoV-2. DockCoV2 focuses on predicting the binding affinity of FDA-approved and Taiwan National Health Insurance (NHI) drugs with the seven proteins mentioned above. This database contains a total of 3,109 drugs. DockCoV2 is easy to use and search against, is well cross-linked to external databases, and provides the state-of-the-art prediction results in one site. Users can download their drug-protein docking data of interest and examine additional drug-related information on DockCoV2. Furthermore, DockCoV2 provides experimental information to help users understand which drugs have already been reported to be effective against MERS or SARS-CoV. DockCoV2 is available at https://covirus.cc/drugs/.', 'authors': [{'name': 'Chen T.-F.'}, {'name': 'Chang Y.-C.'}, {'name': 'Hsiao Y.'}, {'name': 'Lee K.-H.'}, {'name': 'Hsiao Y.-C.'}, {'name': 'Lin Y.-H.'}, {'name': 'Tu Y.-C.E.'}, {'name': 'Huang H.-C.'}, {'name': 'Chen C.-Y.'}, {'name': 'Juan H.-F.'}], 'citationCount': 3, 'date': '2021-01-08T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'DockCoV2: A drug database against SARS-CoV-2'}, 'pmid': '33035337'}]"
217,yukijuan@ntu.edu.tw,Hsueh-Fen Juan,Person,,,,,,,dockcov2,Open access,Kigaard,"[{'doi': '10.1093/NAR/GKAA861', 'metadata': {'abstract': '© 2021 The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.The current state of the COVID-19 pandemic is a global health crisis. To fight the novel coronavirus, one of the best-known ways is to block enzymes essential for virus replication. Currently, we know that the SARS-CoV-2 virus encodes about 29 proteins such as spike protein, 3C-like protease (3CLpro), RNA-dependent RNA polymerase (RdRp), Papain-like protease (PLpro), and nucleocapsid (N) protein. SARS-CoV-2 uses human angiotensin-converting enzyme 2 (ACE2) for viral entry and transmembrane serine protease family member II (TMPRSS2) for spike protein priming. Thus in order to speed up the discovery of potential drugs, we develop DockCoV2, a drug database for SARS-CoV-2. DockCoV2 focuses on predicting the binding affinity of FDA-approved and Taiwan National Health Insurance (NHI) drugs with the seven proteins mentioned above. This database contains a total of 3,109 drugs. DockCoV2 is easy to use and search against, is well cross-linked to external databases, and provides the state-of-the-art prediction results in one site. Users can download their drug-protein docking data of interest and examine additional drug-related information on DockCoV2. Furthermore, DockCoV2 provides experimental information to help users understand which drugs have already been reported to be effective against MERS or SARS-CoV. DockCoV2 is available at https://covirus.cc/drugs/.', 'authors': [{'name': 'Chen T.-F.'}, {'name': 'Chang Y.-C.'}, {'name': 'Hsiao Y.'}, {'name': 'Lee K.-H.'}, {'name': 'Hsiao Y.-C.'}, {'name': 'Lin Y.-H.'}, {'name': 'Tu Y.-C.E.'}, {'name': 'Huang H.-C.'}, {'name': 'Chen C.-Y.'}, {'name': 'Juan H.-F.'}], 'citationCount': 3, 'date': '2021-01-08T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'DockCoV2: A drug database against SARS-CoV-2'}, 'pmid': '33035337'}]"
218,fpsom@certh.gr,Fotis E. Psomopoulos,Person,https://orcid.org/0000-0002-0222-4273,['Primary contact'],,,,,lineagespot,Open access,fpsom,"[{'doi': '10.1101/2021.03.17.21252673', 'version': '1.0'}]"
219,andreas.kramer@qiagen.com,Andreas Krämer,Person,https://orcid.org/0000-0003-1352-7242,['Primary contact'],,,,,coronavirus-network-explorer,,Kigaard,"[{'doi': '10.1186/S12859-021-04148-X', 'metadata': {'abstract': '© 2021, The Author(s).Background: Leveraging previously identified viral interactions with human host proteins, we apply a machine learning-based approach to connect SARS-CoV-2 viral proteins to relevant host biological functions, diseases, and pathways in a large-scale knowledge graph derived from the biomedical literature. Our goal is to explore how SARS-CoV-2 could interfere with various host cell functions, and to identify drug targets amongst the host genes that could potentially be modulated against COVID-19 by repurposing existing drugs. The machine learning model employed here involves gene embeddings that leverage causal gene expression signatures curated from literature. In contrast to other network-based approaches for drug repurposing, our approach explicitly takes the direction of effects into account, distinguishing between activation and inhibition. Results: We have constructed 70 networks connecting SARS-CoV-2 viral proteins to various biological functions, diseases, and pathways reflecting viral biology, clinical observations, and co-morbidities in the context of COVID-19. Results are presented in the form of interactive network visualizations through a web interface, the Coronavirus Network Explorer (CNE), that allows exploration of underlying experimental evidence. We find that existing drugs targeting genes in those networks are strongly enriched in the set of drugs that are already in clinical trials against COVID-19. Conclusions: The approach presented here can identify biologically plausible hypotheses for COVID-19 pathogenesis, explicitly connected to the immunological, virological and pathological observations seen in SARS-CoV-2 infected patients. The discovery of repurposable drugs is driven by prior knowledge of relevant functional endpoints that reflect known viral biology or clinical observations, therefore suggesting potential mechanisms of action. We believe that the CNE offers relevant insights that go beyond more conventional network approaches, and can be a valuable tool for drug repurposing. The CNE is available at https://digitalinsights.qiagen.com/coronavirus-network-explorer.', 'authors': [{'name': 'Kramer A.'}, {'name': 'Billaud J.-N.'}, {'name': 'Tugendreich S.'}, {'name': 'Shiffman D.'}, {'name': 'Jones M.'}, {'name': 'Green J.'}], 'citationCount': 1, 'date': '2021-12-01T00:00:00Z', 'journal': 'BMC Bioinformatics', 'title': 'The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function'}, 'pmcid': 'PMC8091149', 'pmid': '33941085', 'type': ['Primary']}]"
220,jlever@stanford.edu,Jake Lever,Person,https://orcid.org/0000-0001-8198-2939,['Primary contact'],,,,,coronacentral,,Kigaard,"[{'doi': '10.1073/PNAS.2100766118', 'metadata': {'abstract': '© This open access article is distributed under Creative Commons Attribution License 4.0 (CC BY).The SARS-CoV-2 pandemic has caused a surge in research exploring all aspects of the virus and its effects on human health. The overwhelming publication rate means that researchers are unable to keep abreast of the literature. To ameliorate this, we present the CoronaCentral resource that uses machine learning to process the research literature on SARS-CoV-2 together with SARS-CoV and MERS-CoV. We categorize the literature into useful topics and article types and enable analysis of the contents, pace, and emphasis of research during the crisis with integration of Altmetric data. These topics include therapeutics, disease forecasting, as well as growing areas such as “long COVID” and studies of inequality. This resource, available at https://coronacentral.ai, is updated daily.', 'authors': [{'name': 'Lever J.'}, {'name': 'Altman R.B.'}], 'citationCount': 2, 'date': '2021-06-08T00:00:00Z', 'journal': 'Proceedings of the National Academy of Sciences of the United States of America', 'title': 'Analyzing the vast coronavirus literature with CoronaCentral'}, 'pmid': '34016708', 'type': ['Primary']}]"
221,beisi.xu@stjude.org,Beisi Xu,Person,https://orcid.org/0000-0003-0099-858X,['Primary contact'],,,,,covidexpress,,Kigaard,[{'doi': '10.1101/2021.05.14.444026'}]
222,stefano.ceri@polimi.it,Stefano Ceri,Person,https://orcid.org/0000-0003-0671-2415,['Primary contact'],Professor of Database Systems at Politecnico di Milano,https://ceri.faculty.polimi.it/,,,virusurf,Open access,abernasconi,"[{'doi': '10.1093/nar/gkaa846', 'pmcid': 'PMC7778888', 'pmid': '33045721', 'type': ['Primary']}]"
223,arif.canakoglu@polimi.it,Arif Canakoglu,Person,https://orcid.org/0000-0003-4528-6586,['Contributor'],Research assistant at Politecnico di Milano,https://www.deib.polimi.it/eng/people/details/626632,,,virusurf,Open access,abernasconi,"[{'doi': '10.1093/nar/gkaa846', 'pmcid': 'PMC7778888', 'pmid': '33045721', 'type': ['Primary']}]"
224,pietro.pinoli@polimi.it,Pietro Pinoli,,https://orcid.org/0000-0001-9786-2851,['Contributor'],Researcher at Politecnico di Milano,https://www.deib.polimi.it/ita/personale/dettagli/585322,,,virusurf,Open access,abernasconi,"[{'doi': '10.1093/nar/gkaa846', 'pmcid': 'PMC7778888', 'pmid': '33045721', 'type': ['Primary']}]"
225,anna.bernasconi@polimi.it,Anna Bernasconi,Person,https://orcid.org/0000-0001-8016-5750,['Contributor'],Research assistant at Politecnico di Milano,https://annabernasconi.faculty.polimi.it/,,,virusurf,Open access,abernasconi,"[{'doi': '10.1093/nar/gkaa846', 'pmcid': 'PMC7778888', 'pmid': '33045721', 'type': ['Primary']}]"
226,kleistm@rki.de,Max von Kleist,Person,https://orcid.org/0000-0001-6587-6394,['Primary contact'],,,,,ginpipe,,Kigaard,"[{'doi': '10.1101/2021.05.14.21257234', 'type': ['Primary']}]"
227,stefano.ceri@polimi.it,Stefano Ceri,Person,https://orcid.org/0000-0003-0671-2415,,,,,,virusviz,,Jennifer,"[{'doi': '10.1093/NAR/GKAB478', 'pmcid': 'PMC8344854', 'pmid': '34107016'}]"
228,milli@di.unipi.it,Letizia Milli,Person,https://orcid.org/0000-0001-5283-0477,,,,,,utldr,,Jennifer,"[{'doi': '10.1007/S10844-021-00649-6', 'metadata': {'abstract': '© 2021, The Author(s).Due to the SARS-CoV-2 pandemic, epidemic modeling is now experiencing a constantly growing interest from researchers of heterogeneous study fields. Indeed, due to such an increased attention, several software libraries and scientific tools have been developed to ease the access to epidemic modeling. However, only a handful of such resources were designed with the aim of providing a simple proxy for the study of the potential effects of public interventions (e.g., lockdown, testing, contact tracing). In this work, we introduce UTLDR, a framework that, overcoming such limitations, allows to generate “what if” epidemic scenarios incorporating several public interventions (and their combinations). UTLDR is designed to be easy to use and capable to leverage information provided by stratified populations of agents (e.g., age, gender, geographical allocation, and mobility patterns…). Moreover, the proposed framework is generic and not tailored for a specific epidemic phenomena: it aims to provide a qualitative support to understanding the effects of restrictions, rather than produce forecasts/explanation of specific data-driven phenomena.', 'authors': [{'name': 'Rossetti G.'}, {'name': 'Milli L.'}, {'name': 'Citraro S.'}, {'name': 'Morini V.'}], 'date': '2021-10-01T00:00:00Z', 'journal': 'Journal of Intelligent Information Systems', 'title': 'UTLDR: an agent-based framework for modeling infectious diseases and public interventions'}, 'pmcid': 'PMC8210516', 'pmid': '34155422'}]"
229,vincent.navratil@univ-lyon1.fr,VirHostNet Support,Person,https://orcid.org/0000-0001-9974-1877,['Primary contact'],Head of the prabi-amsb bioinformatics core facility (http://amsb.prabi.fr),,,,virhostnet,Open access,vincent.navratil@univ-lyon1.fr,"[{'metadata': {'abstract': 'Infectious diseases caused by viral agents kill millions of people every year. The improvement of prevention and treatment of viral infections and their associated diseases remains one of the main public health challenges. Towards this goal, deciphering virus-host molecular interactions opens new perspectives to understand the biology of infection and for the design of new antiviral strategies. Indeed, modelling of an infection network between viral and cellular proteins will provide a conceptual and analytic framework to efficiently formulate new biological hypothesis at the proteome scale and to rationalize drug discovery. Therefore, we present the first release of VirHostNet (Virus-Host Network), a public knowledge base specialized in the management and analysis of integrated virus-virus, virus-host and host-host interaction networks coupled to their functional annotations. VirHostNet integrates an extensive and original literature-curated dataset of virus-virus and virus-host interactions (2671 non-redundant interactions) representing more than 180 distinct viral species and one of the largest human interactome (10 672 proteins and 68 252 non-redundant interactions) reconstructed from publicly available data. The VirHostNet Web interface provides appropriate tools that allow efficient query and visualization of this infected cellular network. Public access to the VirHostNet knowledge-based system is available at http://pbildb1.univ-lyon1.fr/virhostnet. © 2008 The Author(s).', 'authors': [{'name': 'Navratil V.'}, {'name': 'De chassey B.'}, {'name': 'Meyniel L.'}, {'name': 'Delmotte S.'}, {'name': 'Gautier C.'}, {'name': 'Andre P.'}, {'name': 'Lotteau V.'}, {'name': 'Rabourdin-Combe C.'}], 'citationCount': 119, 'date': '2009-01-09T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'VirHostNet: A knowledge base for the management and the analysis of proteome-wide virus-host interaction networks'}, 'pmid': '18984613'}, {'metadata': {'abstract': '© The Author(s) 2014.VirHostNet release 2.0 (http://virhostnet.prabi.fr) is a knowledgebase dedicated to the network-based exploration of virus-host protein-protein interactions. Since the previous VirhostNet release (2009), a second run of manual curation was performed to annotate the new torrent of high-throughput protein-protein interactions data from the literature. This resource is shared publicly, in PSI-MI TAB 2.5 format, using a PSICQUIC web service. The new interface of VirHostNet 2.0 is based on Cytoscape web library and provides a user-friendly access to the most complete and accurate resource of virus-virus and virus-host protein-protein interactions as well as their projection onto their corresponding host cell protein interaction networks. We hope that the VirHostNet 2.0 system will facilitate systems biology and gene-centered analysis of infectious diseases and will help to identify new molecular targets for antiviral drugs design. This resource will also continue to help worldwide scientists to improve our knowledge on molecular mechanisms involved in the antiviral response mediated by the cell and in the viral strategies selected by viruses to hijack the host immune system.', 'authors': [{'name': 'Guirimand T.'}, {'name': 'Delmotte S.'}, {'name': 'Navratil V.'}], 'citationCount': 89, 'date': '2015-01-28T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'VirHostNet 2.0: Surfing on the web of virus/host molecular interactions data'}, 'pmid': '25392406'}, {'metadata': {'abstract': '© 2020 The Author(s) 2020. Published by Oxford University Press.SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a novel virus of the family Coronaviridae. The virus causes the infectious disease COVID-19. The biology of coronaviruses has been studied for many years. However, bioinformatics tools designed explicitly for SARS-CoV-2 have only recently been developed as a rapid reaction to the need for fast detection, understanding and treatment of COVID-19. To control the ongoing COVID-19 pandemic, it is of utmost importance to get insight into the evolution and pathogenesis of the virus. In this review, we cover bioinformatics workflows and tools for the routine detection of SARS-CoV-2 infection, the reliable analysis of sequencing data, the tracking of the COVID-19 pandemic and evaluation of containment measures, the study of coronavirus evolution, the discovery of potential drug targets and development of therapeutic strategies. For each tool, we briefly describe its use case and how it advances research specifically for SARS-CoV-2. All tools are free to use and available online, either through web applications or public code repositories. Contact:evbc@unj-jena.de', 'authors': [{'name': 'Hufsky F.'}, {'name': 'Lamkiewicz K.'}, {'name': 'Almeida A.'}, {'name': 'Aouacheria A.'}, {'name': 'Arighi C.'}, {'name': 'Bateman A.'}, {'name': 'Baumbach J.'}, {'name': 'Beerenwinkel N.'}, {'name': 'Brandt C.'}, {'name': 'Cacciabue M.'}, {'name': 'Chuguransky S.'}, {'name': 'Drechsel O.'}, {'name': 'Finn R.D.'}, {'name': 'Fritz A.'}, {'name': 'Fuchs S.'}, {'name': 'Hattab G.'}, {'name': 'Hauschild A.-C.'}, {'name': 'Heider D.'}, {'name': 'Hoffmann M.'}, {'name': 'Holzer M.'}, {'name': 'Hoops S.'}, {'name': 'Kaderali L.'}, {'name': 'Kalvari I.'}, {'name': 'Von Kleist M.'}, {'name': 'Kmiecinski R.'}, {'name': 'Kuhnert D.'}, {'name': 'Lasso G.'}, {'name': 'Libin P.'}, {'name': 'List M.'}, {'name': 'Lochel H.F.'}, {'name': 'Martin M.J.'}, {'name': 'Martin R.'}, {'name': 'Matschinske J.'}, {'name': 'McHardy A.C.'}, {'name': 'Mendes P.'}, {'name': 'Mistry J.'}, {'name': 'Navratil V.'}, {'name': 'Nawrocki E.P.'}, {'name': ""O'Toole A.N.""}, {'name': 'Ontiveros-Palacios N.'}, {'name': 'Petrov A.I.'}, {'name': 'Rangel-Pineros G.'}, {'name': 'Redaschi N.'}, {'name': 'Reimering S.'}, {'name': 'Reinert K.'}, {'name': 'Reyes A.'}, {'name': 'Richardson L.'}, {'name': 'Robertson D.L.'}, {'name': 'Sadegh S.'}, {'name': 'Singer J.B.'}, {'name': 'Theys K.'}, {'name': 'Upton C.'}, {'name': 'Welzel M.'}, {'name': 'Williams L.'}, {'name': 'Marz M.'}], 'citationCount': 13, 'date': '2021-03-01T00:00:00Z', 'journal': 'Briefings in Bioinformatics', 'title': 'Computational strategies to combat COVID-19: Useful tools to accelerate SARS-CoV-2 and coronavirus research'}, 'pmid': '33147627'}]"
230,,SIB Swiss Institute of Bioinformatics,Institute,,['Provider'],,,,,viralzone,,SIB,"[{'doi': '10.1093/nar/gkq901', 'metadata': {'abstract': 'The molecular diversity of viruses complicates the interpretation of viral genomic and proteomic data. To make sense of viral gene functions, investigators must be familiar with the virus host range, replication cycle and virion structure. Our aim is to provide a comprehensive resource bridging together textbook knowledge with genomic and proteomic sequences. ViralZone web resource (www.expasy.org/viralzone/) provides fact sheets on all known virus families/genera with easy access to sequence data. A selection of reference strains (RefStrain) provides annotated standards to circumvent the exponential increase of virus sequences. Moreover ViralZone offers a complete set of detailed and accurate virion pictures. © The Author(s) 2010.', 'authors': [{'name': 'Hulo C.'}, {'name': 'De Castro E.'}, {'name': 'Masson P.'}, {'name': 'Bougueleret L.'}, {'name': 'Bairoch A.'}, {'name': 'Xenarios I.'}, {'name': 'Le Mercier P.'}], 'citationCount': 179, 'date': '2011-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'ViralZone: A knowledge resource to understand virus diversity'}, 'pmcid': 'PMC3013774', 'pmid': '20947564', 'type': ['Primary']}]"
231,viralzone@isb-sib.ch,,Person,,['Primary contact'],,,,,viralzone,,SIB,"[{'doi': '10.1093/nar/gkq901', 'metadata': {'abstract': 'The molecular diversity of viruses complicates the interpretation of viral genomic and proteomic data. To make sense of viral gene functions, investigators must be familiar with the virus host range, replication cycle and virion structure. Our aim is to provide a comprehensive resource bridging together textbook knowledge with genomic and proteomic sequences. ViralZone web resource (www.expasy.org/viralzone/) provides fact sheets on all known virus families/genera with easy access to sequence data. A selection of reference strains (RefStrain) provides annotated standards to circumvent the exponential increase of virus sequences. Moreover ViralZone offers a complete set of detailed and accurate virion pictures. © The Author(s) 2010.', 'authors': [{'name': 'Hulo C.'}, {'name': 'De Castro E.'}, {'name': 'Masson P.'}, {'name': 'Bougueleret L.'}, {'name': 'Bairoch A.'}, {'name': 'Xenarios I.'}, {'name': 'Le Mercier P.'}], 'citationCount': 179, 'date': '2011-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'ViralZone: A knowledge resource to understand virus diversity'}, 'pmcid': 'PMC3013774', 'pmid': '20947564', 'type': ['Primary']}]"
232,,University of Hamburg - Center for Bioinformatics,Institute,,['Provider'],,,,,edia,,stierand,"[{'doi': '10.1021/acs.jcim.7b00391', 'metadata': {'abstract': ""© 2017 American Chemical Society.Macromolecular structures resolved by X-ray crystallography are essential for life science research. While some methods exist to automatically quantify the quality of the electron density fit, none of them is without flaws. Especially the question of how well individual parts like atoms, small fragments, or molecules are supported by electron density is difficult to quantify. While taking experimental uncertainties correctly into account, they do not offer an answer on how reliable an individual atom position is. A rapid quantification of this atomic position reliability would be highly valuable in structure-based molecular design. To overcome this limitation, we introduce the electron density score EDIA for individual atoms and molecular fragments. EDIA assesses rapidly, automatically, and intuitively the fit of individual as well as multiple atoms (EDIAm) into electron density accompanied by an integrated error analysis. The computation is based on the standard 2fo - fc electron density map in combination with the model of the molecular structure. For evaluating partial structures, EDIAm shows significant advantages compared to the real-space R correlation coefficient (RSCC) and the real-space difference density Z score (RSZD) from the molecular modeler's point of view. Thus, EDIA abolishes the time-consuming step of visually inspecting the electron density during structure selection and curation. It supports daily modeling tasks of medicinal and computational chemists and enables a fully automated assembly of large-scale, high-quality structure data sets. Furthermore, EDIA scores can be applied for model validation and method development in computer-aided molecular design. In contrast to measuring the deviation from the structure model by root-mean-squared deviation, EDIA scores allow comparison to the underlying experimental data taking its uncertainty into account."", 'authors': [{'name': 'Meyder A.'}, {'name': 'Nittinger E.'}, {'name': 'Lange G.'}, {'name': 'Klein R.'}, {'name': 'Rarey M.'}], 'citationCount': 33, 'date': '2017-10-23T00:00:00Z', 'journal': 'Journal of Chemical Information and Modeling', 'title': 'Estimating Electron Density Support for Individual Atoms and Molecular Fragments in X-ray Structures'}, 'pmid': '28981269', 'type': ['Primary']}]"
233,rarey-office@zbh.uni-hamburg.de,,Person,,['Primary contact'],,,,,edia,,stierand,"[{'doi': '10.1021/acs.jcim.7b00391', 'metadata': {'abstract': ""© 2017 American Chemical Society.Macromolecular structures resolved by X-ray crystallography are essential for life science research. While some methods exist to automatically quantify the quality of the electron density fit, none of them is without flaws. Especially the question of how well individual parts like atoms, small fragments, or molecules are supported by electron density is difficult to quantify. While taking experimental uncertainties correctly into account, they do not offer an answer on how reliable an individual atom position is. A rapid quantification of this atomic position reliability would be highly valuable in structure-based molecular design. To overcome this limitation, we introduce the electron density score EDIA for individual atoms and molecular fragments. EDIA assesses rapidly, automatically, and intuitively the fit of individual as well as multiple atoms (EDIAm) into electron density accompanied by an integrated error analysis. The computation is based on the standard 2fo - fc electron density map in combination with the model of the molecular structure. For evaluating partial structures, EDIAm shows significant advantages compared to the real-space R correlation coefficient (RSCC) and the real-space difference density Z score (RSZD) from the molecular modeler's point of view. Thus, EDIA abolishes the time-consuming step of visually inspecting the electron density during structure selection and curation. It supports daily modeling tasks of medicinal and computational chemists and enables a fully automated assembly of large-scale, high-quality structure data sets. Furthermore, EDIA scores can be applied for model validation and method development in computer-aided molecular design. In contrast to measuring the deviation from the structure model by root-mean-squared deviation, EDIA scores allow comparison to the underlying experimental data taking its uncertainty into account."", 'authors': [{'name': 'Meyder A.'}, {'name': 'Nittinger E.'}, {'name': 'Lange G.'}, {'name': 'Klein R.'}, {'name': 'Rarey M.'}], 'citationCount': 33, 'date': '2017-10-23T00:00:00Z', 'journal': 'Journal of Chemical Information and Modeling', 'title': 'Estimating Electron Density Support for Individual Atoms and Molecular Fragments in X-ray Structures'}, 'pmid': '28981269', 'type': ['Primary']}]"
234,,University of Hamburg - Center for Bioinformatics,,,,,,,,proteinsplus,,stierand,"[{'doi': '10.1093/nar/gkx333', 'metadata': {'abstract': '© The Author(s) 2017. Published by Oxford University Press on behalf of Nucleic Acids Research.With currently more than 126 000 publicly available structures and an increasing growth rate, the Protein Data Bank constitutes a rich data source for structure-driven research in fields like drug discovery, crop science and biotechnology in general. Typical workflows in these areas involve manifold computational tools for the analysis and prediction of molecular functions. Here, we present the ProteinsPlus web server that offers a unified easy-to-use interface to a broad range of tools for the early phase of structure-based molecular modeling. This includes solutions for commonly required pre-processing tasks like structure quality assessment (EDIA), hydrogen placement (Protoss) and the search for alternative conformations (SIENA). Beyond that, it also addresses frequent problems as the generation of 2D-interaction diagrams (PoseView), protein-protein interface classification (HyPPI) as well as automatic pocket detection and druggablity assessment (DoGSiteScorer). The unified ProteinsPlus interface covering all featured approaches provides various facilities for intuitive input and result visualization, case-specific parameterization and download options for further processing. Moreover, its generalized workflow allows the user a quick familiarization with the different tools. ProteinsPlus also stores the calculated results temporarily for future request and thus facilitates convenient result communication and re-access.', 'authors': [{'name': 'Fahrrolfes R.'}, {'name': 'Bietz S.'}, {'name': 'Flachsenberg F.'}, {'name': 'Meyder A.'}, {'name': 'Nittinger E.'}, {'name': 'Otto T.'}, {'name': 'Volkamer A.'}, {'name': 'Rarey M.'}], 'citationCount': 59, 'date': '2017-07-03T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'Proteins Plus: A web portal for structure analysis of macromolecules'}, 'type': ['Primary']}, {'doi': '10.1093/nar/gkaa235', 'metadata': {'abstract': '© The Author(s) 2020.Due to the increasing amount of publicly available protein structures searching, enriching and investigating these data still poses a challenging task. The ProteinsPlus web service (https://proteins.plus) offers a broad range of tools addressing these challenges. The web interface to the tool collection focusing on protein–ligand interactions has been geared towards easy and intuitive access to a large variety of functionality for life scientists. Since our last publication, the ProteinsPlus web service has been extended by additional services as well as it has undergone substantial infrastructural improvements. A keyword search functionality was added on the start page of ProteinsPlus enabling users to work on structures without knowing their PDB code. The tool collection has been augmented by three tools: StructureProfiler validates ligands and active sites using selection criteria of well-established protein–ligand benchmark data sets, WarPP places water molecules in the lig- and binding sites of a protein, and METALizer calculates, predicts and scores coordination geometries of metal ions based on surrounding complex atoms. Additionally, all tools provided by ProteinsPlus are available through a REST service enabling the automated integration in structure processing and modeling pipelines.', 'authors': [{'name': 'Schoning-Stierand K.'}, {'name': 'Diedrich K.'}, {'name': 'Fahrrolfes R.'}, {'name': 'Flachsenberg F.'}, {'name': 'Meyder A.'}, {'name': 'Nittinger E.'}, {'name': 'Steinegger R.'}, {'name': 'Rarey M.'}], 'citationCount': 6, 'date': '2020-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'ProteinsPlus: Interactive analysis of protein–ligand binding interfaces'}, 'type': ['Primary']}]"
235,rarey-office@zbh.uni-hamburg.de,,Person,,['Primary contact'],,,,,proteinsplus,,stierand,"[{'doi': '10.1093/nar/gkx333', 'metadata': {'abstract': '© The Author(s) 2017. Published by Oxford University Press on behalf of Nucleic Acids Research.With currently more than 126 000 publicly available structures and an increasing growth rate, the Protein Data Bank constitutes a rich data source for structure-driven research in fields like drug discovery, crop science and biotechnology in general. Typical workflows in these areas involve manifold computational tools for the analysis and prediction of molecular functions. Here, we present the ProteinsPlus web server that offers a unified easy-to-use interface to a broad range of tools for the early phase of structure-based molecular modeling. This includes solutions for commonly required pre-processing tasks like structure quality assessment (EDIA), hydrogen placement (Protoss) and the search for alternative conformations (SIENA). Beyond that, it also addresses frequent problems as the generation of 2D-interaction diagrams (PoseView), protein-protein interface classification (HyPPI) as well as automatic pocket detection and druggablity assessment (DoGSiteScorer). The unified ProteinsPlus interface covering all featured approaches provides various facilities for intuitive input and result visualization, case-specific parameterization and download options for further processing. Moreover, its generalized workflow allows the user a quick familiarization with the different tools. ProteinsPlus also stores the calculated results temporarily for future request and thus facilitates convenient result communication and re-access.', 'authors': [{'name': 'Fahrrolfes R.'}, {'name': 'Bietz S.'}, {'name': 'Flachsenberg F.'}, {'name': 'Meyder A.'}, {'name': 'Nittinger E.'}, {'name': 'Otto T.'}, {'name': 'Volkamer A.'}, {'name': 'Rarey M.'}], 'citationCount': 59, 'date': '2017-07-03T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'Proteins Plus: A web portal for structure analysis of macromolecules'}, 'type': ['Primary']}, {'doi': '10.1093/nar/gkaa235', 'metadata': {'abstract': '© The Author(s) 2020.Due to the increasing amount of publicly available protein structures searching, enriching and investigating these data still poses a challenging task. The ProteinsPlus web service (https://proteins.plus) offers a broad range of tools addressing these challenges. The web interface to the tool collection focusing on protein–ligand interactions has been geared towards easy and intuitive access to a large variety of functionality for life scientists. Since our last publication, the ProteinsPlus web service has been extended by additional services as well as it has undergone substantial infrastructural improvements. A keyword search functionality was added on the start page of ProteinsPlus enabling users to work on structures without knowing their PDB code. The tool collection has been augmented by three tools: StructureProfiler validates ligands and active sites using selection criteria of well-established protein–ligand benchmark data sets, WarPP places water molecules in the lig- and binding sites of a protein, and METALizer calculates, predicts and scores coordination geometries of metal ions based on surrounding complex atoms. Additionally, all tools provided by ProteinsPlus are available through a REST service enabling the automated integration in structure processing and modeling pipelines.', 'authors': [{'name': 'Schoning-Stierand K.'}, {'name': 'Diedrich K.'}, {'name': 'Fahrrolfes R.'}, {'name': 'Flachsenberg F.'}, {'name': 'Meyder A.'}, {'name': 'Nittinger E.'}, {'name': 'Steinegger R.'}, {'name': 'Rarey M.'}], 'citationCount': 6, 'date': '2020-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'ProteinsPlus: Interactive analysis of protein–ligand binding interfaces'}, 'type': ['Primary']}]"
236,,University of Hamburg - Center for Bioinformatics,Institute,,['Provider'],,,,,protoss,,stierand,"[{'doi': '10.1186/1758-2946-6-12', 'metadata': {'abstract': 'The calculation of hydrogen positions is a common preprocessing step when working with crystal structures of protein-ligand complexes. An explicit description of hydrogen atoms is generally needed in order to analyze the binding mode of particular ligands or to calculate the associated binding energies. Due to the large number of degrees of freedom resulting from different chemical moieties and the high degree of mutual dependence this problem is anything but trivial. In addition to an efficient algorithm to take care of the complexity resulting from complicated hydrogen bonding networks, a robust chemical model is needed to describe effects such as tautomerism and ionization consistently. We present a novel method for the placement of hydrogen coordinates in protein-ligand complexes which takes tautomers and protonation states of both protein and ligand into account. Our method generates the most probable hydrogen positions on the basis of an optimal hydrogen bonding network using an empirical scoring function. The high quality of our results could be verified by comparison to the manually adjusted Astex diverse set and a remarkably low rate of undesirable hydrogen contacts compared to other tools. © 2014 Bietz et al.; licensee Chemistry Central Ltd.', 'authors': [{'name': 'Bietz S.'}, {'name': 'Urbaczek S.'}, {'name': 'Schulz B.'}, {'name': 'Rarey M.'}], 'citationCount': 84, 'date': '2014-04-03T00:00:00Z', 'journal': 'Journal of Cheminformatics', 'title': 'Protoss: A holistic approach to predict tautomers and protonation states in protein-ligand complexes'}, 'type': ['Primary']}, {'doi': '10.1186/1758-2946-1-13', 'metadata': {'abstract': 'Background. Hydrogen bonds play a major role in the stabilization of protein-ligand complexes. The ability of a functional group to form them depends on the position of its hydrogen atoms. An accurate knowledge of the positions of hydrogen atoms in proteins is therefore important to correctly identify hydrogen bonds and their properties. The high mobility of hydrogen atoms introduces several degrees of freedom: Tautomeric states, where a hydrogen atom alters its binding partner, torsional changes where the position of the hydrogen atom is rotated around the last heavy-atom bond in a residue, and protonation states, where the number of hydrogen atoms at a functional group may change. Also, side-chain flips in glutamine and asparagine and histidine residues, which are common crystallographic ambiguities must be identified before structure-based calculations can be conducted. Results. We have implemented a method to determine the most probable hydrogen atom positions in a given protein-ligand complex. Optimality of hydrogen bond geometries is determined by an empirical scoring function which is used in molecular docking. This allows to evaluate protein-ligand interactions with an established model. Also, our method allows to resolve common crystallographic ambiguities such as as flipped amide groups and histidine residues. To ensure high speed, we make use of a dynamic programming approach. Conclusion. Our results were checked against selected high-resolution structures from an external dataset, for which the positions of the hydrogen atoms have been validated manually. The quality of our results is comparable to that of other programs, with the advantage of being fast enough to be applied on-the-fly for interactive usage or during score evaluation. © 2009 Lippert and Rarey; licensee BioMed Central Ltd.', 'authors': [{'name': 'Lippert T.'}, {'name': 'Rarey M.'}], 'citationCount': 25, 'date': '2009-12-01T00:00:00Z', 'journal': 'Journal of Cheminformatics', 'title': 'Fast automated placement of polar hydrogen atoms in protein-ligand complexes'}, 'type': ['Other']}]"
237,rarey-office@zbh.uni-hambugr.de,,Person,,['Primary contact'],,,,,protoss,,stierand,"[{'doi': '10.1186/1758-2946-6-12', 'metadata': {'abstract': 'The calculation of hydrogen positions is a common preprocessing step when working with crystal structures of protein-ligand complexes. An explicit description of hydrogen atoms is generally needed in order to analyze the binding mode of particular ligands or to calculate the associated binding energies. Due to the large number of degrees of freedom resulting from different chemical moieties and the high degree of mutual dependence this problem is anything but trivial. In addition to an efficient algorithm to take care of the complexity resulting from complicated hydrogen bonding networks, a robust chemical model is needed to describe effects such as tautomerism and ionization consistently. We present a novel method for the placement of hydrogen coordinates in protein-ligand complexes which takes tautomers and protonation states of both protein and ligand into account. Our method generates the most probable hydrogen positions on the basis of an optimal hydrogen bonding network using an empirical scoring function. The high quality of our results could be verified by comparison to the manually adjusted Astex diverse set and a remarkably low rate of undesirable hydrogen contacts compared to other tools. © 2014 Bietz et al.; licensee Chemistry Central Ltd.', 'authors': [{'name': 'Bietz S.'}, {'name': 'Urbaczek S.'}, {'name': 'Schulz B.'}, {'name': 'Rarey M.'}], 'citationCount': 84, 'date': '2014-04-03T00:00:00Z', 'journal': 'Journal of Cheminformatics', 'title': 'Protoss: A holistic approach to predict tautomers and protonation states in protein-ligand complexes'}, 'type': ['Primary']}, {'doi': '10.1186/1758-2946-1-13', 'metadata': {'abstract': 'Background. Hydrogen bonds play a major role in the stabilization of protein-ligand complexes. The ability of a functional group to form them depends on the position of its hydrogen atoms. An accurate knowledge of the positions of hydrogen atoms in proteins is therefore important to correctly identify hydrogen bonds and their properties. The high mobility of hydrogen atoms introduces several degrees of freedom: Tautomeric states, where a hydrogen atom alters its binding partner, torsional changes where the position of the hydrogen atom is rotated around the last heavy-atom bond in a residue, and protonation states, where the number of hydrogen atoms at a functional group may change. Also, side-chain flips in glutamine and asparagine and histidine residues, which are common crystallographic ambiguities must be identified before structure-based calculations can be conducted. Results. We have implemented a method to determine the most probable hydrogen atom positions in a given protein-ligand complex. Optimality of hydrogen bond geometries is determined by an empirical scoring function which is used in molecular docking. This allows to evaluate protein-ligand interactions with an established model. Also, our method allows to resolve common crystallographic ambiguities such as as flipped amide groups and histidine residues. To ensure high speed, we make use of a dynamic programming approach. Conclusion. Our results were checked against selected high-resolution structures from an external dataset, for which the positions of the hydrogen atoms have been validated manually. The quality of our results is comparable to that of other programs, with the advantage of being fast enough to be applied on-the-fly for interactive usage or during score evaluation. © 2009 Lippert and Rarey; licensee BioMed Central Ltd.', 'authors': [{'name': 'Lippert T.'}, {'name': 'Rarey M.'}], 'citationCount': 25, 'date': '2009-12-01T00:00:00Z', 'journal': 'Journal of Cheminformatics', 'title': 'Fast automated placement of polar hydrogen atoms in protein-ligand complexes'}, 'type': ['Other']}]"
238,,University of Hamburg - Center for Bioinformatics,Institute,,['Provider'],,,,,dogsitescorer,,stierand,"[{'doi': '10.1021/ci100241y', 'metadata': {'abstract': 'Automated prediction of protein active sites is essential for large-scale protein function prediction, classification, and druggability estimates. In this work, we present DoGSite, a new structure-based method to predict active sites in proteins based on a Difference of Gaussian (DoG) approach which originates from image processing. In contrast to existing methods, DoGSite splits predicted pockets into subpockets, revealing a refined description of the topology of active sites. DoGSite correctly predicts binding pockets for over 92% of the PDBBind and the scPDB data set, being in line with the best-performing methods available. In 63% of the PDBBind data set the detected pockets can be subdivided into smaller subpockets. The cocrystallized ligand is contained in exactly one subpocket in 87% of the predictions. Furthermore, we introduce a more precise prediction performance measure by taking the pairwise ligand and pocket coverage into account. In 90% of the cases DoGSite predicts a pocket that contains at least half of the ligand. In 70% of the cases additionally more than a quarter of the respective pocket itself is covered by the cocrystallized ligand. Consideration of subpockets produces an increase in coverage yielding a success rate of 83% for the latter measure. © 2010 American Chemical Society.', 'authors': [{'name': 'Volkamer A.'}, {'name': 'Griewel A.'}, {'name': 'Grombacher T.'}, {'name': 'Rarey M.'}], 'citationCount': 90, 'date': '2010-11-22T00:00:00Z', 'journal': 'Journal of Chemical Information and Modeling', 'title': 'Analyzing the topology of active sites: On the prediction of pockets and subpockets'}, 'type': ['Primary']}, {'doi': '10.1093/bioinformatics/bts310', 'metadata': {'abstract': 'Motivation: Many drug discovery projects fail because the underlying target is finally found to be undruggable. Progress in structure elucidation of proteins now opens up a route to automatic structure-based target assessment. DoGSiteScorer is a newly developed automatic tool combining pocket prediction, characterization and druggability estimation and is now available through a web server. © The Author 2012. Published by Oxford University Press. All rights reserved.', 'authors': [{'name': 'Volkamer A.'}, {'name': 'Kuhn D.'}, {'name': 'Rippmann F.'}, {'name': 'Rarey M.'}], 'citationCount': 187, 'date': '2012-08-01T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'Dogsitescorer: A web server for automatic binding site prediction, analysis and druggability assessment'}, 'type': ['Other']}]"
239,rarey-office@zbh.uni-hamburg.de,,Person,,['Primary contact'],,,,,dogsitescorer,,stierand,"[{'doi': '10.1021/ci100241y', 'metadata': {'abstract': 'Automated prediction of protein active sites is essential for large-scale protein function prediction, classification, and druggability estimates. In this work, we present DoGSite, a new structure-based method to predict active sites in proteins based on a Difference of Gaussian (DoG) approach which originates from image processing. In contrast to existing methods, DoGSite splits predicted pockets into subpockets, revealing a refined description of the topology of active sites. DoGSite correctly predicts binding pockets for over 92% of the PDBBind and the scPDB data set, being in line with the best-performing methods available. In 63% of the PDBBind data set the detected pockets can be subdivided into smaller subpockets. The cocrystallized ligand is contained in exactly one subpocket in 87% of the predictions. Furthermore, we introduce a more precise prediction performance measure by taking the pairwise ligand and pocket coverage into account. In 90% of the cases DoGSite predicts a pocket that contains at least half of the ligand. In 70% of the cases additionally more than a quarter of the respective pocket itself is covered by the cocrystallized ligand. Consideration of subpockets produces an increase in coverage yielding a success rate of 83% for the latter measure. © 2010 American Chemical Society.', 'authors': [{'name': 'Volkamer A.'}, {'name': 'Griewel A.'}, {'name': 'Grombacher T.'}, {'name': 'Rarey M.'}], 'citationCount': 90, 'date': '2010-11-22T00:00:00Z', 'journal': 'Journal of Chemical Information and Modeling', 'title': 'Analyzing the topology of active sites: On the prediction of pockets and subpockets'}, 'type': ['Primary']}, {'doi': '10.1093/bioinformatics/bts310', 'metadata': {'abstract': 'Motivation: Many drug discovery projects fail because the underlying target is finally found to be undruggable. Progress in structure elucidation of proteins now opens up a route to automatic structure-based target assessment. DoGSiteScorer is a newly developed automatic tool combining pocket prediction, characterization and druggability estimation and is now available through a web server. © The Author 2012. Published by Oxford University Press. All rights reserved.', 'authors': [{'name': 'Volkamer A.'}, {'name': 'Kuhn D.'}, {'name': 'Rippmann F.'}, {'name': 'Rarey M.'}], 'citationCount': 187, 'date': '2012-08-01T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'Dogsitescorer: A web server for automatic binding site prediction, analysis and druggability assessment'}, 'type': ['Other']}]"
240,,University of Hamburg - Center for Bioinformatics,Institute,,['Provider'],,,,,siena,,stierand,"[{'doi': '10.1021/acs.jcim.5b00588', 'metadata': {'abstract': '© 2016 American Chemical Society.Structural flexibility of proteins has an important influence on molecular recognition and enzymatic function. In modeling, structure ensembles are therefore often applied as a valuable source of alternative protein conformations. However, their usage is often complicated by structural artifacts and inconsistent data annotation. Here, we present SIENA, a new computational approach for the automated assembly and preprocessing of protein binding site ensembles. Starting with an arbitrarily defined binding site in a single protein structure, SIENA searches for alternative conformations of the same or sequentially closely related binding sites. The method is based on an indexed database for identifying perfect k-mer matches and a recently published algorithm for the alignment of protein binding site conformations. Furthermore, SIENA provides a new algorithm for the interaction-based selection of binding site conformations which aims at covering all known ligand-binding geometries. Various experiments highlight that SIENA is able to generate comprehensive and well selected binding site ensembles improving the compatibility to both known and unconsidered ligand molecules. Starting with the whole PDB as data source, the computation time of the whole ensemble generation takes only a few seconds. SIENA is available via a Web service at www.zbh.uni-hamburg.de/siena.', 'authors': [{'name': 'Bietz S.'}, {'name': 'Rarey M.'}], 'citationCount': 21, 'date': '2016-01-25T00:00:00Z', 'journal': 'Journal of Chemical Information and Modeling', 'title': 'SIENA: Efficient Compilation of Selective Protein Binding Site Ensembles'}, 'type': ['Primary']}, {'doi': '10.1021/acs.jcim.5b00210', 'metadata': {'abstract': '© 2015 American Chemical Society.The usage of conformational ensembles constitutes a widespread technique for the consideration of protein flexibility in computational biology. When experimental structures are applied for this purpose, alignment techniques are usually required in dealing with structural deviations and annotation inconsistencies. Moreover, many application scenarios focus on protein ligand binding sites. Here, we introduce our new alignment algorithm ASCONA that has been specially geared to the problem of aligning multiple conformations of sequentially similar binding sites. Intense efforts have been directed to an accurate detection of highly flexible backbone deviations, multiple binding site matches within a single structure, and a reliable, but at the same time highly efficient, search algorithm. In contrast, most available alignment methods rather target other issues, e.g., the global alignment of distantly related proteins that share structurally conserved regions. For conformational ensembles, this might not only result in an overhead of computation time but could also affect the achieved accuracy, especially for more complicated cases as highly flexible proteins. ASCONA was evaluated on a test set containing 1107 structures of 65 diverse proteins. In all cases, ASCONA was able to correctly align the binding site at an average alignment computation time of 4 ms per target. Furthermore, no false positive matches were observed when searching the same query sites in the structures of other proteins. ASCONA proved to cope with highly deviating backbone structures and to tolerate structural gaps and moderate mutation rates. ASCONA is available free of charge for academic use at http://www.zbh.uni-hamburg.de/ascona. (Figure Presented).', 'authors': [{'name': 'Bietz S.'}, {'name': 'Rarey M.'}], 'citationCount': 9, 'date': '2015-08-24T00:00:00Z', 'journal': 'Journal of Chemical Information and Modeling', 'title': 'ASCONA: Rapid Detection and Alignment of Protein Binding Site Conformations'}, 'type': ['Method']}]"
241,rarey-office@zbh.uni-hamburg.de,,Person,,['Primary contact'],,,,,siena,,stierand,"[{'doi': '10.1021/acs.jcim.5b00588', 'metadata': {'abstract': '© 2016 American Chemical Society.Structural flexibility of proteins has an important influence on molecular recognition and enzymatic function. In modeling, structure ensembles are therefore often applied as a valuable source of alternative protein conformations. However, their usage is often complicated by structural artifacts and inconsistent data annotation. Here, we present SIENA, a new computational approach for the automated assembly and preprocessing of protein binding site ensembles. Starting with an arbitrarily defined binding site in a single protein structure, SIENA searches for alternative conformations of the same or sequentially closely related binding sites. The method is based on an indexed database for identifying perfect k-mer matches and a recently published algorithm for the alignment of protein binding site conformations. Furthermore, SIENA provides a new algorithm for the interaction-based selection of binding site conformations which aims at covering all known ligand-binding geometries. Various experiments highlight that SIENA is able to generate comprehensive and well selected binding site ensembles improving the compatibility to both known and unconsidered ligand molecules. Starting with the whole PDB as data source, the computation time of the whole ensemble generation takes only a few seconds. SIENA is available via a Web service at www.zbh.uni-hamburg.de/siena.', 'authors': [{'name': 'Bietz S.'}, {'name': 'Rarey M.'}], 'citationCount': 21, 'date': '2016-01-25T00:00:00Z', 'journal': 'Journal of Chemical Information and Modeling', 'title': 'SIENA: Efficient Compilation of Selective Protein Binding Site Ensembles'}, 'type': ['Primary']}, {'doi': '10.1021/acs.jcim.5b00210', 'metadata': {'abstract': '© 2015 American Chemical Society.The usage of conformational ensembles constitutes a widespread technique for the consideration of protein flexibility in computational biology. When experimental structures are applied for this purpose, alignment techniques are usually required in dealing with structural deviations and annotation inconsistencies. Moreover, many application scenarios focus on protein ligand binding sites. Here, we introduce our new alignment algorithm ASCONA that has been specially geared to the problem of aligning multiple conformations of sequentially similar binding sites. Intense efforts have been directed to an accurate detection of highly flexible backbone deviations, multiple binding site matches within a single structure, and a reliable, but at the same time highly efficient, search algorithm. In contrast, most available alignment methods rather target other issues, e.g., the global alignment of distantly related proteins that share structurally conserved regions. For conformational ensembles, this might not only result in an overhead of computation time but could also affect the achieved accuracy, especially for more complicated cases as highly flexible proteins. ASCONA was evaluated on a test set containing 1107 structures of 65 diverse proteins. In all cases, ASCONA was able to correctly align the binding site at an average alignment computation time of 4 ms per target. Furthermore, no false positive matches were observed when searching the same query sites in the structures of other proteins. ASCONA proved to cope with highly deviating backbone structures and to tolerate structural gaps and moderate mutation rates. ASCONA is available free of charge for academic use at http://www.zbh.uni-hamburg.de/ascona. (Figure Presented).', 'authors': [{'name': 'Bietz S.'}, {'name': 'Rarey M.'}], 'citationCount': 9, 'date': '2015-08-24T00:00:00Z', 'journal': 'Journal of Chemical Information and Modeling', 'title': 'ASCONA: Rapid Detection and Alignment of Protein Binding Site Conformations'}, 'type': ['Method']}]"
242,livia.perfetto@fht.org,Livia Perfetto,Person,,['Primary contact'],,,,,signor,Open access,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gkz949', 'metadata': {'abstract': '© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.The SIGnaling Network Open Resource 2.0 (SIGNOR 2.0) is a public repository that stores signaling information as binary causal relationships between biological entities. The captured information is represented graphically as a signed directed graph. Each signaling relationship is associated to an effect (up/down-regulation) and to the mechanism (e.g. binding, phosphorylation, transcriptional activation, etc.) causing the up/down-regulation of the target entity. Since its first release, SIGNOR has undergone a significant content increase and the number of annotated causal interactions have almost doubled. SIGNOR 2.0 now stores almost 23 000 manually-annotated causal relationships between proteins and other biologically relevant entities: chemicals, phenotypes, complexes, etc. We describe here significant changes in curation policy and a new confidence score, which is assigned to each interaction. We have also improved the compliance to the FAIR data principles by providing (i) SIGNOR stable identifiers, (ii) programmatic access through REST APIs, (iii) bioschemas and (iv) downloadable data in standard-compliant formats, such as PSI-MI CausalTAB and GMT. The data are freely accessible and downloadable at https://signor.uniroma2.it/.', 'authors': [{'name': 'Licata L.'}, {'name': 'Lo Surdo P.'}, {'name': 'Iannuccelli M.'}, {'name': 'Palma A.'}, {'name': 'Micarelli E.'}, {'name': 'Perfetto L.'}, {'name': 'Peluso D.'}, {'name': 'Calderone A.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 44, 'date': '2020-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SIGNOR 2.0, the SIGnaling Network Open Resource 2.0: 2019 update'}, 'pmid': '31665520', 'type': ['Primary']}, {'doi': '10.1093/nar/gkv1048', 'metadata': {'abstract': '© The Author(s) 2015.Assembly of large biochemical networks can be achieved by confronting new cell-specific experimental data with an interaction subspace constrained by prior literature evidence. The SIGnaling Network Open Resource, SIGNOR (available on line at http://signor.uniroma2.it), was developed to support such a strategy by providing a scaffold of prior experimental evidence of causal relationships between biological entities. The core of SIGNOR is a collection of approximately 12 000 manuallyannotated causal relationships between over 2800 human proteins participating in signal transduction. Other entities annotated in SIGNOR are complexes, chemicals, phenotypes and stimuli. The information captured in SIGNOR can be represented as a signed directed graph illustrating the activation/inactivation relationships between signalling entities. Each entry is associated to the post-translational modifications that cause the activation/inactivation of the target proteins. More than 4900 modified residues causing a change in protein concentration or activity have been curated and linked to the modifying enzymes (about 351 human kinases and 94 phosphatases). Additional modifications such as ubiquitinations, sumoylations, acetylations and their effect on the modified target proteins are also annotated. This wealth of structured information can support experimental approaches based on multi-parametric analysis of cell systems after physiological or pathological perturbations and to assemble large logic models.', 'authors': [{'name': 'Perfetto L.'}, {'name': 'Briganti L.'}, {'name': 'Calderone A.'}, {'name': 'Perpetuini A.C.'}, {'name': 'Iannuccelli M.'}, {'name': 'Langone F.'}, {'name': 'Licata L.'}, {'name': 'Marinkovic M.'}, {'name': 'Mattioni A.'}, {'name': 'Pavlidou T.'}, {'name': 'Peluso D.'}, {'name': 'Petrilli L.L.'}, {'name': 'Pirro S.'}, {'name': 'Posca D.'}, {'name': 'Santonico E.'}, {'name': 'Silvestri A.'}, {'name': 'Spada F.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 123, 'date': '2016-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SIGNOR: A database of causal relationships between biological entities'}, 'type': ['Other']}, {'doi': '10.1002/cpbi.28', 'metadata': {'abstract': '© 2017 by John Wiley & Sons, Inc.SIGNOR (http://signor.uniroma2.it), the SIGnaling Network Open Resource, is a database designed to store experimentally validated causal interactions, i.e., interactions where a source entity has a regulatory effect (up-regulation, down-regulation, etc.) on a second target entity. SIGNOR acts both as a source of signaling information and a support for data analysis, modeling, and prediction. A user-friendly interface features the ability to search entries for any given protein or group of proteins and to display their interactions graphically in a network view. At the time of writing, SIGNOR stores approximately 16,000 manually curated interactions connecting more than 4,000 biological entities (proteins, chemicals, protein complexes, etc.) that play a role in signal transduction. SIGNOR also offers a collection of 37 signaling pathways. SIGNOR can be queried by three search tools: “single-entity” search, “multiple-entity” search, and “pathway” search. This manuscript describes two basic protocols detailing how to navigate and search the SIGNOR database and how to download the annotated dataset for local use. Finally, the support protocol reviews the utilities of the graphic visualizer.', 'authors': [{'name': 'Surdo P.L.'}, {'name': 'Calderone A.'}, {'name': 'Cesareni G.'}, {'name': 'Perfetto L.'}], 'citationCount': 3, 'date': '2017-06-01T00:00:00Z', 'journal': 'Current Protocols in Bioinformatics', 'title': 'SIGNOR: A database of causal relationships between biological entities-a short guide to searching and browsing'}, 'pmid': '28654729', 'type': ['Method']}]"
243,luana.licata@uniroma2.it,Luana Licata,Person,https://orcid.org/0000-0001-5084-9000,['Contributor'],,,,,signor,Open access,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gkz949', 'metadata': {'abstract': '© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.The SIGnaling Network Open Resource 2.0 (SIGNOR 2.0) is a public repository that stores signaling information as binary causal relationships between biological entities. The captured information is represented graphically as a signed directed graph. Each signaling relationship is associated to an effect (up/down-regulation) and to the mechanism (e.g. binding, phosphorylation, transcriptional activation, etc.) causing the up/down-regulation of the target entity. Since its first release, SIGNOR has undergone a significant content increase and the number of annotated causal interactions have almost doubled. SIGNOR 2.0 now stores almost 23 000 manually-annotated causal relationships between proteins and other biologically relevant entities: chemicals, phenotypes, complexes, etc. We describe here significant changes in curation policy and a new confidence score, which is assigned to each interaction. We have also improved the compliance to the FAIR data principles by providing (i) SIGNOR stable identifiers, (ii) programmatic access through REST APIs, (iii) bioschemas and (iv) downloadable data in standard-compliant formats, such as PSI-MI CausalTAB and GMT. The data are freely accessible and downloadable at https://signor.uniroma2.it/.', 'authors': [{'name': 'Licata L.'}, {'name': 'Lo Surdo P.'}, {'name': 'Iannuccelli M.'}, {'name': 'Palma A.'}, {'name': 'Micarelli E.'}, {'name': 'Perfetto L.'}, {'name': 'Peluso D.'}, {'name': 'Calderone A.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 44, 'date': '2020-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SIGNOR 2.0, the SIGnaling Network Open Resource 2.0: 2019 update'}, 'pmid': '31665520', 'type': ['Primary']}, {'doi': '10.1093/nar/gkv1048', 'metadata': {'abstract': '© The Author(s) 2015.Assembly of large biochemical networks can be achieved by confronting new cell-specific experimental data with an interaction subspace constrained by prior literature evidence. The SIGnaling Network Open Resource, SIGNOR (available on line at http://signor.uniroma2.it), was developed to support such a strategy by providing a scaffold of prior experimental evidence of causal relationships between biological entities. The core of SIGNOR is a collection of approximately 12 000 manuallyannotated causal relationships between over 2800 human proteins participating in signal transduction. Other entities annotated in SIGNOR are complexes, chemicals, phenotypes and stimuli. The information captured in SIGNOR can be represented as a signed directed graph illustrating the activation/inactivation relationships between signalling entities. Each entry is associated to the post-translational modifications that cause the activation/inactivation of the target proteins. More than 4900 modified residues causing a change in protein concentration or activity have been curated and linked to the modifying enzymes (about 351 human kinases and 94 phosphatases). Additional modifications such as ubiquitinations, sumoylations, acetylations and their effect on the modified target proteins are also annotated. This wealth of structured information can support experimental approaches based on multi-parametric analysis of cell systems after physiological or pathological perturbations and to assemble large logic models.', 'authors': [{'name': 'Perfetto L.'}, {'name': 'Briganti L.'}, {'name': 'Calderone A.'}, {'name': 'Perpetuini A.C.'}, {'name': 'Iannuccelli M.'}, {'name': 'Langone F.'}, {'name': 'Licata L.'}, {'name': 'Marinkovic M.'}, {'name': 'Mattioni A.'}, {'name': 'Pavlidou T.'}, {'name': 'Peluso D.'}, {'name': 'Petrilli L.L.'}, {'name': 'Pirro S.'}, {'name': 'Posca D.'}, {'name': 'Santonico E.'}, {'name': 'Silvestri A.'}, {'name': 'Spada F.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 123, 'date': '2016-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SIGNOR: A database of causal relationships between biological entities'}, 'type': ['Other']}, {'doi': '10.1002/cpbi.28', 'metadata': {'abstract': '© 2017 by John Wiley & Sons, Inc.SIGNOR (http://signor.uniroma2.it), the SIGnaling Network Open Resource, is a database designed to store experimentally validated causal interactions, i.e., interactions where a source entity has a regulatory effect (up-regulation, down-regulation, etc.) on a second target entity. SIGNOR acts both as a source of signaling information and a support for data analysis, modeling, and prediction. A user-friendly interface features the ability to search entries for any given protein or group of proteins and to display their interactions graphically in a network view. At the time of writing, SIGNOR stores approximately 16,000 manually curated interactions connecting more than 4,000 biological entities (proteins, chemicals, protein complexes, etc.) that play a role in signal transduction. SIGNOR also offers a collection of 37 signaling pathways. SIGNOR can be queried by three search tools: “single-entity” search, “multiple-entity” search, and “pathway” search. This manuscript describes two basic protocols detailing how to navigate and search the SIGNOR database and how to download the annotated dataset for local use. Finally, the support protocol reviews the utilities of the graphic visualizer.', 'authors': [{'name': 'Surdo P.L.'}, {'name': 'Calderone A.'}, {'name': 'Cesareni G.'}, {'name': 'Perfetto L.'}], 'citationCount': 3, 'date': '2017-06-01T00:00:00Z', 'journal': 'Current Protocols in Bioinformatics', 'title': 'SIGNOR: A database of causal relationships between biological entities-a short guide to searching and browsing'}, 'pmid': '28654729', 'type': ['Method']}]"
244,,Gianni Cesareni,Person,,['Contributor'],,,,,signor,Open access,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gkz949', 'metadata': {'abstract': '© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.The SIGnaling Network Open Resource 2.0 (SIGNOR 2.0) is a public repository that stores signaling information as binary causal relationships between biological entities. The captured information is represented graphically as a signed directed graph. Each signaling relationship is associated to an effect (up/down-regulation) and to the mechanism (e.g. binding, phosphorylation, transcriptional activation, etc.) causing the up/down-regulation of the target entity. Since its first release, SIGNOR has undergone a significant content increase and the number of annotated causal interactions have almost doubled. SIGNOR 2.0 now stores almost 23 000 manually-annotated causal relationships between proteins and other biologically relevant entities: chemicals, phenotypes, complexes, etc. We describe here significant changes in curation policy and a new confidence score, which is assigned to each interaction. We have also improved the compliance to the FAIR data principles by providing (i) SIGNOR stable identifiers, (ii) programmatic access through REST APIs, (iii) bioschemas and (iv) downloadable data in standard-compliant formats, such as PSI-MI CausalTAB and GMT. The data are freely accessible and downloadable at https://signor.uniroma2.it/.', 'authors': [{'name': 'Licata L.'}, {'name': 'Lo Surdo P.'}, {'name': 'Iannuccelli M.'}, {'name': 'Palma A.'}, {'name': 'Micarelli E.'}, {'name': 'Perfetto L.'}, {'name': 'Peluso D.'}, {'name': 'Calderone A.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 44, 'date': '2020-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SIGNOR 2.0, the SIGnaling Network Open Resource 2.0: 2019 update'}, 'pmid': '31665520', 'type': ['Primary']}, {'doi': '10.1093/nar/gkv1048', 'metadata': {'abstract': '© The Author(s) 2015.Assembly of large biochemical networks can be achieved by confronting new cell-specific experimental data with an interaction subspace constrained by prior literature evidence. The SIGnaling Network Open Resource, SIGNOR (available on line at http://signor.uniroma2.it), was developed to support such a strategy by providing a scaffold of prior experimental evidence of causal relationships between biological entities. The core of SIGNOR is a collection of approximately 12 000 manuallyannotated causal relationships between over 2800 human proteins participating in signal transduction. Other entities annotated in SIGNOR are complexes, chemicals, phenotypes and stimuli. The information captured in SIGNOR can be represented as a signed directed graph illustrating the activation/inactivation relationships between signalling entities. Each entry is associated to the post-translational modifications that cause the activation/inactivation of the target proteins. More than 4900 modified residues causing a change in protein concentration or activity have been curated and linked to the modifying enzymes (about 351 human kinases and 94 phosphatases). Additional modifications such as ubiquitinations, sumoylations, acetylations and their effect on the modified target proteins are also annotated. This wealth of structured information can support experimental approaches based on multi-parametric analysis of cell systems after physiological or pathological perturbations and to assemble large logic models.', 'authors': [{'name': 'Perfetto L.'}, {'name': 'Briganti L.'}, {'name': 'Calderone A.'}, {'name': 'Perpetuini A.C.'}, {'name': 'Iannuccelli M.'}, {'name': 'Langone F.'}, {'name': 'Licata L.'}, {'name': 'Marinkovic M.'}, {'name': 'Mattioni A.'}, {'name': 'Pavlidou T.'}, {'name': 'Peluso D.'}, {'name': 'Petrilli L.L.'}, {'name': 'Pirro S.'}, {'name': 'Posca D.'}, {'name': 'Santonico E.'}, {'name': 'Silvestri A.'}, {'name': 'Spada F.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 123, 'date': '2016-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SIGNOR: A database of causal relationships between biological entities'}, 'type': ['Other']}, {'doi': '10.1002/cpbi.28', 'metadata': {'abstract': '© 2017 by John Wiley & Sons, Inc.SIGNOR (http://signor.uniroma2.it), the SIGnaling Network Open Resource, is a database designed to store experimentally validated causal interactions, i.e., interactions where a source entity has a regulatory effect (up-regulation, down-regulation, etc.) on a second target entity. SIGNOR acts both as a source of signaling information and a support for data analysis, modeling, and prediction. A user-friendly interface features the ability to search entries for any given protein or group of proteins and to display their interactions graphically in a network view. At the time of writing, SIGNOR stores approximately 16,000 manually curated interactions connecting more than 4,000 biological entities (proteins, chemicals, protein complexes, etc.) that play a role in signal transduction. SIGNOR also offers a collection of 37 signaling pathways. SIGNOR can be queried by three search tools: “single-entity” search, “multiple-entity” search, and “pathway” search. This manuscript describes two basic protocols detailing how to navigate and search the SIGNOR database and how to download the annotated dataset for local use. Finally, the support protocol reviews the utilities of the graphic visualizer.', 'authors': [{'name': 'Surdo P.L.'}, {'name': 'Calderone A.'}, {'name': 'Cesareni G.'}, {'name': 'Perfetto L.'}], 'citationCount': 3, 'date': '2017-06-01T00:00:00Z', 'journal': 'Current Protocols in Bioinformatics', 'title': 'SIGNOR: A database of causal relationships between biological entities-a short guide to searching and browsing'}, 'pmid': '28654729', 'type': ['Method']}]"
245,,"Molecular Genetic Group, University of Rome ""Tor Vergata"", Rome, Italy",Institute,,['Provider'],,,,,signor,Open access,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gkz949', 'metadata': {'abstract': '© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.The SIGnaling Network Open Resource 2.0 (SIGNOR 2.0) is a public repository that stores signaling information as binary causal relationships between biological entities. The captured information is represented graphically as a signed directed graph. Each signaling relationship is associated to an effect (up/down-regulation) and to the mechanism (e.g. binding, phosphorylation, transcriptional activation, etc.) causing the up/down-regulation of the target entity. Since its first release, SIGNOR has undergone a significant content increase and the number of annotated causal interactions have almost doubled. SIGNOR 2.0 now stores almost 23 000 manually-annotated causal relationships between proteins and other biologically relevant entities: chemicals, phenotypes, complexes, etc. We describe here significant changes in curation policy and a new confidence score, which is assigned to each interaction. We have also improved the compliance to the FAIR data principles by providing (i) SIGNOR stable identifiers, (ii) programmatic access through REST APIs, (iii) bioschemas and (iv) downloadable data in standard-compliant formats, such as PSI-MI CausalTAB and GMT. The data are freely accessible and downloadable at https://signor.uniroma2.it/.', 'authors': [{'name': 'Licata L.'}, {'name': 'Lo Surdo P.'}, {'name': 'Iannuccelli M.'}, {'name': 'Palma A.'}, {'name': 'Micarelli E.'}, {'name': 'Perfetto L.'}, {'name': 'Peluso D.'}, {'name': 'Calderone A.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 44, 'date': '2020-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SIGNOR 2.0, the SIGnaling Network Open Resource 2.0: 2019 update'}, 'pmid': '31665520', 'type': ['Primary']}, {'doi': '10.1093/nar/gkv1048', 'metadata': {'abstract': '© The Author(s) 2015.Assembly of large biochemical networks can be achieved by confronting new cell-specific experimental data with an interaction subspace constrained by prior literature evidence. The SIGnaling Network Open Resource, SIGNOR (available on line at http://signor.uniroma2.it), was developed to support such a strategy by providing a scaffold of prior experimental evidence of causal relationships between biological entities. The core of SIGNOR is a collection of approximately 12 000 manuallyannotated causal relationships between over 2800 human proteins participating in signal transduction. Other entities annotated in SIGNOR are complexes, chemicals, phenotypes and stimuli. The information captured in SIGNOR can be represented as a signed directed graph illustrating the activation/inactivation relationships between signalling entities. Each entry is associated to the post-translational modifications that cause the activation/inactivation of the target proteins. More than 4900 modified residues causing a change in protein concentration or activity have been curated and linked to the modifying enzymes (about 351 human kinases and 94 phosphatases). Additional modifications such as ubiquitinations, sumoylations, acetylations and their effect on the modified target proteins are also annotated. This wealth of structured information can support experimental approaches based on multi-parametric analysis of cell systems after physiological or pathological perturbations and to assemble large logic models.', 'authors': [{'name': 'Perfetto L.'}, {'name': 'Briganti L.'}, {'name': 'Calderone A.'}, {'name': 'Perpetuini A.C.'}, {'name': 'Iannuccelli M.'}, {'name': 'Langone F.'}, {'name': 'Licata L.'}, {'name': 'Marinkovic M.'}, {'name': 'Mattioni A.'}, {'name': 'Pavlidou T.'}, {'name': 'Peluso D.'}, {'name': 'Petrilli L.L.'}, {'name': 'Pirro S.'}, {'name': 'Posca D.'}, {'name': 'Santonico E.'}, {'name': 'Silvestri A.'}, {'name': 'Spada F.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 123, 'date': '2016-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SIGNOR: A database of causal relationships between biological entities'}, 'type': ['Other']}, {'doi': '10.1002/cpbi.28', 'metadata': {'abstract': '© 2017 by John Wiley & Sons, Inc.SIGNOR (http://signor.uniroma2.it), the SIGnaling Network Open Resource, is a database designed to store experimentally validated causal interactions, i.e., interactions where a source entity has a regulatory effect (up-regulation, down-regulation, etc.) on a second target entity. SIGNOR acts both as a source of signaling information and a support for data analysis, modeling, and prediction. A user-friendly interface features the ability to search entries for any given protein or group of proteins and to display their interactions graphically in a network view. At the time of writing, SIGNOR stores approximately 16,000 manually curated interactions connecting more than 4,000 biological entities (proteins, chemicals, protein complexes, etc.) that play a role in signal transduction. SIGNOR also offers a collection of 37 signaling pathways. SIGNOR can be queried by three search tools: “single-entity” search, “multiple-entity” search, and “pathway” search. This manuscript describes two basic protocols detailing how to navigate and search the SIGNOR database and how to download the annotated dataset for local use. Finally, the support protocol reviews the utilities of the graphic visualizer.', 'authors': [{'name': 'Surdo P.L.'}, {'name': 'Calderone A.'}, {'name': 'Cesareni G.'}, {'name': 'Perfetto L.'}], 'citationCount': 3, 'date': '2017-06-01T00:00:00Z', 'journal': 'Current Protocols in Bioinformatics', 'title': 'SIGNOR: A database of causal relationships between biological entities-a short guide to searching and browsing'}, 'pmid': '28654729', 'type': ['Method']}]"
246,,ELIXIR-ITA-TORVERGATA,Institute,,['Provider'],,,,,signor,Open access,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gkz949', 'metadata': {'abstract': '© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.The SIGnaling Network Open Resource 2.0 (SIGNOR 2.0) is a public repository that stores signaling information as binary causal relationships between biological entities. The captured information is represented graphically as a signed directed graph. Each signaling relationship is associated to an effect (up/down-regulation) and to the mechanism (e.g. binding, phosphorylation, transcriptional activation, etc.) causing the up/down-regulation of the target entity. Since its first release, SIGNOR has undergone a significant content increase and the number of annotated causal interactions have almost doubled. SIGNOR 2.0 now stores almost 23 000 manually-annotated causal relationships between proteins and other biologically relevant entities: chemicals, phenotypes, complexes, etc. We describe here significant changes in curation policy and a new confidence score, which is assigned to each interaction. We have also improved the compliance to the FAIR data principles by providing (i) SIGNOR stable identifiers, (ii) programmatic access through REST APIs, (iii) bioschemas and (iv) downloadable data in standard-compliant formats, such as PSI-MI CausalTAB and GMT. The data are freely accessible and downloadable at https://signor.uniroma2.it/.', 'authors': [{'name': 'Licata L.'}, {'name': 'Lo Surdo P.'}, {'name': 'Iannuccelli M.'}, {'name': 'Palma A.'}, {'name': 'Micarelli E.'}, {'name': 'Perfetto L.'}, {'name': 'Peluso D.'}, {'name': 'Calderone A.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 44, 'date': '2020-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SIGNOR 2.0, the SIGnaling Network Open Resource 2.0: 2019 update'}, 'pmid': '31665520', 'type': ['Primary']}, {'doi': '10.1093/nar/gkv1048', 'metadata': {'abstract': '© The Author(s) 2015.Assembly of large biochemical networks can be achieved by confronting new cell-specific experimental data with an interaction subspace constrained by prior literature evidence. The SIGnaling Network Open Resource, SIGNOR (available on line at http://signor.uniroma2.it), was developed to support such a strategy by providing a scaffold of prior experimental evidence of causal relationships between biological entities. The core of SIGNOR is a collection of approximately 12 000 manuallyannotated causal relationships between over 2800 human proteins participating in signal transduction. Other entities annotated in SIGNOR are complexes, chemicals, phenotypes and stimuli. The information captured in SIGNOR can be represented as a signed directed graph illustrating the activation/inactivation relationships between signalling entities. Each entry is associated to the post-translational modifications that cause the activation/inactivation of the target proteins. More than 4900 modified residues causing a change in protein concentration or activity have been curated and linked to the modifying enzymes (about 351 human kinases and 94 phosphatases). Additional modifications such as ubiquitinations, sumoylations, acetylations and their effect on the modified target proteins are also annotated. This wealth of structured information can support experimental approaches based on multi-parametric analysis of cell systems after physiological or pathological perturbations and to assemble large logic models.', 'authors': [{'name': 'Perfetto L.'}, {'name': 'Briganti L.'}, {'name': 'Calderone A.'}, {'name': 'Perpetuini A.C.'}, {'name': 'Iannuccelli M.'}, {'name': 'Langone F.'}, {'name': 'Licata L.'}, {'name': 'Marinkovic M.'}, {'name': 'Mattioni A.'}, {'name': 'Pavlidou T.'}, {'name': 'Peluso D.'}, {'name': 'Petrilli L.L.'}, {'name': 'Pirro S.'}, {'name': 'Posca D.'}, {'name': 'Santonico E.'}, {'name': 'Silvestri A.'}, {'name': 'Spada F.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 123, 'date': '2016-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SIGNOR: A database of causal relationships between biological entities'}, 'type': ['Other']}, {'doi': '10.1002/cpbi.28', 'metadata': {'abstract': '© 2017 by John Wiley & Sons, Inc.SIGNOR (http://signor.uniroma2.it), the SIGnaling Network Open Resource, is a database designed to store experimentally validated causal interactions, i.e., interactions where a source entity has a regulatory effect (up-regulation, down-regulation, etc.) on a second target entity. SIGNOR acts both as a source of signaling information and a support for data analysis, modeling, and prediction. A user-friendly interface features the ability to search entries for any given protein or group of proteins and to display their interactions graphically in a network view. At the time of writing, SIGNOR stores approximately 16,000 manually curated interactions connecting more than 4,000 biological entities (proteins, chemicals, protein complexes, etc.) that play a role in signal transduction. SIGNOR also offers a collection of 37 signaling pathways. SIGNOR can be queried by three search tools: “single-entity” search, “multiple-entity” search, and “pathway” search. This manuscript describes two basic protocols detailing how to navigate and search the SIGNOR database and how to download the annotated dataset for local use. Finally, the support protocol reviews the utilities of the graphic visualizer.', 'authors': [{'name': 'Surdo P.L.'}, {'name': 'Calderone A.'}, {'name': 'Cesareni G.'}, {'name': 'Perfetto L.'}], 'citationCount': 3, 'date': '2017-06-01T00:00:00Z', 'journal': 'Current Protocols in Bioinformatics', 'title': 'SIGNOR: A database of causal relationships between biological entities-a short guide to searching and browsing'}, 'pmid': '28654729', 'type': ['Method']}]"
247,,Marta Iannuccelli,Person,,['Contributor'],,,,,signor,Open access,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gkz949', 'metadata': {'abstract': '© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.The SIGnaling Network Open Resource 2.0 (SIGNOR 2.0) is a public repository that stores signaling information as binary causal relationships between biological entities. The captured information is represented graphically as a signed directed graph. Each signaling relationship is associated to an effect (up/down-regulation) and to the mechanism (e.g. binding, phosphorylation, transcriptional activation, etc.) causing the up/down-regulation of the target entity. Since its first release, SIGNOR has undergone a significant content increase and the number of annotated causal interactions have almost doubled. SIGNOR 2.0 now stores almost 23 000 manually-annotated causal relationships between proteins and other biologically relevant entities: chemicals, phenotypes, complexes, etc. We describe here significant changes in curation policy and a new confidence score, which is assigned to each interaction. We have also improved the compliance to the FAIR data principles by providing (i) SIGNOR stable identifiers, (ii) programmatic access through REST APIs, (iii) bioschemas and (iv) downloadable data in standard-compliant formats, such as PSI-MI CausalTAB and GMT. The data are freely accessible and downloadable at https://signor.uniroma2.it/.', 'authors': [{'name': 'Licata L.'}, {'name': 'Lo Surdo P.'}, {'name': 'Iannuccelli M.'}, {'name': 'Palma A.'}, {'name': 'Micarelli E.'}, {'name': 'Perfetto L.'}, {'name': 'Peluso D.'}, {'name': 'Calderone A.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 44, 'date': '2020-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SIGNOR 2.0, the SIGnaling Network Open Resource 2.0: 2019 update'}, 'pmid': '31665520', 'type': ['Primary']}, {'doi': '10.1093/nar/gkv1048', 'metadata': {'abstract': '© The Author(s) 2015.Assembly of large biochemical networks can be achieved by confronting new cell-specific experimental data with an interaction subspace constrained by prior literature evidence. The SIGnaling Network Open Resource, SIGNOR (available on line at http://signor.uniroma2.it), was developed to support such a strategy by providing a scaffold of prior experimental evidence of causal relationships between biological entities. The core of SIGNOR is a collection of approximately 12 000 manuallyannotated causal relationships between over 2800 human proteins participating in signal transduction. Other entities annotated in SIGNOR are complexes, chemicals, phenotypes and stimuli. The information captured in SIGNOR can be represented as a signed directed graph illustrating the activation/inactivation relationships between signalling entities. Each entry is associated to the post-translational modifications that cause the activation/inactivation of the target proteins. More than 4900 modified residues causing a change in protein concentration or activity have been curated and linked to the modifying enzymes (about 351 human kinases and 94 phosphatases). Additional modifications such as ubiquitinations, sumoylations, acetylations and their effect on the modified target proteins are also annotated. This wealth of structured information can support experimental approaches based on multi-parametric analysis of cell systems after physiological or pathological perturbations and to assemble large logic models.', 'authors': [{'name': 'Perfetto L.'}, {'name': 'Briganti L.'}, {'name': 'Calderone A.'}, {'name': 'Perpetuini A.C.'}, {'name': 'Iannuccelli M.'}, {'name': 'Langone F.'}, {'name': 'Licata L.'}, {'name': 'Marinkovic M.'}, {'name': 'Mattioni A.'}, {'name': 'Pavlidou T.'}, {'name': 'Peluso D.'}, {'name': 'Petrilli L.L.'}, {'name': 'Pirro S.'}, {'name': 'Posca D.'}, {'name': 'Santonico E.'}, {'name': 'Silvestri A.'}, {'name': 'Spada F.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 123, 'date': '2016-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SIGNOR: A database of causal relationships between biological entities'}, 'type': ['Other']}, {'doi': '10.1002/cpbi.28', 'metadata': {'abstract': '© 2017 by John Wiley & Sons, Inc.SIGNOR (http://signor.uniroma2.it), the SIGnaling Network Open Resource, is a database designed to store experimentally validated causal interactions, i.e., interactions where a source entity has a regulatory effect (up-regulation, down-regulation, etc.) on a second target entity. SIGNOR acts both as a source of signaling information and a support for data analysis, modeling, and prediction. A user-friendly interface features the ability to search entries for any given protein or group of proteins and to display their interactions graphically in a network view. At the time of writing, SIGNOR stores approximately 16,000 manually curated interactions connecting more than 4,000 biological entities (proteins, chemicals, protein complexes, etc.) that play a role in signal transduction. SIGNOR also offers a collection of 37 signaling pathways. SIGNOR can be queried by three search tools: “single-entity” search, “multiple-entity” search, and “pathway” search. This manuscript describes two basic protocols detailing how to navigate and search the SIGNOR database and how to download the annotated dataset for local use. Finally, the support protocol reviews the utilities of the graphic visualizer.', 'authors': [{'name': 'Surdo P.L.'}, {'name': 'Calderone A.'}, {'name': 'Cesareni G.'}, {'name': 'Perfetto L.'}], 'citationCount': 3, 'date': '2017-06-01T00:00:00Z', 'journal': 'Current Protocols in Bioinformatics', 'title': 'SIGNOR: A database of causal relationships between biological entities-a short guide to searching and browsing'}, 'pmid': '28654729', 'type': ['Method']}]"
248,,Alberto Calderone,Person,,['Developer'],,,,,signor,Open access,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gkz949', 'metadata': {'abstract': '© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.The SIGnaling Network Open Resource 2.0 (SIGNOR 2.0) is a public repository that stores signaling information as binary causal relationships between biological entities. The captured information is represented graphically as a signed directed graph. Each signaling relationship is associated to an effect (up/down-regulation) and to the mechanism (e.g. binding, phosphorylation, transcriptional activation, etc.) causing the up/down-regulation of the target entity. Since its first release, SIGNOR has undergone a significant content increase and the number of annotated causal interactions have almost doubled. SIGNOR 2.0 now stores almost 23 000 manually-annotated causal relationships between proteins and other biologically relevant entities: chemicals, phenotypes, complexes, etc. We describe here significant changes in curation policy and a new confidence score, which is assigned to each interaction. We have also improved the compliance to the FAIR data principles by providing (i) SIGNOR stable identifiers, (ii) programmatic access through REST APIs, (iii) bioschemas and (iv) downloadable data in standard-compliant formats, such as PSI-MI CausalTAB and GMT. The data are freely accessible and downloadable at https://signor.uniroma2.it/.', 'authors': [{'name': 'Licata L.'}, {'name': 'Lo Surdo P.'}, {'name': 'Iannuccelli M.'}, {'name': 'Palma A.'}, {'name': 'Micarelli E.'}, {'name': 'Perfetto L.'}, {'name': 'Peluso D.'}, {'name': 'Calderone A.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 44, 'date': '2020-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SIGNOR 2.0, the SIGnaling Network Open Resource 2.0: 2019 update'}, 'pmid': '31665520', 'type': ['Primary']}, {'doi': '10.1093/nar/gkv1048', 'metadata': {'abstract': '© The Author(s) 2015.Assembly of large biochemical networks can be achieved by confronting new cell-specific experimental data with an interaction subspace constrained by prior literature evidence. The SIGnaling Network Open Resource, SIGNOR (available on line at http://signor.uniroma2.it), was developed to support such a strategy by providing a scaffold of prior experimental evidence of causal relationships between biological entities. The core of SIGNOR is a collection of approximately 12 000 manuallyannotated causal relationships between over 2800 human proteins participating in signal transduction. Other entities annotated in SIGNOR are complexes, chemicals, phenotypes and stimuli. The information captured in SIGNOR can be represented as a signed directed graph illustrating the activation/inactivation relationships between signalling entities. Each entry is associated to the post-translational modifications that cause the activation/inactivation of the target proteins. More than 4900 modified residues causing a change in protein concentration or activity have been curated and linked to the modifying enzymes (about 351 human kinases and 94 phosphatases). Additional modifications such as ubiquitinations, sumoylations, acetylations and their effect on the modified target proteins are also annotated. This wealth of structured information can support experimental approaches based on multi-parametric analysis of cell systems after physiological or pathological perturbations and to assemble large logic models.', 'authors': [{'name': 'Perfetto L.'}, {'name': 'Briganti L.'}, {'name': 'Calderone A.'}, {'name': 'Perpetuini A.C.'}, {'name': 'Iannuccelli M.'}, {'name': 'Langone F.'}, {'name': 'Licata L.'}, {'name': 'Marinkovic M.'}, {'name': 'Mattioni A.'}, {'name': 'Pavlidou T.'}, {'name': 'Peluso D.'}, {'name': 'Petrilli L.L.'}, {'name': 'Pirro S.'}, {'name': 'Posca D.'}, {'name': 'Santonico E.'}, {'name': 'Silvestri A.'}, {'name': 'Spada F.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 123, 'date': '2016-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SIGNOR: A database of causal relationships between biological entities'}, 'type': ['Other']}, {'doi': '10.1002/cpbi.28', 'metadata': {'abstract': '© 2017 by John Wiley & Sons, Inc.SIGNOR (http://signor.uniroma2.it), the SIGnaling Network Open Resource, is a database designed to store experimentally validated causal interactions, i.e., interactions where a source entity has a regulatory effect (up-regulation, down-regulation, etc.) on a second target entity. SIGNOR acts both as a source of signaling information and a support for data analysis, modeling, and prediction. A user-friendly interface features the ability to search entries for any given protein or group of proteins and to display their interactions graphically in a network view. At the time of writing, SIGNOR stores approximately 16,000 manually curated interactions connecting more than 4,000 biological entities (proteins, chemicals, protein complexes, etc.) that play a role in signal transduction. SIGNOR also offers a collection of 37 signaling pathways. SIGNOR can be queried by three search tools: “single-entity” search, “multiple-entity” search, and “pathway” search. This manuscript describes two basic protocols detailing how to navigate and search the SIGNOR database and how to download the annotated dataset for local use. Finally, the support protocol reviews the utilities of the graphic visualizer.', 'authors': [{'name': 'Surdo P.L.'}, {'name': 'Calderone A.'}, {'name': 'Cesareni G.'}, {'name': 'Perfetto L.'}], 'citationCount': 3, 'date': '2017-06-01T00:00:00Z', 'journal': 'Current Protocols in Bioinformatics', 'title': 'SIGNOR: A database of causal relationships between biological entities-a short guide to searching and browsing'}, 'pmid': '28654729', 'type': ['Method']}]"
249,,Prisca Lo Surdo,Person,,['Developer'],,,,,signor,Open access,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gkz949', 'metadata': {'abstract': '© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.The SIGnaling Network Open Resource 2.0 (SIGNOR 2.0) is a public repository that stores signaling information as binary causal relationships between biological entities. The captured information is represented graphically as a signed directed graph. Each signaling relationship is associated to an effect (up/down-regulation) and to the mechanism (e.g. binding, phosphorylation, transcriptional activation, etc.) causing the up/down-regulation of the target entity. Since its first release, SIGNOR has undergone a significant content increase and the number of annotated causal interactions have almost doubled. SIGNOR 2.0 now stores almost 23 000 manually-annotated causal relationships between proteins and other biologically relevant entities: chemicals, phenotypes, complexes, etc. We describe here significant changes in curation policy and a new confidence score, which is assigned to each interaction. We have also improved the compliance to the FAIR data principles by providing (i) SIGNOR stable identifiers, (ii) programmatic access through REST APIs, (iii) bioschemas and (iv) downloadable data in standard-compliant formats, such as PSI-MI CausalTAB and GMT. The data are freely accessible and downloadable at https://signor.uniroma2.it/.', 'authors': [{'name': 'Licata L.'}, {'name': 'Lo Surdo P.'}, {'name': 'Iannuccelli M.'}, {'name': 'Palma A.'}, {'name': 'Micarelli E.'}, {'name': 'Perfetto L.'}, {'name': 'Peluso D.'}, {'name': 'Calderone A.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 44, 'date': '2020-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SIGNOR 2.0, the SIGnaling Network Open Resource 2.0: 2019 update'}, 'pmid': '31665520', 'type': ['Primary']}, {'doi': '10.1093/nar/gkv1048', 'metadata': {'abstract': '© The Author(s) 2015.Assembly of large biochemical networks can be achieved by confronting new cell-specific experimental data with an interaction subspace constrained by prior literature evidence. The SIGnaling Network Open Resource, SIGNOR (available on line at http://signor.uniroma2.it), was developed to support such a strategy by providing a scaffold of prior experimental evidence of causal relationships between biological entities. The core of SIGNOR is a collection of approximately 12 000 manuallyannotated causal relationships between over 2800 human proteins participating in signal transduction. Other entities annotated in SIGNOR are complexes, chemicals, phenotypes and stimuli. The information captured in SIGNOR can be represented as a signed directed graph illustrating the activation/inactivation relationships between signalling entities. Each entry is associated to the post-translational modifications that cause the activation/inactivation of the target proteins. More than 4900 modified residues causing a change in protein concentration or activity have been curated and linked to the modifying enzymes (about 351 human kinases and 94 phosphatases). Additional modifications such as ubiquitinations, sumoylations, acetylations and their effect on the modified target proteins are also annotated. This wealth of structured information can support experimental approaches based on multi-parametric analysis of cell systems after physiological or pathological perturbations and to assemble large logic models.', 'authors': [{'name': 'Perfetto L.'}, {'name': 'Briganti L.'}, {'name': 'Calderone A.'}, {'name': 'Perpetuini A.C.'}, {'name': 'Iannuccelli M.'}, {'name': 'Langone F.'}, {'name': 'Licata L.'}, {'name': 'Marinkovic M.'}, {'name': 'Mattioni A.'}, {'name': 'Pavlidou T.'}, {'name': 'Peluso D.'}, {'name': 'Petrilli L.L.'}, {'name': 'Pirro S.'}, {'name': 'Posca D.'}, {'name': 'Santonico E.'}, {'name': 'Silvestri A.'}, {'name': 'Spada F.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 123, 'date': '2016-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SIGNOR: A database of causal relationships between biological entities'}, 'type': ['Other']}, {'doi': '10.1002/cpbi.28', 'metadata': {'abstract': '© 2017 by John Wiley & Sons, Inc.SIGNOR (http://signor.uniroma2.it), the SIGnaling Network Open Resource, is a database designed to store experimentally validated causal interactions, i.e., interactions where a source entity has a regulatory effect (up-regulation, down-regulation, etc.) on a second target entity. SIGNOR acts both as a source of signaling information and a support for data analysis, modeling, and prediction. A user-friendly interface features the ability to search entries for any given protein or group of proteins and to display their interactions graphically in a network view. At the time of writing, SIGNOR stores approximately 16,000 manually curated interactions connecting more than 4,000 biological entities (proteins, chemicals, protein complexes, etc.) that play a role in signal transduction. SIGNOR also offers a collection of 37 signaling pathways. SIGNOR can be queried by three search tools: “single-entity” search, “multiple-entity” search, and “pathway” search. This manuscript describes two basic protocols detailing how to navigate and search the SIGNOR database and how to download the annotated dataset for local use. Finally, the support protocol reviews the utilities of the graphic visualizer.', 'authors': [{'name': 'Surdo P.L.'}, {'name': 'Calderone A.'}, {'name': 'Cesareni G.'}, {'name': 'Perfetto L.'}], 'citationCount': 3, 'date': '2017-06-01T00:00:00Z', 'journal': 'Current Protocols in Bioinformatics', 'title': 'SIGNOR: A database of causal relationships between biological entities-a short guide to searching and browsing'}, 'pmid': '28654729', 'type': ['Method']}]"
250,,Leonardo Briganti,Person,,['Developer'],,,,,signor,Open access,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gkz949', 'metadata': {'abstract': '© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.The SIGnaling Network Open Resource 2.0 (SIGNOR 2.0) is a public repository that stores signaling information as binary causal relationships between biological entities. The captured information is represented graphically as a signed directed graph. Each signaling relationship is associated to an effect (up/down-regulation) and to the mechanism (e.g. binding, phosphorylation, transcriptional activation, etc.) causing the up/down-regulation of the target entity. Since its first release, SIGNOR has undergone a significant content increase and the number of annotated causal interactions have almost doubled. SIGNOR 2.0 now stores almost 23 000 manually-annotated causal relationships between proteins and other biologically relevant entities: chemicals, phenotypes, complexes, etc. We describe here significant changes in curation policy and a new confidence score, which is assigned to each interaction. We have also improved the compliance to the FAIR data principles by providing (i) SIGNOR stable identifiers, (ii) programmatic access through REST APIs, (iii) bioschemas and (iv) downloadable data in standard-compliant formats, such as PSI-MI CausalTAB and GMT. The data are freely accessible and downloadable at https://signor.uniroma2.it/.', 'authors': [{'name': 'Licata L.'}, {'name': 'Lo Surdo P.'}, {'name': 'Iannuccelli M.'}, {'name': 'Palma A.'}, {'name': 'Micarelli E.'}, {'name': 'Perfetto L.'}, {'name': 'Peluso D.'}, {'name': 'Calderone A.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 44, 'date': '2020-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SIGNOR 2.0, the SIGnaling Network Open Resource 2.0: 2019 update'}, 'pmid': '31665520', 'type': ['Primary']}, {'doi': '10.1093/nar/gkv1048', 'metadata': {'abstract': '© The Author(s) 2015.Assembly of large biochemical networks can be achieved by confronting new cell-specific experimental data with an interaction subspace constrained by prior literature evidence. The SIGnaling Network Open Resource, SIGNOR (available on line at http://signor.uniroma2.it), was developed to support such a strategy by providing a scaffold of prior experimental evidence of causal relationships between biological entities. The core of SIGNOR is a collection of approximately 12 000 manuallyannotated causal relationships between over 2800 human proteins participating in signal transduction. Other entities annotated in SIGNOR are complexes, chemicals, phenotypes and stimuli. The information captured in SIGNOR can be represented as a signed directed graph illustrating the activation/inactivation relationships between signalling entities. Each entry is associated to the post-translational modifications that cause the activation/inactivation of the target proteins. More than 4900 modified residues causing a change in protein concentration or activity have been curated and linked to the modifying enzymes (about 351 human kinases and 94 phosphatases). Additional modifications such as ubiquitinations, sumoylations, acetylations and their effect on the modified target proteins are also annotated. This wealth of structured information can support experimental approaches based on multi-parametric analysis of cell systems after physiological or pathological perturbations and to assemble large logic models.', 'authors': [{'name': 'Perfetto L.'}, {'name': 'Briganti L.'}, {'name': 'Calderone A.'}, {'name': 'Perpetuini A.C.'}, {'name': 'Iannuccelli M.'}, {'name': 'Langone F.'}, {'name': 'Licata L.'}, {'name': 'Marinkovic M.'}, {'name': 'Mattioni A.'}, {'name': 'Pavlidou T.'}, {'name': 'Peluso D.'}, {'name': 'Petrilli L.L.'}, {'name': 'Pirro S.'}, {'name': 'Posca D.'}, {'name': 'Santonico E.'}, {'name': 'Silvestri A.'}, {'name': 'Spada F.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 123, 'date': '2016-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SIGNOR: A database of causal relationships between biological entities'}, 'type': ['Other']}, {'doi': '10.1002/cpbi.28', 'metadata': {'abstract': '© 2017 by John Wiley & Sons, Inc.SIGNOR (http://signor.uniroma2.it), the SIGnaling Network Open Resource, is a database designed to store experimentally validated causal interactions, i.e., interactions where a source entity has a regulatory effect (up-regulation, down-regulation, etc.) on a second target entity. SIGNOR acts both as a source of signaling information and a support for data analysis, modeling, and prediction. A user-friendly interface features the ability to search entries for any given protein or group of proteins and to display their interactions graphically in a network view. At the time of writing, SIGNOR stores approximately 16,000 manually curated interactions connecting more than 4,000 biological entities (proteins, chemicals, protein complexes, etc.) that play a role in signal transduction. SIGNOR also offers a collection of 37 signaling pathways. SIGNOR can be queried by three search tools: “single-entity” search, “multiple-entity” search, and “pathway” search. This manuscript describes two basic protocols detailing how to navigate and search the SIGNOR database and how to download the annotated dataset for local use. Finally, the support protocol reviews the utilities of the graphic visualizer.', 'authors': [{'name': 'Surdo P.L.'}, {'name': 'Calderone A.'}, {'name': 'Cesareni G.'}, {'name': 'Perfetto L.'}], 'citationCount': 3, 'date': '2017-06-01T00:00:00Z', 'journal': 'Current Protocols in Bioinformatics', 'title': 'SIGNOR: A database of causal relationships between biological entities-a short guide to searching and browsing'}, 'pmid': '28654729', 'type': ['Method']}]"
251,,Amburose Sekar,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/2597911-amburose-sekar,,,covid-19riskprediction,Open access (with restrictions),Kigaard,
252,wladek@iwonka.med.virginia.edu,Wladek Minor,Person,https://orcid.org/0000-0001-7075-7090,,,,,,covid-19-bioreproducibility,,Kigaard,"[{'doi': '10.1002/PRO.3959', 'metadata': {'abstract': '© 2020 The Protein SocietyThe COVID-19 pandemic has triggered numerous scientific activities aimed at understanding the SARS-CoV-2 virus and ultimately developing treatments. Structural biologists have already determined hundreds of experimental X-ray, cryo-EM, and NMR structures of proteins and nucleic acids related to this coronavirus, and this number is still growing. To help biomedical researchers, who may not necessarily be experts in structural biology, navigate through the flood of structural models, we have created an online resource, covid19.bioreproducibility.org, that aggregates expert-verified information about SARS-CoV-2-related macromolecular models. In this article, we describe this web resource along with the suite of tools and methodologies used for assessing the structures presented therein.', 'authors': [{'name': 'Brzezinski D.'}, {'name': 'Kowiel M.'}, {'name': 'Cooper D.R.'}, {'name': 'Cymborowski M.'}, {'name': 'Grabowski M.'}, {'name': 'Wlodawer A.'}, {'name': 'Dauter Z.'}, {'name': 'Shabalin I.G.'}, {'name': 'Gilski M.'}, {'name': 'Rupp B.'}, {'name': 'Jaskolski M.'}, {'name': 'Minor W.'}], 'citationCount': 9, 'date': '2021-01-01T00:00:00Z', 'journal': 'Protein Science', 'title': 'Covid-19.bioreproducibility.org: A web resource for SARS-CoV-2-related structural models'}, 'pmcid': 'PMC7537053', 'pmid': '32981130'}]"
253,,Lateef Adewale Kareem,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/2376472-lateef-adewale-kareem,,,covid19-spread-visualizer,Open access (with restrictions),Kigaard,
254,,Matthias Chung,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/3657573-matthias-chung,,,covid19data,Open access (with restrictions),Kigaard,
255,,milan batista,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/3576565-milan-batista,,,fitviruscovid19,Open access (with restrictions),Kigaard,
256,,Siddharth Kumar,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/10596875-siddharth-kumar,,,covid19-india-spread-animation,Open access (with restrictions),Kigaard,
257,,Ismael Abdulrahman,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/16602986-ismael-abdulrahman,,,simcovid,Open access (with restrictions),Kigaard,"[{'doi': '10.1101/2020.04.13.20063354', 'type': ['Primary']}]"
258,,Lorand Gabriel Parajdi,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/14104325-lorand-gabriel-parajdi,,,covid19-data-fitting,Open access (with restrictions),Kigaard,
259,,JM2,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/10845200-jm2,,,fitviruscv19-state,Open access (with restrictions),Kigaard,
260,,JM2,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/10845200-jm2,,,fitviruscv19v3,Open access (with restrictions),Kigaard,
261,,JM2,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/10845200-jm2,,,covid19-modeling,Open access (with restrictions),Kigaard,
262,,Ajitesh Srivastava,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/4952978-ajitesh-srivastava,,,recover,Open access (with restrictions),zsmag19,
263,,Tom Viering,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/9176402-tom-viering,,,corona-exponential-fit,Open access (with restrictions),Kigaard,
264,,Peter Seibold,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/2474090-peter-seibold,,,covid-gui,Open access (with restrictions),zsmag19,
265,michael.turewicz@rub.de,"Ruhr-Universitaet Bochum, Medizinisches Proteom-Center (MPC)",,,['Contributor'],,,,,bionda,Open access (with restrictions),BioInfra.Prot,
266,anika.frericks@rub.de,"Ruhr-Universitaet Bochum, Medizinisches Proteom-Center (MPC)",,,['Developer'],,,,,bionda,Open access (with restrictions),BioInfra.Prot,
267,,bioinfoservice@rub.de,Division,,['Primary contact'],,,,,bionda,Open access (with restrictions),BioInfra.Prot,
268,,Sarai Varona,Person,https://orcid.org/0000-0002-2245-210X,"['Primary contact', 'Developer', 'Maintainer']",,,,,nf-core-viralrecon,Open access,nf-core,"[{'doi': '10.1038/s41587-020-0439-x', 'metadata': {'authors': [{'name': 'Ewels P.A.'}, {'name': 'Peltzer A.'}, {'name': 'Fillinger S.'}, {'name': 'Patel H.'}, {'name': 'Alneberg J.'}, {'name': 'Wilm A.'}, {'name': 'Garcia M.U.'}, {'name': 'Di Tommaso P.'}, {'name': 'Nahnsen S.'}], 'citationCount': 76, 'date': '2020-03-01T00:00:00Z', 'journal': 'Nature Biotechnology', 'title': 'The nf-core framework for community-curated bioinformatics pipelines'}, 'note': 'nf-core framework publication', 'pmid': '32055031', 'type': ['Primary']}]"
269,,Miguel Juliá,Person,https://orcid.org/0000-0002-4403-1840,"['Primary contact', 'Developer', 'Maintainer']",,,,,nf-core-viralrecon,Open access,nf-core,"[{'doi': '10.1038/s41587-020-0439-x', 'metadata': {'authors': [{'name': 'Ewels P.A.'}, {'name': 'Peltzer A.'}, {'name': 'Fillinger S.'}, {'name': 'Patel H.'}, {'name': 'Alneberg J.'}, {'name': 'Wilm A.'}, {'name': 'Garcia M.U.'}, {'name': 'Di Tommaso P.'}, {'name': 'Nahnsen S.'}], 'citationCount': 76, 'date': '2020-03-01T00:00:00Z', 'journal': 'Nature Biotechnology', 'title': 'The nf-core framework for community-curated bioinformatics pipelines'}, 'note': 'nf-core framework publication', 'pmid': '32055031', 'type': ['Primary']}]"
270,,Sara Monzón,Person,https://orcid.org/0000-0002-0740-6324,"['Primary contact', 'Developer', 'Maintainer']",,,,,nf-core-viralrecon,Open access,nf-core,"[{'doi': '10.1038/s41587-020-0439-x', 'metadata': {'authors': [{'name': 'Ewels P.A.'}, {'name': 'Peltzer A.'}, {'name': 'Fillinger S.'}, {'name': 'Patel H.'}, {'name': 'Alneberg J.'}, {'name': 'Wilm A.'}, {'name': 'Garcia M.U.'}, {'name': 'Di Tommaso P.'}, {'name': 'Nahnsen S.'}], 'citationCount': 76, 'date': '2020-03-01T00:00:00Z', 'journal': 'Nature Biotechnology', 'title': 'The nf-core framework for community-curated bioinformatics pipelines'}, 'note': 'nf-core framework publication', 'pmid': '32055031', 'type': ['Primary']}]"
271,Harshil.Patel@crick.ac.uk,Harshil Patel,Person,https://orcid.org/0000-0003-2707-7940,"['Primary contact', 'Developer', 'Maintainer']",,,,,nf-core-viralrecon,Open access,nf-core,"[{'doi': '10.1038/s41587-020-0439-x', 'metadata': {'authors': [{'name': 'Ewels P.A.'}, {'name': 'Peltzer A.'}, {'name': 'Fillinger S.'}, {'name': 'Patel H.'}, {'name': 'Alneberg J.'}, {'name': 'Wilm A.'}, {'name': 'Garcia M.U.'}, {'name': 'Di Tommaso P.'}, {'name': 'Nahnsen S.'}], 'citationCount': 76, 'date': '2020-03-01T00:00:00Z', 'journal': 'Nature Biotechnology', 'title': 'The nf-core framework for community-curated bioinformatics pipelines'}, 'note': 'nf-core framework publication', 'pmid': '32055031', 'type': ['Primary']}]"
272,phil.ewels@scilifelab.se,Philip A. Ewels,Person,https://orcid.org/0000-0003-4101-2502,['Primary contact'],,https://phil.ewels.co.uk/,,,nf-core-viralrecon,Open access,nf-core,"[{'doi': '10.1038/s41587-020-0439-x', 'metadata': {'authors': [{'name': 'Ewels P.A.'}, {'name': 'Peltzer A.'}, {'name': 'Fillinger S.'}, {'name': 'Patel H.'}, {'name': 'Alneberg J.'}, {'name': 'Wilm A.'}, {'name': 'Garcia M.U.'}, {'name': 'Di Tommaso P.'}, {'name': 'Nahnsen S.'}], 'citationCount': 76, 'date': '2020-03-01T00:00:00Z', 'journal': 'Nature Biotechnology', 'title': 'The nf-core framework for community-curated bioinformatics pipelines'}, 'note': 'nf-core framework publication', 'pmid': '32055031', 'type': ['Primary']}]"
273,maxime.garcia@scilifelab.se,Maxime U. Garcia,Person,https://orcid.org/0000-0003-2827-9261,['Primary contact'],,https://maxulysse.github.io/,,,nf-core-viralrecon,Open access,nf-core,"[{'doi': '10.1038/s41587-020-0439-x', 'metadata': {'authors': [{'name': 'Ewels P.A.'}, {'name': 'Peltzer A.'}, {'name': 'Fillinger S.'}, {'name': 'Patel H.'}, {'name': 'Alneberg J.'}, {'name': 'Wilm A.'}, {'name': 'Garcia M.U.'}, {'name': 'Di Tommaso P.'}, {'name': 'Nahnsen S.'}], 'citationCount': 76, 'date': '2020-03-01T00:00:00Z', 'journal': 'Nature Biotechnology', 'title': 'The nf-core framework for community-curated bioinformatics pipelines'}, 'note': 'nf-core framework publication', 'pmid': '32055031', 'type': ['Primary']}]"
274,joseantonio.espinosa@crg.eu,Jose Espinosa-Carrasco,Person,https://orcid.org/0000-0002-1541-042X,['Primary contact'],,,,,nf-core-viralrecon,Open access,nf-core,"[{'doi': '10.1038/s41587-020-0439-x', 'metadata': {'authors': [{'name': 'Ewels P.A.'}, {'name': 'Peltzer A.'}, {'name': 'Fillinger S.'}, {'name': 'Patel H.'}, {'name': 'Alneberg J.'}, {'name': 'Wilm A.'}, {'name': 'Garcia M.U.'}, {'name': 'Di Tommaso P.'}, {'name': 'Nahnsen S.'}], 'citationCount': 76, 'date': '2020-03-01T00:00:00Z', 'journal': 'Nature Biotechnology', 'title': 'The nf-core framework for community-curated bioinformatics pipelines'}, 'note': 'nf-core framework publication', 'pmid': '32055031', 'type': ['Primary']}]"
275,,nf-core,Consortium,,,,https://nf-co.re,,,nf-core-viralrecon,Open access,nf-core,"[{'doi': '10.1038/s41587-020-0439-x', 'metadata': {'authors': [{'name': 'Ewels P.A.'}, {'name': 'Peltzer A.'}, {'name': 'Fillinger S.'}, {'name': 'Patel H.'}, {'name': 'Alneberg J.'}, {'name': 'Wilm A.'}, {'name': 'Garcia M.U.'}, {'name': 'Di Tommaso P.'}, {'name': 'Nahnsen S.'}], 'citationCount': 76, 'date': '2020-03-01T00:00:00Z', 'journal': 'Nature Biotechnology', 'title': 'The nf-core framework for community-curated bioinformatics pipelines'}, 'note': 'nf-core framework publication', 'pmid': '32055031', 'type': ['Primary']}]"
276,,Tom Beekhuysen,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/12696783-tom-beekhuysen,,,sir-model-virus-spread,Open access (with restrictions),Kigaard,
277,,hangjun ji,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/17739628-hangjun-ji,,,analysis-the-trajectory-covid19-close-contacts,Open access (with restrictions),Kigaard,
278,,Siddharth Kumar,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/10596875-siddharth-kumar,,,covid19-realtime-tracking-simulation-indian-states,Open access (with restrictions),Kigaard,
279,,Joshua Gafford,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/14092049-joshua-gafford,,,simulitis,Open access (with restrictions),zsmag19,
280,,Siddharth Kumar,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/10596875-siddharth-kumar,,,sir-model-covid19-india-real-time-tracking,Open access (with restrictions),Kigaard,
281,,Plamen Trayanov,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/12981225-plamen-trayanov,,,branching-process-simulator,Open access (with restrictions),Kigaard,
282,luana.licata@uniroma2.it,Luana Licata,Person,https://orcid.org/0000-0001-5084-9000,['Primary contact'],,,,,mint,Open access,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gkr930', 'metadata': {'abstract': 'The Molecular INTeraction Database (MINT, http://mint.bio.uniroma2.it/mint/ ) is a public repository for protein-protein interactions (PPI) reported in peer-reviewed journals. The database grows steadily over the years and at September 2011 contains approximately 235 000 binary interactions captured from over 4750 publications. The web interface allows the users to search, visualize and download interactions data. MINT is one of the members of the International Molecular Exchange consortium (IMEx) and adopts the Molecular Interaction Ontology of the Proteomics Standard Initiative (PSI-MI) standards for curation and data exchange. MINT data are freely accessible and downloadable at http://mint.bio.uniroma2.it/mint/download.do. We report here the growth of the database, the major changes in curation policy and a new algorithm to assign a confidence to each interaction. © The Author(s) 2011.', 'authors': [{'name': 'Licata L.'}, {'name': 'Briganti L.'}, {'name': 'Peluso D.'}, {'name': 'Perfetto L.'}, {'name': 'Iannuccelli M.'}, {'name': 'Galeota E.'}, {'name': 'Sacco F.'}, {'name': 'Palma A.'}, {'name': 'Nardozza A.P.'}, {'name': 'Santonico E.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 630, 'date': '2012-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'MINT, the molecular interaction database: 2012 Update'}, 'pmcid': 'PMC3244991', 'pmid': '22096227', 'type': ['Primary']}, {'metadata': {'abstract': 'IntAct (freely available at http://www.ebi.ac.uk/intact) is an open-source, open data molecular interaction database populated by data either curated from the literature or from direct data depositions. IntAct has developed a sophisticated web-based curation tool, capable of supporting both IMEx- and MIMIx-level curation. This tool is now utilized by multiple additional curation teams, all of whom annotate data directly into the IntAct database. Members of the IntAct team supply appropriate levels of training, perform quality control on entries and take responsibility for long-term data maintenance. Recently, the MINT and IntAct databases decided to merge their separate efforts to make optimal use of limited developer resources and maximize the curation output. All data manually curated by the MINT curators have been moved into the IntAct database at EMBL-EBI and are merged with the existing IntAct dataset. Both IntAct and MINT are active contributors to the IMEx consortium (http://www.imexconsortium.org). © 2013 The Author(s). Published by Oxford University Press.', 'authors': [{'name': 'Orchard S.'}, {'name': 'Ammari M.'}, {'name': 'Aranda B.'}, {'name': 'Breuza L.'}, {'name': 'Briganti L.'}, {'name': 'Broackes-Carter F.'}, {'name': 'Campbell N.H.'}, {'name': 'Chavali G.'}, {'name': 'Chen C.'}, {'name': 'Del-Toro N.'}, {'name': 'Duesbury M.'}, {'name': 'Dumousseau M.'}, {'name': 'Galeota E.'}, {'name': 'Hinz U.'}, {'name': 'Iannuccelli M.'}, {'name': 'Jagannathan S.'}, {'name': 'Jimenez R.'}, {'name': 'Khadake J.'}, {'name': 'Lagreid A.'}, {'name': 'Licata L.'}, {'name': 'Lovering R.C.'}, {'name': 'Meldal B.'}, {'name': 'Melidoni A.N.'}, {'name': 'Milagros M.'}, {'name': 'Peluso D.'}, {'name': 'Perfetto L.'}, {'name': 'Porras P.'}, {'name': 'Raghunath A.'}, {'name': 'Ricard-Blum S.'}, {'name': 'Roechert B.'}, {'name': 'Stutz A.'}, {'name': 'Tognolli M.'}, {'name': 'Van Roey K.'}, {'name': 'Cesareni G.'}, {'name': 'Hermjakob H.'}], 'citationCount': 886, 'date': '2014-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'The MIntAct project - IntAct as a common curation platform for 11 molecular interaction databases'}, 'pmid': '24234451', 'type': ['Primary']}, {'doi': '10.1002/cpbi.93', 'metadata': {'abstract': '© 2020 John Wiley & Sons, Inc.The Molecular INTeractions Database (MINT) is a public database designed to store information about protein interactions. Protein interactions are extracted from scientific literature and annotated in the database by expert curators. Currently (October 2019), MINT contains information on more than 26,000 proteins and more than 131,600 interactions in over 30 model organisms. This article provides protocols for searching MINT over the Internet, using the new MINT Web Page. © 2020 by John Wiley & Sons, Inc. Basic Protocol 1: Searching MINT over the internet. Alternate Protocol: MINT visualizer. Basic Protocol 2: Submitting interaction data.', 'authors': [{'name': 'Calderone A.'}, {'name': 'Iannuccelli M.'}, {'name': 'Peluso D.'}, {'name': 'Licata L.'}], 'citationCount': 2, 'date': '2020-03-01T00:00:00Z', 'journal': 'Current Protocols in Bioinformatics', 'title': 'Using the MINT Database to Search Protein Interactions'}, 'type': ['Method']}]"
283,,Marta Iannuccelli,Person,,['Contributor'],,,,,mint,Open access,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gkr930', 'metadata': {'abstract': 'The Molecular INTeraction Database (MINT, http://mint.bio.uniroma2.it/mint/ ) is a public repository for protein-protein interactions (PPI) reported in peer-reviewed journals. The database grows steadily over the years and at September 2011 contains approximately 235 000 binary interactions captured from over 4750 publications. The web interface allows the users to search, visualize and download interactions data. MINT is one of the members of the International Molecular Exchange consortium (IMEx) and adopts the Molecular Interaction Ontology of the Proteomics Standard Initiative (PSI-MI) standards for curation and data exchange. MINT data are freely accessible and downloadable at http://mint.bio.uniroma2.it/mint/download.do. We report here the growth of the database, the major changes in curation policy and a new algorithm to assign a confidence to each interaction. © The Author(s) 2011.', 'authors': [{'name': 'Licata L.'}, {'name': 'Briganti L.'}, {'name': 'Peluso D.'}, {'name': 'Perfetto L.'}, {'name': 'Iannuccelli M.'}, {'name': 'Galeota E.'}, {'name': 'Sacco F.'}, {'name': 'Palma A.'}, {'name': 'Nardozza A.P.'}, {'name': 'Santonico E.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 630, 'date': '2012-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'MINT, the molecular interaction database: 2012 Update'}, 'pmcid': 'PMC3244991', 'pmid': '22096227', 'type': ['Primary']}, {'metadata': {'abstract': 'IntAct (freely available at http://www.ebi.ac.uk/intact) is an open-source, open data molecular interaction database populated by data either curated from the literature or from direct data depositions. IntAct has developed a sophisticated web-based curation tool, capable of supporting both IMEx- and MIMIx-level curation. This tool is now utilized by multiple additional curation teams, all of whom annotate data directly into the IntAct database. Members of the IntAct team supply appropriate levels of training, perform quality control on entries and take responsibility for long-term data maintenance. Recently, the MINT and IntAct databases decided to merge their separate efforts to make optimal use of limited developer resources and maximize the curation output. All data manually curated by the MINT curators have been moved into the IntAct database at EMBL-EBI and are merged with the existing IntAct dataset. Both IntAct and MINT are active contributors to the IMEx consortium (http://www.imexconsortium.org). © 2013 The Author(s). Published by Oxford University Press.', 'authors': [{'name': 'Orchard S.'}, {'name': 'Ammari M.'}, {'name': 'Aranda B.'}, {'name': 'Breuza L.'}, {'name': 'Briganti L.'}, {'name': 'Broackes-Carter F.'}, {'name': 'Campbell N.H.'}, {'name': 'Chavali G.'}, {'name': 'Chen C.'}, {'name': 'Del-Toro N.'}, {'name': 'Duesbury M.'}, {'name': 'Dumousseau M.'}, {'name': 'Galeota E.'}, {'name': 'Hinz U.'}, {'name': 'Iannuccelli M.'}, {'name': 'Jagannathan S.'}, {'name': 'Jimenez R.'}, {'name': 'Khadake J.'}, {'name': 'Lagreid A.'}, {'name': 'Licata L.'}, {'name': 'Lovering R.C.'}, {'name': 'Meldal B.'}, {'name': 'Melidoni A.N.'}, {'name': 'Milagros M.'}, {'name': 'Peluso D.'}, {'name': 'Perfetto L.'}, {'name': 'Porras P.'}, {'name': 'Raghunath A.'}, {'name': 'Ricard-Blum S.'}, {'name': 'Roechert B.'}, {'name': 'Stutz A.'}, {'name': 'Tognolli M.'}, {'name': 'Van Roey K.'}, {'name': 'Cesareni G.'}, {'name': 'Hermjakob H.'}], 'citationCount': 886, 'date': '2014-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'The MIntAct project - IntAct as a common curation platform for 11 molecular interaction databases'}, 'pmid': '24234451', 'type': ['Primary']}, {'doi': '10.1002/cpbi.93', 'metadata': {'abstract': '© 2020 John Wiley & Sons, Inc.The Molecular INTeractions Database (MINT) is a public database designed to store information about protein interactions. Protein interactions are extracted from scientific literature and annotated in the database by expert curators. Currently (October 2019), MINT contains information on more than 26,000 proteins and more than 131,600 interactions in over 30 model organisms. This article provides protocols for searching MINT over the Internet, using the new MINT Web Page. © 2020 by John Wiley & Sons, Inc. Basic Protocol 1: Searching MINT over the internet. Alternate Protocol: MINT visualizer. Basic Protocol 2: Submitting interaction data.', 'authors': [{'name': 'Calderone A.'}, {'name': 'Iannuccelli M.'}, {'name': 'Peluso D.'}, {'name': 'Licata L.'}], 'citationCount': 2, 'date': '2020-03-01T00:00:00Z', 'journal': 'Current Protocols in Bioinformatics', 'title': 'Using the MINT Database to Search Protein Interactions'}, 'type': ['Method']}]"
284,,Livia Perfetto,Person,,['Contributor'],,,,,mint,Open access,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gkr930', 'metadata': {'abstract': 'The Molecular INTeraction Database (MINT, http://mint.bio.uniroma2.it/mint/ ) is a public repository for protein-protein interactions (PPI) reported in peer-reviewed journals. The database grows steadily over the years and at September 2011 contains approximately 235 000 binary interactions captured from over 4750 publications. The web interface allows the users to search, visualize and download interactions data. MINT is one of the members of the International Molecular Exchange consortium (IMEx) and adopts the Molecular Interaction Ontology of the Proteomics Standard Initiative (PSI-MI) standards for curation and data exchange. MINT data are freely accessible and downloadable at http://mint.bio.uniroma2.it/mint/download.do. We report here the growth of the database, the major changes in curation policy and a new algorithm to assign a confidence to each interaction. © The Author(s) 2011.', 'authors': [{'name': 'Licata L.'}, {'name': 'Briganti L.'}, {'name': 'Peluso D.'}, {'name': 'Perfetto L.'}, {'name': 'Iannuccelli M.'}, {'name': 'Galeota E.'}, {'name': 'Sacco F.'}, {'name': 'Palma A.'}, {'name': 'Nardozza A.P.'}, {'name': 'Santonico E.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 630, 'date': '2012-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'MINT, the molecular interaction database: 2012 Update'}, 'pmcid': 'PMC3244991', 'pmid': '22096227', 'type': ['Primary']}, {'metadata': {'abstract': 'IntAct (freely available at http://www.ebi.ac.uk/intact) is an open-source, open data molecular interaction database populated by data either curated from the literature or from direct data depositions. IntAct has developed a sophisticated web-based curation tool, capable of supporting both IMEx- and MIMIx-level curation. This tool is now utilized by multiple additional curation teams, all of whom annotate data directly into the IntAct database. Members of the IntAct team supply appropriate levels of training, perform quality control on entries and take responsibility for long-term data maintenance. Recently, the MINT and IntAct databases decided to merge their separate efforts to make optimal use of limited developer resources and maximize the curation output. All data manually curated by the MINT curators have been moved into the IntAct database at EMBL-EBI and are merged with the existing IntAct dataset. Both IntAct and MINT are active contributors to the IMEx consortium (http://www.imexconsortium.org). © 2013 The Author(s). Published by Oxford University Press.', 'authors': [{'name': 'Orchard S.'}, {'name': 'Ammari M.'}, {'name': 'Aranda B.'}, {'name': 'Breuza L.'}, {'name': 'Briganti L.'}, {'name': 'Broackes-Carter F.'}, {'name': 'Campbell N.H.'}, {'name': 'Chavali G.'}, {'name': 'Chen C.'}, {'name': 'Del-Toro N.'}, {'name': 'Duesbury M.'}, {'name': 'Dumousseau M.'}, {'name': 'Galeota E.'}, {'name': 'Hinz U.'}, {'name': 'Iannuccelli M.'}, {'name': 'Jagannathan S.'}, {'name': 'Jimenez R.'}, {'name': 'Khadake J.'}, {'name': 'Lagreid A.'}, {'name': 'Licata L.'}, {'name': 'Lovering R.C.'}, {'name': 'Meldal B.'}, {'name': 'Melidoni A.N.'}, {'name': 'Milagros M.'}, {'name': 'Peluso D.'}, {'name': 'Perfetto L.'}, {'name': 'Porras P.'}, {'name': 'Raghunath A.'}, {'name': 'Ricard-Blum S.'}, {'name': 'Roechert B.'}, {'name': 'Stutz A.'}, {'name': 'Tognolli M.'}, {'name': 'Van Roey K.'}, {'name': 'Cesareni G.'}, {'name': 'Hermjakob H.'}], 'citationCount': 886, 'date': '2014-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'The MIntAct project - IntAct as a common curation platform for 11 molecular interaction databases'}, 'pmid': '24234451', 'type': ['Primary']}, {'doi': '10.1002/cpbi.93', 'metadata': {'abstract': '© 2020 John Wiley & Sons, Inc.The Molecular INTeractions Database (MINT) is a public database designed to store information about protein interactions. Protein interactions are extracted from scientific literature and annotated in the database by expert curators. Currently (October 2019), MINT contains information on more than 26,000 proteins and more than 131,600 interactions in over 30 model organisms. This article provides protocols for searching MINT over the Internet, using the new MINT Web Page. © 2020 by John Wiley & Sons, Inc. Basic Protocol 1: Searching MINT over the internet. Alternate Protocol: MINT visualizer. Basic Protocol 2: Submitting interaction data.', 'authors': [{'name': 'Calderone A.'}, {'name': 'Iannuccelli M.'}, {'name': 'Peluso D.'}, {'name': 'Licata L.'}], 'citationCount': 2, 'date': '2020-03-01T00:00:00Z', 'journal': 'Current Protocols in Bioinformatics', 'title': 'Using the MINT Database to Search Protein Interactions'}, 'type': ['Method']}]"
285,,Alberto Calderone,Person,,['Developer'],,,,,mint,Open access,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gkr930', 'metadata': {'abstract': 'The Molecular INTeraction Database (MINT, http://mint.bio.uniroma2.it/mint/ ) is a public repository for protein-protein interactions (PPI) reported in peer-reviewed journals. The database grows steadily over the years and at September 2011 contains approximately 235 000 binary interactions captured from over 4750 publications. The web interface allows the users to search, visualize and download interactions data. MINT is one of the members of the International Molecular Exchange consortium (IMEx) and adopts the Molecular Interaction Ontology of the Proteomics Standard Initiative (PSI-MI) standards for curation and data exchange. MINT data are freely accessible and downloadable at http://mint.bio.uniroma2.it/mint/download.do. We report here the growth of the database, the major changes in curation policy and a new algorithm to assign a confidence to each interaction. © The Author(s) 2011.', 'authors': [{'name': 'Licata L.'}, {'name': 'Briganti L.'}, {'name': 'Peluso D.'}, {'name': 'Perfetto L.'}, {'name': 'Iannuccelli M.'}, {'name': 'Galeota E.'}, {'name': 'Sacco F.'}, {'name': 'Palma A.'}, {'name': 'Nardozza A.P.'}, {'name': 'Santonico E.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 630, 'date': '2012-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'MINT, the molecular interaction database: 2012 Update'}, 'pmcid': 'PMC3244991', 'pmid': '22096227', 'type': ['Primary']}, {'metadata': {'abstract': 'IntAct (freely available at http://www.ebi.ac.uk/intact) is an open-source, open data molecular interaction database populated by data either curated from the literature or from direct data depositions. IntAct has developed a sophisticated web-based curation tool, capable of supporting both IMEx- and MIMIx-level curation. This tool is now utilized by multiple additional curation teams, all of whom annotate data directly into the IntAct database. Members of the IntAct team supply appropriate levels of training, perform quality control on entries and take responsibility for long-term data maintenance. Recently, the MINT and IntAct databases decided to merge their separate efforts to make optimal use of limited developer resources and maximize the curation output. All data manually curated by the MINT curators have been moved into the IntAct database at EMBL-EBI and are merged with the existing IntAct dataset. Both IntAct and MINT are active contributors to the IMEx consortium (http://www.imexconsortium.org). © 2013 The Author(s). Published by Oxford University Press.', 'authors': [{'name': 'Orchard S.'}, {'name': 'Ammari M.'}, {'name': 'Aranda B.'}, {'name': 'Breuza L.'}, {'name': 'Briganti L.'}, {'name': 'Broackes-Carter F.'}, {'name': 'Campbell N.H.'}, {'name': 'Chavali G.'}, {'name': 'Chen C.'}, {'name': 'Del-Toro N.'}, {'name': 'Duesbury M.'}, {'name': 'Dumousseau M.'}, {'name': 'Galeota E.'}, {'name': 'Hinz U.'}, {'name': 'Iannuccelli M.'}, {'name': 'Jagannathan S.'}, {'name': 'Jimenez R.'}, {'name': 'Khadake J.'}, {'name': 'Lagreid A.'}, {'name': 'Licata L.'}, {'name': 'Lovering R.C.'}, {'name': 'Meldal B.'}, {'name': 'Melidoni A.N.'}, {'name': 'Milagros M.'}, {'name': 'Peluso D.'}, {'name': 'Perfetto L.'}, {'name': 'Porras P.'}, {'name': 'Raghunath A.'}, {'name': 'Ricard-Blum S.'}, {'name': 'Roechert B.'}, {'name': 'Stutz A.'}, {'name': 'Tognolli M.'}, {'name': 'Van Roey K.'}, {'name': 'Cesareni G.'}, {'name': 'Hermjakob H.'}], 'citationCount': 886, 'date': '2014-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'The MIntAct project - IntAct as a common curation platform for 11 molecular interaction databases'}, 'pmid': '24234451', 'type': ['Primary']}, {'doi': '10.1002/cpbi.93', 'metadata': {'abstract': '© 2020 John Wiley & Sons, Inc.The Molecular INTeractions Database (MINT) is a public database designed to store information about protein interactions. Protein interactions are extracted from scientific literature and annotated in the database by expert curators. Currently (October 2019), MINT contains information on more than 26,000 proteins and more than 131,600 interactions in over 30 model organisms. This article provides protocols for searching MINT over the Internet, using the new MINT Web Page. © 2020 by John Wiley & Sons, Inc. Basic Protocol 1: Searching MINT over the internet. Alternate Protocol: MINT visualizer. Basic Protocol 2: Submitting interaction data.', 'authors': [{'name': 'Calderone A.'}, {'name': 'Iannuccelli M.'}, {'name': 'Peluso D.'}, {'name': 'Licata L.'}], 'citationCount': 2, 'date': '2020-03-01T00:00:00Z', 'journal': 'Current Protocols in Bioinformatics', 'title': 'Using the MINT Database to Search Protein Interactions'}, 'type': ['Method']}]"
286,,Daniele Peluso,Person,,['Developer'],,,,,mint,Open access,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gkr930', 'metadata': {'abstract': 'The Molecular INTeraction Database (MINT, http://mint.bio.uniroma2.it/mint/ ) is a public repository for protein-protein interactions (PPI) reported in peer-reviewed journals. The database grows steadily over the years and at September 2011 contains approximately 235 000 binary interactions captured from over 4750 publications. The web interface allows the users to search, visualize and download interactions data. MINT is one of the members of the International Molecular Exchange consortium (IMEx) and adopts the Molecular Interaction Ontology of the Proteomics Standard Initiative (PSI-MI) standards for curation and data exchange. MINT data are freely accessible and downloadable at http://mint.bio.uniroma2.it/mint/download.do. We report here the growth of the database, the major changes in curation policy and a new algorithm to assign a confidence to each interaction. © The Author(s) 2011.', 'authors': [{'name': 'Licata L.'}, {'name': 'Briganti L.'}, {'name': 'Peluso D.'}, {'name': 'Perfetto L.'}, {'name': 'Iannuccelli M.'}, {'name': 'Galeota E.'}, {'name': 'Sacco F.'}, {'name': 'Palma A.'}, {'name': 'Nardozza A.P.'}, {'name': 'Santonico E.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 630, 'date': '2012-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'MINT, the molecular interaction database: 2012 Update'}, 'pmcid': 'PMC3244991', 'pmid': '22096227', 'type': ['Primary']}, {'metadata': {'abstract': 'IntAct (freely available at http://www.ebi.ac.uk/intact) is an open-source, open data molecular interaction database populated by data either curated from the literature or from direct data depositions. IntAct has developed a sophisticated web-based curation tool, capable of supporting both IMEx- and MIMIx-level curation. This tool is now utilized by multiple additional curation teams, all of whom annotate data directly into the IntAct database. Members of the IntAct team supply appropriate levels of training, perform quality control on entries and take responsibility for long-term data maintenance. Recently, the MINT and IntAct databases decided to merge their separate efforts to make optimal use of limited developer resources and maximize the curation output. All data manually curated by the MINT curators have been moved into the IntAct database at EMBL-EBI and are merged with the existing IntAct dataset. Both IntAct and MINT are active contributors to the IMEx consortium (http://www.imexconsortium.org). © 2013 The Author(s). Published by Oxford University Press.', 'authors': [{'name': 'Orchard S.'}, {'name': 'Ammari M.'}, {'name': 'Aranda B.'}, {'name': 'Breuza L.'}, {'name': 'Briganti L.'}, {'name': 'Broackes-Carter F.'}, {'name': 'Campbell N.H.'}, {'name': 'Chavali G.'}, {'name': 'Chen C.'}, {'name': 'Del-Toro N.'}, {'name': 'Duesbury M.'}, {'name': 'Dumousseau M.'}, {'name': 'Galeota E.'}, {'name': 'Hinz U.'}, {'name': 'Iannuccelli M.'}, {'name': 'Jagannathan S.'}, {'name': 'Jimenez R.'}, {'name': 'Khadake J.'}, {'name': 'Lagreid A.'}, {'name': 'Licata L.'}, {'name': 'Lovering R.C.'}, {'name': 'Meldal B.'}, {'name': 'Melidoni A.N.'}, {'name': 'Milagros M.'}, {'name': 'Peluso D.'}, {'name': 'Perfetto L.'}, {'name': 'Porras P.'}, {'name': 'Raghunath A.'}, {'name': 'Ricard-Blum S.'}, {'name': 'Roechert B.'}, {'name': 'Stutz A.'}, {'name': 'Tognolli M.'}, {'name': 'Van Roey K.'}, {'name': 'Cesareni G.'}, {'name': 'Hermjakob H.'}], 'citationCount': 886, 'date': '2014-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'The MIntAct project - IntAct as a common curation platform for 11 molecular interaction databases'}, 'pmid': '24234451', 'type': ['Primary']}, {'doi': '10.1002/cpbi.93', 'metadata': {'abstract': '© 2020 John Wiley & Sons, Inc.The Molecular INTeractions Database (MINT) is a public database designed to store information about protein interactions. Protein interactions are extracted from scientific literature and annotated in the database by expert curators. Currently (October 2019), MINT contains information on more than 26,000 proteins and more than 131,600 interactions in over 30 model organisms. This article provides protocols for searching MINT over the Internet, using the new MINT Web Page. © 2020 by John Wiley & Sons, Inc. Basic Protocol 1: Searching MINT over the internet. Alternate Protocol: MINT visualizer. Basic Protocol 2: Submitting interaction data.', 'authors': [{'name': 'Calderone A.'}, {'name': 'Iannuccelli M.'}, {'name': 'Peluso D.'}, {'name': 'Licata L.'}], 'citationCount': 2, 'date': '2020-03-01T00:00:00Z', 'journal': 'Current Protocols in Bioinformatics', 'title': 'Using the MINT Database to Search Protein Interactions'}, 'type': ['Method']}]"
287,,Gianni Cesareni,Person,,['Contributor'],,,,,mint,Open access,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gkr930', 'metadata': {'abstract': 'The Molecular INTeraction Database (MINT, http://mint.bio.uniroma2.it/mint/ ) is a public repository for protein-protein interactions (PPI) reported in peer-reviewed journals. The database grows steadily over the years and at September 2011 contains approximately 235 000 binary interactions captured from over 4750 publications. The web interface allows the users to search, visualize and download interactions data. MINT is one of the members of the International Molecular Exchange consortium (IMEx) and adopts the Molecular Interaction Ontology of the Proteomics Standard Initiative (PSI-MI) standards for curation and data exchange. MINT data are freely accessible and downloadable at http://mint.bio.uniroma2.it/mint/download.do. We report here the growth of the database, the major changes in curation policy and a new algorithm to assign a confidence to each interaction. © The Author(s) 2011.', 'authors': [{'name': 'Licata L.'}, {'name': 'Briganti L.'}, {'name': 'Peluso D.'}, {'name': 'Perfetto L.'}, {'name': 'Iannuccelli M.'}, {'name': 'Galeota E.'}, {'name': 'Sacco F.'}, {'name': 'Palma A.'}, {'name': 'Nardozza A.P.'}, {'name': 'Santonico E.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 630, 'date': '2012-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'MINT, the molecular interaction database: 2012 Update'}, 'pmcid': 'PMC3244991', 'pmid': '22096227', 'type': ['Primary']}, {'metadata': {'abstract': 'IntAct (freely available at http://www.ebi.ac.uk/intact) is an open-source, open data molecular interaction database populated by data either curated from the literature or from direct data depositions. IntAct has developed a sophisticated web-based curation tool, capable of supporting both IMEx- and MIMIx-level curation. This tool is now utilized by multiple additional curation teams, all of whom annotate data directly into the IntAct database. Members of the IntAct team supply appropriate levels of training, perform quality control on entries and take responsibility for long-term data maintenance. Recently, the MINT and IntAct databases decided to merge their separate efforts to make optimal use of limited developer resources and maximize the curation output. All data manually curated by the MINT curators have been moved into the IntAct database at EMBL-EBI and are merged with the existing IntAct dataset. Both IntAct and MINT are active contributors to the IMEx consortium (http://www.imexconsortium.org). © 2013 The Author(s). Published by Oxford University Press.', 'authors': [{'name': 'Orchard S.'}, {'name': 'Ammari M.'}, {'name': 'Aranda B.'}, {'name': 'Breuza L.'}, {'name': 'Briganti L.'}, {'name': 'Broackes-Carter F.'}, {'name': 'Campbell N.H.'}, {'name': 'Chavali G.'}, {'name': 'Chen C.'}, {'name': 'Del-Toro N.'}, {'name': 'Duesbury M.'}, {'name': 'Dumousseau M.'}, {'name': 'Galeota E.'}, {'name': 'Hinz U.'}, {'name': 'Iannuccelli M.'}, {'name': 'Jagannathan S.'}, {'name': 'Jimenez R.'}, {'name': 'Khadake J.'}, {'name': 'Lagreid A.'}, {'name': 'Licata L.'}, {'name': 'Lovering R.C.'}, {'name': 'Meldal B.'}, {'name': 'Melidoni A.N.'}, {'name': 'Milagros M.'}, {'name': 'Peluso D.'}, {'name': 'Perfetto L.'}, {'name': 'Porras P.'}, {'name': 'Raghunath A.'}, {'name': 'Ricard-Blum S.'}, {'name': 'Roechert B.'}, {'name': 'Stutz A.'}, {'name': 'Tognolli M.'}, {'name': 'Van Roey K.'}, {'name': 'Cesareni G.'}, {'name': 'Hermjakob H.'}], 'citationCount': 886, 'date': '2014-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'The MIntAct project - IntAct as a common curation platform for 11 molecular interaction databases'}, 'pmid': '24234451', 'type': ['Primary']}, {'doi': '10.1002/cpbi.93', 'metadata': {'abstract': '© 2020 John Wiley & Sons, Inc.The Molecular INTeractions Database (MINT) is a public database designed to store information about protein interactions. Protein interactions are extracted from scientific literature and annotated in the database by expert curators. Currently (October 2019), MINT contains information on more than 26,000 proteins and more than 131,600 interactions in over 30 model organisms. This article provides protocols for searching MINT over the Internet, using the new MINT Web Page. © 2020 by John Wiley & Sons, Inc. Basic Protocol 1: Searching MINT over the internet. Alternate Protocol: MINT visualizer. Basic Protocol 2: Submitting interaction data.', 'authors': [{'name': 'Calderone A.'}, {'name': 'Iannuccelli M.'}, {'name': 'Peluso D.'}, {'name': 'Licata L.'}], 'citationCount': 2, 'date': '2020-03-01T00:00:00Z', 'journal': 'Current Protocols in Bioinformatics', 'title': 'Using the MINT Database to Search Protein Interactions'}, 'type': ['Method']}]"
288,,"Dept. of Molecular Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, Rome",Institute,,['Provider'],,,,,mint,Open access,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gkr930', 'metadata': {'abstract': 'The Molecular INTeraction Database (MINT, http://mint.bio.uniroma2.it/mint/ ) is a public repository for protein-protein interactions (PPI) reported in peer-reviewed journals. The database grows steadily over the years and at September 2011 contains approximately 235 000 binary interactions captured from over 4750 publications. The web interface allows the users to search, visualize and download interactions data. MINT is one of the members of the International Molecular Exchange consortium (IMEx) and adopts the Molecular Interaction Ontology of the Proteomics Standard Initiative (PSI-MI) standards for curation and data exchange. MINT data are freely accessible and downloadable at http://mint.bio.uniroma2.it/mint/download.do. We report here the growth of the database, the major changes in curation policy and a new algorithm to assign a confidence to each interaction. © The Author(s) 2011.', 'authors': [{'name': 'Licata L.'}, {'name': 'Briganti L.'}, {'name': 'Peluso D.'}, {'name': 'Perfetto L.'}, {'name': 'Iannuccelli M.'}, {'name': 'Galeota E.'}, {'name': 'Sacco F.'}, {'name': 'Palma A.'}, {'name': 'Nardozza A.P.'}, {'name': 'Santonico E.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 630, 'date': '2012-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'MINT, the molecular interaction database: 2012 Update'}, 'pmcid': 'PMC3244991', 'pmid': '22096227', 'type': ['Primary']}, {'metadata': {'abstract': 'IntAct (freely available at http://www.ebi.ac.uk/intact) is an open-source, open data molecular interaction database populated by data either curated from the literature or from direct data depositions. IntAct has developed a sophisticated web-based curation tool, capable of supporting both IMEx- and MIMIx-level curation. This tool is now utilized by multiple additional curation teams, all of whom annotate data directly into the IntAct database. Members of the IntAct team supply appropriate levels of training, perform quality control on entries and take responsibility for long-term data maintenance. Recently, the MINT and IntAct databases decided to merge their separate efforts to make optimal use of limited developer resources and maximize the curation output. All data manually curated by the MINT curators have been moved into the IntAct database at EMBL-EBI and are merged with the existing IntAct dataset. Both IntAct and MINT are active contributors to the IMEx consortium (http://www.imexconsortium.org). © 2013 The Author(s). Published by Oxford University Press.', 'authors': [{'name': 'Orchard S.'}, {'name': 'Ammari M.'}, {'name': 'Aranda B.'}, {'name': 'Breuza L.'}, {'name': 'Briganti L.'}, {'name': 'Broackes-Carter F.'}, {'name': 'Campbell N.H.'}, {'name': 'Chavali G.'}, {'name': 'Chen C.'}, {'name': 'Del-Toro N.'}, {'name': 'Duesbury M.'}, {'name': 'Dumousseau M.'}, {'name': 'Galeota E.'}, {'name': 'Hinz U.'}, {'name': 'Iannuccelli M.'}, {'name': 'Jagannathan S.'}, {'name': 'Jimenez R.'}, {'name': 'Khadake J.'}, {'name': 'Lagreid A.'}, {'name': 'Licata L.'}, {'name': 'Lovering R.C.'}, {'name': 'Meldal B.'}, {'name': 'Melidoni A.N.'}, {'name': 'Milagros M.'}, {'name': 'Peluso D.'}, {'name': 'Perfetto L.'}, {'name': 'Porras P.'}, {'name': 'Raghunath A.'}, {'name': 'Ricard-Blum S.'}, {'name': 'Roechert B.'}, {'name': 'Stutz A.'}, {'name': 'Tognolli M.'}, {'name': 'Van Roey K.'}, {'name': 'Cesareni G.'}, {'name': 'Hermjakob H.'}], 'citationCount': 886, 'date': '2014-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'The MIntAct project - IntAct as a common curation platform for 11 molecular interaction databases'}, 'pmid': '24234451', 'type': ['Primary']}, {'doi': '10.1002/cpbi.93', 'metadata': {'abstract': '© 2020 John Wiley & Sons, Inc.The Molecular INTeractions Database (MINT) is a public database designed to store information about protein interactions. Protein interactions are extracted from scientific literature and annotated in the database by expert curators. Currently (October 2019), MINT contains information on more than 26,000 proteins and more than 131,600 interactions in over 30 model organisms. This article provides protocols for searching MINT over the Internet, using the new MINT Web Page. © 2020 by John Wiley & Sons, Inc. Basic Protocol 1: Searching MINT over the internet. Alternate Protocol: MINT visualizer. Basic Protocol 2: Submitting interaction data.', 'authors': [{'name': 'Calderone A.'}, {'name': 'Iannuccelli M.'}, {'name': 'Peluso D.'}, {'name': 'Licata L.'}], 'citationCount': 2, 'date': '2020-03-01T00:00:00Z', 'journal': 'Current Protocols in Bioinformatics', 'title': 'Using the MINT Database to Search Protein Interactions'}, 'type': ['Method']}]"
289,,ELIXIR-ITA-TORVERGATA,Institute,,['Support'],,,,,mint,Open access,ELIXIR-ITA-TORVERGATA,"[{'doi': '10.1093/nar/gkr930', 'metadata': {'abstract': 'The Molecular INTeraction Database (MINT, http://mint.bio.uniroma2.it/mint/ ) is a public repository for protein-protein interactions (PPI) reported in peer-reviewed journals. The database grows steadily over the years and at September 2011 contains approximately 235 000 binary interactions captured from over 4750 publications. The web interface allows the users to search, visualize and download interactions data. MINT is one of the members of the International Molecular Exchange consortium (IMEx) and adopts the Molecular Interaction Ontology of the Proteomics Standard Initiative (PSI-MI) standards for curation and data exchange. MINT data are freely accessible and downloadable at http://mint.bio.uniroma2.it/mint/download.do. We report here the growth of the database, the major changes in curation policy and a new algorithm to assign a confidence to each interaction. © The Author(s) 2011.', 'authors': [{'name': 'Licata L.'}, {'name': 'Briganti L.'}, {'name': 'Peluso D.'}, {'name': 'Perfetto L.'}, {'name': 'Iannuccelli M.'}, {'name': 'Galeota E.'}, {'name': 'Sacco F.'}, {'name': 'Palma A.'}, {'name': 'Nardozza A.P.'}, {'name': 'Santonico E.'}, {'name': 'Castagnoli L.'}, {'name': 'Cesareni G.'}], 'citationCount': 630, 'date': '2012-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'MINT, the molecular interaction database: 2012 Update'}, 'pmcid': 'PMC3244991', 'pmid': '22096227', 'type': ['Primary']}, {'metadata': {'abstract': 'IntAct (freely available at http://www.ebi.ac.uk/intact) is an open-source, open data molecular interaction database populated by data either curated from the literature or from direct data depositions. IntAct has developed a sophisticated web-based curation tool, capable of supporting both IMEx- and MIMIx-level curation. This tool is now utilized by multiple additional curation teams, all of whom annotate data directly into the IntAct database. Members of the IntAct team supply appropriate levels of training, perform quality control on entries and take responsibility for long-term data maintenance. Recently, the MINT and IntAct databases decided to merge their separate efforts to make optimal use of limited developer resources and maximize the curation output. All data manually curated by the MINT curators have been moved into the IntAct database at EMBL-EBI and are merged with the existing IntAct dataset. Both IntAct and MINT are active contributors to the IMEx consortium (http://www.imexconsortium.org). © 2013 The Author(s). Published by Oxford University Press.', 'authors': [{'name': 'Orchard S.'}, {'name': 'Ammari M.'}, {'name': 'Aranda B.'}, {'name': 'Breuza L.'}, {'name': 'Briganti L.'}, {'name': 'Broackes-Carter F.'}, {'name': 'Campbell N.H.'}, {'name': 'Chavali G.'}, {'name': 'Chen C.'}, {'name': 'Del-Toro N.'}, {'name': 'Duesbury M.'}, {'name': 'Dumousseau M.'}, {'name': 'Galeota E.'}, {'name': 'Hinz U.'}, {'name': 'Iannuccelli M.'}, {'name': 'Jagannathan S.'}, {'name': 'Jimenez R.'}, {'name': 'Khadake J.'}, {'name': 'Lagreid A.'}, {'name': 'Licata L.'}, {'name': 'Lovering R.C.'}, {'name': 'Meldal B.'}, {'name': 'Melidoni A.N.'}, {'name': 'Milagros M.'}, {'name': 'Peluso D.'}, {'name': 'Perfetto L.'}, {'name': 'Porras P.'}, {'name': 'Raghunath A.'}, {'name': 'Ricard-Blum S.'}, {'name': 'Roechert B.'}, {'name': 'Stutz A.'}, {'name': 'Tognolli M.'}, {'name': 'Van Roey K.'}, {'name': 'Cesareni G.'}, {'name': 'Hermjakob H.'}], 'citationCount': 886, 'date': '2014-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'The MIntAct project - IntAct as a common curation platform for 11 molecular interaction databases'}, 'pmid': '24234451', 'type': ['Primary']}, {'doi': '10.1002/cpbi.93', 'metadata': {'abstract': '© 2020 John Wiley & Sons, Inc.The Molecular INTeractions Database (MINT) is a public database designed to store information about protein interactions. Protein interactions are extracted from scientific literature and annotated in the database by expert curators. Currently (October 2019), MINT contains information on more than 26,000 proteins and more than 131,600 interactions in over 30 model organisms. This article provides protocols for searching MINT over the Internet, using the new MINT Web Page. © 2020 by John Wiley & Sons, Inc. Basic Protocol 1: Searching MINT over the internet. Alternate Protocol: MINT visualizer. Basic Protocol 2: Submitting interaction data.', 'authors': [{'name': 'Calderone A.'}, {'name': 'Iannuccelli M.'}, {'name': 'Peluso D.'}, {'name': 'Licata L.'}], 'citationCount': 2, 'date': '2020-03-01T00:00:00Z', 'journal': 'Current Protocols in Bioinformatics', 'title': 'Using the MINT Database to Search Protein Interactions'}, 'type': ['Method']}]"
290,,SIB Swiss Institute of Bioinformatics,Institute,,['Provider'],,,,,swiss-model_workspace,,Torsten.Schwede,"[{'doi': '10.1093/nar/gky427', 'metadata': {'abstract': '© The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research.Homology modelling has matured into an important technique in structural biology, significantly contributing to narrowing the gap between known protein sequences and experimentally determined structures. Fully automated workflows and servers simplify and streamline the homology modelling process, also allowing users without a specific computational expertise to generate reliable protein models and have easy access to modelling results, their visualization and interpretation. Here, we present an update to the SWISS-MODEL server, which pioneered the field of automated modelling 25 years ago and been continuously further developed. Recently, its functionality has been extended to the modelling of homo- and heteromeric complexes. Starting from the amino acid sequences of the interacting proteins, both the stoichiometry and the overall structure of the complex are inferred by homology modelling. Other major improvements include the implementation of a new modelling engine, ProMod3 and the introduction a new local model quality estimation method, QMEANDisCo. SWISS-MODEL is freely available at https://swissmodel.expasy.org.', 'authors': [{'name': 'Waterhouse A.'}, {'name': 'Bertoni M.'}, {'name': 'Bienert S.'}, {'name': 'Studer G.'}, {'name': 'Tauriello G.'}, {'name': 'Gumienny R.'}, {'name': 'Heer F.T.'}, {'name': 'De Beer T.A.P.'}, {'name': 'Rempfer C.'}, {'name': 'Bordoli L.'}, {'name': 'Lepore R.'}, {'name': 'Schwede T.'}], 'citationCount': 2837, 'date': '2018-07-02T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SWISS-MODEL: Homology modelling of protein structures and complexes'}, 'pmcid': 'PMC6030848', 'pmid': '29788355', 'type': ['Primary']}]"
291,torsten.schwede@unibas.ch,Torsten Schwede,Person,https://orcid.org/0000-0003-2715-335X,['Primary contact'],,http://schwedelab.org,,,swiss-model_workspace,,Torsten.Schwede,"[{'doi': '10.1093/nar/gky427', 'metadata': {'abstract': '© The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research.Homology modelling has matured into an important technique in structural biology, significantly contributing to narrowing the gap between known protein sequences and experimentally determined structures. Fully automated workflows and servers simplify and streamline the homology modelling process, also allowing users without a specific computational expertise to generate reliable protein models and have easy access to modelling results, their visualization and interpretation. Here, we present an update to the SWISS-MODEL server, which pioneered the field of automated modelling 25 years ago and been continuously further developed. Recently, its functionality has been extended to the modelling of homo- and heteromeric complexes. Starting from the amino acid sequences of the interacting proteins, both the stoichiometry and the overall structure of the complex are inferred by homology modelling. Other major improvements include the implementation of a new modelling engine, ProMod3 and the introduction a new local model quality estimation method, QMEANDisCo. SWISS-MODEL is freely available at https://swissmodel.expasy.org.', 'authors': [{'name': 'Waterhouse A.'}, {'name': 'Bertoni M.'}, {'name': 'Bienert S.'}, {'name': 'Studer G.'}, {'name': 'Tauriello G.'}, {'name': 'Gumienny R.'}, {'name': 'Heer F.T.'}, {'name': 'De Beer T.A.P.'}, {'name': 'Rempfer C.'}, {'name': 'Bordoli L.'}, {'name': 'Lepore R.'}, {'name': 'Schwede T.'}], 'citationCount': 2837, 'date': '2018-07-02T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SWISS-MODEL: Homology modelling of protein structures and complexes'}, 'pmcid': 'PMC6030848', 'pmid': '29788355', 'type': ['Primary']}]"
292,help-swissmodel@unibas.ch,,Project,,['Support'],,,,,swiss-model_workspace,,Torsten.Schwede,"[{'doi': '10.1093/nar/gky427', 'metadata': {'abstract': '© The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research.Homology modelling has matured into an important technique in structural biology, significantly contributing to narrowing the gap between known protein sequences and experimentally determined structures. Fully automated workflows and servers simplify and streamline the homology modelling process, also allowing users without a specific computational expertise to generate reliable protein models and have easy access to modelling results, their visualization and interpretation. Here, we present an update to the SWISS-MODEL server, which pioneered the field of automated modelling 25 years ago and been continuously further developed. Recently, its functionality has been extended to the modelling of homo- and heteromeric complexes. Starting from the amino acid sequences of the interacting proteins, both the stoichiometry and the overall structure of the complex are inferred by homology modelling. Other major improvements include the implementation of a new modelling engine, ProMod3 and the introduction a new local model quality estimation method, QMEANDisCo. SWISS-MODEL is freely available at https://swissmodel.expasy.org.', 'authors': [{'name': 'Waterhouse A.'}, {'name': 'Bertoni M.'}, {'name': 'Bienert S.'}, {'name': 'Studer G.'}, {'name': 'Tauriello G.'}, {'name': 'Gumienny R.'}, {'name': 'Heer F.T.'}, {'name': 'De Beer T.A.P.'}, {'name': 'Rempfer C.'}, {'name': 'Bordoli L.'}, {'name': 'Lepore R.'}, {'name': 'Schwede T.'}], 'citationCount': 2837, 'date': '2018-07-02T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SWISS-MODEL: Homology modelling of protein structures and complexes'}, 'pmcid': 'PMC6030848', 'pmid': '29788355', 'type': ['Primary']}]"
293,ferran.sanz@upf.edu,Ferran Sanz,Person,http://orcid.org/0000-0002-7534-7661,['Contributor'],,,,,disgenet,Open access (with restrictions),lfurlong,"[{'doi': '10.1093/database/bav028', 'metadata': {'abstract': '© The Author(s) 2015. Published by Oxford University Press.DisGeNET is a comprehensive discovery platform designed to address a variety of questions concerning the genetic underpinning of human diseases. DisGeNET contains over 380 000 associations between >16 000 genes and 13 000 diseases, which makes it one of the largest repositories currently available of its kind. DisGeNET integrates expert-curated databases with text-mined data, covers information on Mendelian and complex diseases, and includes data from animal disease models. It features a score based on the supporting evidence to prioritize gene-disease associations. It is an open access resource available through a web interface, a Cytoscape plugin and as a Semantic Web resource. The web interface supports user-friendly data exploration and navigation. DisGeNET data can also be analysed via the DisGeNET Cytoscape plugin, and enriched with the annotations of other plugins of this popular network analysis software suite. Finally, the information contained in DisGeNET can be expanded and complemented using Semantic Web technologies and linked to a variety of resources already present in the Linked Data cloud. Hence, DisGeNET offers one of the most comprehensive collections of human gene-disease associations and a valuable set of tools for investigating the molecular mechanisms underlying diseases of genetic origin, designed to fulfill the needs of different user profiles, including bioinformaticians, biologists and health-care practitioners.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Queralt-Rosinach N.'}, {'name': 'Bravo A.'}, {'name': 'Deu-Pons J.'}, {'name': 'Bauer-Mehren A.'}, {'name': 'Baron M.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 448, 'date': '2015-01-01T00:00:00Z', 'journal': 'Database', 'title': 'DisGeNET: A discovery platform for the dynamical exploration of human diseases and their genes'}, 'type': ['Other']}, {'doi': '10.1093/nar/gkw943', 'metadata': {'abstract': '© The Author(s) 2016.The information about the genetic basis of human diseases lies at the heart of precision medicine and drug discovery. However, to realize its full potential to support these goals, several problems, such as fragmentation, heterogeneity, availability and different conceptualization of the data must be overcome. To provide the community with a resource free of these hurdles, we have developed DisGeNET (http://www.disgenet.org), one of the largest available collections of genes and variants involved in human diseases. DisGeNET integrates data from expert curated repositories, GWAS catalogues, animal models and the scientific literature. DisGeNET data are homogeneously annotated with controlled vocabularies and community-driven ontologies. Additionally, several original metrics are provided to assist the prioritization of genotype-phenotype relationships. The information is accessible through a web interface, a Cytoscape App, an RDF SPARQL endpoint, scripts in several programming languages and an R package. DisGeNET is a versatile platform that can be used for different research purposes including the investigation of the molecular underpinnings of specific human diseases and their comorbidities, the analysis of the properties of disease genes, the generation of hypothesis on drug therapeutic action and drug adverse effects, the validation of computationally predicted disease genes and the evaluation of text-mining methods performance.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Bravo A.'}, {'name': 'Queralt-Rosinach N.'}, {'name': 'Gutierrez-Sacristan A.'}, {'name': 'Deu-Pons J.'}, {'name': 'Centeno E.'}, {'name': 'Garcia-Garcia J.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 756, 'date': '2017-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants'}, 'type': ['Other']}, {'doi': '10.1093/bioinformatics/btq538', 'metadata': {'abstract': 'Summary: DisGeNET is a plugin for Cytoscape to query and analyze human gene-disease networks. DisGeNET allows user-friendly access to a new gene-disease database that we have developed by integrating data from several public sources. DisGeNET permits queries restricted to (i) the original data source, (ii) the association type, (iii) the disease class or (iv) specific gene(s)/disease(s). It represents gene-disease associations in terms of bipartite graphs and provides gene centric and disease centric views of the data. It assists the user in the interpretation and exploration of the genetic basis of human diseases by a variety of built-in functions. Moreover, DisGeNET permits multicolouring of nodes (genes/diseases) according to standard disease classification for expedient visualization. © The Author 2010. Published by Oxford University Press. All rights reserved.', 'authors': [{'name': 'Bauer-Mehren A.'}, {'name': 'Rautschka M.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 137, 'date': '2010-11-01T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'DisGeNET: A Cytoscape plugin to visualize, integrate, search and analyze gene-disease networks'}, 'type': ['Method']}, {'doi': '10.1093/bioinformatics/btw214', 'metadata': {'abstract': '© 2016 The Author 2016. Published by Oxford University Press.Motivation: DisGeNET-RDF makes available knowledge on the genetic basis of human diseases in the Semantic Web. Gene-disease associations (GDAs) and their provenance metadata are published as human-readable and machine-processable web resources. The information on GDAs included in DisGeNET-RDF is interlinked to other biomedical databases to support the development of bioinformatics approaches for translational research through evidence-based exploitation of a rich and fully interconnected linked open data. Availability and implementation: http://rdf.disgenet.org/ Contact:', 'authors': [{'name': 'Queralt-Rosinach N.'}, {'name': 'Pinero J.'}, {'name': 'Bravo A.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 32, 'date': '2016-07-15T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'DisGeNET-RDF: Harnessing the innovative power of the Semantic Web to explore the genetic basis of diseases'}, 'type': ['Method']}, {'doi': '10.1371/journal.pone.0020284', 'metadata': {'abstract': 'Background: Scientists have been trying to understand the molecular mechanisms of diseases to design preventive and therapeutic strategies for a long time. For some diseases, it has become evident that it is not enough to obtain a catalogue of the disease-related genes but to uncover how disruptions of molecular networks in the cell give rise to disease phenotypes. Moreover, with the unprecedented wealth of information available, even obtaining such catalogue is extremely difficult. Principal Findings: We developed a comprehensive gene-disease association database by integrating associations from several sources that cover different biomedical aspects of diseases. In particular, we focus on the current knowledge of human genetic diseases including mendelian, complex and environmental diseases. To assess the concept of modularity of human diseases, we performed a systematic study of the emergent properties of human gene-disease networks by means of network topology and functional annotation analysis. The results indicate a highly shared genetic origin of human diseases and show that for most diseases, including mendelian, complex and environmental diseases, functional modules exist. Moreover, a core set of biological pathways is found to be associated with most human diseases. We obtained similar results when studying clusters of diseases, suggesting that related diseases might arise due to dysfunction of common biological processes in the cell. Conclusions: For the first time, we include mendelian, complex and environmental diseases in an integrated gene-disease association database and show that the concept of modularity applies for all of them. We furthermore provide a functional analysis of disease-related modules providing important new biological insights, which might not be discovered when considering each of the gene-disease association repositories independently. Hence, we present a suitable framework for the study of how genetic and environmental factors, such as drugs, contribute to diseases. Availability: The gene-disease networks used in this study and part of the analysis are available at http://ibi.imim.es/DisGeNET/DisGeNETweb.html#Download. © 2011 Bauer-Mehren et al.', 'authors': [{'name': 'Bauer-Mehren A.'}, {'name': 'Bundschus M.'}, {'name': 'Rautschka M.'}, {'name': 'Mayer M.A.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 112, 'date': '2011-06-20T00:00:00Z', 'journal': 'PLoS ONE', 'title': 'Gene-disease network analysis reveals functional modules in mendelian, complex and environmental diseases'}, 'type': ['Usage']}, {'doi': '10.1093/nar/gkw943', 'metadata': {'abstract': '© The Author(s) 2016.The information about the genetic basis of human diseases lies at the heart of precision medicine and drug discovery. However, to realize its full potential to support these goals, several problems, such as fragmentation, heterogeneity, availability and different conceptualization of the data must be overcome. To provide the community with a resource free of these hurdles, we have developed DisGeNET (http://www.disgenet.org), one of the largest available collections of genes and variants involved in human diseases. DisGeNET integrates data from expert curated repositories, GWAS catalogues, animal models and the scientific literature. DisGeNET data are homogeneously annotated with controlled vocabularies and community-driven ontologies. Additionally, several original metrics are provided to assist the prioritization of genotype-phenotype relationships. The information is accessible through a web interface, a Cytoscape App, an RDF SPARQL endpoint, scripts in several programming languages and an R package. DisGeNET is a versatile platform that can be used for different research purposes including the investigation of the molecular underpinnings of specific human diseases and their comorbidities, the analysis of the properties of disease genes, the generation of hypothesis on drug therapeutic action and drug adverse effects, the validation of computationally predicted disease genes and the evaluation of text-mining methods performance.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Bravo A.'}, {'name': 'Queralt-Rosinach N.'}, {'name': 'Gutierrez-Sacristan A.'}, {'name': 'Deu-Pons J.'}, {'name': 'Centeno E.'}, {'name': 'Garcia-Garcia J.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 756, 'date': '2017-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants'}, 'type': ['Other']}, {'doi': '10.1093/nar/gkz1021', 'metadata': {'abstract': '© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.One of the most pressing challenges in genomic medicine is to understand the role played by genetic variation in health and disease. Thanks to the exploration of genomic variants at large scale, hundreds of thousands of disease-Associated loci have been uncovered. However, the identification of variants of clinical relevance is a significant challenge that requires comprehensive interrogation of previous knowledge and linkage to new experimental results. To assist in this complex task, we created DisGeNET (http://www.disgenet.org/), a knowledge management platform integrating and standardizing data about disease associated genes and variants from multiple sources, including the scientific literature. DisGeNET covers the full spectrum of human diseases as well as normal and abnormal traits. The current release covers more than 24 000 diseases and traits, 17 000 genes and 117 000 genomic variants. The latest developments of DisGeNET include new sources of data, novel data attributes and prioritization metrics, a redesigned web interface and recently launched APIs. Thanks to the data standardization, the combination of expert curated information with data automatically mined from the scientific literature, and a suite of tools for accessing its publicly available data, DisGeNET is an interoperable resource supporting a variety of applications in genomic medicine and drug R&D.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Ramirez-Anguita J.M.'}, {'name': 'Sauch-Pitarch J.'}, {'name': 'Ronzano F.'}, {'name': 'Centeno E.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 242, 'date': '2020-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'The DisGeNET knowledge platform for disease genomics: 2019 update'}, 'type': ['Primary']}]"
294,janet.pinero@upf.edu,Janet Piñero,Person,http://orcid.org/0000-0003-1244-7654,"['Contributor', 'Developer', 'Maintainer', 'Support']",,,,,disgenet,Open access (with restrictions),lfurlong,"[{'doi': '10.1093/database/bav028', 'metadata': {'abstract': '© The Author(s) 2015. Published by Oxford University Press.DisGeNET is a comprehensive discovery platform designed to address a variety of questions concerning the genetic underpinning of human diseases. DisGeNET contains over 380 000 associations between >16 000 genes and 13 000 diseases, which makes it one of the largest repositories currently available of its kind. DisGeNET integrates expert-curated databases with text-mined data, covers information on Mendelian and complex diseases, and includes data from animal disease models. It features a score based on the supporting evidence to prioritize gene-disease associations. It is an open access resource available through a web interface, a Cytoscape plugin and as a Semantic Web resource. The web interface supports user-friendly data exploration and navigation. DisGeNET data can also be analysed via the DisGeNET Cytoscape plugin, and enriched with the annotations of other plugins of this popular network analysis software suite. Finally, the information contained in DisGeNET can be expanded and complemented using Semantic Web technologies and linked to a variety of resources already present in the Linked Data cloud. Hence, DisGeNET offers one of the most comprehensive collections of human gene-disease associations and a valuable set of tools for investigating the molecular mechanisms underlying diseases of genetic origin, designed to fulfill the needs of different user profiles, including bioinformaticians, biologists and health-care practitioners.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Queralt-Rosinach N.'}, {'name': 'Bravo A.'}, {'name': 'Deu-Pons J.'}, {'name': 'Bauer-Mehren A.'}, {'name': 'Baron M.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 448, 'date': '2015-01-01T00:00:00Z', 'journal': 'Database', 'title': 'DisGeNET: A discovery platform for the dynamical exploration of human diseases and their genes'}, 'type': ['Other']}, {'doi': '10.1093/nar/gkw943', 'metadata': {'abstract': '© The Author(s) 2016.The information about the genetic basis of human diseases lies at the heart of precision medicine and drug discovery. However, to realize its full potential to support these goals, several problems, such as fragmentation, heterogeneity, availability and different conceptualization of the data must be overcome. To provide the community with a resource free of these hurdles, we have developed DisGeNET (http://www.disgenet.org), one of the largest available collections of genes and variants involved in human diseases. DisGeNET integrates data from expert curated repositories, GWAS catalogues, animal models and the scientific literature. DisGeNET data are homogeneously annotated with controlled vocabularies and community-driven ontologies. Additionally, several original metrics are provided to assist the prioritization of genotype-phenotype relationships. The information is accessible through a web interface, a Cytoscape App, an RDF SPARQL endpoint, scripts in several programming languages and an R package. DisGeNET is a versatile platform that can be used for different research purposes including the investigation of the molecular underpinnings of specific human diseases and their comorbidities, the analysis of the properties of disease genes, the generation of hypothesis on drug therapeutic action and drug adverse effects, the validation of computationally predicted disease genes and the evaluation of text-mining methods performance.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Bravo A.'}, {'name': 'Queralt-Rosinach N.'}, {'name': 'Gutierrez-Sacristan A.'}, {'name': 'Deu-Pons J.'}, {'name': 'Centeno E.'}, {'name': 'Garcia-Garcia J.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 756, 'date': '2017-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants'}, 'type': ['Other']}, {'doi': '10.1093/bioinformatics/btq538', 'metadata': {'abstract': 'Summary: DisGeNET is a plugin for Cytoscape to query and analyze human gene-disease networks. DisGeNET allows user-friendly access to a new gene-disease database that we have developed by integrating data from several public sources. DisGeNET permits queries restricted to (i) the original data source, (ii) the association type, (iii) the disease class or (iv) specific gene(s)/disease(s). It represents gene-disease associations in terms of bipartite graphs and provides gene centric and disease centric views of the data. It assists the user in the interpretation and exploration of the genetic basis of human diseases by a variety of built-in functions. Moreover, DisGeNET permits multicolouring of nodes (genes/diseases) according to standard disease classification for expedient visualization. © The Author 2010. Published by Oxford University Press. All rights reserved.', 'authors': [{'name': 'Bauer-Mehren A.'}, {'name': 'Rautschka M.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 137, 'date': '2010-11-01T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'DisGeNET: A Cytoscape plugin to visualize, integrate, search and analyze gene-disease networks'}, 'type': ['Method']}, {'doi': '10.1093/bioinformatics/btw214', 'metadata': {'abstract': '© 2016 The Author 2016. Published by Oxford University Press.Motivation: DisGeNET-RDF makes available knowledge on the genetic basis of human diseases in the Semantic Web. Gene-disease associations (GDAs) and their provenance metadata are published as human-readable and machine-processable web resources. The information on GDAs included in DisGeNET-RDF is interlinked to other biomedical databases to support the development of bioinformatics approaches for translational research through evidence-based exploitation of a rich and fully interconnected linked open data. Availability and implementation: http://rdf.disgenet.org/ Contact:', 'authors': [{'name': 'Queralt-Rosinach N.'}, {'name': 'Pinero J.'}, {'name': 'Bravo A.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 32, 'date': '2016-07-15T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'DisGeNET-RDF: Harnessing the innovative power of the Semantic Web to explore the genetic basis of diseases'}, 'type': ['Method']}, {'doi': '10.1371/journal.pone.0020284', 'metadata': {'abstract': 'Background: Scientists have been trying to understand the molecular mechanisms of diseases to design preventive and therapeutic strategies for a long time. For some diseases, it has become evident that it is not enough to obtain a catalogue of the disease-related genes but to uncover how disruptions of molecular networks in the cell give rise to disease phenotypes. Moreover, with the unprecedented wealth of information available, even obtaining such catalogue is extremely difficult. Principal Findings: We developed a comprehensive gene-disease association database by integrating associations from several sources that cover different biomedical aspects of diseases. In particular, we focus on the current knowledge of human genetic diseases including mendelian, complex and environmental diseases. To assess the concept of modularity of human diseases, we performed a systematic study of the emergent properties of human gene-disease networks by means of network topology and functional annotation analysis. The results indicate a highly shared genetic origin of human diseases and show that for most diseases, including mendelian, complex and environmental diseases, functional modules exist. Moreover, a core set of biological pathways is found to be associated with most human diseases. We obtained similar results when studying clusters of diseases, suggesting that related diseases might arise due to dysfunction of common biological processes in the cell. Conclusions: For the first time, we include mendelian, complex and environmental diseases in an integrated gene-disease association database and show that the concept of modularity applies for all of them. We furthermore provide a functional analysis of disease-related modules providing important new biological insights, which might not be discovered when considering each of the gene-disease association repositories independently. Hence, we present a suitable framework for the study of how genetic and environmental factors, such as drugs, contribute to diseases. Availability: The gene-disease networks used in this study and part of the analysis are available at http://ibi.imim.es/DisGeNET/DisGeNETweb.html#Download. © 2011 Bauer-Mehren et al.', 'authors': [{'name': 'Bauer-Mehren A.'}, {'name': 'Bundschus M.'}, {'name': 'Rautschka M.'}, {'name': 'Mayer M.A.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 112, 'date': '2011-06-20T00:00:00Z', 'journal': 'PLoS ONE', 'title': 'Gene-disease network analysis reveals functional modules in mendelian, complex and environmental diseases'}, 'type': ['Usage']}, {'doi': '10.1093/nar/gkw943', 'metadata': {'abstract': '© The Author(s) 2016.The information about the genetic basis of human diseases lies at the heart of precision medicine and drug discovery. However, to realize its full potential to support these goals, several problems, such as fragmentation, heterogeneity, availability and different conceptualization of the data must be overcome. To provide the community with a resource free of these hurdles, we have developed DisGeNET (http://www.disgenet.org), one of the largest available collections of genes and variants involved in human diseases. DisGeNET integrates data from expert curated repositories, GWAS catalogues, animal models and the scientific literature. DisGeNET data are homogeneously annotated with controlled vocabularies and community-driven ontologies. Additionally, several original metrics are provided to assist the prioritization of genotype-phenotype relationships. The information is accessible through a web interface, a Cytoscape App, an RDF SPARQL endpoint, scripts in several programming languages and an R package. DisGeNET is a versatile platform that can be used for different research purposes including the investigation of the molecular underpinnings of specific human diseases and their comorbidities, the analysis of the properties of disease genes, the generation of hypothesis on drug therapeutic action and drug adverse effects, the validation of computationally predicted disease genes and the evaluation of text-mining methods performance.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Bravo A.'}, {'name': 'Queralt-Rosinach N.'}, {'name': 'Gutierrez-Sacristan A.'}, {'name': 'Deu-Pons J.'}, {'name': 'Centeno E.'}, {'name': 'Garcia-Garcia J.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 756, 'date': '2017-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants'}, 'type': ['Other']}, {'doi': '10.1093/nar/gkz1021', 'metadata': {'abstract': '© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.One of the most pressing challenges in genomic medicine is to understand the role played by genetic variation in health and disease. Thanks to the exploration of genomic variants at large scale, hundreds of thousands of disease-Associated loci have been uncovered. However, the identification of variants of clinical relevance is a significant challenge that requires comprehensive interrogation of previous knowledge and linkage to new experimental results. To assist in this complex task, we created DisGeNET (http://www.disgenet.org/), a knowledge management platform integrating and standardizing data about disease associated genes and variants from multiple sources, including the scientific literature. DisGeNET covers the full spectrum of human diseases as well as normal and abnormal traits. The current release covers more than 24 000 diseases and traits, 17 000 genes and 117 000 genomic variants. The latest developments of DisGeNET include new sources of data, novel data attributes and prioritization metrics, a redesigned web interface and recently launched APIs. Thanks to the data standardization, the combination of expert curated information with data automatically mined from the scientific literature, and a suite of tools for accessing its publicly available data, DisGeNET is an interoperable resource supporting a variety of applications in genomic medicine and drug R&D.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Ramirez-Anguita J.M.'}, {'name': 'Sauch-Pitarch J.'}, {'name': 'Ronzano F.'}, {'name': 'Centeno E.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 242, 'date': '2020-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'The DisGeNET knowledge platform for disease genomics: 2019 update'}, 'type': ['Primary']}]"
295,laura.furlong@upf.edu,Laura I. Furlong,Person,https://orcid.org/0000-0002-9383-528X,['Primary contact'],,http://grib.imim.es/about-us/laurai-furlong/,,,disgenet,Open access (with restrictions),lfurlong,"[{'doi': '10.1093/database/bav028', 'metadata': {'abstract': '© The Author(s) 2015. Published by Oxford University Press.DisGeNET is a comprehensive discovery platform designed to address a variety of questions concerning the genetic underpinning of human diseases. DisGeNET contains over 380 000 associations between >16 000 genes and 13 000 diseases, which makes it one of the largest repositories currently available of its kind. DisGeNET integrates expert-curated databases with text-mined data, covers information on Mendelian and complex diseases, and includes data from animal disease models. It features a score based on the supporting evidence to prioritize gene-disease associations. It is an open access resource available through a web interface, a Cytoscape plugin and as a Semantic Web resource. The web interface supports user-friendly data exploration and navigation. DisGeNET data can also be analysed via the DisGeNET Cytoscape plugin, and enriched with the annotations of other plugins of this popular network analysis software suite. Finally, the information contained in DisGeNET can be expanded and complemented using Semantic Web technologies and linked to a variety of resources already present in the Linked Data cloud. Hence, DisGeNET offers one of the most comprehensive collections of human gene-disease associations and a valuable set of tools for investigating the molecular mechanisms underlying diseases of genetic origin, designed to fulfill the needs of different user profiles, including bioinformaticians, biologists and health-care practitioners.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Queralt-Rosinach N.'}, {'name': 'Bravo A.'}, {'name': 'Deu-Pons J.'}, {'name': 'Bauer-Mehren A.'}, {'name': 'Baron M.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 448, 'date': '2015-01-01T00:00:00Z', 'journal': 'Database', 'title': 'DisGeNET: A discovery platform for the dynamical exploration of human diseases and their genes'}, 'type': ['Other']}, {'doi': '10.1093/nar/gkw943', 'metadata': {'abstract': '© The Author(s) 2016.The information about the genetic basis of human diseases lies at the heart of precision medicine and drug discovery. However, to realize its full potential to support these goals, several problems, such as fragmentation, heterogeneity, availability and different conceptualization of the data must be overcome. To provide the community with a resource free of these hurdles, we have developed DisGeNET (http://www.disgenet.org), one of the largest available collections of genes and variants involved in human diseases. DisGeNET integrates data from expert curated repositories, GWAS catalogues, animal models and the scientific literature. DisGeNET data are homogeneously annotated with controlled vocabularies and community-driven ontologies. Additionally, several original metrics are provided to assist the prioritization of genotype-phenotype relationships. The information is accessible through a web interface, a Cytoscape App, an RDF SPARQL endpoint, scripts in several programming languages and an R package. DisGeNET is a versatile platform that can be used for different research purposes including the investigation of the molecular underpinnings of specific human diseases and their comorbidities, the analysis of the properties of disease genes, the generation of hypothesis on drug therapeutic action and drug adverse effects, the validation of computationally predicted disease genes and the evaluation of text-mining methods performance.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Bravo A.'}, {'name': 'Queralt-Rosinach N.'}, {'name': 'Gutierrez-Sacristan A.'}, {'name': 'Deu-Pons J.'}, {'name': 'Centeno E.'}, {'name': 'Garcia-Garcia J.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 756, 'date': '2017-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants'}, 'type': ['Other']}, {'doi': '10.1093/bioinformatics/btq538', 'metadata': {'abstract': 'Summary: DisGeNET is a plugin for Cytoscape to query and analyze human gene-disease networks. DisGeNET allows user-friendly access to a new gene-disease database that we have developed by integrating data from several public sources. DisGeNET permits queries restricted to (i) the original data source, (ii) the association type, (iii) the disease class or (iv) specific gene(s)/disease(s). It represents gene-disease associations in terms of bipartite graphs and provides gene centric and disease centric views of the data. It assists the user in the interpretation and exploration of the genetic basis of human diseases by a variety of built-in functions. Moreover, DisGeNET permits multicolouring of nodes (genes/diseases) according to standard disease classification for expedient visualization. © The Author 2010. Published by Oxford University Press. All rights reserved.', 'authors': [{'name': 'Bauer-Mehren A.'}, {'name': 'Rautschka M.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 137, 'date': '2010-11-01T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'DisGeNET: A Cytoscape plugin to visualize, integrate, search and analyze gene-disease networks'}, 'type': ['Method']}, {'doi': '10.1093/bioinformatics/btw214', 'metadata': {'abstract': '© 2016 The Author 2016. Published by Oxford University Press.Motivation: DisGeNET-RDF makes available knowledge on the genetic basis of human diseases in the Semantic Web. Gene-disease associations (GDAs) and their provenance metadata are published as human-readable and machine-processable web resources. The information on GDAs included in DisGeNET-RDF is interlinked to other biomedical databases to support the development of bioinformatics approaches for translational research through evidence-based exploitation of a rich and fully interconnected linked open data. Availability and implementation: http://rdf.disgenet.org/ Contact:', 'authors': [{'name': 'Queralt-Rosinach N.'}, {'name': 'Pinero J.'}, {'name': 'Bravo A.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 32, 'date': '2016-07-15T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'DisGeNET-RDF: Harnessing the innovative power of the Semantic Web to explore the genetic basis of diseases'}, 'type': ['Method']}, {'doi': '10.1371/journal.pone.0020284', 'metadata': {'abstract': 'Background: Scientists have been trying to understand the molecular mechanisms of diseases to design preventive and therapeutic strategies for a long time. For some diseases, it has become evident that it is not enough to obtain a catalogue of the disease-related genes but to uncover how disruptions of molecular networks in the cell give rise to disease phenotypes. Moreover, with the unprecedented wealth of information available, even obtaining such catalogue is extremely difficult. Principal Findings: We developed a comprehensive gene-disease association database by integrating associations from several sources that cover different biomedical aspects of diseases. In particular, we focus on the current knowledge of human genetic diseases including mendelian, complex and environmental diseases. To assess the concept of modularity of human diseases, we performed a systematic study of the emergent properties of human gene-disease networks by means of network topology and functional annotation analysis. The results indicate a highly shared genetic origin of human diseases and show that for most diseases, including mendelian, complex and environmental diseases, functional modules exist. Moreover, a core set of biological pathways is found to be associated with most human diseases. We obtained similar results when studying clusters of diseases, suggesting that related diseases might arise due to dysfunction of common biological processes in the cell. Conclusions: For the first time, we include mendelian, complex and environmental diseases in an integrated gene-disease association database and show that the concept of modularity applies for all of them. We furthermore provide a functional analysis of disease-related modules providing important new biological insights, which might not be discovered when considering each of the gene-disease association repositories independently. Hence, we present a suitable framework for the study of how genetic and environmental factors, such as drugs, contribute to diseases. Availability: The gene-disease networks used in this study and part of the analysis are available at http://ibi.imim.es/DisGeNET/DisGeNETweb.html#Download. © 2011 Bauer-Mehren et al.', 'authors': [{'name': 'Bauer-Mehren A.'}, {'name': 'Bundschus M.'}, {'name': 'Rautschka M.'}, {'name': 'Mayer M.A.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 112, 'date': '2011-06-20T00:00:00Z', 'journal': 'PLoS ONE', 'title': 'Gene-disease network analysis reveals functional modules in mendelian, complex and environmental diseases'}, 'type': ['Usage']}, {'doi': '10.1093/nar/gkw943', 'metadata': {'abstract': '© The Author(s) 2016.The information about the genetic basis of human diseases lies at the heart of precision medicine and drug discovery. However, to realize its full potential to support these goals, several problems, such as fragmentation, heterogeneity, availability and different conceptualization of the data must be overcome. To provide the community with a resource free of these hurdles, we have developed DisGeNET (http://www.disgenet.org), one of the largest available collections of genes and variants involved in human diseases. DisGeNET integrates data from expert curated repositories, GWAS catalogues, animal models and the scientific literature. DisGeNET data are homogeneously annotated with controlled vocabularies and community-driven ontologies. Additionally, several original metrics are provided to assist the prioritization of genotype-phenotype relationships. The information is accessible through a web interface, a Cytoscape App, an RDF SPARQL endpoint, scripts in several programming languages and an R package. DisGeNET is a versatile platform that can be used for different research purposes including the investigation of the molecular underpinnings of specific human diseases and their comorbidities, the analysis of the properties of disease genes, the generation of hypothesis on drug therapeutic action and drug adverse effects, the validation of computationally predicted disease genes and the evaluation of text-mining methods performance.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Bravo A.'}, {'name': 'Queralt-Rosinach N.'}, {'name': 'Gutierrez-Sacristan A.'}, {'name': 'Deu-Pons J.'}, {'name': 'Centeno E.'}, {'name': 'Garcia-Garcia J.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 756, 'date': '2017-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants'}, 'type': ['Other']}, {'doi': '10.1093/nar/gkz1021', 'metadata': {'abstract': '© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.One of the most pressing challenges in genomic medicine is to understand the role played by genetic variation in health and disease. Thanks to the exploration of genomic variants at large scale, hundreds of thousands of disease-Associated loci have been uncovered. However, the identification of variants of clinical relevance is a significant challenge that requires comprehensive interrogation of previous knowledge and linkage to new experimental results. To assist in this complex task, we created DisGeNET (http://www.disgenet.org/), a knowledge management platform integrating and standardizing data about disease associated genes and variants from multiple sources, including the scientific literature. DisGeNET covers the full spectrum of human diseases as well as normal and abnormal traits. The current release covers more than 24 000 diseases and traits, 17 000 genes and 117 000 genomic variants. The latest developments of DisGeNET include new sources of data, novel data attributes and prioritization metrics, a redesigned web interface and recently launched APIs. Thanks to the data standardization, the combination of expert curated information with data automatically mined from the scientific literature, and a suite of tools for accessing its publicly available data, DisGeNET is an interoperable resource supporting a variety of applications in genomic medicine and drug R&D.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Ramirez-Anguita J.M.'}, {'name': 'Sauch-Pitarch J.'}, {'name': 'Ronzano F.'}, {'name': 'Centeno E.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 242, 'date': '2020-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'The DisGeNET knowledge platform for disease genomics: 2019 update'}, 'type': ['Primary']}]"
296,jsauch@imim.es,Josep Sauch Pitchard,Person,,['Developer'],,,,,disgenet,Open access (with restrictions),lfurlong,"[{'doi': '10.1093/database/bav028', 'metadata': {'abstract': '© The Author(s) 2015. Published by Oxford University Press.DisGeNET is a comprehensive discovery platform designed to address a variety of questions concerning the genetic underpinning of human diseases. DisGeNET contains over 380 000 associations between >16 000 genes and 13 000 diseases, which makes it one of the largest repositories currently available of its kind. DisGeNET integrates expert-curated databases with text-mined data, covers information on Mendelian and complex diseases, and includes data from animal disease models. It features a score based on the supporting evidence to prioritize gene-disease associations. It is an open access resource available through a web interface, a Cytoscape plugin and as a Semantic Web resource. The web interface supports user-friendly data exploration and navigation. DisGeNET data can also be analysed via the DisGeNET Cytoscape plugin, and enriched with the annotations of other plugins of this popular network analysis software suite. Finally, the information contained in DisGeNET can be expanded and complemented using Semantic Web technologies and linked to a variety of resources already present in the Linked Data cloud. Hence, DisGeNET offers one of the most comprehensive collections of human gene-disease associations and a valuable set of tools for investigating the molecular mechanisms underlying diseases of genetic origin, designed to fulfill the needs of different user profiles, including bioinformaticians, biologists and health-care practitioners.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Queralt-Rosinach N.'}, {'name': 'Bravo A.'}, {'name': 'Deu-Pons J.'}, {'name': 'Bauer-Mehren A.'}, {'name': 'Baron M.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 448, 'date': '2015-01-01T00:00:00Z', 'journal': 'Database', 'title': 'DisGeNET: A discovery platform for the dynamical exploration of human diseases and their genes'}, 'type': ['Other']}, {'doi': '10.1093/nar/gkw943', 'metadata': {'abstract': '© The Author(s) 2016.The information about the genetic basis of human diseases lies at the heart of precision medicine and drug discovery. However, to realize its full potential to support these goals, several problems, such as fragmentation, heterogeneity, availability and different conceptualization of the data must be overcome. To provide the community with a resource free of these hurdles, we have developed DisGeNET (http://www.disgenet.org), one of the largest available collections of genes and variants involved in human diseases. DisGeNET integrates data from expert curated repositories, GWAS catalogues, animal models and the scientific literature. DisGeNET data are homogeneously annotated with controlled vocabularies and community-driven ontologies. Additionally, several original metrics are provided to assist the prioritization of genotype-phenotype relationships. The information is accessible through a web interface, a Cytoscape App, an RDF SPARQL endpoint, scripts in several programming languages and an R package. DisGeNET is a versatile platform that can be used for different research purposes including the investigation of the molecular underpinnings of specific human diseases and their comorbidities, the analysis of the properties of disease genes, the generation of hypothesis on drug therapeutic action and drug adverse effects, the validation of computationally predicted disease genes and the evaluation of text-mining methods performance.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Bravo A.'}, {'name': 'Queralt-Rosinach N.'}, {'name': 'Gutierrez-Sacristan A.'}, {'name': 'Deu-Pons J.'}, {'name': 'Centeno E.'}, {'name': 'Garcia-Garcia J.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 756, 'date': '2017-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants'}, 'type': ['Other']}, {'doi': '10.1093/bioinformatics/btq538', 'metadata': {'abstract': 'Summary: DisGeNET is a plugin for Cytoscape to query and analyze human gene-disease networks. DisGeNET allows user-friendly access to a new gene-disease database that we have developed by integrating data from several public sources. DisGeNET permits queries restricted to (i) the original data source, (ii) the association type, (iii) the disease class or (iv) specific gene(s)/disease(s). It represents gene-disease associations in terms of bipartite graphs and provides gene centric and disease centric views of the data. It assists the user in the interpretation and exploration of the genetic basis of human diseases by a variety of built-in functions. Moreover, DisGeNET permits multicolouring of nodes (genes/diseases) according to standard disease classification for expedient visualization. © The Author 2010. Published by Oxford University Press. All rights reserved.', 'authors': [{'name': 'Bauer-Mehren A.'}, {'name': 'Rautschka M.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 137, 'date': '2010-11-01T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'DisGeNET: A Cytoscape plugin to visualize, integrate, search and analyze gene-disease networks'}, 'type': ['Method']}, {'doi': '10.1093/bioinformatics/btw214', 'metadata': {'abstract': '© 2016 The Author 2016. Published by Oxford University Press.Motivation: DisGeNET-RDF makes available knowledge on the genetic basis of human diseases in the Semantic Web. Gene-disease associations (GDAs) and their provenance metadata are published as human-readable and machine-processable web resources. The information on GDAs included in DisGeNET-RDF is interlinked to other biomedical databases to support the development of bioinformatics approaches for translational research through evidence-based exploitation of a rich and fully interconnected linked open data. Availability and implementation: http://rdf.disgenet.org/ Contact:', 'authors': [{'name': 'Queralt-Rosinach N.'}, {'name': 'Pinero J.'}, {'name': 'Bravo A.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 32, 'date': '2016-07-15T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'DisGeNET-RDF: Harnessing the innovative power of the Semantic Web to explore the genetic basis of diseases'}, 'type': ['Method']}, {'doi': '10.1371/journal.pone.0020284', 'metadata': {'abstract': 'Background: Scientists have been trying to understand the molecular mechanisms of diseases to design preventive and therapeutic strategies for a long time. For some diseases, it has become evident that it is not enough to obtain a catalogue of the disease-related genes but to uncover how disruptions of molecular networks in the cell give rise to disease phenotypes. Moreover, with the unprecedented wealth of information available, even obtaining such catalogue is extremely difficult. Principal Findings: We developed a comprehensive gene-disease association database by integrating associations from several sources that cover different biomedical aspects of diseases. In particular, we focus on the current knowledge of human genetic diseases including mendelian, complex and environmental diseases. To assess the concept of modularity of human diseases, we performed a systematic study of the emergent properties of human gene-disease networks by means of network topology and functional annotation analysis. The results indicate a highly shared genetic origin of human diseases and show that for most diseases, including mendelian, complex and environmental diseases, functional modules exist. Moreover, a core set of biological pathways is found to be associated with most human diseases. We obtained similar results when studying clusters of diseases, suggesting that related diseases might arise due to dysfunction of common biological processes in the cell. Conclusions: For the first time, we include mendelian, complex and environmental diseases in an integrated gene-disease association database and show that the concept of modularity applies for all of them. We furthermore provide a functional analysis of disease-related modules providing important new biological insights, which might not be discovered when considering each of the gene-disease association repositories independently. Hence, we present a suitable framework for the study of how genetic and environmental factors, such as drugs, contribute to diseases. Availability: The gene-disease networks used in this study and part of the analysis are available at http://ibi.imim.es/DisGeNET/DisGeNETweb.html#Download. © 2011 Bauer-Mehren et al.', 'authors': [{'name': 'Bauer-Mehren A.'}, {'name': 'Bundschus M.'}, {'name': 'Rautschka M.'}, {'name': 'Mayer M.A.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 112, 'date': '2011-06-20T00:00:00Z', 'journal': 'PLoS ONE', 'title': 'Gene-disease network analysis reveals functional modules in mendelian, complex and environmental diseases'}, 'type': ['Usage']}, {'doi': '10.1093/nar/gkw943', 'metadata': {'abstract': '© The Author(s) 2016.The information about the genetic basis of human diseases lies at the heart of precision medicine and drug discovery. However, to realize its full potential to support these goals, several problems, such as fragmentation, heterogeneity, availability and different conceptualization of the data must be overcome. To provide the community with a resource free of these hurdles, we have developed DisGeNET (http://www.disgenet.org), one of the largest available collections of genes and variants involved in human diseases. DisGeNET integrates data from expert curated repositories, GWAS catalogues, animal models and the scientific literature. DisGeNET data are homogeneously annotated with controlled vocabularies and community-driven ontologies. Additionally, several original metrics are provided to assist the prioritization of genotype-phenotype relationships. The information is accessible through a web interface, a Cytoscape App, an RDF SPARQL endpoint, scripts in several programming languages and an R package. DisGeNET is a versatile platform that can be used for different research purposes including the investigation of the molecular underpinnings of specific human diseases and their comorbidities, the analysis of the properties of disease genes, the generation of hypothesis on drug therapeutic action and drug adverse effects, the validation of computationally predicted disease genes and the evaluation of text-mining methods performance.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Bravo A.'}, {'name': 'Queralt-Rosinach N.'}, {'name': 'Gutierrez-Sacristan A.'}, {'name': 'Deu-Pons J.'}, {'name': 'Centeno E.'}, {'name': 'Garcia-Garcia J.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 756, 'date': '2017-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants'}, 'type': ['Other']}, {'doi': '10.1093/nar/gkz1021', 'metadata': {'abstract': '© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.One of the most pressing challenges in genomic medicine is to understand the role played by genetic variation in health and disease. Thanks to the exploration of genomic variants at large scale, hundreds of thousands of disease-Associated loci have been uncovered. However, the identification of variants of clinical relevance is a significant challenge that requires comprehensive interrogation of previous knowledge and linkage to new experimental results. To assist in this complex task, we created DisGeNET (http://www.disgenet.org/), a knowledge management platform integrating and standardizing data about disease associated genes and variants from multiple sources, including the scientific literature. DisGeNET covers the full spectrum of human diseases as well as normal and abnormal traits. The current release covers more than 24 000 diseases and traits, 17 000 genes and 117 000 genomic variants. The latest developments of DisGeNET include new sources of data, novel data attributes and prioritization metrics, a redesigned web interface and recently launched APIs. Thanks to the data standardization, the combination of expert curated information with data automatically mined from the scientific literature, and a suite of tools for accessing its publicly available data, DisGeNET is an interoperable resource supporting a variety of applications in genomic medicine and drug R&D.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Ramirez-Anguita J.M.'}, {'name': 'Sauch-Pitarch J.'}, {'name': 'Ronzano F.'}, {'name': 'Centeno E.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 242, 'date': '2020-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'The DisGeNET knowledge platform for disease genomics: 2019 update'}, 'type': ['Primary']}]"
297,,Juan Manuel Ramirez Anguita,Person,,['Developer'],,,,,disgenet,Open access (with restrictions),lfurlong,"[{'doi': '10.1093/database/bav028', 'metadata': {'abstract': '© The Author(s) 2015. Published by Oxford University Press.DisGeNET is a comprehensive discovery platform designed to address a variety of questions concerning the genetic underpinning of human diseases. DisGeNET contains over 380 000 associations between >16 000 genes and 13 000 diseases, which makes it one of the largest repositories currently available of its kind. DisGeNET integrates expert-curated databases with text-mined data, covers information on Mendelian and complex diseases, and includes data from animal disease models. It features a score based on the supporting evidence to prioritize gene-disease associations. It is an open access resource available through a web interface, a Cytoscape plugin and as a Semantic Web resource. The web interface supports user-friendly data exploration and navigation. DisGeNET data can also be analysed via the DisGeNET Cytoscape plugin, and enriched with the annotations of other plugins of this popular network analysis software suite. Finally, the information contained in DisGeNET can be expanded and complemented using Semantic Web technologies and linked to a variety of resources already present in the Linked Data cloud. Hence, DisGeNET offers one of the most comprehensive collections of human gene-disease associations and a valuable set of tools for investigating the molecular mechanisms underlying diseases of genetic origin, designed to fulfill the needs of different user profiles, including bioinformaticians, biologists and health-care practitioners.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Queralt-Rosinach N.'}, {'name': 'Bravo A.'}, {'name': 'Deu-Pons J.'}, {'name': 'Bauer-Mehren A.'}, {'name': 'Baron M.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 448, 'date': '2015-01-01T00:00:00Z', 'journal': 'Database', 'title': 'DisGeNET: A discovery platform for the dynamical exploration of human diseases and their genes'}, 'type': ['Other']}, {'doi': '10.1093/nar/gkw943', 'metadata': {'abstract': '© The Author(s) 2016.The information about the genetic basis of human diseases lies at the heart of precision medicine and drug discovery. However, to realize its full potential to support these goals, several problems, such as fragmentation, heterogeneity, availability and different conceptualization of the data must be overcome. To provide the community with a resource free of these hurdles, we have developed DisGeNET (http://www.disgenet.org), one of the largest available collections of genes and variants involved in human diseases. DisGeNET integrates data from expert curated repositories, GWAS catalogues, animal models and the scientific literature. DisGeNET data are homogeneously annotated with controlled vocabularies and community-driven ontologies. Additionally, several original metrics are provided to assist the prioritization of genotype-phenotype relationships. The information is accessible through a web interface, a Cytoscape App, an RDF SPARQL endpoint, scripts in several programming languages and an R package. DisGeNET is a versatile platform that can be used for different research purposes including the investigation of the molecular underpinnings of specific human diseases and their comorbidities, the analysis of the properties of disease genes, the generation of hypothesis on drug therapeutic action and drug adverse effects, the validation of computationally predicted disease genes and the evaluation of text-mining methods performance.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Bravo A.'}, {'name': 'Queralt-Rosinach N.'}, {'name': 'Gutierrez-Sacristan A.'}, {'name': 'Deu-Pons J.'}, {'name': 'Centeno E.'}, {'name': 'Garcia-Garcia J.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 756, 'date': '2017-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants'}, 'type': ['Other']}, {'doi': '10.1093/bioinformatics/btq538', 'metadata': {'abstract': 'Summary: DisGeNET is a plugin for Cytoscape to query and analyze human gene-disease networks. DisGeNET allows user-friendly access to a new gene-disease database that we have developed by integrating data from several public sources. DisGeNET permits queries restricted to (i) the original data source, (ii) the association type, (iii) the disease class or (iv) specific gene(s)/disease(s). It represents gene-disease associations in terms of bipartite graphs and provides gene centric and disease centric views of the data. It assists the user in the interpretation and exploration of the genetic basis of human diseases by a variety of built-in functions. Moreover, DisGeNET permits multicolouring of nodes (genes/diseases) according to standard disease classification for expedient visualization. © The Author 2010. Published by Oxford University Press. All rights reserved.', 'authors': [{'name': 'Bauer-Mehren A.'}, {'name': 'Rautschka M.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 137, 'date': '2010-11-01T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'DisGeNET: A Cytoscape plugin to visualize, integrate, search and analyze gene-disease networks'}, 'type': ['Method']}, {'doi': '10.1093/bioinformatics/btw214', 'metadata': {'abstract': '© 2016 The Author 2016. Published by Oxford University Press.Motivation: DisGeNET-RDF makes available knowledge on the genetic basis of human diseases in the Semantic Web. Gene-disease associations (GDAs) and their provenance metadata are published as human-readable and machine-processable web resources. The information on GDAs included in DisGeNET-RDF is interlinked to other biomedical databases to support the development of bioinformatics approaches for translational research through evidence-based exploitation of a rich and fully interconnected linked open data. Availability and implementation: http://rdf.disgenet.org/ Contact:', 'authors': [{'name': 'Queralt-Rosinach N.'}, {'name': 'Pinero J.'}, {'name': 'Bravo A.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 32, 'date': '2016-07-15T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'DisGeNET-RDF: Harnessing the innovative power of the Semantic Web to explore the genetic basis of diseases'}, 'type': ['Method']}, {'doi': '10.1371/journal.pone.0020284', 'metadata': {'abstract': 'Background: Scientists have been trying to understand the molecular mechanisms of diseases to design preventive and therapeutic strategies for a long time. For some diseases, it has become evident that it is not enough to obtain a catalogue of the disease-related genes but to uncover how disruptions of molecular networks in the cell give rise to disease phenotypes. Moreover, with the unprecedented wealth of information available, even obtaining such catalogue is extremely difficult. Principal Findings: We developed a comprehensive gene-disease association database by integrating associations from several sources that cover different biomedical aspects of diseases. In particular, we focus on the current knowledge of human genetic diseases including mendelian, complex and environmental diseases. To assess the concept of modularity of human diseases, we performed a systematic study of the emergent properties of human gene-disease networks by means of network topology and functional annotation analysis. The results indicate a highly shared genetic origin of human diseases and show that for most diseases, including mendelian, complex and environmental diseases, functional modules exist. Moreover, a core set of biological pathways is found to be associated with most human diseases. We obtained similar results when studying clusters of diseases, suggesting that related diseases might arise due to dysfunction of common biological processes in the cell. Conclusions: For the first time, we include mendelian, complex and environmental diseases in an integrated gene-disease association database and show that the concept of modularity applies for all of them. We furthermore provide a functional analysis of disease-related modules providing important new biological insights, which might not be discovered when considering each of the gene-disease association repositories independently. Hence, we present a suitable framework for the study of how genetic and environmental factors, such as drugs, contribute to diseases. Availability: The gene-disease networks used in this study and part of the analysis are available at http://ibi.imim.es/DisGeNET/DisGeNETweb.html#Download. © 2011 Bauer-Mehren et al.', 'authors': [{'name': 'Bauer-Mehren A.'}, {'name': 'Bundschus M.'}, {'name': 'Rautschka M.'}, {'name': 'Mayer M.A.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 112, 'date': '2011-06-20T00:00:00Z', 'journal': 'PLoS ONE', 'title': 'Gene-disease network analysis reveals functional modules in mendelian, complex and environmental diseases'}, 'type': ['Usage']}, {'doi': '10.1093/nar/gkw943', 'metadata': {'abstract': '© The Author(s) 2016.The information about the genetic basis of human diseases lies at the heart of precision medicine and drug discovery. However, to realize its full potential to support these goals, several problems, such as fragmentation, heterogeneity, availability and different conceptualization of the data must be overcome. To provide the community with a resource free of these hurdles, we have developed DisGeNET (http://www.disgenet.org), one of the largest available collections of genes and variants involved in human diseases. DisGeNET integrates data from expert curated repositories, GWAS catalogues, animal models and the scientific literature. DisGeNET data are homogeneously annotated with controlled vocabularies and community-driven ontologies. Additionally, several original metrics are provided to assist the prioritization of genotype-phenotype relationships. The information is accessible through a web interface, a Cytoscape App, an RDF SPARQL endpoint, scripts in several programming languages and an R package. DisGeNET is a versatile platform that can be used for different research purposes including the investigation of the molecular underpinnings of specific human diseases and their comorbidities, the analysis of the properties of disease genes, the generation of hypothesis on drug therapeutic action and drug adverse effects, the validation of computationally predicted disease genes and the evaluation of text-mining methods performance.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Bravo A.'}, {'name': 'Queralt-Rosinach N.'}, {'name': 'Gutierrez-Sacristan A.'}, {'name': 'Deu-Pons J.'}, {'name': 'Centeno E.'}, {'name': 'Garcia-Garcia J.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 756, 'date': '2017-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants'}, 'type': ['Other']}, {'doi': '10.1093/nar/gkz1021', 'metadata': {'abstract': '© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.One of the most pressing challenges in genomic medicine is to understand the role played by genetic variation in health and disease. Thanks to the exploration of genomic variants at large scale, hundreds of thousands of disease-Associated loci have been uncovered. However, the identification of variants of clinical relevance is a significant challenge that requires comprehensive interrogation of previous knowledge and linkage to new experimental results. To assist in this complex task, we created DisGeNET (http://www.disgenet.org/), a knowledge management platform integrating and standardizing data about disease associated genes and variants from multiple sources, including the scientific literature. DisGeNET covers the full spectrum of human diseases as well as normal and abnormal traits. The current release covers more than 24 000 diseases and traits, 17 000 genes and 117 000 genomic variants. The latest developments of DisGeNET include new sources of data, novel data attributes and prioritization metrics, a redesigned web interface and recently launched APIs. Thanks to the data standardization, the combination of expert curated information with data automatically mined from the scientific literature, and a suite of tools for accessing its publicly available data, DisGeNET is an interoperable resource supporting a variety of applications in genomic medicine and drug R&D.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Ramirez-Anguita J.M.'}, {'name': 'Sauch-Pitarch J.'}, {'name': 'Ronzano F.'}, {'name': 'Centeno E.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 242, 'date': '2020-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'The DisGeNET knowledge platform for disease genomics: 2019 update'}, 'type': ['Primary']}]"
298,francesco.ronzano@upf.edu,Francesco Ronzano,Person,https://orcid.org/0000-0001-5037-9061,['Contributor'],,,,,disgenet,Open access (with restrictions),lfurlong,"[{'doi': '10.1093/database/bav028', 'metadata': {'abstract': '© The Author(s) 2015. Published by Oxford University Press.DisGeNET is a comprehensive discovery platform designed to address a variety of questions concerning the genetic underpinning of human diseases. DisGeNET contains over 380 000 associations between >16 000 genes and 13 000 diseases, which makes it one of the largest repositories currently available of its kind. DisGeNET integrates expert-curated databases with text-mined data, covers information on Mendelian and complex diseases, and includes data from animal disease models. It features a score based on the supporting evidence to prioritize gene-disease associations. It is an open access resource available through a web interface, a Cytoscape plugin and as a Semantic Web resource. The web interface supports user-friendly data exploration and navigation. DisGeNET data can also be analysed via the DisGeNET Cytoscape plugin, and enriched with the annotations of other plugins of this popular network analysis software suite. Finally, the information contained in DisGeNET can be expanded and complemented using Semantic Web technologies and linked to a variety of resources already present in the Linked Data cloud. Hence, DisGeNET offers one of the most comprehensive collections of human gene-disease associations and a valuable set of tools for investigating the molecular mechanisms underlying diseases of genetic origin, designed to fulfill the needs of different user profiles, including bioinformaticians, biologists and health-care practitioners.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Queralt-Rosinach N.'}, {'name': 'Bravo A.'}, {'name': 'Deu-Pons J.'}, {'name': 'Bauer-Mehren A.'}, {'name': 'Baron M.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 448, 'date': '2015-01-01T00:00:00Z', 'journal': 'Database', 'title': 'DisGeNET: A discovery platform for the dynamical exploration of human diseases and their genes'}, 'type': ['Other']}, {'doi': '10.1093/nar/gkw943', 'metadata': {'abstract': '© The Author(s) 2016.The information about the genetic basis of human diseases lies at the heart of precision medicine and drug discovery. However, to realize its full potential to support these goals, several problems, such as fragmentation, heterogeneity, availability and different conceptualization of the data must be overcome. To provide the community with a resource free of these hurdles, we have developed DisGeNET (http://www.disgenet.org), one of the largest available collections of genes and variants involved in human diseases. DisGeNET integrates data from expert curated repositories, GWAS catalogues, animal models and the scientific literature. DisGeNET data are homogeneously annotated with controlled vocabularies and community-driven ontologies. Additionally, several original metrics are provided to assist the prioritization of genotype-phenotype relationships. The information is accessible through a web interface, a Cytoscape App, an RDF SPARQL endpoint, scripts in several programming languages and an R package. DisGeNET is a versatile platform that can be used for different research purposes including the investigation of the molecular underpinnings of specific human diseases and their comorbidities, the analysis of the properties of disease genes, the generation of hypothesis on drug therapeutic action and drug adverse effects, the validation of computationally predicted disease genes and the evaluation of text-mining methods performance.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Bravo A.'}, {'name': 'Queralt-Rosinach N.'}, {'name': 'Gutierrez-Sacristan A.'}, {'name': 'Deu-Pons J.'}, {'name': 'Centeno E.'}, {'name': 'Garcia-Garcia J.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 756, 'date': '2017-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants'}, 'type': ['Other']}, {'doi': '10.1093/bioinformatics/btq538', 'metadata': {'abstract': 'Summary: DisGeNET is a plugin for Cytoscape to query and analyze human gene-disease networks. DisGeNET allows user-friendly access to a new gene-disease database that we have developed by integrating data from several public sources. DisGeNET permits queries restricted to (i) the original data source, (ii) the association type, (iii) the disease class or (iv) specific gene(s)/disease(s). It represents gene-disease associations in terms of bipartite graphs and provides gene centric and disease centric views of the data. It assists the user in the interpretation and exploration of the genetic basis of human diseases by a variety of built-in functions. Moreover, DisGeNET permits multicolouring of nodes (genes/diseases) according to standard disease classification for expedient visualization. © The Author 2010. Published by Oxford University Press. All rights reserved.', 'authors': [{'name': 'Bauer-Mehren A.'}, {'name': 'Rautschka M.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 137, 'date': '2010-11-01T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'DisGeNET: A Cytoscape plugin to visualize, integrate, search and analyze gene-disease networks'}, 'type': ['Method']}, {'doi': '10.1093/bioinformatics/btw214', 'metadata': {'abstract': '© 2016 The Author 2016. Published by Oxford University Press.Motivation: DisGeNET-RDF makes available knowledge on the genetic basis of human diseases in the Semantic Web. Gene-disease associations (GDAs) and their provenance metadata are published as human-readable and machine-processable web resources. The information on GDAs included in DisGeNET-RDF is interlinked to other biomedical databases to support the development of bioinformatics approaches for translational research through evidence-based exploitation of a rich and fully interconnected linked open data. Availability and implementation: http://rdf.disgenet.org/ Contact:', 'authors': [{'name': 'Queralt-Rosinach N.'}, {'name': 'Pinero J.'}, {'name': 'Bravo A.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 32, 'date': '2016-07-15T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'DisGeNET-RDF: Harnessing the innovative power of the Semantic Web to explore the genetic basis of diseases'}, 'type': ['Method']}, {'doi': '10.1371/journal.pone.0020284', 'metadata': {'abstract': 'Background: Scientists have been trying to understand the molecular mechanisms of diseases to design preventive and therapeutic strategies for a long time. For some diseases, it has become evident that it is not enough to obtain a catalogue of the disease-related genes but to uncover how disruptions of molecular networks in the cell give rise to disease phenotypes. Moreover, with the unprecedented wealth of information available, even obtaining such catalogue is extremely difficult. Principal Findings: We developed a comprehensive gene-disease association database by integrating associations from several sources that cover different biomedical aspects of diseases. In particular, we focus on the current knowledge of human genetic diseases including mendelian, complex and environmental diseases. To assess the concept of modularity of human diseases, we performed a systematic study of the emergent properties of human gene-disease networks by means of network topology and functional annotation analysis. The results indicate a highly shared genetic origin of human diseases and show that for most diseases, including mendelian, complex and environmental diseases, functional modules exist. Moreover, a core set of biological pathways is found to be associated with most human diseases. We obtained similar results when studying clusters of diseases, suggesting that related diseases might arise due to dysfunction of common biological processes in the cell. Conclusions: For the first time, we include mendelian, complex and environmental diseases in an integrated gene-disease association database and show that the concept of modularity applies for all of them. We furthermore provide a functional analysis of disease-related modules providing important new biological insights, which might not be discovered when considering each of the gene-disease association repositories independently. Hence, we present a suitable framework for the study of how genetic and environmental factors, such as drugs, contribute to diseases. Availability: The gene-disease networks used in this study and part of the analysis are available at http://ibi.imim.es/DisGeNET/DisGeNETweb.html#Download. © 2011 Bauer-Mehren et al.', 'authors': [{'name': 'Bauer-Mehren A.'}, {'name': 'Bundschus M.'}, {'name': 'Rautschka M.'}, {'name': 'Mayer M.A.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 112, 'date': '2011-06-20T00:00:00Z', 'journal': 'PLoS ONE', 'title': 'Gene-disease network analysis reveals functional modules in mendelian, complex and environmental diseases'}, 'type': ['Usage']}, {'doi': '10.1093/nar/gkw943', 'metadata': {'abstract': '© The Author(s) 2016.The information about the genetic basis of human diseases lies at the heart of precision medicine and drug discovery. However, to realize its full potential to support these goals, several problems, such as fragmentation, heterogeneity, availability and different conceptualization of the data must be overcome. To provide the community with a resource free of these hurdles, we have developed DisGeNET (http://www.disgenet.org), one of the largest available collections of genes and variants involved in human diseases. DisGeNET integrates data from expert curated repositories, GWAS catalogues, animal models and the scientific literature. DisGeNET data are homogeneously annotated with controlled vocabularies and community-driven ontologies. Additionally, several original metrics are provided to assist the prioritization of genotype-phenotype relationships. The information is accessible through a web interface, a Cytoscape App, an RDF SPARQL endpoint, scripts in several programming languages and an R package. DisGeNET is a versatile platform that can be used for different research purposes including the investigation of the molecular underpinnings of specific human diseases and their comorbidities, the analysis of the properties of disease genes, the generation of hypothesis on drug therapeutic action and drug adverse effects, the validation of computationally predicted disease genes and the evaluation of text-mining methods performance.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Bravo A.'}, {'name': 'Queralt-Rosinach N.'}, {'name': 'Gutierrez-Sacristan A.'}, {'name': 'Deu-Pons J.'}, {'name': 'Centeno E.'}, {'name': 'Garcia-Garcia J.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 756, 'date': '2017-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants'}, 'type': ['Other']}, {'doi': '10.1093/nar/gkz1021', 'metadata': {'abstract': '© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.One of the most pressing challenges in genomic medicine is to understand the role played by genetic variation in health and disease. Thanks to the exploration of genomic variants at large scale, hundreds of thousands of disease-Associated loci have been uncovered. However, the identification of variants of clinical relevance is a significant challenge that requires comprehensive interrogation of previous knowledge and linkage to new experimental results. To assist in this complex task, we created DisGeNET (http://www.disgenet.org/), a knowledge management platform integrating and standardizing data about disease associated genes and variants from multiple sources, including the scientific literature. DisGeNET covers the full spectrum of human diseases as well as normal and abnormal traits. The current release covers more than 24 000 diseases and traits, 17 000 genes and 117 000 genomic variants. The latest developments of DisGeNET include new sources of data, novel data attributes and prioritization metrics, a redesigned web interface and recently launched APIs. Thanks to the data standardization, the combination of expert curated information with data automatically mined from the scientific literature, and a suite of tools for accessing its publicly available data, DisGeNET is an interoperable resource supporting a variety of applications in genomic medicine and drug R&D.', 'authors': [{'name': 'Pinero J.'}, {'name': 'Ramirez-Anguita J.M.'}, {'name': 'Sauch-Pitarch J.'}, {'name': 'Ronzano F.'}, {'name': 'Centeno E.'}, {'name': 'Sanz F.'}, {'name': 'Furlong L.I.'}], 'citationCount': 242, 'date': '2020-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'The DisGeNET knowledge platform for disease genomics: 2019 update'}, 'type': ['Primary']}]"
299,murugan.rmn@ece.nits.ac.in,R. Murugan,Person,https://orcid.org/0000-0002-9341-3810,,,,,,optconet,,Niclaskn,"[{'doi': '10.1007/S10489-020-01904-Z', 'metadata': {'abstract': '© 2020, Springer Science+Business Media, LLC, part of Springer Nature.The quick spread of coronavirus disease (COVID-19) has become a global concern and affected more than 15 million confirmed patients as of July 2020. To combat this spread, clinical imaging, for example, X-ray images, can be utilized for diagnosis. Automatic identification software tools are essential to facilitate the screening of COVID-19 using X-ray images. This paper aims to classify COVID-19, normal, and pneumonia patients from chest X-ray images. As such, an Optimized Convolutional Neural network (OptCoNet) is proposed in this work for the automatic diagnosis of COVID-19. The proposed OptCoNet architecture is composed of optimized feature extraction and classification components. The Grey Wolf Optimizer (GWO) algorithm is used to optimize the hyperparameters for training the CNN layers. The proposed model is tested and compared with different classification strategies utilizing an openly accessible dataset of COVID-19, normal, and pneumonia images. The presented optimized CNN model provides accuracy, sensitivity, specificity, precision, and F1 score values of 97.78%, 97.75%, 96.25%, 92.88%, and 95.25%, respectively, which are better than those of state-of-the-art models. This proposed CNN model can help in the automatic screening of COVID-19 patients and decrease the burden on medicinal services frameworks.', 'authors': [{'name': 'Goel T.'}, {'name': 'Murugan R.'}, {'name': 'Mirjalili S.'}, {'name': 'Chakrabartty D.K.'}], 'citationCount': 8, 'date': '2021-03-01T00:00:00Z', 'journal': 'Applied Intelligence', 'title': 'OptCoNet: an optimized convolutional neural network for an automatic diagnosis of COVID-19'}, 'pmcid': 'PMC7502308'}]"
300,adam.godzik@medsch.ucr.edu,Adam Godzik,Person,https://orcid.org/0000-0002-2425-852X,,,,,,h4coronavirus3d,,Niclaskn,"[{'doi': '10.1093/BIOINFORMATICS/BTAA550', 'metadata': {'abstract': '© The Author(s) 2020. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.comMotivation: As the COVID-19 pandemic is spreading around the world, the SARS-CoV-2 virus is evolving with mutations that potentially change and fine-tune functions of the proteins coded in its genome. Results: Coronavirus3D website integrates data on the SARS-CoV-2 virus mutations with information about 3D structures of its proteins, allowing users to visually analyze the mutations in their 3D context. Availability and implementation: Coronavirus3D server is freely available at https://coronavirus3d.org.', 'authors': [{'name': 'Sedova M.'}, {'name': 'Jaroszewski L.'}, {'name': 'Alisoltani A.'}, {'name': 'Godzik A.'}], 'citationCount': 11, 'date': '2020-08-01T00:00:00Z', 'journal': 'Bioinformatics', 'title': 'Coronavirus3D: 3D structural visualization of COVID-19 genomic divergence'}, 'pmcid': 'PMC7314196', 'pmid': '32470119'}]"
301,enriquetomas.martinezb@um.es,Enrique Tomás Martínez Beltrán,Person,,,,,,,convida,,Kigaard,"[{'doi': '10.1016/J.JBI.2021.103760', 'metadata': {'abstract': '© 2021 Elsevier Inc.Since the first reported case in Wuhan in late 2019, COVID-19 has rapidly spread worldwide, dramatically impacting the lives of millions of citizens. To deal with the severe crisis resulting from the pandemic, worldwide institutions have been forced to make decisions that profoundly affect the socio-economic realm. In this sense, researchers from diverse knowledge areas are investigating the behavior of the disease in a rush against time. In both cases, the lack of reliable data has been an obstacle to carry out such tasks with accuracy. To tackle this challenge, COnVIDa (https://convida.inf.um.es) has been designed and developed as a user-friendly tool that easily gathers rigorous multidisciplinary data related to the COVID-19 pandemic from different data sources. In particular, the pandemic expansion is analyzed with variables of health nature, but also social ones, mobility, etc. Besides, COnVIDa permits to smoothly join such data, compare and download them for further analysis. Due to the open-science nature of the project, COnVIDa is easily extensible to any other region of the planet. In this way, COnVIDa becomes a data facilitator for decision-making processes, as well as a catalyst for new scientific researches related to this pandemic.', 'authors': [{'name': 'Martinez Beltran E.T.'}, {'name': 'Quiles Perez M.'}, {'name': 'Pastor-Galindo J.'}, {'name': 'Nespoli P.'}, {'name': 'Garcia Clemente F.J.'}, {'name': 'Gomez Marmol F.'}], 'date': '2021-05-01T00:00:00Z', 'journal': 'Journal of Biomedical Informatics', 'title': 'COnVIDa: COVID-19 multidisciplinary data collection and dashboard'}, 'pmcid': 'PMC8007529', 'pmid': '33798715', 'type': ['Primary']}]"
302,felixgm@um.es,Félix Gómez Mármol,Person,,,,,,,convida,,Kigaard,"[{'doi': '10.1016/J.JBI.2021.103760', 'metadata': {'abstract': '© 2021 Elsevier Inc.Since the first reported case in Wuhan in late 2019, COVID-19 has rapidly spread worldwide, dramatically impacting the lives of millions of citizens. To deal with the severe crisis resulting from the pandemic, worldwide institutions have been forced to make decisions that profoundly affect the socio-economic realm. In this sense, researchers from diverse knowledge areas are investigating the behavior of the disease in a rush against time. In both cases, the lack of reliable data has been an obstacle to carry out such tasks with accuracy. To tackle this challenge, COnVIDa (https://convida.inf.um.es) has been designed and developed as a user-friendly tool that easily gathers rigorous multidisciplinary data related to the COVID-19 pandemic from different data sources. In particular, the pandemic expansion is analyzed with variables of health nature, but also social ones, mobility, etc. Besides, COnVIDa permits to smoothly join such data, compare and download them for further analysis. Due to the open-science nature of the project, COnVIDa is easily extensible to any other region of the planet. In this way, COnVIDa becomes a data facilitator for decision-making processes, as well as a catalyst for new scientific researches related to this pandemic.', 'authors': [{'name': 'Martinez Beltran E.T.'}, {'name': 'Quiles Perez M.'}, {'name': 'Pastor-Galindo J.'}, {'name': 'Nespoli P.'}, {'name': 'Garcia Clemente F.J.'}, {'name': 'Gomez Marmol F.'}], 'date': '2021-05-01T00:00:00Z', 'journal': 'Journal of Biomedical Informatics', 'title': 'COnVIDa: COVID-19 multidisciplinary data collection and dashboard'}, 'pmcid': 'PMC8007529', 'pmid': '33798715', 'type': ['Primary']}]"
303,,JM2,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/10845200-jm2,,,coronavirus-tracker,Open access (with restrictions),Kigaard,
304,,milan batista,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/3576565-milan-batista,,,fitvirus,Open access (with restrictions),zsmag19,
305,,Guy Rouleau,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/1248313-guy-rouleau,,,simulink-virus-simulator,Open access (with restrictions),Kigaard,
306,,Tianjian Zhou,Person,,,,,,,baysir,,Kigaard,"[{'doi': '10.1016/J.CCT.2020.106146', 'metadata': {'abstract': '© 2020 Elsevier Inc.The outbreak of Coronavirus Disease 2019 (COVID-19) is an ongoing pandemic affecting over 200 countries and regions. Inference about the transmission dynamics of COVID-19 can provide important insights into the speed of disease spread and the effects of mitigation policies. We develop a novel Bayesian approach to such inference based on a probabilistic compartmental model using data of daily confirmed COVID-19 cases. In particular, we consider a probabilistic extension of the classical susceptible-infectious-recovered model, which takes into account undocumented infections and allows the epidemiological parameters to vary over time. We estimate the disease transmission rate via a Gaussian process prior, which captures nonlinear changes over time without the need of specific parametric assumptions. We utilize a parallel-tempering Markov chain Monte Carlo algorithm to efficiently sample from the highly correlated posterior space. Predictions for future observations are done by sampling from their posterior predictive distributions. Performance of the proposed approach is assessed using simulated datasets. Finally, our approach is applied to COVID-19 data from six states of the United States: Washington, New York, California, Florida, Texas, and Illinois. An R package BaySIR is made available at https://github.com/tianjianzhou/BaySIR for the public to conduct independent analysis or reproduce the results in this paper.', 'authors': [{'name': 'Zhou T.'}, {'name': 'Ji Y.'}], 'date': '2020-10-01T00:00:00Z', 'journal': 'Contemporary Clinical Trials', 'title': 'Semiparametric Bayesian inference for the transmission dynamics of COVID-19 with a state-space model'}, 'pmcid': 'PMC7491370', 'pmid': '32947047', 'type': ['Primary']}]"
307,,Kevin Chng,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/12813571-kevin-chng,,,gui-fying-classification-dl-model-builder,Open access (with restrictions),Kigaard,
308,,Carlos Tapia,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/13235075-carlos-tapia,,,covid19-analysis,Open access (with restrictions),zsmag19,
309,,Phaneendra K. Yalavarthy,Person,https://orcid.org/0000-0003-4810-352X,['Primary contact'],,,,,mini-covidnet,,Kigaard,"[{'doi': '10.1109/TUFFC.2021.3068190', 'metadata': {'abstract': '© 1986-2012 IEEE.Lung ultrasound (US) imaging has the potential to be an effective point-of-care test for detection of COVID-19, due to its ease of operation with minimal personal protection equipment along with easy disinfection. The current state-of-the-art deep learning models for detection of COVID-19 are heavy models that may not be easy to deploy in commonly utilized mobile platforms in point-of-care testing. In this work, we develop a lightweight mobile friendly efficient deep learning model for detection of COVID-19 using lung US images. Three different classes including COVID-19, pneumonia, and healthy were included in this task. The developed network, named as Mini-COVIDNet, was bench-marked with other lightweight neural network models along with state-of-the-art heavy model. It was shown that the proposed network can achieve the highest accuracy of 83.2% and requires a training time of only 24 min. The proposed Mini-COVIDNet has 4.39 times less number of parameters in the network compared to its next best performing network and requires a memory of only 51.29 MB, making the point-of-care detection of COVID-19 using lung US imaging plausible on a mobile platform. Deployment of these lightweight networks on embedded platforms shows that the proposed Mini-COVIDNet is highly versatile and provides optimal performance in terms of being accurate as well as having latency in the same order as other lightweight networks. The developed lightweight models are available at https://github.com/navchetan-awasthi/Mini-COVIDNet.', 'authors': [{'name': 'Awasthi N.'}, {'name': 'Dayal A.'}, {'name': 'Cenkeramaddi L.R.'}, {'name': 'Yalavarthy P.K.'}], 'citationCount': 3, 'date': '2021-06-01T00:00:00Z', 'journal': 'IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control', 'title': 'Mini-COVIDNet: Efficient Lightweight Deep Neural Network for Ultrasound Based Point-of-Care Detection of COVID-19'}, 'pmid': '33755565', 'type': ['Primary']}]"
310,dennis.ko@duke.edu,Dennis C. Ko,Person,https://orcid.org/0000-0002-0113-5981,,,,,,icpagdb,,Kigaard,"[{'doi': '10.1186/S13073-021-00904-Z', 'metadata': {'abstract': '© 2021, The Author(s).Background: While genome-wide associations studies (GWAS) have successfully elucidated the genetic architecture of complex human traits and diseases, understanding mechanisms that lead from genetic variation to pathophysiology remains an important challenge. Methods are needed to systematically bridge this crucial gap to facilitate experimental testing of hypotheses and translation to clinical utility. Results: Here, we leveraged cross-phenotype associations to identify traits with shared genetic architecture, using linkage disequilibrium (LD) information to accurately capture shared SNPs by proxy, and calculate significance of enrichment. This shared genetic architecture was examined across differing biological scales through incorporating data from catalogs of clinical, cellular, and molecular GWAS. We have created an interactive web database (interactive Cross-Phenotype Analysis of GWAS database (iCPAGdb)) to facilitate exploration and allow rapid analysis of user-uploaded GWAS summary statistics. This database revealed well-known relationships among phenotypes, as well as the generation of novel hypotheses to explain the pathophysiology of common diseases. Application of iCPAGdb to a recent GWAS of severe COVID-19 demonstrated unexpected overlap of GWAS signals between COVID-19 and human diseases, including with idiopathic pulmonary fibrosis driven by the DPP9 locus. Transcriptomics from peripheral blood of COVID-19 patients demonstrated that DPP9 was induced in SARS-CoV-2 compared to healthy controls or those with bacterial infection. Further investigation of cross-phenotype SNPs associated with both severe COVID-19 and other human traits demonstrated colocalization of the GWAS signal at the ABO locus with plasma protein levels of a reported receptor of SARS-CoV-2, CD209 (DC-SIGN). This finding points to a possible mechanism whereby glycosylation of CD209 by ABO may regulate COVID-19 disease severity. Conclusions: Thus, connecting genetically related traits across phenotypic scales links human diseases to molecular and cellular measurements that can reveal mechanisms and lead to novel biomarkers and therapeutic approaches. The iCPAGdb web portal is accessible at http://cpag.oit.duke.edu and the software code at https://github.com/tbalmat/iCPAGdb.', 'authors': [{'name': 'Wang L.'}, {'name': 'Balmat T.J.'}, {'name': 'Antonia A.L.'}, {'name': 'Constantine F.J.'}, {'name': 'Henao R.'}, {'name': 'Burke T.W.'}, {'name': 'Ingham A.'}, {'name': 'McClain M.T.'}, {'name': 'Tsalik E.L.'}, {'name': 'Ko E.R.'}, {'name': 'Ginsburg G.S.'}, {'name': 'DeLong M.R.'}, {'name': 'Shen X.'}, {'name': 'Woods C.W.'}, {'name': 'Hauser E.R.'}, {'name': 'Ko D.C.'}], 'date': '2021-12-01T00:00:00Z', 'journal': 'Genome Medicine', 'title': 'An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility'}, 'pmcid': 'PMC8127495', 'pmid': '34001247'}]"
311,arzucan.ozgur@boun.edu.tr,Arzucan Özgür,Person,,,,,,,vapur,,zsmag19,[{'doi': '10.1101/2020.09.05.284224'}]
312,amit.icgeb@gmail.com,Amit Sharma,Person,,,,,,,pracriti,,zsmag19,"[{'doi': '10.1016/J.HELIYON.2020.E05722', 'metadata': {'abstract': '© 2020The SARS-CoV-2 driven disease COVID-19 is pandemic with increasing human and monetary costs. COVID-19 has put an unexpected and inordinate degree of pressure on healthcare systems of strong and fragile countries alike. To launch both containment and mitigation measures, each country requires estimates of COVID-19 incidence as such preparedness allows agencies to plan efficient resource allocation and to design control strategies. Here, we have developed a new adaptive, interacting, and cluster-based mathematical model to predict the granular trajectory of COVID-19. We have analyzed incidence data from three currently afflicted countries of Italy, the United States of America, and India. We show that our approach predicts state-wise COVID-19 spread for each country with reasonable accuracy. We show that Rt, as the effective reproduction number, exhibits significant spatial variations in these countries. However, by accounting for the spatial variation of Rt in an adaptive fashion, the predictive model provides estimates of the possible asymptomatic and undetected COVID-19 cases, both of which are key contributors in COVID-19 transmission. We have applied our methodology to make detailed predictions for COVID19 incidences at the district and state level in India. Finally, to make the models available to the public at large, we have developed a web-based dashboard, namely “Predictions and Assessment of Corona Infections and Transmission in India” (PRACRITI, see http://pracriti.iitd.ac.in), which provides the detailed Rt values and a three-week forecast of COVID cases. © 2020Microbiology; Computational Mathematics; Mathematical Modeling; Epidemiology; Public Health; Infectious Disease; COVID-19; Transmission dynamics; Effective reproduction number; RT', 'authors': [{'name': 'Ravinder R.'}, {'name': 'Singh S.'}, {'name': 'Bishnoi S.'}, {'name': 'Jan A.'}, {'name': 'Sharma A.'}, {'name': 'Kodamana H.'}, {'name': 'Krishnan N.M.A.'}], 'citationCount': 2, 'date': '2020-12-01T00:00:00Z', 'journal': 'Heliyon', 'title': 'An adaptive, interacting, cluster-based model for predicting the transmission dynamics of COVID-19'}, 'pmcid': 'PMC7749387', 'pmid': '33367130'}]"
313,kodamana@iitd.ac.in,Hariprasad Kodamana,Person,,,,,,,pracriti,,zsmag19,"[{'doi': '10.1016/J.HELIYON.2020.E05722', 'metadata': {'abstract': '© 2020The SARS-CoV-2 driven disease COVID-19 is pandemic with increasing human and monetary costs. COVID-19 has put an unexpected and inordinate degree of pressure on healthcare systems of strong and fragile countries alike. To launch both containment and mitigation measures, each country requires estimates of COVID-19 incidence as such preparedness allows agencies to plan efficient resource allocation and to design control strategies. Here, we have developed a new adaptive, interacting, and cluster-based mathematical model to predict the granular trajectory of COVID-19. We have analyzed incidence data from three currently afflicted countries of Italy, the United States of America, and India. We show that our approach predicts state-wise COVID-19 spread for each country with reasonable accuracy. We show that Rt, as the effective reproduction number, exhibits significant spatial variations in these countries. However, by accounting for the spatial variation of Rt in an adaptive fashion, the predictive model provides estimates of the possible asymptomatic and undetected COVID-19 cases, both of which are key contributors in COVID-19 transmission. We have applied our methodology to make detailed predictions for COVID19 incidences at the district and state level in India. Finally, to make the models available to the public at large, we have developed a web-based dashboard, namely “Predictions and Assessment of Corona Infections and Transmission in India” (PRACRITI, see http://pracriti.iitd.ac.in), which provides the detailed Rt values and a three-week forecast of COVID cases. © 2020Microbiology; Computational Mathematics; Mathematical Modeling; Epidemiology; Public Health; Infectious Disease; COVID-19; Transmission dynamics; Effective reproduction number; RT', 'authors': [{'name': 'Ravinder R.'}, {'name': 'Singh S.'}, {'name': 'Bishnoi S.'}, {'name': 'Jan A.'}, {'name': 'Sharma A.'}, {'name': 'Kodamana H.'}, {'name': 'Krishnan N.M.A.'}], 'citationCount': 2, 'date': '2020-12-01T00:00:00Z', 'journal': 'Heliyon', 'title': 'An adaptive, interacting, cluster-based model for predicting the transmission dynamics of COVID-19'}, 'pmcid': 'PMC7749387', 'pmid': '33367130'}]"
314,krishnan@iitd.ac.in,N.M. Anoop Krishnan,Person,,,,,,,pracriti,,zsmag19,"[{'doi': '10.1016/J.HELIYON.2020.E05722', 'metadata': {'abstract': '© 2020The SARS-CoV-2 driven disease COVID-19 is pandemic with increasing human and monetary costs. COVID-19 has put an unexpected and inordinate degree of pressure on healthcare systems of strong and fragile countries alike. To launch both containment and mitigation measures, each country requires estimates of COVID-19 incidence as such preparedness allows agencies to plan efficient resource allocation and to design control strategies. Here, we have developed a new adaptive, interacting, and cluster-based mathematical model to predict the granular trajectory of COVID-19. We have analyzed incidence data from three currently afflicted countries of Italy, the United States of America, and India. We show that our approach predicts state-wise COVID-19 spread for each country with reasonable accuracy. We show that Rt, as the effective reproduction number, exhibits significant spatial variations in these countries. However, by accounting for the spatial variation of Rt in an adaptive fashion, the predictive model provides estimates of the possible asymptomatic and undetected COVID-19 cases, both of which are key contributors in COVID-19 transmission. We have applied our methodology to make detailed predictions for COVID19 incidences at the district and state level in India. Finally, to make the models available to the public at large, we have developed a web-based dashboard, namely “Predictions and Assessment of Corona Infections and Transmission in India” (PRACRITI, see http://pracriti.iitd.ac.in), which provides the detailed Rt values and a three-week forecast of COVID cases. © 2020Microbiology; Computational Mathematics; Mathematical Modeling; Epidemiology; Public Health; Infectious Disease; COVID-19; Transmission dynamics; Effective reproduction number; RT', 'authors': [{'name': 'Ravinder R.'}, {'name': 'Singh S.'}, {'name': 'Bishnoi S.'}, {'name': 'Jan A.'}, {'name': 'Sharma A.'}, {'name': 'Kodamana H.'}, {'name': 'Krishnan N.M.A.'}], 'citationCount': 2, 'date': '2020-12-01T00:00:00Z', 'journal': 'Heliyon', 'title': 'An adaptive, interacting, cluster-based model for predicting the transmission dynamics of COVID-19'}, 'pmcid': 'PMC7749387', 'pmid': '33367130'}]"
315,,Lateef Adewale Kareem,Person,,['Primary contact'],,https://www.mathworks.com/matlabcentral/profile/2376472-lateef-adewale-kareem,,,fitviruscv19varw,Open access (with restrictions),Kigaard,
316,tks_jp@seikai.org,Tetsuro Kawano-Sugaya,Person,,,,,,,haplotype_explorer,,Niclaskn,[{'doi': '10.1101/2020.07.19.179101'}]
317,julien.gobeill@hesge.ch,Julien Gobeill,Person,https://orcid.org/0000-0001-9809-7741,,,,,,sibils,,zsmag19,"[{'doi': '10.1093/NAR/GKAA328', 'metadata': {'abstract': '© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.Thanks to recent efforts by the text mining community, biocurators have now access to plenty of good tools and Web interfaces for identifying and visualizing biomedical entities in literature. Yet, many of these systems start with a PubMed query, which is limited by strong Boolean constraints. Some semantic search engines exploit entities for Information Retrieval, and/or deliver relevance-based ranked results. Yet, they are not designed for supporting a specific curation workflow, and allow very limited control on the search process. The Swiss Institute of Bioinformatics Literature Services (SIBiLS) provide personalized Information Retrieval in the biological literature. Indeed, SIBiLS allow fully customizable search in semantically enriched contents, based on keywords and/or mapped biomedical entities from a growing set of standardized and legacy vocabularies. The services have been used and favourably evaluated to assist the curation of genes and gene products, by delivering customized literature triage engines to different curation teams. SIBiLS (https://candy.hesge.ch/SIBiLS) are freely accessible via REST APIs and are ready to empower any curation workflow, built on modern technologies scalable with big data: MongoDB and Elasticsearch. They cover MEDLINE and PubMed Central Open Access enriched by nearly 2 billion of mapped biomedical entities, and are daily updated.', 'authors': [{'name': 'Gobeill J.'}, {'name': 'Caucheteur D.'}, {'name': 'Michel P.-A.'}, {'name': 'Mottin L.'}, {'name': 'Pasche E.'}, {'name': 'Ruch P.'}], 'citationCount': 1, 'date': '2020-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SIB literature services: RESTful customizable search engines in biomedical literature, enriched with automatically mapped biomedical concepts'}, 'pmcid': 'PMC7319474', 'pmid': '32379317'}]"
318,patrick.ruch@sib.swiss,Patrick Ruch,Person,,,,,,,sibils,,zsmag19,"[{'doi': '10.1093/NAR/GKAA328', 'metadata': {'abstract': '© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.Thanks to recent efforts by the text mining community, biocurators have now access to plenty of good tools and Web interfaces for identifying and visualizing biomedical entities in literature. Yet, many of these systems start with a PubMed query, which is limited by strong Boolean constraints. Some semantic search engines exploit entities for Information Retrieval, and/or deliver relevance-based ranked results. Yet, they are not designed for supporting a specific curation workflow, and allow very limited control on the search process. The Swiss Institute of Bioinformatics Literature Services (SIBiLS) provide personalized Information Retrieval in the biological literature. Indeed, SIBiLS allow fully customizable search in semantically enriched contents, based on keywords and/or mapped biomedical entities from a growing set of standardized and legacy vocabularies. The services have been used and favourably evaluated to assist the curation of genes and gene products, by delivering customized literature triage engines to different curation teams. SIBiLS (https://candy.hesge.ch/SIBiLS) are freely accessible via REST APIs and are ready to empower any curation workflow, built on modern technologies scalable with big data: MongoDB and Elasticsearch. They cover MEDLINE and PubMed Central Open Access enriched by nearly 2 billion of mapped biomedical entities, and are daily updated.', 'authors': [{'name': 'Gobeill J.'}, {'name': 'Caucheteur D.'}, {'name': 'Michel P.-A.'}, {'name': 'Mottin L.'}, {'name': 'Pasche E.'}, {'name': 'Ruch P.'}], 'citationCount': 1, 'date': '2020-01-01T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'SIB literature services: RESTful customizable search engines in biomedical literature, enriched with automatically mapped biomedical concepts'}, 'pmcid': 'PMC7319474', 'pmid': '32379317'}]"
319,david.fitch@nyu.edu,David H. A. Fitch,Person,,,,,,,euadb,,Kigaard,[{'doi': '10.1101/2020.07.30.228890'}]
320,isabel_fulcher@hms.harvard.edu,,Person,,,,,,,lqas-imp,,Niclaskn,[{'doi': '10.1101/2020.09.11.20193052'}]
321,mclisbee@pih.org,,Person,,,,,,,lqas-imp,,Niclaskn,[{'doi': '10.1101/2020.09.11.20193052'}]
322,wlambert@pih.org,,Person,,,,,,,lqas-imp,,Niclaskn,[{'doi': '10.1101/2020.09.11.20193052'}]
323,fleandre@pih.org,,Person,,,,,,,lqas-imp,,Niclaskn,[{'doi': '10.1101/2020.09.11.20193052'}]
324,bethany_gauthier@hms.harvard.edu,,Person,,,,,,,lqas-imp,,Niclaskn,[{'doi': '10.1101/2020.09.11.20193052'}]
325,kathryn.north@mcri.edu.au,Kathryn N. North,Person,,,,,,,australian-genomics,,Niclaskn,"[{'doi': '10.1016/J.AJHG.2019.06.003', 'metadata': {'abstract': '© 2019Australian Genomics is a national collaborative research partnership of more than 80 organizations piloting a whole-of-system approach to integrating genomics into healthcare that is based on federation principles. The aim of Australian Genomics is to assess the application of genomic testing in healthcare at the translational interface between research and clinical delivery, with an emphasis on robust evaluation of outcomes. It encompasses two bodies of work: a research program prospectively providing genomic testing through exemplar clinical projects in rare diseases, cancers, and reproductive carrier screening and interdependent programs for advancing the diagnostic, health informatics, regulatory, ethical, policy, and workforce infrastructure necessary for the integration of genomics into the Australian health system.', 'authors': [{'name': 'Stark Z.'}, {'name': 'Boughtwood T.'}, {'name': 'Phillips P.'}, {'name': 'Christodoulou J.'}, {'name': 'Hansen D.P.'}, {'name': 'Braithwaite J.'}, {'name': 'Newson A.J.'}, {'name': 'Gaff C.L.'}, {'name': 'Sinclair A.H.'}, {'name': 'North K.N.'}], 'citationCount': 25, 'date': '2019-07-03T00:00:00Z', 'journal': 'American Journal of Human Genetics', 'title': 'Australian Genomics: A Federated Model for Integrating Genomics into Healthcare'}, 'pmcid': 'PMC6612707', 'pmid': '31271757'}]"
326,zz374@drexel.edu,Zhengqiao Zhao,Person,,,,,,,ism,,Niclaskn,[{'doi': '10.1101/2020.04.07.030759'}]
327,science@symptoma.com,Jama Nateqi,Person,,,,,,,symptoma,,zsmag19,[{'doi': '10.1101/2020.03.25.008805'}]
328,drashutoshkumar@aiimspatna.org,Ashutosh Kumar,Person,,,,,,,sars-cov-2,,zsmag19,"[{'doi': '10.1101/2020.04.14.040204'}, {'doi': '10.1101/2020.04.02.021725'}, {'doi': '10.1186/S40249-020-00650-1', 'metadata': {'abstract': '© 2020 The Author(s).The outbreak of coronavirus disease 2019 (COVID-19) has caused more than 80 813 confirmed cases in all provinces of China, and 21 110 cases reported in 93 countries of six continents as of 7 March 2020 since middle December 2019. Due to biological nature of the novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with faster spreading and unknown transmission pattern, it makes us in a difficulty position to contain the disease transmission globally. To date, we have found it is one of the greatest challenges to human beings in fighting against COVID-19 in the history, because SARS-CoV-2 is different from SARS-CoV and MERS-CoV in terms of biological features and transmissibility, and also found the containment strategies including the non-pharmaceutical public health measures implemented in China are effective and successful. In order to prevent a potential pandemic-level outbreak of COVID-19, we, as a community of shared future for mankind, recommend for all international leaders to support preparedness in low and middle income countries especially, take strong global interventions by using old approaches or new tools, mobilize global resources to equip hospital facilities and supplies to protect noisome infections and to provide personal protective tools such as facemask to general population, and quickly initiate research projects on drug and vaccine development. We also recommend for the international community to develop better coordination, cooperation, and strong solidarity in the joint efforts of fighting against COVID-19 spreading recommended by the joint mission report of the WHO-China experts, against violating the International Health Regulation (WHO, 2005), and against stigmatization, in order to eventually win the battle against our common enemy-COVID-19.', 'authors': [{'name': 'Qian X.'}, {'name': 'Ren R.'}, {'name': 'Wang Y.'}, {'name': 'Guo Y.'}, {'name': 'Fang J.'}, {'name': 'Wu Z.-D.'}, {'name': 'Liu P.-L.'}, {'name': 'Han T.-R.'}], 'citationCount': 57, 'date': '2020-04-07T00:00:00Z', 'journal': 'Infectious Diseases of Poverty', 'title': 'Fighting against the common enemy of COVID-19: A practice of building a community with a shared future for mankind'}, 'pmcid': 'PMC7137400', 'pmid': '32264957'}, {'doi': '10.1101/2020.03.29.014381'}, {'doi': '10.1101/2020.04.21.052084'}, {'doi': '10.1101/2020.04.23.20076042', 'pmid': '33196625'}, {'doi': '10.1101/2020.04.09.034868'}]"
329,maitism@rediffmail.com,,Person,,,,,,,sars-cov-2,,zsmag19,"[{'doi': '10.1101/2020.04.14.040204'}, {'doi': '10.1101/2020.04.02.021725'}, {'doi': '10.1186/S40249-020-00650-1', 'metadata': {'abstract': '© 2020 The Author(s).The outbreak of coronavirus disease 2019 (COVID-19) has caused more than 80 813 confirmed cases in all provinces of China, and 21 110 cases reported in 93 countries of six continents as of 7 March 2020 since middle December 2019. Due to biological nature of the novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with faster spreading and unknown transmission pattern, it makes us in a difficulty position to contain the disease transmission globally. To date, we have found it is one of the greatest challenges to human beings in fighting against COVID-19 in the history, because SARS-CoV-2 is different from SARS-CoV and MERS-CoV in terms of biological features and transmissibility, and also found the containment strategies including the non-pharmaceutical public health measures implemented in China are effective and successful. In order to prevent a potential pandemic-level outbreak of COVID-19, we, as a community of shared future for mankind, recommend for all international leaders to support preparedness in low and middle income countries especially, take strong global interventions by using old approaches or new tools, mobilize global resources to equip hospital facilities and supplies to protect noisome infections and to provide personal protective tools such as facemask to general population, and quickly initiate research projects on drug and vaccine development. We also recommend for the international community to develop better coordination, cooperation, and strong solidarity in the joint efforts of fighting against COVID-19 spreading recommended by the joint mission report of the WHO-China experts, against violating the International Health Regulation (WHO, 2005), and against stigmatization, in order to eventually win the battle against our common enemy-COVID-19.', 'authors': [{'name': 'Qian X.'}, {'name': 'Ren R.'}, {'name': 'Wang Y.'}, {'name': 'Guo Y.'}, {'name': 'Fang J.'}, {'name': 'Wu Z.-D.'}, {'name': 'Liu P.-L.'}, {'name': 'Han T.-R.'}], 'citationCount': 57, 'date': '2020-04-07T00:00:00Z', 'journal': 'Infectious Diseases of Poverty', 'title': 'Fighting against the common enemy of COVID-19: A practice of building a community with a shared future for mankind'}, 'pmcid': 'PMC7137400', 'pmid': '32264957'}, {'doi': '10.1101/2020.03.29.014381'}, {'doi': '10.1101/2020.04.21.052084'}, {'doi': '10.1101/2020.04.23.20076042', 'pmid': '33196625'}, {'doi': '10.1101/2020.04.09.034868'}]"
330,bamrita.bioinfo@gmail.com,,Person,,,,,,,sars-cov-2,,zsmag19,"[{'doi': '10.1101/2020.04.14.040204'}, {'doi': '10.1101/2020.04.02.021725'}, {'doi': '10.1186/S40249-020-00650-1', 'metadata': {'abstract': '© 2020 The Author(s).The outbreak of coronavirus disease 2019 (COVID-19) has caused more than 80 813 confirmed cases in all provinces of China, and 21 110 cases reported in 93 countries of six continents as of 7 March 2020 since middle December 2019. Due to biological nature of the novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with faster spreading and unknown transmission pattern, it makes us in a difficulty position to contain the disease transmission globally. To date, we have found it is one of the greatest challenges to human beings in fighting against COVID-19 in the history, because SARS-CoV-2 is different from SARS-CoV and MERS-CoV in terms of biological features and transmissibility, and also found the containment strategies including the non-pharmaceutical public health measures implemented in China are effective and successful. In order to prevent a potential pandemic-level outbreak of COVID-19, we, as a community of shared future for mankind, recommend for all international leaders to support preparedness in low and middle income countries especially, take strong global interventions by using old approaches or new tools, mobilize global resources to equip hospital facilities and supplies to protect noisome infections and to provide personal protective tools such as facemask to general population, and quickly initiate research projects on drug and vaccine development. We also recommend for the international community to develop better coordination, cooperation, and strong solidarity in the joint efforts of fighting against COVID-19 spreading recommended by the joint mission report of the WHO-China experts, against violating the International Health Regulation (WHO, 2005), and against stigmatization, in order to eventually win the battle against our common enemy-COVID-19.', 'authors': [{'name': 'Qian X.'}, {'name': 'Ren R.'}, {'name': 'Wang Y.'}, {'name': 'Guo Y.'}, {'name': 'Fang J.'}, {'name': 'Wu Z.-D.'}, {'name': 'Liu P.-L.'}, {'name': 'Han T.-R.'}], 'citationCount': 57, 'date': '2020-04-07T00:00:00Z', 'journal': 'Infectious Diseases of Poverty', 'title': 'Fighting against the common enemy of COVID-19: A practice of building a community with a shared future for mankind'}, 'pmcid': 'PMC7137400', 'pmid': '32264957'}, {'doi': '10.1101/2020.03.29.014381'}, {'doi': '10.1101/2020.04.21.052084'}, {'doi': '10.1101/2020.04.23.20076042', 'pmid': '33196625'}, {'doi': '10.1101/2020.04.09.034868'}]"
331,xqian@shmu.edu.cn,Xu Qian,Person,,,,,,,sars-cov-2,,zsmag19,"[{'doi': '10.1101/2020.04.14.040204'}, {'doi': '10.1101/2020.04.02.021725'}, {'doi': '10.1186/S40249-020-00650-1', 'metadata': {'abstract': '© 2020 The Author(s).The outbreak of coronavirus disease 2019 (COVID-19) has caused more than 80 813 confirmed cases in all provinces of China, and 21 110 cases reported in 93 countries of six continents as of 7 March 2020 since middle December 2019. Due to biological nature of the novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with faster spreading and unknown transmission pattern, it makes us in a difficulty position to contain the disease transmission globally. To date, we have found it is one of the greatest challenges to human beings in fighting against COVID-19 in the history, because SARS-CoV-2 is different from SARS-CoV and MERS-CoV in terms of biological features and transmissibility, and also found the containment strategies including the non-pharmaceutical public health measures implemented in China are effective and successful. In order to prevent a potential pandemic-level outbreak of COVID-19, we, as a community of shared future for mankind, recommend for all international leaders to support preparedness in low and middle income countries especially, take strong global interventions by using old approaches or new tools, mobilize global resources to equip hospital facilities and supplies to protect noisome infections and to provide personal protective tools such as facemask to general population, and quickly initiate research projects on drug and vaccine development. We also recommend for the international community to develop better coordination, cooperation, and strong solidarity in the joint efforts of fighting against COVID-19 spreading recommended by the joint mission report of the WHO-China experts, against violating the International Health Regulation (WHO, 2005), and against stigmatization, in order to eventually win the battle against our common enemy-COVID-19.', 'authors': [{'name': 'Qian X.'}, {'name': 'Ren R.'}, {'name': 'Wang Y.'}, {'name': 'Guo Y.'}, {'name': 'Fang J.'}, {'name': 'Wu Z.-D.'}, {'name': 'Liu P.-L.'}, {'name': 'Han T.-R.'}], 'citationCount': 57, 'date': '2020-04-07T00:00:00Z', 'journal': 'Infectious Diseases of Poverty', 'title': 'Fighting against the common enemy of COVID-19: A practice of building a community with a shared future for mankind'}, 'pmcid': 'PMC7137400', 'pmid': '32264957'}, {'doi': '10.1101/2020.03.29.014381'}, {'doi': '10.1101/2020.04.21.052084'}, {'doi': '10.1101/2020.04.23.20076042', 'pmid': '33196625'}, {'doi': '10.1101/2020.04.09.034868'}]"
332,hantieru@hotmail.com,Tie-Ru Han,Person,,,,,,,sars-cov-2,,zsmag19,"[{'doi': '10.1101/2020.04.14.040204'}, {'doi': '10.1101/2020.04.02.021725'}, {'doi': '10.1186/S40249-020-00650-1', 'metadata': {'abstract': '© 2020 The Author(s).The outbreak of coronavirus disease 2019 (COVID-19) has caused more than 80 813 confirmed cases in all provinces of China, and 21 110 cases reported in 93 countries of six continents as of 7 March 2020 since middle December 2019. Due to biological nature of the novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with faster spreading and unknown transmission pattern, it makes us in a difficulty position to contain the disease transmission globally. To date, we have found it is one of the greatest challenges to human beings in fighting against COVID-19 in the history, because SARS-CoV-2 is different from SARS-CoV and MERS-CoV in terms of biological features and transmissibility, and also found the containment strategies including the non-pharmaceutical public health measures implemented in China are effective and successful. In order to prevent a potential pandemic-level outbreak of COVID-19, we, as a community of shared future for mankind, recommend for all international leaders to support preparedness in low and middle income countries especially, take strong global interventions by using old approaches or new tools, mobilize global resources to equip hospital facilities and supplies to protect noisome infections and to provide personal protective tools such as facemask to general population, and quickly initiate research projects on drug and vaccine development. We also recommend for the international community to develop better coordination, cooperation, and strong solidarity in the joint efforts of fighting against COVID-19 spreading recommended by the joint mission report of the WHO-China experts, against violating the International Health Regulation (WHO, 2005), and against stigmatization, in order to eventually win the battle against our common enemy-COVID-19.', 'authors': [{'name': 'Qian X.'}, {'name': 'Ren R.'}, {'name': 'Wang Y.'}, {'name': 'Guo Y.'}, {'name': 'Fang J.'}, {'name': 'Wu Z.-D.'}, {'name': 'Liu P.-L.'}, {'name': 'Han T.-R.'}], 'citationCount': 57, 'date': '2020-04-07T00:00:00Z', 'journal': 'Infectious Diseases of Poverty', 'title': 'Fighting against the common enemy of COVID-19: A practice of building a community with a shared future for mankind'}, 'pmcid': 'PMC7137400', 'pmid': '32264957'}, {'doi': '10.1101/2020.03.29.014381'}, {'doi': '10.1101/2020.04.21.052084'}, {'doi': '10.1101/2020.04.23.20076042', 'pmid': '33196625'}, {'doi': '10.1101/2020.04.09.034868'}]"
333,jrgreen@sce.carleton.ca,James R. Green,Person,,,,,,,sars-cov-2,,zsmag19,"[{'doi': '10.1101/2020.04.14.040204'}, {'doi': '10.1101/2020.04.02.021725'}, {'doi': '10.1186/S40249-020-00650-1', 'metadata': {'abstract': '© 2020 The Author(s).The outbreak of coronavirus disease 2019 (COVID-19) has caused more than 80 813 confirmed cases in all provinces of China, and 21 110 cases reported in 93 countries of six continents as of 7 March 2020 since middle December 2019. Due to biological nature of the novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with faster spreading and unknown transmission pattern, it makes us in a difficulty position to contain the disease transmission globally. To date, we have found it is one of the greatest challenges to human beings in fighting against COVID-19 in the history, because SARS-CoV-2 is different from SARS-CoV and MERS-CoV in terms of biological features and transmissibility, and also found the containment strategies including the non-pharmaceutical public health measures implemented in China are effective and successful. In order to prevent a potential pandemic-level outbreak of COVID-19, we, as a community of shared future for mankind, recommend for all international leaders to support preparedness in low and middle income countries especially, take strong global interventions by using old approaches or new tools, mobilize global resources to equip hospital facilities and supplies to protect noisome infections and to provide personal protective tools such as facemask to general population, and quickly initiate research projects on drug and vaccine development. We also recommend for the international community to develop better coordination, cooperation, and strong solidarity in the joint efforts of fighting against COVID-19 spreading recommended by the joint mission report of the WHO-China experts, against violating the International Health Regulation (WHO, 2005), and against stigmatization, in order to eventually win the battle against our common enemy-COVID-19.', 'authors': [{'name': 'Qian X.'}, {'name': 'Ren R.'}, {'name': 'Wang Y.'}, {'name': 'Guo Y.'}, {'name': 'Fang J.'}, {'name': 'Wu Z.-D.'}, {'name': 'Liu P.-L.'}, {'name': 'Han T.-R.'}], 'citationCount': 57, 'date': '2020-04-07T00:00:00Z', 'journal': 'Infectious Diseases of Poverty', 'title': 'Fighting against the common enemy of COVID-19: A practice of building a community with a shared future for mankind'}, 'pmcid': 'PMC7137400', 'pmid': '32264957'}, {'doi': '10.1101/2020.03.29.014381'}, {'doi': '10.1101/2020.04.21.052084'}, {'doi': '10.1101/2020.04.23.20076042', 'pmid': '33196625'}, {'doi': '10.1101/2020.04.09.034868'}]"
334,trevor@oncoimmunity.com,Trevor Clancy,Person,,,,,,,sars-cov-2,,zsmag19,"[{'doi': '10.1101/2020.04.14.040204'}, {'doi': '10.1101/2020.04.02.021725'}, {'doi': '10.1186/S40249-020-00650-1', 'metadata': {'abstract': '© 2020 The Author(s).The outbreak of coronavirus disease 2019 (COVID-19) has caused more than 80 813 confirmed cases in all provinces of China, and 21 110 cases reported in 93 countries of six continents as of 7 March 2020 since middle December 2019. Due to biological nature of the novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with faster spreading and unknown transmission pattern, it makes us in a difficulty position to contain the disease transmission globally. To date, we have found it is one of the greatest challenges to human beings in fighting against COVID-19 in the history, because SARS-CoV-2 is different from SARS-CoV and MERS-CoV in terms of biological features and transmissibility, and also found the containment strategies including the non-pharmaceutical public health measures implemented in China are effective and successful. In order to prevent a potential pandemic-level outbreak of COVID-19, we, as a community of shared future for mankind, recommend for all international leaders to support preparedness in low and middle income countries especially, take strong global interventions by using old approaches or new tools, mobilize global resources to equip hospital facilities and supplies to protect noisome infections and to provide personal protective tools such as facemask to general population, and quickly initiate research projects on drug and vaccine development. We also recommend for the international community to develop better coordination, cooperation, and strong solidarity in the joint efforts of fighting against COVID-19 spreading recommended by the joint mission report of the WHO-China experts, against violating the International Health Regulation (WHO, 2005), and against stigmatization, in order to eventually win the battle against our common enemy-COVID-19.', 'authors': [{'name': 'Qian X.'}, {'name': 'Ren R.'}, {'name': 'Wang Y.'}, {'name': 'Guo Y.'}, {'name': 'Fang J.'}, {'name': 'Wu Z.-D.'}, {'name': 'Liu P.-L.'}, {'name': 'Han T.-R.'}], 'citationCount': 57, 'date': '2020-04-07T00:00:00Z', 'journal': 'Infectious Diseases of Poverty', 'title': 'Fighting against the common enemy of COVID-19: A practice of building a community with a shared future for mankind'}, 'pmcid': 'PMC7137400', 'pmid': '32264957'}, {'doi': '10.1101/2020.03.29.014381'}, {'doi': '10.1101/2020.04.21.052084'}, {'doi': '10.1101/2020.04.23.20076042', 'pmid': '33196625'}, {'doi': '10.1101/2020.04.09.034868'}]"
335,m.g.semple@liverpool.ac.uk,,Person,,,,,,,sars-cov-2,,zsmag19,"[{'doi': '10.1101/2020.04.14.040204'}, {'doi': '10.1101/2020.04.02.021725'}, {'doi': '10.1186/S40249-020-00650-1', 'metadata': {'abstract': '© 2020 The Author(s).The outbreak of coronavirus disease 2019 (COVID-19) has caused more than 80 813 confirmed cases in all provinces of China, and 21 110 cases reported in 93 countries of six continents as of 7 March 2020 since middle December 2019. Due to biological nature of the novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with faster spreading and unknown transmission pattern, it makes us in a difficulty position to contain the disease transmission globally. To date, we have found it is one of the greatest challenges to human beings in fighting against COVID-19 in the history, because SARS-CoV-2 is different from SARS-CoV and MERS-CoV in terms of biological features and transmissibility, and also found the containment strategies including the non-pharmaceutical public health measures implemented in China are effective and successful. In order to prevent a potential pandemic-level outbreak of COVID-19, we, as a community of shared future for mankind, recommend for all international leaders to support preparedness in low and middle income countries especially, take strong global interventions by using old approaches or new tools, mobilize global resources to equip hospital facilities and supplies to protect noisome infections and to provide personal protective tools such as facemask to general population, and quickly initiate research projects on drug and vaccine development. We also recommend for the international community to develop better coordination, cooperation, and strong solidarity in the joint efforts of fighting against COVID-19 spreading recommended by the joint mission report of the WHO-China experts, against violating the International Health Regulation (WHO, 2005), and against stigmatization, in order to eventually win the battle against our common enemy-COVID-19.', 'authors': [{'name': 'Qian X.'}, {'name': 'Ren R.'}, {'name': 'Wang Y.'}, {'name': 'Guo Y.'}, {'name': 'Fang J.'}, {'name': 'Wu Z.-D.'}, {'name': 'Liu P.-L.'}, {'name': 'Han T.-R.'}], 'citationCount': 57, 'date': '2020-04-07T00:00:00Z', 'journal': 'Infectious Diseases of Poverty', 'title': 'Fighting against the common enemy of COVID-19: A practice of building a community with a shared future for mankind'}, 'pmcid': 'PMC7137400', 'pmid': '32264957'}, {'doi': '10.1101/2020.03.29.014381'}, {'doi': '10.1101/2020.04.21.052084'}, {'doi': '10.1101/2020.04.23.20076042', 'pmid': '33196625'}, {'doi': '10.1101/2020.04.09.034868'}]"
336,costas@psu.edu,Costas D. Maranas,Person,,,,,,,sars-cov-2,,zsmag19,"[{'doi': '10.1101/2020.04.14.040204'}, {'doi': '10.1101/2020.04.02.021725'}, {'doi': '10.1186/S40249-020-00650-1', 'metadata': {'abstract': '© 2020 The Author(s).The outbreak of coronavirus disease 2019 (COVID-19) has caused more than 80 813 confirmed cases in all provinces of China, and 21 110 cases reported in 93 countries of six continents as of 7 March 2020 since middle December 2019. Due to biological nature of the novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with faster spreading and unknown transmission pattern, it makes us in a difficulty position to contain the disease transmission globally. To date, we have found it is one of the greatest challenges to human beings in fighting against COVID-19 in the history, because SARS-CoV-2 is different from SARS-CoV and MERS-CoV in terms of biological features and transmissibility, and also found the containment strategies including the non-pharmaceutical public health measures implemented in China are effective and successful. In order to prevent a potential pandemic-level outbreak of COVID-19, we, as a community of shared future for mankind, recommend for all international leaders to support preparedness in low and middle income countries especially, take strong global interventions by using old approaches or new tools, mobilize global resources to equip hospital facilities and supplies to protect noisome infections and to provide personal protective tools such as facemask to general population, and quickly initiate research projects on drug and vaccine development. We also recommend for the international community to develop better coordination, cooperation, and strong solidarity in the joint efforts of fighting against COVID-19 spreading recommended by the joint mission report of the WHO-China experts, against violating the International Health Regulation (WHO, 2005), and against stigmatization, in order to eventually win the battle against our common enemy-COVID-19.', 'authors': [{'name': 'Qian X.'}, {'name': 'Ren R.'}, {'name': 'Wang Y.'}, {'name': 'Guo Y.'}, {'name': 'Fang J.'}, {'name': 'Wu Z.-D.'}, {'name': 'Liu P.-L.'}, {'name': 'Han T.-R.'}], 'citationCount': 57, 'date': '2020-04-07T00:00:00Z', 'journal': 'Infectious Diseases of Poverty', 'title': 'Fighting against the common enemy of COVID-19: A practice of building a community with a shared future for mankind'}, 'pmcid': 'PMC7137400', 'pmid': '32264957'}, {'doi': '10.1101/2020.03.29.014381'}, {'doi': '10.1101/2020.04.21.052084'}, {'doi': '10.1101/2020.04.23.20076042', 'pmid': '33196625'}, {'doi': '10.1101/2020.04.09.034868'}]"
337,roman.neruda@gmail.com,Roman Neruda,Person,https://orcid.org/0000-0003-2364-5357,['Primary contact'],,,,,model-m,,Kigaard,"[{'doi': '10.1101/2021.05.13.21257139', 'type': ['Primary']}]"
338,Eric.Engle@niaid.nih.gov,Eric Engle,Person,https://orcid.org/0000-0003-2136-8069,,,,,,qure.ai,,zsmag19,"[{'doi': '10.1371/JOURNAL.PONE.0224445', 'metadata': {'abstract': '© 2020 Public Library of Science. All rights reserved.Availability of trained radiologists for fast processing of CXRs in regions burdened with tuberculosis always has been a challenge, affecting both timely diagnosis and patient monitoring. The paucity of annotated images of lungs of TB patients hampers attempts to apply data-oriented algorithms for research and clinical practices. The TB Portals Program database (TBPP, https://TBPortals.niaid.nih.gov) is a global collaboration curating a large collection of the most dangerous, hard-to-cure drug-resistant tuberculosis (DR-TB) patient cases. TBPP, with 1,179 (83%) DR-TB patient cases, is a unique collection that is well positioned as a testing ground for deep learning classifiers. As of January 2019, the TBPP database contains 1,538 CXRs, of which 346 (22.5%) are annotated by a radiologist and 104 (6.7%) by a pulmonologist-leaving 1,088 (70.7%) CXRs without annotations. The Qure.ai qXR artificial intelligence automated CXR interpretation tool, was blind-tested on the 346 radiologistannotated CXRs from the TBPP database. Qure.ai qXR CXR predictions for cavity, nodule, pleural effusion, hilar lymphadenopathy was successfully matching human expert annotations. In addition, we tested the 12 Qure.ai classifiers to find whether they correlate with treatment success (information provided by treating physicians). Ten descriptors were found as significant: abnormal CXR (p = 0.0005), pleural effusion (p = 0.048), nodule (p = 0.0004), hilar lymphadenopathy (p = 0.0038), cavity (p = 0.0002), opacity (p = 0.0006), atelectasis (p = 0.0074), consolidation (p = 0.0004), indicator of TB disease (p = < .0001), and fibrosis (p = < .0001). We conclude that applying fully automated Qure.ai CXR analysis tool is useful for fast, accurate, uniform, large-scale CXR annotation assistance, as it performed well even for DR-TB cases that were not used for initial training. Testing artificial intelligence algorithms (encapsulating both machine learning and deep learning classifiers) on diverse data collections, such as TBPP, is critically important toward progressing to clinically adopted automatic assistants for medical data analysis.', 'authors': [{'name': 'Engle E.'}, {'name': 'Gabrielian A.'}, {'name': 'Long A.'}, {'name': 'Hurt D.E.'}, {'name': 'Rosenthal A.'}], 'citationCount': 4, 'date': '2020-01-01T00:00:00Z', 'journal': 'PLoS ONE', 'title': 'Performance of Qure.ai automatic classifiers against a large annotated database of patients with diverse forms of tuberculosis'}, 'pmcid': 'PMC6980594', 'pmid': '31978149'}]"
339,msaito@whoi.edu,Mak A. Saito,Person,,,,,,,metatryp,,Niclaskn,[{'doi': '10.1101/2020.05.20.107490'}]
340,junwan@iu.edu,Jun Wan,Person,,,,,,,gess-db,,Niclaskn,"[{'doi': '10.1093/NAR/GKAA808', 'metadata': {'abstract': ""© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.The COVID-19 outbreak has become a global emergency since December 2019. Analysis of SARS-CoV-2 sequences can uncover single nucleotide variants (SNVs) and corresponding evolution patterns. The Global Evaluation of SARS-CoV-2/hCoV-19 Sequences (GESS, https://wan-bioinfo.shinyapps. io/GESS/) is a resource to provide comprehensive analysis results based on tens of thousands of high-coverage and high-quality SARS-CoV-2 complete genomes. The database allows user to browse, search and download SNVs at any individual or multiple SARS-CoV-2 genomic positions, or within a chosen genomic region or protein, or in certain country/area of interest. GESS reveals geographical distributions of SNVs around the world and across the states of USA, while exhibiting time-dependent patterns for SNV occurrences which reflect development of SARS-CoV-2 genomes. For each month, the top 100 SNVs that were firstly identified world-widely can be retrieved. GESS also explores SNVs occurring simultaneously with specific SNVs of user's interests. Furthermore, the database can be of great help to calibrate mutation rates and identify conserved genome regions. Taken together, GESS is a powerful resource and tool to monitor SARS-CoV-2 migration and evolution according to featured genomic variations. It provides potential directive information for prevalence prediction, related public health policy making, and vaccine designs."", 'authors': [{'name': 'Fang S.'}, {'name': 'Li K.'}, {'name': 'Shen J.'}, {'name': 'Liu S.'}, {'name': 'Liu J.'}, {'name': 'Yang L.'}, {'name': 'Hu C.-D.'}, {'name': 'Wan J.'}], 'citationCount': 8, 'date': '2021-01-08T00:00:00Z', 'journal': 'Nucleic Acids Research', 'title': 'GESS: A database of global evaluation of SARS-CoV-2/hCoV-19 sequences'}, 'pmid': '33045727'}]"
341,,Patrick Willems,,,"['Provider', 'Primary contact']",,,,,plant_ptm_viewer,Open access,bits@vib.be,"[{'doi': '10.1111/tpj.14345', 'metadata': {'abstract': '© 2019 The Authors The Plant Journal © 2019 John Wiley & Sons LtdPost-translational modifications (PTMs) of proteins are central in any kind of cellular signaling. Modern mass spectrometry technologies enable comprehensive identification and quantification of various PTMs. Given the increased numbers and types of mapped protein modifications, a database is necessary that simultaneously integrates and compares site-specific information for different PTMs, especially in plants for which the available PTM data are poorly catalogued. Here, we present the Plant PTM Viewer (http://www.psb.ugent.be/PlantPTMViewer), an integrative PTM resource that comprises approximately 370 000 PTM sites for 19 types of protein modifications in plant proteins from five different species. The Plant PTM Viewer provides the user with a protein sequence overview in which the experimentally evidenced PTMs are highlighted together with an estimate of the confidence by which the modified peptides and, if possible, the actual modification sites were identified and with functional protein domains or active site residues. The PTM sequence search tool can query PTM combinations in specific protein sequences, whereas the PTM BLAST tool searches for modified protein sequences to detect conserved PTMs in homologous sequences. Taken together, these tools help to assume the role and potential interplay of PTMs in specific proteins or within a broader systems biology context. The Plant PTM Viewer is an open repository that allows the submission of mass spectrometry-based PTM data to remain at pace with future PTM plant studies.', 'authors': [{'name': 'Willems P.'}, {'name': 'Horne A.'}, {'name': 'Van Parys T.'}, {'name': 'Goormachtig S.'}, {'name': 'De Smet I.'}, {'name': 'Botzki A.'}, {'name': 'Van Breusegem F.'}, {'name': 'Gevaert K.'}], 'citationCount': 16, 'date': '2019-01-01T00:00:00Z', 'journal': 'Plant Journal', 'title': 'The Plant PTM Viewer, a central resource for exploring plant protein modifications'}, 'pmid': '31004550', 'type': ['Primary'], 'version': '1.0'}]"
342,,Thomas Van Parys,,,['Developer'],,,,,plant_ptm_viewer,Open access,bits@vib.be,"[{'doi': '10.1111/tpj.14345', 'metadata': {'abstract': '© 2019 The Authors The Plant Journal © 2019 John Wiley & Sons LtdPost-translational modifications (PTMs) of proteins are central in any kind of cellular signaling. Modern mass spectrometry technologies enable comprehensive identification and quantification of various PTMs. Given the increased numbers and types of mapped protein modifications, a database is necessary that simultaneously integrates and compares site-specific information for different PTMs, especially in plants for which the available PTM data are poorly catalogued. Here, we present the Plant PTM Viewer (http://www.psb.ugent.be/PlantPTMViewer), an integrative PTM resource that comprises approximately 370 000 PTM sites for 19 types of protein modifications in plant proteins from five different species. The Plant PTM Viewer provides the user with a protein sequence overview in which the experimentally evidenced PTMs are highlighted together with an estimate of the confidence by which the modified peptides and, if possible, the actual modification sites were identified and with functional protein domains or active site residues. The PTM sequence search tool can query PTM combinations in specific protein sequences, whereas the PTM BLAST tool searches for modified protein sequences to detect conserved PTMs in homologous sequences. Taken together, these tools help to assume the role and potential interplay of PTMs in specific proteins or within a broader systems biology context. The Plant PTM Viewer is an open repository that allows the submission of mass spectrometry-based PTM data to remain at pace with future PTM plant studies.', 'authors': [{'name': 'Willems P.'}, {'name': 'Horne A.'}, {'name': 'Van Parys T.'}, {'name': 'Goormachtig S.'}, {'name': 'De Smet I.'}, {'name': 'Botzki A.'}, {'name': 'Van Breusegem F.'}, {'name': 'Gevaert K.'}], 'citationCount': 16, 'date': '2019-01-01T00:00:00Z', 'journal': 'Plant Journal', 'title': 'The Plant PTM Viewer, a central resource for exploring plant protein modifications'}, 'pmid': '31004550', 'type': ['Primary'], 'version': '1.0'}]"
343,,Alison Horne,,,['Developer'],,,,,plant_ptm_viewer,Open access,bits@vib.be,"[{'doi': '10.1111/tpj.14345', 'metadata': {'abstract': '© 2019 The Authors The Plant Journal © 2019 John Wiley & Sons LtdPost-translational modifications (PTMs) of proteins are central in any kind of cellular signaling. Modern mass spectrometry technologies enable comprehensive identification and quantification of various PTMs. Given the increased numbers and types of mapped protein modifications, a database is necessary that simultaneously integrates and compares site-specific information for different PTMs, especially in plants for which the available PTM data are poorly catalogued. Here, we present the Plant PTM Viewer (http://www.psb.ugent.be/PlantPTMViewer), an integrative PTM resource that comprises approximately 370 000 PTM sites for 19 types of protein modifications in plant proteins from five different species. The Plant PTM Viewer provides the user with a protein sequence overview in which the experimentally evidenced PTMs are highlighted together with an estimate of the confidence by which the modified peptides and, if possible, the actual modification sites were identified and with functional protein domains or active site residues. The PTM sequence search tool can query PTM combinations in specific protein sequences, whereas the PTM BLAST tool searches for modified protein sequences to detect conserved PTMs in homologous sequences. Taken together, these tools help to assume the role and potential interplay of PTMs in specific proteins or within a broader systems biology context. The Plant PTM Viewer is an open repository that allows the submission of mass spectrometry-based PTM data to remain at pace with future PTM plant studies.', 'authors': [{'name': 'Willems P.'}, {'name': 'Horne A.'}, {'name': 'Van Parys T.'}, {'name': 'Goormachtig S.'}, {'name': 'De Smet I.'}, {'name': 'Botzki A.'}, {'name': 'Van Breusegem F.'}, {'name': 'Gevaert K.'}], 'citationCount': 16, 'date': '2019-01-01T00:00:00Z', 'journal': 'Plant Journal', 'title': 'The Plant PTM Viewer, a central resource for exploring plant protein modifications'}, 'pmid': '31004550', 'type': ['Primary'], 'version': '1.0'}]"
344,sunxq6@mail.sysu.edu.cn,,Person,,,,,,,scmlnet,,zsmag19,"[{'doi': '10.1093/BIB/BBAA327', 'metadata': {'abstract': '© 2020 The Author(s).Inferring how gene expression in a cell is influenced by cellular microenvironment is of great importance yet challenging. In this study, we present a single-cell RNA-sequencing data based multilayer network method (scMLnet) that models not only functional intercellular communications but also intracellular gene regulatory networks (http://github.com/SunXQlab/scMLnet). scMLnet was applied to a scRNA-seq dataset of COVID-19 patients to decipher the microenvironmental regulation of expression of SARS-CoV-2 receptor ACE2 that has been reported to be correlated with inflammatory cytokines and COVID-19 severity. The predicted elevation of ACE2 by extracellular cytokines EGF, IFN-γor TNF-α were experimentally validated in human lung cells and the related signaling pathway were verified to be significantly activated during SARS-COV-2 infection. Our study provided a new approach to uncover inter-/intra-cellular signaling mechanisms of gene expression and revealed microenvironmental regulators of ACE2 expression, which may facilitate designing anti-cytokine therapies or targeted therapies for controlling COVID-19 infection. In addition, we summarized and compared different methods of scRNA-seq based inter-/intra-cellular signaling network inference for facilitating new methodology development and applications.', 'authors': [{'name': 'Cheng J.'}, {'name': 'Zhang J.'}, {'name': 'Wu Z.'}, {'name': 'Sun X.'}], 'citationCount': 3, 'date': '2021-03-01T00:00:00Z', 'journal': 'Briefings in Bioinformatics', 'title': 'Inferring microenvironmental regulation of gene expression from single-cell RNA sequencing data using scMLnet with an application to COVID-19'}, 'pmid': '33341869'}]"
345,xiaoqiangsun88@gmail.com,,Person,,,,,,,scmlnet,,zsmag19,"[{'doi': '10.1093/BIB/BBAA327', 'metadata': {'abstract': '© 2020 The Author(s).Inferring how gene expression in a cell is influenced by cellular microenvironment is of great importance yet challenging. In this study, we present a single-cell RNA-sequencing data based multilayer network method (scMLnet) that models not only functional intercellular communications but also intracellular gene regulatory networks (http://github.com/SunXQlab/scMLnet). scMLnet was applied to a scRNA-seq dataset of COVID-19 patients to decipher the microenvironmental regulation of expression of SARS-CoV-2 receptor ACE2 that has been reported to be correlated with inflammatory cytokines and COVID-19 severity. The predicted elevation of ACE2 by extracellular cytokines EGF, IFN-γor TNF-α were experimentally validated in human lung cells and the related signaling pathway were verified to be significantly activated during SARS-COV-2 infection. Our study provided a new approach to uncover inter-/intra-cellular signaling mechanisms of gene expression and revealed microenvironmental regulators of ACE2 expression, which may facilitate designing anti-cytokine therapies or targeted therapies for controlling COVID-19 infection. In addition, we summarized and compared different methods of scRNA-seq based inter-/intra-cellular signaling network inference for facilitating new methodology development and applications.', 'authors': [{'name': 'Cheng J.'}, {'name': 'Zhang J.'}, {'name': 'Wu Z.'}, {'name': 'Sun X.'}], 'citationCount': 3, 'date': '2021-03-01T00:00:00Z', 'journal': 'Briefings in Bioinformatics', 'title': 'Inferring microenvironmental regulation of gene expression from single-cell RNA sequencing data using scMLnet with an application to COVID-19'}, 'pmid': '33341869'}]"
346,nohkura@ifrec.osaka-u.ac.jp,,Person,,,,,,,virtus,,zsmag19,[{'doi': '10.1101/2020.05.08.085308'}]
347,rainer.koenig@uni-jena.de,Rainer König,Person,,,,,,,miprip,,Niclaskn,"[{'doi': '10.1186/S12859-019-3323-2', 'metadata': {'abstract': '© 2019 The Author(s).Background: Reactivation of the telomerase reverse transcriptase gene TERT is a central feature for unlimited proliferation of the majority of cancers. However, the underlying regulatory processes are only partly understood. Results: We assembled regulator binding information from serveral sources to construct a generic human and mouse gene regulatory network. Advancing our ""Mixed Integer linear Programming based Regulatory Interaction Predictor"" (MIPRIP) approach, we identified the most common and cancer-type specific regulators of TERT across 19 different human cancers. The results were validated by using the well-known TERT regulation by the ETS1 transcription factor in a subset of melanomas with mutations in the TERT promoter. Our improved MIPRIP2 R-package and the associated generic regulatory networks are freely available at https://github.com/KoenigLabNM/MIPRIP. Conclusion: MIPRIP 2.0 identified common as well as tumor type specific regulators of TERT. The software can be easily applied to transcriptome datasets to predict gene regulation for any gene and disease/condition under investigation.', 'authors': [{'name': 'Poos A.M.'}, {'name': 'Kordass T.'}, {'name': 'Kolte A.'}, {'name': 'Ast V.'}, {'name': 'Oswald M.'}, {'name': 'Rippe K.'}, {'name': 'Konig R.'}], 'citationCount': 1, 'date': '2019-12-30T00:00:00Z', 'journal': 'BMC Bioinformatics', 'title': 'Modelling TERT regulation across 19 different cancer types based on the MIPRIP 2.0 gene regulatory network approach'}, 'pmcid': 'PMC6937852', 'pmid': '31888467'}]"
348,lago@psych.ucsb.edu,Miguel A. Lago,Person,,,,,,,simplephy,,zsmag19,"[{'doi': '10.3758/S13428-020-01515-Z', 'metadata': {'abstract': '© 2021, The Psychonomic Society, Inc.Because of the COVID-19 pandemic, researchers are facing unprecedented challenges that affect our ability to run in-person experiments. With mandated social distancing in a controlled laboratory environment, many researchers are searching for alternative options to conduct research, such as online experimentation. However, online experimentation comes at a cost; learning online tools for building and publishing psychophysics experiments can be complicated and time-consuming. This learning cost is unfortunate because researchers typically only need to use a small percentage of these tools’ capabilities, but they still have to deal with these systems’ complexities (e.g., complex graphical user interfaces or difficult programming languages). Furthermore, after the experiment is built, researchers often have to find an online platform compatible with the tool they used to program the experiment. To simplify and streamline the online process of programming and hosting an experiment, I have created SimplePhy. SimplePhy can save researchers’ time and energy by allowing them to create a study in just a few clicks. All researchers have to do is select among a few experiment settings and upload the stimuli. SimplePhy is able to run most psychophysical perception experiments that require mouse clicks and button presses. In addition to collecting online behavioral data, SimplePhy can also collect information regarding the estimated viewing distance between the participant and the monitor, the screen size, and the experimental trial’s timing—features not always offered in other online platforms. Overall, SimplePhy is a simple, free, open-source tool (code can be found here: https://gitlab.com/malago/simplephy) aimed to help labs conduct their experiments online.', 'authors': [{'name': 'Lago M.A.'}], 'date': '2021-08-01T00:00:00Z', 'journal': 'Behavior Research Methods', 'title': 'SimplePhy: An open-source tool for quick online perception experiments'}, 'pmcid': 'PMC7808115', 'pmid': '33443729'}]"
349,weixiaofeng@cngb.org,Xiaofeng Wei,Person,,,,,,,virusdip,,zsmag19,[{'doi': '10.1101/2020.06.08.139451'}]
350,roger.w.barrette@usda.gov,Roger W. Barrette,Person,https://orcid.org/0000-0002-4355-0286,,,,,,asf-fast,,Kigaard,"[{'doi': '10.1128/JCM.01104-19', 'metadata': {'abstract': '© 2020 American Society for Microbiology. All rights reserved.African swine fever virus (ASFV) is the causative agent of a severe and highly contagious viral disease of pigs that poses serious economic consequences to the swine industry due to the high mortality rate and impact on international trade. There is no effective vaccine to control African swine fever (ASF), and therefore, efficient disease control is dependent on early detection and diagnosis of ASFV. The large size of the ASFV genome (∼180 kb) has historically hindered efforts to rapidly obtain a full-genome sequence. Rapid acquisition of data is critical for characterization of the isolate and to support epidemiological efforts. Here, we investigated the capacity of the Oxford Nanopore MinION sequence sensing device to act as a rapid sequencing tool. When coupled with our novel companion software script, the African swine fever fast analysis sequencing tool (ASF-FAST), the analysis of output data was performed in real time. Complete ASFV genome sequences were generated from cell culture isolates and blood samples obtained from experimentally infected pigs. Removal of the host-methylated DNA from the extracted nucleic acid facilitated rapid ASFV sequence identification, with reads specific to ASFV detected within 6 min after the initiation of sequencing. Regardless of the starting material, sufficient sequence was available for complete genome resolution (up to 100%) within 10 min. Overall, this paper highlights the use of Nanopore sequencing technology in combination with the ASF-FAST software for the purpose of rapid and real-time resolution of the full ASFV genome from a diagnostic sample.', 'authors': [{'name': ""O'Donnell V.K.""}, {'name': 'Mayr G.A.'}, {'name': 'Sturgill Samayoa T.L.'}, {'name': 'Dodd K.A.'}, {'name': 'Barrette R.W.'}], 'citationCount': 6, 'date': '2020-01-01T00:00:00Z', 'journal': 'Journal of Clinical Microbiology', 'title': 'Rapid sequence-based characterization of African swine fever virus by use of the Oxford Nanopore MiniOn sequence sensing device and a companion analysis software tool'}, 'pmcid': 'PMC6935939', 'pmid': '31694969'}]"
351,alicia.oshlack@mcri.edu.au,Alicia Oshlack,Person,https://orcid.org/0000-0001-9788-5690,,,,,,stretch,,Niclaskn,"[{'doi': '10.1186/S13059-018-1505-2', 'metadata': {'abstract': '© 2018 The Author(s).Short tandem repeat (STR) expansions have been identified as the causal DNA mutation in dozens of Mendelian diseases. Most existing tools for detecting STR variation with short reads do so within the read length and so are unable to detect the majority of pathogenic expansions. Here we present STRetch, a new genome-wide method to scan for STR expansions at all loci across the human genome. We demonstrate the use of STRetch for detecting STR expansions using short-read whole-genome sequencing data at known pathogenic loci as well as novel STR loci. STRetch is open source software, available from github.com/Oshlack/STRetch.', 'authors': [{'name': 'Dashnow H.'}, {'name': 'Lek M.'}, {'name': 'Phipson B.'}, {'name': 'Halman A.'}, {'name': 'Sadedin S.'}, {'name': 'Lonsdale A.'}, {'name': 'Davis M.'}, {'name': 'Lamont P.'}, {'name': 'Clayton J.S.'}, {'name': 'Laing N.G.'}, {'name': 'MacArthur D.G.'}, {'name': 'Oshlack A.'}], 'citationCount': 36, 'date': '2018-08-21T00:00:00Z', 'journal': 'Genome Biology', 'title': 'STRetch: Detecting and discovering pathogenic short tandem repeat expansions'}, 'pmcid': 'PMC6102892', 'pmid': '30129428'}]"
352,,,Person,,['Primary contact'],,http://academic.reed.edu/biology/,,,gelymac,,mbs_import,
353,leandromartins@ufba.br,Leandro Martins de Freitas,Person,https://orcid.org/0000-0003-4327-2922,,,,,,pdac-ann,,zsmag19,"[{'doi': '10.1186/S12885-020-6533-0', 'metadata': {'abstract': '© 2020 The Author(s).Background: Although the pancreatic ductal adenocarcinoma (PDAC) presents high mortality and metastatic potential, there is a lack of effective therapies and a low survival rate for this disease. This PDAC scenario urges new strategies for diagnosis, drug targets, and treatment. Methods: We performed a gene expression microarray meta-analysis of the tumor against normal tissues in order to identify differentially expressed genes (DEG) shared among all datasets, named core-genes (CG). We confirmed the CG protein expression in pancreatic tissue through The Human Protein Atlas. It was selected five genes with the highest area under the curve (AUC) among these proteins with expression confirmed in the tumor group to train an artificial neural network (ANN) to classify samples. Results: This microarray included 461 tumor and 187 normal samples. We identified a CG composed of 40 genes, 39 upregulated, and one downregulated. The upregulated CG included proteins and extracellular matrix receptors linked to actin cytoskeleton reorganization. With the Human Protein Atlas, we verified that fourteen genes of the CG are translated, with high or medium expression in most of the pancreatic tumor samples. To train our ANN, we selected the best genes (AHNAK2, KRT19, LAMB3, LAMC2, and S100P) to classify the samples based on AUC using mRNA expression. The network classified tumor samples with an f1-score of 0.83 for the normal samples and 0.88 for the PDAC samples, with an average of 0.86. The PDAC-ANN could classify the test samples with a sensitivity of 87.6 and specificity of 83.1. Conclusion: The gene expression meta-analysis and confirmation of the protein expression allow us to select five genes highly expressed PDAC samples. We could build a python script to classify the samples based on RNA expression. This software can be useful in the PDAC diagnosis.', 'authors': [{'name': 'Almeida P.P.'}, {'name': 'Cardoso C.P.'}, {'name': 'De Freitas L.M.'}], 'citationCount': 7, 'date': '2020-01-31T00:00:00Z', 'journal': 'BMC Cancer', 'title': 'PDAC-ANN: An artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression'}, 'pmcid': 'PMC6995241', 'pmid': '32005189'}]"
354,ross.jones@ed.ac.uk,Ross A. Jones,Person,https://orcid.org/0000-0002-1569-2500,,,,,,anmj-morph,,Kigaard,"[{'doi': '10.1098/RSOS.200128', 'metadata': {'abstract': ""© 2020 The Authors.Large-scale data analysis of synaptic morphology is becoming increasingly important to the field of neurobiological research (e.g. 'connectomics'). In particular, a detailed knowledge of neuromuscular junction (NMJ) morphology has proven to be important for understanding the form and function of synapses in both health and disease. The recent introduction of a standardized approach to the morphometric analysis of the NMJ - 'NMJ-morph' - has provided the first common software platform with which to analyse and integrate NMJ data from different research laboratories. Here, we describe the design and development of a novel macro - 'automated NMJ-morph' or 'aNMJ-morph' - to update and streamline the original NMJ-morph methodology. ImageJ macro language was used to encode the complete NMJ-morph workflow into seven navigation windows that generate robust data for 19 individual pre-/post-synaptic variables. The aNMJ-morph scripting was first validated against reference data generated by the parent workflow to confirm data reproducibility. aNMJ-morph was then compared with the parent workflow in large-scale data analysis of original NMJ images (240 NMJs) by multiple independent investigators. aNMJ-morph conferred a fourfold increase in data acquisition rate compared with the parent workflow, with average analysis times reduced to approximately 1 min per NMJ. Strong concordance was demonstrated between the two approaches for all 19morphological variables, confirming the robust nature of aNMJ-morph. aNMJ-morph is a freely available and easy-to-use macro for the rapid and robust analysis of NMJ morphology and offers significant improvements in data acquisition and learning curve compared to the original NMJ-morph workflow."", 'authors': [{'name': 'Minty G.'}, {'name': 'Hoppen A.'}, {'name': 'Boehm I.'}, {'name': 'Alhindi A.'}, {'name': 'Gibb L.'}, {'name': 'Potter E.'}, {'name': 'Wagner B.C.'}, {'name': 'Miller J.'}, {'name': 'Skipworth R.J.E.'}, {'name': 'Gillingwater T.H.'}, {'name': 'Jones R.A.'}], 'citationCount': 3, 'date': '2020-04-01T00:00:00Z', 'journal': 'Royal Society Open Science', 'title': 'ANMJ-morph: A simple macro for rapid analysis of neuromuscular junction morphology'}, 'pmcid': 'PMC7211862', 'pmid': '32431902'}]"
355,pim@calacademy.org,Pim Bongaerts,Person,https://orcid.org/0000-0001-6747-6044,,,,,,mesophotic.org,,Pub2Tools,"[{'doi': '10.1093/DATABASE/BAZ140', 'metadata': {'abstract': ""© The Author(s) 2019. Published by Oxford University Press.Mesophotic coral ecosystems (MCEs) and temperate mesophotic ecosystems (TMEs) occur at depths of roughly 30-150 m depth and are characterized by the presence of photosynthetic organisms despite reduced light availability. Exploration of these ecosystems dates back several decades, but our knowledge remained extremely limited until about a decade ago, when a renewed interest resulted in the establishment of a rapidly growing research community. Here, we present the 'mesophotic.org' database, a comprehensive and curated repository of scientific literature on mesophotic ecosystems. Through both manually curated and automatically extracted metadata, the repository facilitates rapid retrieval of available information about particular topics (e.g. taxa or geographic regions), exploration of spatial/temporal trends in research and identification of knowledge gaps. The repository can be queried to comprehensively obtain available data to address large-scale questions and guide future research directions. Overall, the 'mesophotic.org' repository provides an independent and open-source platform for the ever-growing research community working on MCEs and TMEs to collate and expedite our understanding of the occurrence, composition and functioning of these ecosystems. Database URL: http://mesophotic.org/."", 'authors': [{'name': 'Bongaerts P.'}, {'name': 'Perez-Rosales G.'}, {'name': 'Radice V.Z.'}, {'name': 'Eyal G.'}, {'name': 'Gori A.'}, {'name': 'Gress E.'}, {'name': 'Hammerman N.M.'}, {'name': 'Hernandez-Agreda A.'}, {'name': 'Laverick J.'}, {'name': 'Muir P.'}, {'name': 'Pinheiro H.'}, {'name': 'Pyle R.L.'}, {'name': 'Rocha L.'}, {'name': 'Turner J.A.'}, {'name': 'Booker R.'}], 'citationCount': 4, 'date': '2019-01-01T00:00:00Z', 'journal': 'Database : the journal of biological databases and curation', 'title': 'Mesophotic.org: a repository for scientific information on mesophotic ecosystems'}, 'pmcid': 'PMC6911162', 'pmid': '31836897'}]"
356,,Veronica Z Radice,Person,,,,,,,mesophotic.org,,Pub2Tools,"[{'doi': '10.1093/DATABASE/BAZ140', 'metadata': {'abstract': ""© The Author(s) 2019. Published by Oxford University Press.Mesophotic coral ecosystems (MCEs) and temperate mesophotic ecosystems (TMEs) occur at depths of roughly 30-150 m depth and are characterized by the presence of photosynthetic organisms despite reduced light availability. Exploration of these ecosystems dates back several decades, but our knowledge remained extremely limited until about a decade ago, when a renewed interest resulted in the establishment of a rapidly growing research community. Here, we present the 'mesophotic.org' database, a comprehensive and curated repository of scientific literature on mesophotic ecosystems. Through both manually curated and automatically extracted metadata, the repository facilitates rapid retrieval of available information about particular topics (e.g. taxa or geographic regions), exploration of spatial/temporal trends in research and identification of knowledge gaps. The repository can be queried to comprehensively obtain available data to address large-scale questions and guide future research directions. Overall, the 'mesophotic.org' repository provides an independent and open-source platform for the ever-growing research community working on MCEs and TMEs to collate and expedite our understanding of the occurrence, composition and functioning of these ecosystems. Database URL: http://mesophotic.org/."", 'authors': [{'name': 'Bongaerts P.'}, {'name': 'Perez-Rosales G.'}, {'name': 'Radice V.Z.'}, {'name': 'Eyal G.'}, {'name': 'Gori A.'}, {'name': 'Gress E.'}, {'name': 'Hammerman N.M.'}, {'name': 'Hernandez-Agreda A.'}, {'name': 'Laverick J.'}, {'name': 'Muir P.'}, {'name': 'Pinheiro H.'}, {'name': 'Pyle R.L.'}, {'name': 'Rocha L.'}, {'name': 'Turner J.A.'}, {'name': 'Booker R.'}], 'citationCount': 4, 'date': '2019-01-01T00:00:00Z', 'journal': 'Database : the journal of biological databases and curation', 'title': 'Mesophotic.org: a repository for scientific information on mesophotic ecosystems'}, 'pmcid': 'PMC6911162', 'pmid': '31836897'}]"
357,zhfq@biols.ac.cn,Fangqing Zhao,Person,,,,,,,circatlas,,Kigaard,"[{'doi': '10.1186/S13059-020-02018-Y', 'metadata': {'abstract': '© 2020 The Author(s).Existing circular RNA (circRNA) databases have become essential for transcriptomics. However, most are unsuitable for mining in-depth information for candidate circRNA prioritization. To address this, we integrate circular transcript collections to develop the circAtlas database based on 1070 RNA-seq samples collected from 19 normal tissues across six vertebrate species. This database contains 1,007,087 highly reliable circRNAs, of which over 81.3% have been assembled into full-length sequences. We profile their expression pattern, conservation, and functional annotation. We describe a novel multiple conservation score, co-expression, and regulatory networks for circRNA annotation and prioritization. CircAtlas can be accessed at http://circatlas.biols.ac.cn/.', 'authors': [{'name': 'Wu W.'}, {'name': 'Ji P.'}, {'name': 'Zhao F.'}], 'citationCount': 48, 'date': '2020-04-28T00:00:00Z', 'journal': 'Genome Biology', 'title': 'CircAtlas: An integrated resource of one million highly accurate circular RNAs from 1070 vertebrate transcriptomes'}, 'pmcid': 'PMC7187532', 'pmid': '32345360'}]"
